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	ABSTRACT	
It	 is	 well	 established	 that	 adenoviruses	 degrade	 components	 of	 the	 cellular	 DNA	
damage	response,	such	as	p53,	DNA	ligase	IV	and	Mre11,	 in	order	to	avoid	detection	from	
the	 host	 cell	 and	 thus,	 promote	 viral	 replication.	 Here	 we	 show	 TAB182,	 a	 protein	 of	
previously	unknown	function,	is	degraded	following	adenovirus	serotype	5	and	12	infection.	
Similarly	 to	 other	DNA	 damage	 proteins,	 the	 degradation	 of	 TAB182	 is	 dependent	 on	 the	
adenoviral	 E1B55K	 and	 E4orf6	 proteins,	 together	 with	 the	 cellular	 Cullin	 5	 (during	 Ad5	
infection)	and	Cullin	2	(during	Ad12	infection).	Interestingly,	siRNA-mediated	knockdown	of	
TAB182	 appears	 to	 be	 beneficial	 for	 adenovirus	 infection,	 as	 denoted	 by	 an	 increased	
expression	of	the	adenoviral	E1A	protein	and	Cyclin	E	during	adenovirus	infection.	Together	
with	 other	 studies,	 we	 confirm	 that	 TAB182	 interacts	 with	 the	 large,	multi-subunit	 CNOT	
complex.	This	complex	has	no	defined	function	 in	mammalian	cells,	but	 is	known	to	play	a	
role	 in	 gene	 regulation	 in	 yeast.	 Interestingly,	 components	 of	 the	 CNOT	 complex	 are	 also	
degraded	 during	 adenovirus	 infection,	 whether	 adenovirus	 degrades	 TAB182	 as	 well	 as	
CNOT	for	the	same	advantage	is	currently	unknown.		
Cells	 deficient	 in	 TAB182	 are	 hypersensitive	 to	 agents	 that	 induce	DNA	 replication	
stress	and	also	exhibit	abnormal	 replication	dynamics	 following	release	 from	hydroxyurea-
induced	 fork	 stalling.	 In	 particular,	 they	 display	 increased	 fork	 restart	 and	 elevated	 new	
origin	firing	following	release	from	hydroxyurea	treatment,	suggesting	that	TAB182	prevents	
fork	 recovery	 and	 suppresses	 new	 origin	 firing	 following	 replication	 stress.	 Depletion	 of	
some	 components	 of	 the	 CNOT	 complex	 is	 able	 to	 rescue	 the	 phenotypes	 observed	 in	
TAB182	deficient	cells,	suggesting	that	TAB182	and	the	CNOT	complex	may	act	in	concert	at	
the	replication	fork.	TAB182	deficient	cells	display	 less	DNA	gaps	and	breaks	but	 increased	
	levels	 of	 53BP1	 bodies	 in	 G1	 and	 micronuclei,	 which	 are	 markers	 of	 genome	 instability,	
following	 replication	 stress.	 Whether	 TAB182	 acts	 directly	 at	 the	 replication	 fork,	 or	 in	
conjunction	with	other	proteins	known	to	be	involved	in	replication	restart	such	as	helicases,	
nucleases	or	chromatin	remodelling	complexes,	remains	to	be	elucidated.				
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1.	INTRODUCTION	
1.1	ADENOVIRUS	
1.1.1	Adenovirus	Identification	and	Classification	
Adenovirus	was	first	discovered	in	1953	when	Rowe	and	colleagues	isolated	the	virus	
from	adenoid	tissue	undergoing	spontaneous	degeneration	in	children	(Rowe,	Huebner	et	al.	
1953).	The	name	‘adenovirus’	therefore	derives	from	the	origin	of	its	initial	isolation.	A	year	
later,	 a	 number	 of	 publications	 presented	 evidence	 to	 suggest	 a	 novel	 ‘agent’	 was	
responsible	for	patients	diagnosed	with	‘acute	respiratory	illness’	that	was	not	attributed	to	
the	 common	 cold,	 these	 cases	 would	 later	 be	 recognised	 as	 the	 result	 of	 adenovirus	
infection	(Hilleman	and	Werner	1954,	Ginsberg,	Gold	et	al.	1955).	The	next	major	discovery	
was	by	Trentin	and	colleagues	who	showed	that	adenovirus	serotype	12	(Ad12)	was	able	to	
directly	induce	tumours	in	new-born	hamsters	(Yabe,	Trentin	et	al.	1962).	This	was	the	first	
example	of	a	human	virus	that	was	able	to	cause	cancer.	 In	addition	to	 its	ability	to	cause	
tumours	 in	 new-born	 rodents,	 adenovirus	 can	 also	 transform	mammalian	 cells	 in	 culture;	
every	adenovirus	serotype	is	known	to	have	the	capacity	to	transform	primary	rodent	cells	in	
vitro	(McBride	and	Wiener	1964,	Pope	and	Rowe	1964).		
The	 adenoviridae	 family	 contains	 five	 accepted	 genera	 comprised	 of	
Mastadenoviridae,	 Atadenoviridae,	 Aviadenoviridae,	 Siadenoviridae	 and	 Ictadenoviridae.	
These	 genera	 encompass	 a	 wide	 range	 of	 host	 vertebrate	 species	 from	 humans	 in	 the	
Mastadenoviridae	genus,	to	fish	in	the	Ictadenoviridae	genus.	Mastadenoviridae	is	the	genus	
in	which	 all	 human	 adenovirus	 serotypes	 belong	which	 is	 currently	 believed	 to	 include	 at	
least	55	serotypes.	These	serotypes	can	be	further	categorised	into	six	species	grouped	A	to		
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Group& Serotypes&
Oncogenicity&in&
Rodents&
Transforma7on&in&
7ssue&culture&
A" 12,"18,"31" High" Yes"
B1" 3,"7,"16,"21,"50"" Moderate" Yes"
B2" 11,"14,"34,"35,"55" Moderate" Yes"
C" 1,"2,"5,"6" Low/None" Yes"
D"
8,"9,"10,"13,"15,"17,"19,"20,"22C30,"32,"
33,"36C39,"42C49,"51,"53,"54" Low/None" Yes"
E" 4" Low/None" Yes"
F" 40,"41" Not"reported" Yes"
G" 52" Not"reported" Unknown"
Table	1.1:	Classification	of	Human	Adenoviruses.	The	adenovirus	serotypes	 identified	to	
date	are	indicated,	classified	into	groups	A	to	G.	The	potential	for	these	serotypes	to	cause	
oncogenicity	 in	rodents	and	transformation	 in	tissue	culture	is	also	indicated.	Adenovirus	
serotypes	used	in	this	study	are	highlighted	in	red.				
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G	(Table	1.1).	The	species	to	which	each	serotype	 is	grouped	 is	 largely	dependent	on	their	
oncogenicity	 in	 rodents,	 their	 ability	 to	 agglutinate	 erythrocytes	 and	 their	 DNA	 sequence	
(Russell	2009).	
Certain	 adenovirus	 serotypes	 are	 known	 to	 cause	 gastrointestinal,	 respiratory	 and	
ocular	disease	(Bennett,	Hamilton	et	al.	1957,	Brandt,	Kim	et	al.	1969,	Uhnoo,	Wadell	et	al.	
1984).	 The	 incidence	of	 adenovirus	 infection	 in	 immunocompromised	hosts	 is	 significantly	
increased,	particularly	in	patients	receiving	allogeneic	stem	cell	transplantations.	Adenovirus	
infection	 in	 immunocompromised	 individuals	 is	associated	with	encephalitis,	haemorrhagic	
cystitis,	gastroenteritis,	pneumonitis	and	hepatitis,	all	of	which	carry	a	significant	mortality	
rate	(Carrigan	1997).		
1.1.2	Adenovirus	Structure	and	Genome		
Adenovirus	is	an	icosahedral,	non-enveloped	virus	of	approximately	150	megadaltons	
(mDa)	in	weight,	and	70nm	in	diameter.	In	1959	electron	microscopy	gave	the	first	indication	
of	the	structure	of	the	adenovirus	virion;	the	adenovirus	capsid	was	shown	to	be	composed	
of	 252	 subunits;	 240	 hexons	 and	 12	 pentons	 (Horne,	 Brenner	 et	 al.	 1959).	 Six	 years	 later	
further	 imaging	 by	 electron	 microscopy	 revealed	 fibres	 that	 protruded	 from	 the	 penton	
bases	 of	 the	 capsid	 of	 the	 virus	 (Valentine	 and	 Pereira	 1965).	 More	 recently,	 X-ray	
crystallography	 has	 revealed	 the	 atomic	 structure	 of	 most	 of	 the	 adenovirus	 structural	
proteins	(Roberts,	White	et	al.	1986,	Athappilly,	Murali	et	al.	1994,	Zubieta,	Schoehn	et	al.	
2005).	 Each	virion	 is	 composed	of	multiple	 copies	of	 a	 total	of	11	 structural	proteins.	 The	
icosahedral	capsid	is	formed	from	the	structural	proteins	hexon	(II),	penton	base	(III)	and	the	
protruding	knob	fibre	(IV),	which	are	known	to	be	essential	for	binding	to	the	coxsackievirus	
and	Ad	 receptor	 (CAR)	of	 the	host	 cell	 (Bergelson,	Cunningham	et	 al.	 1997).	 The	 capsid	 is	
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also	 composed	 of	 the	more	minor	 structural	 capsid	 proteins	 IIIa,	 IV,	 VIII	 and	 IX.	 The	 core	
complex	 contains	 the	 proteins	 V,	 VII,	Mu	 and	 the	 terminal	 protein	 (TP).	 Each	 adenovirus	
virion	also	contains	10	copies	of	the	adenovirus	protease	protein	(Anderson	1990).	
The	adenoviral	genome	is	a	linear,	double-stranded	deoxyribonucleic	acid	(dsDNA)	of	
approximately	35kbp	 in	 size.	 The	adenoviral	 genome	 is	 characterised	by	 inverted	 terminal	
repeats	 (ITRs)	 which	 are	 approximately	 100	 bp	 long	 (actual	 length	 varies	 between	
serotypes).	The	TP	 is	 covalently	 linked	 to	each	5’	end	via	 the	 ITR	 region	of	 the	adenovirus	
genome,	its	function	being	to	prime	the	genome	for	DNA	replication	(Rekosh,	Russell	et	al.	
1977).	 The	 remaining	 core	 proteins	 V,	 VII	 and	Mu	 are	 non-covalently	 bound	 to	 the	 viral	
genome.	Protein	V	is	believed	to	provide	a	structural	link	between	the	core	complex	and	the	
viral	capsid	via	protein	VI	(Matthews	and	Russell	1998).	Proteins	VII	and	Mu	are	associated	
with	the	viral	DNA	(Vayda,	Rogers	et	al.	1983,	Chatterjee,	Vayda	et	al.	1985).		
1.1.3	Adenovirus	DNA	Replication	
		 The	 initial	 interaction	between	adenovirus	and	the	host	cell	 involves	the	binding	of	
the	protruding	fibre	knob	to	the	cellular	receptor	CAR	(Bergelson,	Cunningham	et	al.	1997).	
For	most	adenovirus	serotypes,	viral	entry	into	the	host	cell	is	achieved	by	clathrin-mediated	
endocytosis	following	the	binding	of	a	penton	base	protein	(containing	an	Arg-Gly-Asp	(RGD)	
motif)	to	a	cellular	αv	integrin	(Wickham,	Mathias	et	al.	1993).	The	viral	protease	L3/p23	is	
responsible	for	the	degradation	of	the	adenoviral	structural	protein	IV,	therefore	disrupting	
the	viral	 capsid	 in	preparation	 for	exit	of	 the	viral	DNA	 (Greber,	Webster	et	al.	1996).	The	
virus	 is	 then	 transported	 from	 the	 cytoplasm	 to	 the	 nucleus,	 a	 process	 thought	 to	 be	
achieved	 through	 the	 association	with	 the	 cellular	 protein	 p32.	 p32	 shuttles	 between	 the	
mitochondria	and	nucleus	as	part	of	the	cellular	transport	system,	a	system	that	is	believed	
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to	 be	 hijacked	 by	 the	 virus	 in	 order	 to	 enter	 the	 host	 cell	 nucleus	 (Matthews	 and	Russell	
1998).	
The	 adenovirus	 infectious	 cycle	 can	 be	 categorised	 into	 the	 early	 and	 late	 phase,	
which	 is	 separated	 by	 adenoviral	 DNA	 replication.	 The	 early	 phase	 of	 the	 adenovirus	
infectious	cycle	takes	6-8	hours	and	involves	the	transcription	of	the	early	proteins	E1,	E2,	E3	
and	 E4	 (see	 Sections	 1.1.4,	 1.1.5	 and	 1.1.6	 for	 a	 detailed	 discussion	 on	 the	 E1	 and	 E4	
proteins).	 In	 order	 to	 replicate	 its	 genome,	 adenovirus	 uses	 three	 viral	 proteins	 produced	
from	 transcription	 of	 its	 early	 E2	 genes.	 These	 are	 the	 TP	 precursor	 (pTP),	 Adv	 DNA	
polymerase	 (Adv	 Pol)	 and	 the	DNA	 binding	 protein	 (DBP)	 (van	 der	 Vliet	 and	 Levine	 1973,	
Coombs,	Robinson	et	al.	1979).	Adenovirus	also	utilises	 three	cellular	proteins	during	DNA	
replication,	two	transcription	factors:	nuclear	factor	1	(NF1)	and	octamer-binding	protein	1	
(Oct-1),	 as	 well	 as	 the	 type	 1	 topoisomerase	 (TOP)	 nuclear	 factor	 2	 (NF2)	 (Nagata,	
Guggenheimer	et	al.	1982,	Nagata,	Guggenheimer	et	al.	1983,	Pruijn,	van	Driel	et	al.	1986).	
Adenovirus	DNA	replication	begins	from	both	ends	of	the	DNA	termini	whereby	a	covalent	
bond	 is	 formed	between	 the	5’	 terminal	nucleotide	deoxycitidine	monophosphate	 (dCMP)	
and	a	serine	residue	of	pTP,	in	a	reaction	catalysed	by	Ad	pol.	This	dCMP/pTP	complex	then	
acts	as	a	primer	for	nascent	DNA	synthesis.	DBP	stimulates	the	binding	of	the	transcription	
factor	 NF1	 to	 AdV	 Pol,	 whilst	 the	 transcription	 factor	 Oct-1	 interacts	 with	 pTP;	 together	
these	proteins	form	the	pre-initiation	complex	required	for	the	initiation	of	DNA	replication	
(Nagata,	Guggenheimer	et	al.	1982).	DBP	also	promotes	DNA	elongation	and	together	with	
NF2,	 stimulates	 efficient	 elongation	 (Nagata,	 Guggenheimer	 et	 al.	 1983).	 During	 the	
termination	of	DNA	replication,	pTP	is	cleaved	by	a	viral	protease	leading	to	the	generation	
of	viral	DNA	that	is	ready	to	be	packaged	into	virions	and	transported	out	of	the	cell		
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Figure	 1.1:	 Adenovirus	 Genome	 Organisation.	 	 Schematic	 to	 outline	 the	
organisation	 of	 the	 adenovirus	 genome.	 Early	 adenovirus	 transcripts	 are	
indicated	 in	 green,	 late	 adenovirus	 transcripts	 are	 indicated	 in	 blue.	
Direction	 of	 the	 arrows	 represent	 the	 direction	 of	 transcription	 (modified	
from	Russell,	2000).	
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(Dunsworth-Browne,	Schell	et	al.	1980,	Stillman,	Lewis	et	al.	1981,	Schaack,	Ho	et	al.	1990).	
In	order	 for	 this	 to	occur,	 transcription	and	 translation	of	 the	adenovirus	 intermediate	 (IX	
and	Iva2)	and	late	genes	(L1-L5)	is	initiated,	which	produces	the	structural	proteins	required	
for	the	maturation	of	the	virus	(Figure	1.1).			
1.1.4	The	Adenovirus	E1A	Protein	
The	 adenovirus	 E1A	 protein	 is	 the	 first	 messenger	 RNA	 (mRNA)	 to	 be	 transcribed	
following	entry	of	the	virus	into	the	nucleus	and	produces	two	major	mRNA	products	of	289	
and	 243	 amino	 acid	 residues	 in	 length	 in	 adenovirus	 serotype	 5.	 E1As	 from	 other	 virus	
serotypes	vary	in	length	(Avvakumov,	Sahbegovic	et	al.	2002).	These	proteins	contain	three	
conserved	 regions	 (CRs)	 known	 as	 CR1,	 CR2	 and	 CR4,	 whilst	 the	 289	 amino	 acid	 protein	
contains	 an	 additional	 conserved	 region	 designated	 CR3	 (Figure	 1.2).	 The	 E1A	 protein	 is	
known	to	induce	the	immortalisation	of	primary	rodent	cells	but	the	expression	of	E1B	(or	a	
complementary	oncogene	such	as	mutant	Ras)	is	required	in	order	to	completely	transform	
cells	(Graham,	van	der	Eb	et	al.	1974,	Houweling,	van	den	Elsen	et	al.	1980,	Ruley	1983).	The	
E1A	protein	activates	viral	transcription	and	influences	a	number	of	cellular	genes	involved	
in	 gene	 expression	 and	 cell	 growth,	 with	 the	 ultimate	 aim	 of	 replicating	 the	 adenoviral	
genome.	 These	 genes	 include	 transcriptional	 co-repressors,	 co-activators,	 cell	 cycle	
regulatory	 proteins	 and	 the	 transcriptional	 machinery	 (Gallimore	 and	 Turnell	 2001,	 Berk	
2005).		
The	 first	 E1A-binding	 protein	 to	 be	 characterised	 was	 the	 retinoblastoma	 protein	
(pRB)	tumour	suppressor	(Whyte,	Buchkovich	et	al.	1988).	The	CR1	and	CR2	regions	of	E1A	
are	 responsible	 for	 the	 binding	 of	 E1A	 to	 pRB,	 along	 with	 the	 related	 proteins	 p107	 and	
p130.	AdE1A	displaces	pRB	from	E2F	promoters	and	in	turn	stimulates	E2F-dependent	
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Figure	 1.2:	 Representation	 of	 Ad5	 E1A13S.	 Schematic	 shows	 the	Ad5	 E1A13S	 protein	
and	 the	 four	 conserved	 regions	 (CR1-4)	 of	 the	 protein.	 Protein	 binding	 partners	 are	
depicted	 (above),	 together	with	 the	 cellular	 functions	 of	 these	 regions	 (adapted	 from	
Zheng	2010).			
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transcription	of	 the	viral	 gene	E2	and	a	number	of	 cellular	 genes,	 the	end	 result	of	which	
being	 S	phase	entry,	which	drives	 viral	DNA	 replication	 (Bagchi,	 Raychaudhuri	 et	 al.	 1990,	
Grand,	 Ibrahim	 et	 al.	 1998).	 In	 adenovirus	 transformed	 cells	 where	 there	 is	 no	 viral	
replication,	 the	 role	 of	 AdE1A	 is	 to	 drive	 cellular	 proliferation,	 largely	 through	 interaction	
with	the	same	proteins	(Gallimore	and	Turnell	2001).	
Another	 way	 in	 which	 the	 adenovirus	 E1A	 protein	 is	 able	 to	 drive	 cell	 cycle	
progression	is	through	the	interaction	with	the	transcriptional	co-activators	p300	and	CREB-
binding	 protein	 (CBP)	 (Eckner,	 Ewen	 et	 al.	 1994,	 Arany,	 Newsome	 et	 al.	 1995).	 These	
transcriptional	 co-activators	 possess	 histone	 acetyltransferase	 (HAT)	 activity	 which	 is	
thought	 to	 control	 the	 transcriptional	 activation	 of	 other	 key	 cell	 cycle	mediator	 proteins	
such	as	p53	and	nuclear	 factor-kappa	B	 (NF-κB),	again	with	 the	ultimate	aim	to	drive	cells	
into	S	phase	(Ogryzko,	Schiltz	et	al.	1996,	Lill,	Grossman	et	al.	1997).		
Other	 E1A	 interacting	 proteins	 include	 the	 transcriptional	 co-repressor	 C-terminal	
binding	protein	(CtBP)	and	components	of	the	general	transcription	machinery	such	as	the	
TATA-binding	protein	 (TBP)	 and	 a	 number	of	 TBP-associated	 factors	 (TAFs),	 as	well	 as	 the	
transcription	 factors	 AMP-dependent	 transcription	 factor	 2	 (ATF2)	 and	 cJUN	 (Figure	 1.2)	
(Maguire,	 Shi	 et	 al.	 1991,	 Chatton,	 Bocco	 et	 al.	 1993,	 Hateboer,	 Timmers	 et	 al.	 1993,	
Geisberg,	Lee	et	al.	1994,	Mazzarelli,	Atkins	et	al.	1995,	Song,	Loewenstein	et	al.	1995,	Zheng	
2010).		
1.1.5	The	Adenovirus	E1B	Proteins	
The	E1B	gene	encodes	one	mRNA	transcript	which	is	alternatively	spliced	to	give	rise	
to	 five	 different	 E1B	 proteins	 characterised	 as	 E1B19K,	 E1B55K	 and	 the	 less	 abundant	
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proteins	E1B84R,	E1B93R	and	E1B156R	(in	Ad5).	The	main	functions	of	the	E1B	proteins	are	
thought	to	counter	the	pro-apoptotic	environment	that	the	E1A	protein	induces.	
The	E1B55K	protein	has	been	shown	to	directly	inhibit	the	transcriptional	activity	of	
p53	through	binding	to	p53	at	p53-responsive	promoters	(Yew	and	Berk	1992,	Yew,	Liu	et	al.	
1994).	In	addition,	the	E1B55K	protein	has	intrinsic	E3	small-ubiquitin-like	modifier	(SUMO)	
ligase	activity	which	has	been	shown	to	conjugate	a	SUMO	to	p53.	This	SUMO	modification	
induces	the	localisation	of	p53	to	promyelocytic	leukaemia	(PML)	nuclear	bodies,	inhibiting	
its	mobility	and	therefore	 its	 function	 (Muller	and	Dobner	2008,	Pennella,	Liu	et	al.	2010).	
The	E1B55K	protein	then	facilitates	nuclear	export	and	the	subsequent	degradation	of	p53	
(Figure	1.3)	(Muller	and	Dobner	2008).	
In	 addition	 to	 E1B55K	 acting	 alone,	 E1B55K	 also	 interacts	 with	 the	 E4orf6	 viral	
protein,	 the	 results	 of	 which	 are	 two-fold:	 firstly,	 the	 E1B55K	 and	 E4orf6	 proteins	 act	
together	to	induce	the	degradation	of	a	number	of	cellular	proteins	which	would	otherwise	
be	 detrimental	 to	 viral	 DNA	 replication.	 Secondly,	 the	 E1B55K	 and	 E4orf6	 proteins	 inhibit	
cellular	mRNA	 export	 and	 translation	whilst	 facilitating	 the	 transport	 of	 late	 viral	mRNAs.	
Ad5E1B55K	 and	Ad5E4orf6,	 together	with	 the	 cellular	 proteins	 RING-box	 1	 (Rbx1),	 Cullin5	
(Cul5)	and	Elongins	B	and	C	form	an	E3	ubiquitin	ligase	complex	that	is	able	to	ubiquitinate	
target	 proteins	 and	 thus	 direct	 them	 for	 proteasomal-mediated	 degradation	 (Querido,	
Blanchette	 et	 al.	 2001).	 Such	 targets	 include	 p53	 and	 various	 DNA	 damage	 and	 repair	
proteins	 (see	 Section	 1.3.2).	 The	 E1B55K	 and	 E4orf6	 proteins	 also	 have	 roles	 in	 the	 late	
stages	of	 adenovirus	 infection,	where	 they	are	 involved	 in	 the	 inhibition	of	 cellular	mRNA	
transport	and	the	facilitation	of	late	viral	mRNA	transport	from	the	nucleus	
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Figure	 1.3:	 Representation	 of	 Ad5	 E1B55K.	 Schematic	 shows	 the	Ad5	E1B55K	protein	
and	 its	associated	motifs.	 The	 biological	 functions	 of	 these	motifs	are	 indicated	below	
the	schematic.	NES,	nuclear	export	signal;	RNP,	ribonucleoprotein	motif;	Zn	finger,	C2H2	
zinc	finger;	CKI/II,	casein	kinase	I/II;	NLS,	nuclear	localisation	signal	(adapted	from	Zheng	
2010).		
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(Babiss	and	Ginsberg	1984,	Babiss,	Ginsberg	et	al.	1985,	Pilder,	Moore	et	al.	1986,	Gonzalez,	
Huang	et	al.	2006).	The	E1B55K/E4orf6	E3	ubiquitin	ligase	has	been	shown	to	accumulate	at	
viral	replication	centres	(VRCs)	within	the	nucleus	and	has	also	been	shown	to	continuously	
shuttle	between	the	nucleus	and	the	cytoplasm,	suggesting	that	these	proteins	are	required	
for	 viral	 mRNA	 export	 (Ornelles	 and	 Shenk	 1991,	 Dobbelstein,	 Roth	 et	 al.	 1997).	 Indeed,	
E1B55K	 is	known	to	be	required	for	the	transport	of	viral	mRNAs	from	the	nucleus	via	the	
chromosome	 region	maintenance	 1	 (CRM1)	 export	 pathway,	 but	 the	 precise	 roles	 of	 the	
ubiquitin	E3	ligase	complex	in	viral	mRNA	export	is	yet	to	be	defined	(Babiss,	Ginsberg	et	al.	
1985,	Dosch,	Horn	 et	 al.	 2001,	 Kindsmuller,	Groitl	 et	 al.	 2007,	Woo	 and	Berk	 2007).	 Both	
proteins	have	also	been	 implicated	 in	 the	 inhibition	of	cellular	mRNA	export,	although	the	
precise	roles	of	these	proteins	during	cellular	mRNA	export	are	yet	to	be	discovered	(Figure	
1.3)	(Beltz	and	Flint	1979,	Babiss	and	Ginsberg	1984,	Halbert,	Cutt	et	al.	1985,	Pilder,	Moore	
et	al.	1986).		
The	 E1B19K	 protein	 is	 a	 distant	 homolog	 of	 the	 anti-apoptotic	 B-cell	 lymphoma	 2	
(BCL2)	 family	of	proteins	 (Rao,	Debbas	et	al.	1992,	Chiou,	Tseng	et	al.	1994,	Subramanian,	
Tarodi	et	al.	1995).	In	infected	cells,	the	expression	of	the	adenoviral	E1A	protein	induces	the	
degradation	of	the	BCL2	homolog	myeloid	cell	leukaemia	1	(MCL1)	protein,	which	ordinarily	
resides	bound	to	the	pro-apoptotic	protein	BCL2	antagonist	killer	(BAK)	(Debbas	and	White	
1993,	Sabbatini,	Chiou	et	al.	1995).	The	now	dissociated	BAK	protein	oligomerises	with	the	
BCL2-associated	X	 (BAX)	pro-apoptotic	protein,	 resulting	 in	 the	 formation	of	mitochondrial	
membrane	 pores	 from	 which	 the	 pro-apoptotic	 proteins	 that	 activate	 caspases,	 such	 as	
cytochrome	c	and	second	mitochondria-derived	activator	of	caspases	(SMAC),	are	released.	
This	 results	 in	 the	 activation	of	 the	 caspase-dependent	 cell	 death	pathway	 and	ultimately	
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apoptosis.	Since	the	activation	of	this	pathway	would	be	catastrophic	for	the	production	of	
viral	progeny,	the	E1B19K	protein	counteracts	this	process	by	binding	to	the	pro-apoptotic	
proteins	BAK	and	BAX,	inhibiting	the	activation	of	the	caspase-dependent	apoptotic	pathway	
and	 thus	allowing	 the	virus	 to	 survive	 in	 the	host	 cell	 (Debbas	and	White	1993,	Sabbatini,	
Chiou	et	al.	1995,	Zheng	2010).	
1.1.6	The	Adenovirus	E4	Protein	
The	adenovirus	E4	 transcription	unit	encodes	at	 least	18	distinct	mRNAs	which	are	
alternatively	 spliced	 to	 produce	 seven	 known	open	 reading	 frames	 (orfs)	 designated	 orf1,	
orf2,	orf3,	orf3/4,	orf4,	orf6	and	orf6/7	(Virtanen,	Gilardi	et	al.	1984).	 It	 is	well	established	
that	the	E4	region	is	required	for	lytic	infection,	since	adenovirus	mutants	with	deletions	in	
total	E4	have	significantly	reduced	growth.	Interestingly,	the	mutants	in	each	individual	orf	
did	not	recapitulate	the	impact	to	viral	growth	observed	in	the	total	E4	mutant	(Halbert,	Cutt	
et	al.	 1985).	 It	was	 later	 revealed	 that	mutations	 in	orf3	or	orf6	 can	compensate	 for	each	
other,	perhaps	explaining	the	previous	result	 (Bridge	and	Ketner	1989,	Huang	and	Hearing	
1989).	 The	 E4	 proteins	 have	 a	 diverse	 range	 of	 functions	 during	 adenovirus	 infection	
including	 the	 regulation	 of	 transcription,	 mRNA	 nucleocytoplasmic	 transport,	 DNA	
replication,	virion	assembly	and	host-cell	shut	off.			
E4orf4	 has	 a	 number	 of	 roles	 during	 adenovirus	 infection	 including	 the	 negative	
regulation	 of	 E1A	 expression,	 the	 regulation	 of	 hypophosphorylation	 of	 various	 viral	 and	
cellular	proteins	and	the	induction	of	apoptosis.	E4orf4	was	shown	to	repress	E1A-mediated	
transactivation	of	E2	and	E4	promoters	(Bondesson,	Ohman	et	al.	1996,	Mannervik,	Fan	et	
al.	1999).	E4orf4	directly	binds	to	the	protein	phosphatase	2A	(PP2A)	protein	through	the	β	
subunit	 of	 PP2A,	 leading	 to	 the	 hypophosphorylation	 of	 a	 number	 of	 viral	 and	 cellular	
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proteins	 including	 E1A	 and	 the	 c-Fos	 component	 of	 the	 activating	 protein	 1	 (AP1)	
transcription	 factor	 (Muller,	 Kleinberger	 et	 al.	 1992,	 Kleinberger	 and	 Shenk	 1993).	 The	
actions	of	E4orf4	suggest	that	a	negative	feedback	loop	exists	between	E1A	and	E4orf4;	the	
expression	of	E1A	induces	the	initiation	of	E4orf4	transcription,	which	in	turn	downregulates	
the	response	to	E1A	both	directly	through	the	negative	regulation	of	E1A	transcription	and	
the	repression	at	E2	and	E4	promoters,	and	 indirectly	through	the	hypophosphorylation	of	
viral	and	cellular	proteins.	This	negative	 feedback	 loop	 is	 thought	 to	exist	 in	order	 to	 limit	
the	 toxicity	 of	 viral	 infection	 and	 in	 turn	 increase	 viral	 efficiency.	 The	 adenovirus	 E4orf4	
protein	 has	 also	 been	 shown	 to	 induce	 apoptosis,	 the	 expression	 of	 E4orf4	 protein	 was	
shown	 to	 induce	 apoptosis	 independently	 of	 p53	 (Marcellus,	 Lavoie	 et	 al.	 1998).	
Interestingly,	 the	 induction	 of	 apoptosis	 was	 seen	 exclusively	 in	 transformed	 cell	 lines,	
suggesting	that	E4orf4	may	be	a	potential	therapeutic	target	(Shtrichman,	Sharf	et	al.	1999).		
Apart	 from	 the	 adenovirus	 E1A	 and	 E1B	 proteins,	 E4orf1	 is	 the	 only	 other	 known	
adenovirus	protein	to	confer	transforming	capabilities	in	rodent	cells,	albeit	only	during	Ad9	
infection	(Javier,	Raska	et	al.	1992,	Javier	1994).	
	The	 E4orf2	 protein	 has	 been	 detected	 at	 early	 time	 points	 post-infection	 in	 HeLa	
cells,	the	function	of	this	protein	to	date	is	unknown	(Dix	and	Leppard	1995).	The	E4orf3/4	
protein	has	never	been	detected	in	infected	cells,	however	it	is	predicted	to	exist	based	on	
the	analysis	of	mRNA	in	Ad2	infected	cells	(Virtanen,	Gilardi	et	al.	1984).			
The	 E4orf6/7	 gene	 product	 is	 a	 fusion	 protein	 with	 known	 roles	 as	 a	 viral	
transactivator	 together	with	 E1A.	 The	 E4orf6/7	 protein	 is	 known	 to	 bind	 to	 E2F,	where	 it	
dimerises	and	associates	with	E2F	binding	sites	 in	the	viral	Ad5	E2	early	promoter	and	the	
cellular	 E2F1	 promoter	 (Obert,	 O'Connor	 et	 al.	 1994,	 Schaley,	 O'Connor	 et	 al.	 2000).	
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Interestingly,	expression	of	the	E4orf6/7	protein	alone	is	sufficient	to	displace	pRB	and	p107	
from	E2F	dimers,	the	consequence	of	which	being	cellular	E2F	binding	to	the	adenovirus	E2	
promoter	(O'Connor	and	Hearing	2000).			
As	 previously	 discussed	 (see	 Section	 1.1.5),	 E4orf6	 cooperates	 with	 the	 E1B55K	
protein	 and	 together	 with	 a	 number	 of	 cellular	 proteins,	 forms	 an	 E3	 ubiquitin	 ligase	
complex	which	targets	various	proteins	for	degradation.	In	addition,	both	E4orf6	and	E1B55K	
have	been	implicated	in	the	later	stages	of	infection	during	late	viral	mRNA	transport.	E4orf6	
can	also	act	independently	of	E1B55K	during	adenovirus	replication.	The	E4orf6	protein	has	
been	shown	to	interact	with	p53	and	inhibit	p53-mediated	transcriptional	activation.	Binding	
of	E4orf6	to	p53	inhibits	the	ability	of	p53	to	bind	to	the	transcription	factor	IID	(TFIID),	thus	
inhibiting	transcriptional	activation	(Dobner,	Horikoshi	et	al.	1996).				
The	 adenovirus	 E4orf3	 protein	 has	 a	 number	 of	 roles	 during	 adenovirus	 infection.	
E4orf3	 is	 involved	 in	the	splicing	of	the	viral	major	 late	transcript	 (Nordqvist,	Ohman	et	al.	
1994).	E4orf3	has	also	been	shown	to	be	responsible	for	the	reorganisation	of	a	number	of	
cellular	 proteins	 to	 discrete	 nuclear	 structures	 known	 as	 PML	 nuclear	 bodies	 or	 PML	
oncogenic	 domains	 (PODs).	 A	 number	 of	 proteins	 are	 known	 to	 associate	 with	 these	
structures,	 the	most	notable	of	which	 is	 the	PML	protein,	 the	 recruitment	of	a	number	of	
PML	 nuclear	 bodies	 is	 dependent	 on	 this	 protein.	 During	 adenovirus	 infection,	 E4orf3	 is	
responsible	 for	 the	 rapid	 reorganisation	 of	 PODs	 into	 track-like	 structures	 through	 the	
interaction	with	the	PML	isoform	PMLII	(Hoppe,	Beech	et	al.	2006).	The	precise	function	of	
PML	 bodies,	 and	 the	 reason	 for	 the	 reorganisation	 of	 these	 bodies	 during	 adenovirus	
infection	is	to	date	unknown,	however	they	have	been	implicated	in	the	regulation	of	gene	
expression,	the	DNA	damage	response	and	apoptosis	(Zhong,	Salomoni	et	al.	2000,	Dellaire	
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and	 Bazett-Jones	 2004,	 Takahashi,	 Lallemand-Breitenbach	 et	 al.	 2004).	 E4orf3	 is	 also	
responsible	for	the	localisation	of	E4orf6	to	PML	nuclear	bodies	(Leppard	and	Everett	1999).	
E4orf3	also	stimulates	the	reorganisation	of	p53	to	PML	bodies	where	it	 induces	H3K9me3	
heterochromatin	 formation	 at	 p53	 target	 promoter	 regions,	 silencing	 p53	 target	 genes	
(Soria,	Estermann	et	al.	2010).	Finally,	as	well	as	E1B55K,	E4orf3	has	been	shown	to	also	bind	
to	 p53,	 relocating	 it	 from	 the	 nucleus	 to	 the	 cytoplasm.	 The	 function	 of	 the	 E4orf3	
interaction	with	p53	is	thought	to	‘liberate’	p53	from	E1B55K,	subsequently	allowing	it	to	be	
degraded	by	the	E1B55K/E4orf6	E3	ubiquitin	ligase	complex	(Konig,	Roth	et	al.	1999).	E4orf3	
also	prevents	 the	 concatemerisation	of	 the	 viral	 genome	 through	 the	 recruitment	of	DNA	
damage	proteins	to	VRCs	(see	Section	1.3.3).				
1.2	THE	DNA	DAMAGE	RESPONSE,	REPAIR	AND	REPLICATION	STRESS	
The	cellular	genome	is	under	constant	assault	from	agents	that	can	damage	genomic	
DNA.	 DNA	 damage	 occurs	 from	 both	 exogenous	 agents	 as	 well	 as	 endogenous	 cellular	
processes.	 Examples	 of	 exogenous	 agents	 that	 are	 able	 to	 induce	 DNA	 damage	 include	
exposure	 to	ultra-violet	C	 (UV-C)	 irradiation,	which	 leads	 to	 the	 formation	of	bulky	 lesions	
within	 DNA,	 such	 as	 cyclobutane	 pyrimidine	 dimers	 (CPDs)	 or	 6-4	 photoproducts	 (Wood	
1999,	Douki	and	Cadet	2001).	Exposure	to	ionising	radiation	(IR)	generates	a	number	of	DNA	
lesions	including	double-strand	breaks	(DSBs),	single-strand	breaks	(SSBs)	and	oxidative	base	
damage	(Alexander	and	Stacey	1958).	Other	examples	of	agents	that	are	able	to	induce	DNA	
damage	 include	 heterocyclic	 amines	 and	 aflatoxins	 which	 can	 be	 found	 in	 contaminated	
food,	 and	 polycyclic	 aromatic	 hydrocarbons	 found	 in	 tobacco	 smoke	 (Jackson	 and	 Bartek	
2009).	Examples	of	endogenous	cellular	processes	generating	DNA	damage	include	the		
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Figure	1.4:	DNA	Damage,	Repair,	and	the	Maintenance	of	Genome	Stability.	DNA	damage	
can	 be	 generated	 from	 both	 exogenous	 agents	 as	 well	 as	 endogenous	 cellular	 processes.	
Activation	of	the	DNA	damage	response	induces	cell	cycle	arrest	to	prevent	DNA	replication	
until	 the	 damage	 is	 repaired.	 In	 the	 event	 of	 irreparable	 DNA	 damage,	 apoptosis	
mechanisms	are	triggered.	DNA	damage	includes	the	generation	of	DNA	strand	breaks,	bulky	
adducts,	base	mismatches	 and	base	alkylations.	The	 pathways	 through	which	 such	 lesions	
are	repaired	are	also	highlighted.		
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introduction	of	SSBs	from	the	oxidative	attack	of	reactive	oxygen	species	(ROS)	produced	as	
a	by-product	of	normal	cellular	metabolism,	the	abortive	activity	of	enzymes	that	generate	
‘nicks’	 in	 the	DNA	during	DNA	 replication	or	 transcription,	 such	as	 topoisomerase	 I	 (TOPI)	
and	 topoisomerase	 II	 (TOPII),	 leading	 to	 SSBs	 and	 DSBs	 respectively,	 and	 the	 erroneous	
action	of	DNA	polymerases	during	DNA	replication,	leading	to	DNA	base	mismatches	(Weiss,	
King	et	al.	1977,	Ward,	Evans	et	al.	1987).		
The	 rapid	detection	and	 repair	of	DNA	damage	 is	essential	 for	 cellular	 survival	and	
the	maintenance	of	genome	stability.	Unrepaired	DNA	lesions	can	lead	to	the	accumulation	
of	mutations	and	ultimately	genomic	instability,	a	defined	hallmark	for	cancer	development	
or	cell	death	(Hanahan	and	Weinberg	2011).	It	is	therefore	not	surprising	that	a	complex	and	
coordinated	 set	 of	 signalling	 networks	 and	 repair	 pathways	 exist	 in	 order	 to	 protect	 the	
integrity	 of	 the	 genome	 (Figure	 1.4).	 In	 the	 following	 paragraphs,	 the	 process	 of	 DNA	
damage	detection,	repair	and	the	cellular	response	to	replication	stress	will	be	discussed.				
1.2.1	The	DNA	Damage	Response	
1.2.1.1	The	ATM	Kinase	and	the	Detection	of	Double-Strand	Breaks	
DSBs	can	be	defined	as	discontinuities	 in	both	strands	of	the	DNA	double	helix	and	
can	 occur	 both	 endogenously	 and	 from	 environmental	 sources.	 DSBs	 can	 occur	
endogenously	through	the	abortive	activity	of	TOPII,	the	collapse	of	stalled	replication	forks	
and	 from	 the	 collision	of	 an	elongating	 replication	 fork	with	 a	 SSB	during	DNA	 replication	
(Liu,	 Liu	 et	 al.	 1980,	 Michel,	 Ehrlich	 et	 al.	 1997).	 Environmental	 sources	 of	 DSBs	 include	
exposure	to	IR	(Alexander	and	Stacey	1958).	 It	 is	thought	that	a	single	unrepaired	DSB	can	
result	in	cell	death,	and	therefore	DSBs	are	considered	to	be	highly	genotoxic	(Rich,	Allen	et	
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al.	2000).	At	a	frequency	of	10	endogenous	DSB	events	per	cell	occurring	every	day,	it	would	
be	 detrimental	 to	 genome	 integrity	 if	 these	 breaks	 were	 not	 efficiently	 repaired	 (Lieber	
2010).		
The	MRN	complex,	 comprising	Mre11,	Rad51	and	Nbs1	proteins,	 is	 responsible	 for	
the	rapid	detection	of	DSBs.	Following	detection,	the	transducer	kinase	ataxia	telangiectasia	
mutated	(ATM)	is	rapidly	recruited	to	the	site	of	the	break	(Falck,	Coates	et	al.	2005,	Lee	and	
Paull	2005).	Two	events	are	 required	 for	 the	complete	activation	of	ATM:	 firstly,	 the	MRN	
complex	 is	 required	 to	 activate	ATM,	 secondly,	ATM	 is	 acetylated	by	HIV-1	 tat	 interacting	
protein	 60kDa	 (Tip60)	 (Sun,	 Jiang	 et	 al.	 2005).	 In	 its	 inactive	 form,	 ATM	 resides	 in	
homodimers	 but,	 following	 its	 activation,	 it	 becomes	 autophosphorylated	 whereby	 it	
dissociates	to	form	active	monomers	(Bakkenist	and	Kastan	2003).	Following	the	complete	
activation	 of	 ATM	 by	 the	 MRN	 complex	 and	 Tip60,	 ATM	 is	 then	 able	 to	 phosphorylate	
downstream	 components	 of	 the	 DNA	 damage	 response	 (DDR)	 such	 as	 H2AX,	 and	
components	of	 the	 cell	 cycle	 checkpoint	 such	as	p53	and	Chk2,	ultimately	 resulting	 in	 the	
activation	 of	 the	 cell	 cycle	 checkpoint	 and	 the	 subsequent	 halting	 of	 the	 cell	 cycle,	which	
prevents	DNA	replication	from	occurring	until	the	DNA	damage	has	been	accurately	repaired	
(Figure	1.5)(Banin,	Moyal	et	al.	1998,	Canman,	Lim	et	al.	1998,	Khanna,	Keating	et	al.	1998,	
Matsuoka,	Huang	et	al.	1998,	Rogakou,	Pilch	et	al.	1998,	Matsuoka,	Rotman	et	al.	2000).	
Following	 DSB	 formation,	 the	 histone	 H2A	 variant	 H2AX,	 a	 minor	 chromatin	
constituent	 composed	 of	 approximately	 2-25%	 of	 the	 total	 H2A	 pool,	 becomes	 rapidly	
phosphorylated	 by	 ATM	 (termed	 γH2AX)	 (Rogakou,	 Pilch	 et	 al.	 1998).	 This	 leads	 to	 the	
recruitment	of	the	mediator	of	DNA	damage	checkpoint	1	(MDC1)	to	the	site	of	the	break,		
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Figure	1.5:	Activation	of	the	ATM	and	ATR	Kinases	in	Response	to	DNA	Damage.	The	MRN	
complex	 is	 recruited	 to	 sites	 of	 double-strand	 breaks	 facilitating	 the	 recruitment	 and	
subsequent	activation	of	ATM,	together	with	Tip60.	Activated	ATM	is	able	to	phosphorylate	
p53	and	Chk2,	resulting	in	cell	cycle	arrest.	Activated	ATM	also	rapidly	phosphorylates	H2AX	
(termed	γH2AX),	which	leads	to	the	recruitment	of	MDC1	to	the	site	of	the	break,	which	is	
subsequently	 phosphorylated	 by	 ATM.	 MDC1	 recruits	 additional	 ATM	 to	 the	 site	 of	 the	
break,	propagating	the	DNA	damage	signal,	and	also	recruits	RNF8	to	the	site	of	the	break.	
RNF8,	together	with	MDC1	catalyses	the	formation	of	ubiquitin	chains	onto	γH2AX.	RNF168	
is	 then	 recruited	 to	 the	 site	 of	 the	 break	 and	 further	 ubiquitinates	 γH2AX.	 At	 this	 point	
repair	 factors	 such	 as	 53BP1	 and	 BRCA1	 are	 recruited	 to	 the	 site	 of	 the	 break.	 RPA	 is	
responsible	 for	 the	 rapid	 detection	 of	 ssDNA.	 Binding	 of	 RPA	 to	 ssDNA	 recruits	 the	 ATR	
kinase	 through	 its	 association	 with	 ATRIP.	 TOPBP1	 localises	 to	 the	 region	 through	 9-1-1	
complex	 and	 RFC2	 clamp	 loader	 complex	 association.	 TOPBP1	 is	 responsible	 for	 the	
activation	of	ATR	through	interactions	with	ATR	and	the	9-1-1	complex.	Activated	ATR	then	
activates	a	number	of	downstream	repair	proteins	and	induces	cell	cycle	arrest	through	the	
activation	of	Chk1	(adapted	from	Turnell	and	Grand	2012).	
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where	 it	 is	 subsequently	 phosphorylated	 by	 ATM	 (Goldberg,	 Stucki	 et	 al.	 2003).	MDC1	 is	
then	able	to	associate	with	γH2AX,	ATM	and	the	MRN	complex,	the	results	of	which	are	two-
fold	 (Stucki,	Clapperton	et	al.	2005).	Firstly,	MDC1	 is	able	 to	 recruit	additional	ATM	to	 the	
site	 of	 the	 damage,	 where	 it	 is	 able	 to	 propagate	 the	 DNA	 damage	 signal	 through	 the	
phosphorylation	 of	 additional	H2AX	 (Lou,	Minter-Dykhouse	 et	 al.	 2006).	 It	 is	 thought	 that	
this	 action	 is	 able	 to	 ‘spread’	 the	 DNA	 damage	 signal	 along	 up	 to	 2	 megabases	 of	 DNA	
(Celeste,	Petersen	et	al.	2002).	Secondly,	MDC1	is	able	to	form	a	‘scaffold’	onto	which	other	
proteins	involved	in	the	DDR	can	access	the	site	of	the	break.	Following	the	recruitment	and	
phosphorylation	 of	 MDC1	 at	 the	 site	 of	 the	 damage,	 the	 E3	 ubiquitin	 ligase	 ring	 finger	
protein	8	(RNF8)	is	recruited	to	the	site	of	the	break	where	it	associates	with	phosphorylated	
MDC1	(Huen,	Grant	et	al.	2007,	Kolas,	Chapman	et	al.	2007,	Mailand,	Bekker-Jensen	et	al.	
2007).	RNF8	and	MDC1	then	interact	with	the	E2	conjugating	enzyme	Ubc13,	which	together	
are	 responsible	 for	 the	 addition	 of	 K63	 ubiquitin	 chains	 onto	 γH2AX,	 amplifying	 the	 DNA	
damage	signal	 further	 (Bin	and	Elledge	2007).	The	ubiquitination	of	γH2AX	 in	 turn	 recruits	
the	E3	ubiquitin	ligase	RNF168	to	the	site	of	the	damage,	which	is	also	able	to	ubiquitinate	
γH2AX,	further	propagating	the	signal	(Doil,	Mailand	et	al.	2009,	Stewart,	Panier	et	al.	2009,	
Mattiroli,	Vissers	et	al.	2012).	In	addition	to	the	amplification	of	the	DNA	damage	signal,	the	
ubiquitination	of	γH2AX	at	 the	site	of	 the	DSB	also	 leads	to	the	recruitment	of	DNA	repair	
proteins	such	as	receptor-associated	protein	80	(RAP80),	breast	cancer	type	1	susceptibility	
protein	 (BRCA1)	and	p53-binding	protein	1	 (53BP1),	 amongst	others,	ultimately	 leading	 to	
the	repair	of	the	DSB	(Figure	1.5)(Wang,	Matsuoka	et	al.	2002,	Bin	and	Elledge	2007).		
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1.2.1.2	ATR	Kinase	Activation	
The	transducer	kinase	ATR	can	be	activated	by	a	number	of	different	types	of	DNA	
damage	including	DSBs,	and	also	following	replication	stress,	the	common	structure	known	
to	 activate	 ATR	 being	 single-stranded	 DNA	 (ssDNA)(Figure	 1.5)(Zou	 and	 Elledge	 2003,	
Jazayeri,	 Falck	 et	 al.	 2006).	 The	 ssDNA	 binding	 protein,	 replication	 protein	 A	 (RPA),	 is	
responsible	for	the	rapid	coating	of	regions	of	ssDNA,	which	subsequently	recruits	the	ATR	
kinase	 to	 the	 ssDNA	 site	 through	 the	 interaction	 with	 the	 ATR	 binding	 partner	 ATR-
interacting	protein	(ATRIP)(Zou	and	Elledge	2003).	The	Rad9-Rad1-Hus1	(9-1-1)	complex	and	
the	Rad17-replication	factor	C	2	(RFC2)	clamp	loader	complex	are	subsequently	recruited	to	
the	 ssDNA-RPA	 complex,	 which	 results	 in	 topoisomerase	 II	 binding	 protein	 1	 (TOPBP1)	
recruitment	to	the	site	of	ssDNA	(Bermudez,	Lindsey-Boltz	et	al.	2003,	Zou	and	Elledge	2003,	
Parrilla-Castellar,	 Arlander	 et	 al.	 2004).	 TOPBP1	 is	 then	 able	 to	 activate	 ATR	 through	
associations	with	ATRIP	and	the	Rad9	component	of	the	9-1-1-	complex	(Kumagai,	Lee	et	al.	
2006,	 Mordes,	 Glick	 et	 al.	 2008).	 Activated	 ATR	 is	 subsequently	 able	 to	 phosphorylate	
downstream	 effector	 proteins,	 including	 those	 involved	 in	 DNA	 repair	 (H2AX,	 BRCA1	 and	
Bloom	syndrome	protein	(BLM))	and	cell	cycle	arrest	(p53	and	Chk1)	(Lakin,	Hann	et	al.	1999,	
Liu,	Guntuku	et	al.	2000,	Tibbetts,	Cortez	et	al.	2000,	Ward	and	Chen	2001,	Davies,	North	et	
al.	2004).	Induction	of	cell	cycle	arrest	prevents	the	replication	of	damaged	DNA	and	allows	
time	for	the	replication	barrier	and/or	DNA	damage	to	be	repaired	(Figure	1.5).		
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1.2.2	DNA	Repair	and	Genome	Integrity	
1.2.2.1	DSB	Repair	
DSB	 repair	 is	 essential	 for	 the	 maintenance	 of	 genome	 integrity	 since	 failure	 to	
efficiently	 repair	DNA	damage	 can	 lead	 to	 gross	 chromosomal	 translocations	 and	 genome	
instability.	 There	 are	 two	main	 DSB	 repair	mechanisms	 in	 place	 to	 rapidly	 and	 efficiently	
repair	 DSBs	 when	 they	 arise;	 these	 repair	 mechanisms	 are	 non-homologous	 end-joining	
(NHEJ)	and	homologous	recombination	(HR)	repair	(Weibezahn	and	Coquerelle	1981).	NHEJ	
involves	 the	 direct	 end-to-end	 ligation	 of	 DNA	 ends	 with	 relatively	 limited	 DNA	 end	
processing.	This	mechanism	of	DSB	repair	can	on	occasion	lead	to	loss	of	genetic	information	
since	DNA	end	processing	involved	in	this	type	of	repair	can	lead	to	the	loss	of	nucleotides.	
In	addition,	NHEJ	also	has	the	capacity	to	induce	genome	rearrangements	and	chromosomal	
translocations	since	DNA	ends	may	be	joined	with	other	DNA	ends	erroneously	(Liang,	Han	
et	al.	1998,	Heidenreich,	Novotny	et	al.	2003).	In	contrast,	HR	repair	involves	extensive	DNA	
end	 processing	 (end-resection)	 followed	 by	 a	 ‘search’	 for	 homologous	 regions	 in	 the	
undamaged,	 sister	 strand	 of	 the	 DNA;	 once	 found,	 this	 region	 of	 homology	 is	 used	 as	 a	
template	 for	 DNA	 repair.	 Since	 HR	 repair	 involves	 end-processing	with	 no	 loss	 of	 genetic	
information,	 HR	 is	 considered	 to	 be	 an	 error-free	 form	 of	 DSB	 repair.	 However,	 since	 HR	
repair	 requires	 the	 homologous	 sister	 strand	 for	 efficient	 repair,	 this	 form	 of	 repair	 is	
restricted	to	S	and	G2	phases	of	the	cell	cycle,	as	opposed	to	NHEJ	which	can	occur	during	all	
phases	(Bezzubova,	Silbergleit	et	al.	1997,	Liang,	Han	et	al.	1998,	Takata,	Sasaki	et	al.	1998).	
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	1.2.2.1.1	Non-Homologous	End-Joining	(NHEJ)	
The	 initiation	of	NHEJ	begins	with	the	rapid	recognition	of	 the	DSB	by	the	Ku70/80	
heterodimer,	 which	 forms	 a	 ring-like	 structure	 around	 each	 end	 of	 the	 DSB	 (Figure	 1.6)	
(Blier,	 Griffith	 et	 al.	 1993,	 Walker,	 Corpina	 et	 al.	 2001).	 The	 formation	 of	 the	 ring-like	
structure	around	the	DNA	allows	the	structure	to	translocate	along	the	DNA	away	from	the	
break,	 which	 allows	 other	 NHEJ	 proteins	 access	 to	 the	 site	 of	 the	 break	 (Yoo	 and	 Dynan	
1999).	 Following	 the	 recruitment	 of	 the	 Ku70/80	 heterodimer	 to	 the	 break,	 the	 catalytic	
subunit	 of	 the	 DNA-dependent	 protein	 kinase	 (DNA-PKcs)	 associates	 with	 the	 Ku70/80	
heterodimer,	 together	 forming	 the	 DNA-PK	 holoenzyme	 (Suwa,	 Hirakata	 et	 al.	 1994).	 The	
active	DNA-PK	holoenzyme	autophosphorylates	 itself,	as	well	as	phosphorylating	a	number	
of	 downstream	 mediators	 of	 NHEJ	 including	 Ku70/80,	 X-ray	 repair	 cross-complementing	
protein	4	(XRCC4)	and	Artemis	(Lees-Miller,	Chen	et	al.	1990,	Yu,	Wang	et	al.	2003,	Goodarzi,	
Yu	et	al.	2006).	The	role	of	the	autophosphorylation	of	DNA-PK	is	to	allow	the	dissociation	of	
the	holoenzyme	allowing	access	of	other	NHEJ	proteins	to	the	site	of	the	DSB	including	DNA	
ligase	IV,	Artemis,	XRCC4	and	XRCC-like	factor	(XLF)	(Chan	and	Lees-Miller	1996,	Ding,	Reddy	
et	al.	2003).		
DNA	ends	of	 the	DSB	need	to	be	returned	to	their	conventional	3’OH	and	5’P	DNA	
termini	 before	 they	 can	 be	 re-ligated	 by	 NHEJ.	 The	 end-processing	 enzymes	 used	 in	 this	
process	 are	 dependent	 on	 the	 termini	 created	 during	 the	DNA	damage.	 For	 example,	 the	
major	processing	enzyme	during	NHEJ	is	believed	to	be	Artemis,	which	is	responsible	for	the	
processing	 of	 DNA	 overhangs	 and	 hairpins	 (Ma,	 Pannicke	 et	 al.	 2002).	 NHEJ	 is	 complete	
when	DNA	ligase	IV,	together	with	XRCC4	and	XLF	join	the	processed	ends	of	the	DSB		
	 	
		 25	
	 	
DN
A$
PK
cs
)
LigIV)
Ku70/80) Ku70/80)
P) P)
XLF)
XRCC4)LigIV)
XLF)
NHEJ)
DN
A$PKcs)
DN
A$
PK
cs
)
P)
DN
A$PKcs)
P)Artemis) Artemis)
XRCC4)
Detec@on)
End)processing/)
Liga@on)
Figure	1.6:	Non-Homologous	End-Joining.	The	Ku70/Ku80	heterodimer	is	responsible	for	
the	 detection	 of	 DSBs	 during	 NHEJ.	 Following	 initial	 detection,	 the	 Ku70/Ku80	
heterodimer	translocates	along	the	DNA	allowing	access	to	the	break	for	other	DSB	repair	
machinery.	 DNA-PK	 is	 then	 recruited	 to	 the	 site	 of	 the	 break	 and	 together	 with	
Ku70/Ku80,	forms	the	DNA-PK	holoenzyme.	The	autophosphorylation	of	DNA-PK	results	in	
the	accumulation	of	other	DSB	 repair	proteins	at	 the	 site	of	 the	break	 such	as	Artemis,	
DNA	 ligase	IV,	XRCC4	and	XLF.	A	variety	of	end-processing	factors	including	Artemis,	are	
able	 to	 process	 DNA	 ends	 and	 make	 them	 compatible	 for	 ligation.	 DNA	 ligase	 IV,	 in	
conjunction	with	XRCC4	and	XLF	are	responsible	for	DNA	end	ligation.						
	
		 26	
(Figure	 1.6)	 (Leber,	Wise	 et	 al.	 1998,	Matsumoto,	 Suzuki	 et	 al.	 2000,	 Calsou,	Delteil	 et	 al.	
2003,	Ahnesorg,	Smith	et	al.	2006,	Hentges,	Ahnesorg	et	al.	2006,	Tsai,	Kim	et	al.	2007,	Yano,	
Morotomi-Yano	et	al.	2008).		
1.2.2.1.2	Homologous	Recombination	Repair	
The	process	of	HR	repair	begins	with	the	resection	of	each	end	of	the	DSB	to	produce	
a	region	of	ssDNA,	which	is	orchestrated	by	the	MRN	complex	together	with	CtBP	interacting	
protein	 (CtIP)	 (Figure	 1.7)	 (Sartori,	 Lukas	 et	 al.	 2007,	 Huertas	 and	 Jackson	 2009).	 The	 E3	
ubiquitin	 ligase	BRCA1	 is	 responsible	 for	the	targeting	of	CtIP	to	the	DSB	site	 (Yu,	Fu	et	al.	
2006).	The	helicase	BLM	and	 the	exonucleases:	exonuclease	1	 (EXO1)	and	DNA	replication	
helicase/nuclease	 2	 (DNA2)	 are	 responsible	 for	 the	 further	 resection	 of	 the	 DNA	 ends	
(Nimonkar,	Genschel	et	al.	2011).	The	3’	ssDNA	overhang	created	from	resection	of	the	DNA	
ends	is	rapidly	coated	with	RPA,	with	two	major	consequences.	Firstly,	the	coating	of	RPA	on	
the	 ssDNA	 activates	 ATR	 and	 its	 downstream	 proteins.	 Secondly,	 RPA	 binding	 to	 ssDNA	
induces	the	next	steps	in	the	HR	process.	RPA	is	displaced	from	the	ssDNA-RPA	by	Rad51	in	a	
breast	 cancer	 type	 2	 susceptibility	 protein	 (BRCA2)-dependent	 manner,	 which	 forms	 a	
nucleoprotein	 filament	with	the	ssDNA	(Wong,	Pero	et	al.	1997,	Pellegrini,	Yu	et	al.	2002).	
The	 ssDNA-Rad51	 nucleoprotein,	 then	 invades	 the	 undamaged,	 sister	 chromatid	 strand,	
displacing	the	DNA,	which	forms	a	displacement	loop	(D-loop)(Baumann,	Benson	et	al.	1996,	
Sugiyama	and	Kowalczykowski	2002).	The	nucleoprotein	 filament	 then	undergoes	a	search	
for	 the	 homologous	 region	 on	 the	 sister	 chromatid,	 which	 is	 subsequently	 used	 as	 a	
template	to	repair	the	damaged	strand.	The	structure	formed	can	be	resolved	in	one	of	two	
ways.	Firstly,	if	the	D-loop	has	been	‘captured’	by	the	second	DNA	end,	a	double	Holliday		
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Figure	 1.7:	 Homologous	 Recombination	 Repair.	 During	 homologous	 recombination	
repair,	 MRN	 in	 conjunction	 with	 CtIP	 and	 BRCA1,	 are	 responsible	 for	 the	 initial	 5’-3’	
resection	 of	 the	DNA	at	 the	 site	 of	 the	DSB.	 Extensive	 resection	 is	 carried	 out	by	 BLM,	
EXO1	and	DNA2.	RPA	rapidly	binds	the	3’	overhang	ssDNA	generated	by	resection	which	is	
displaced	by	the	recombinase	Rad51	in	conjunction	with	BRCA2,	forming	a	nucleoprotein	
filament	with	the	ssDNA.	The	nucleoprotein	filament	invades	the	undamaged	homologous	
sister	chromatid	and	uses	the	homologous	sequence	as	a	template	for	DNA	synthesis.	The	
resulting	structure	can	be	resolved	either	by	the	classical	recombination	repair	pathway,	
whereby	 the	 D-loop	 captures	 the	 second	 DNA	 end,	 or	 by	 synthesis-dependent	 strand	
annealing	 (SDSA),	 where	 the	 D-loop	 is	 dissolved	 before	 second-end	 capture,	 resulting	
exclusively	in	non-crossover	events.	The	classical	recombination	repair	pathway	results	in	
the	 formation	 of	 double	 Holliday	 junctions,	 which	 are	 resolved	 by	 a	 range	 of	
endonucleases,	resulting	in	both	cross-over	and	non-crossover	products.			
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junction	 is	 formed	 which	 can	 be	 resolved	 by	 the	 endonucleases	 MUS81	 endonuclease	
homologue	(MUS81)/	essential	meiotic	endonuclease	1	homologue	1	(EME1),	SLX1/SLX4	and	
GEN1	 (Boddy,	Gaillard	et	 al.	 2001,	 Ip,	Rass	 et	 al.	 2008,	 Fekairi,	 Scaglione	et	 al.	 2009).	 The	
endonucleases	 are	 responsible	 for	 the	 cleavage	 of	 the	 junction	 and	 depending	 on	 the	
endonuclease	employed,	this	results	in	either	a	chromatid	crossover	event,	whereby	genetic	
information	 between	 the	 chromatids	 is	 exchanged,	 or	 a	 non-crossover	 product	 (Wu	 and	
Hickson	2003).	Secondly,	 if	the	end	of	the	double	Holliday	junction	is	not	‘captured’	by	the	
second	DNA	end,	the	newly	repaired	DNA	strand	can	anneal	to	the	other	side	of	the	break,	a	
process	known	as	synthesis-dependent	strand	annealing	(SDSA).	SDSA	always	results	in	the	
generation	of	a	non-crossover	product	(Figure	1.7)	(Adams,	McVey	et	al.	2003,	Ira,	Satory	et	
al.	2006).		
1.2.2.2	Single-Strand	Break	Repair	
A	single-strand	break	(SSB)	can	be	defined	as	a	discontinuity	in	a	single-strand	of	the	
double-stranded	DNA	helix.	SSBs	are	thought	to	be	one	of	the	most	common	DNA	lesions	to	
occur	 in	 the	 genome,	with	 approximately	 10,000	 endogenously-induced	 SSBs	 per	 cell	 per	
day	 (Lindahl	1993).	 SSBs	are	not	 the	most	genotoxic	DNA	 lesion	 to	 the	cell;	however,	 it	 is	
important	that	 these	 lesions	are	repaired	by	the	cell	 repair	machinery	since	SSBs	have	the	
capacity	to	become	DSBs	if	met	by	a	replication	fork	during	DNA	replication	(Kuzminov	2001)	
(see	Section	1.2.4.2).	
One	of	the	most	common	sources	of	SSB	lesions	is	endogenous	oxidative	attack	from	
ROS	deriving	from	normal	cell	metabolism	(Weiss,	King	et	al.	1977,	Ward,	Evans	et	al.	1987).	
SSBs	can	also	occur	indirectly	from	the	excision	of	damaged	or	incorrect	bases	during	base	
excision	repair	(BER)	(Lindahl	1974).	This	form	of	repair	is	responsible	for	the	removal	of		
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Figure	1.8:	Single-Strand	Break	Repair.	Single-strand	breaks	can	be	generated	indirectly	by	
the	endonuclease	activity	of	APE1,	which	acts	to	cleave	abasic	(AP)	sites	during	base	excision	
repair.	Alternatively,	 single-strand	breaks	 can	be	generated	directly	and	are	 recognised	by	
PARP1.	As	with	DSBs,	SSBs	possess	damaged	termini	which	need	to	be	processed	before	SSB	
repair	 can	 proceed.	 A	 number	 of	 end-processing	 factors	 exist	 to	 process	 the	 termini,	 one	
example	 being	 PNPK.	 Following	 DNA	 end-processing,	 DNA	 gap	 filling	 can	 occur	 either	
incorporating	 1	 nucleotide	 (termed	 short-patch	 repair)	 or	 2-12	 nucleotides	 (termed	 long-
patch	repair).	FEN1	removes	displaced	5’	single	strand	DNA	flaps	associated	with	long-patch	
repair.	DNA	is	ligated	by	either	DNA	ligase	I	or	DNA	ligase	III.		
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alkylated,	 deaminated	 and	 oxidised	 bases	 from	 the	 DNA	 backbone.	 Nucleotide	 excision	
repair	(NER)	also	leads	to	the	indirect	formation	of	SSBs	through	the	removal	of	bulky,	helix	
distorting	 lesions	from	the	DNA	backbone.	SSBs	can	also	occur	from	abortive	TOP1	activity	
during	 DNA	 replication	 and	 transcription.	 The	 function	 of	 TOP1	 is	 to	 reduce	 super-helical	
torsion	produced	during	DNA	replication	and	 transcription	by	creating	a	 ‘nick’	 in	 the	DNA.	
Ordinarily,	TOP1	acts	to	rapidly	reseal	the	‘nick’	in	the	DNA	backbone	however,	occasionally,	
if	the	‘nick’	collides	with	the	DNA	replication	or	transcriptional	machinery,	or	if	TOP1	is	close	
to	a	DNA	lesion,	the	end	result	can	be	TOP1	abortive	activity	and	ultimately	the	generation	
of	an	irreversible	TOP1-associated	SSB	(Pourquier,	Pilon	et	al.	1997).		
1.2.2.2.1	Base	Excision	Repair				
As	previously	discussed,	SSBs	can	also	occur	indirectly	from	the	excision	of	damaged	
or	 incorrect	 bases	 during	 BER	 (Lindahl	 1974).	 During	 BER,	 DNA	 base	 modifications	 are	
excised	 by	 DNA	 glycosylases	 which	 act	 to	 excise	 these	 modifications	 leaving	 an	 apurinic-
apyrimidinic	 (AP)	 site	 (Figure	 1.8).	 There	 are	 known	 to	 be	 two	 types	 of	DNA	 glycosylases;	
mono-functional	 glycosylases	 which	 possess	 glycosylase	 activity	 alone,	 and	 bi-functional	
glycosylases	which	possess	glycosylase	activity	and	AP	lyase	activities	(Lindahl	1974).	Mono-
functional	 glycosylases	excise	 the	damaged	base	 leaving	an	AP	 site,	which	 is	 subsequently	
incised	 by	 AP	 endonuclease	 I	 (APE1),	 leaving	 a	 SSB	 (Demple,	 Herman	 et	 al.	 1991).	 The	
intrinsic	 AP	 lyase	 activities	 of	 the	 bi-functional	 glycosylases	 cleave	 abasic	 sites	 in	 a	 β-
elimination	or	β,δ-	elimination	reaction,	leading	to	a	single	nucleotide	gap	containing	a	5’-P	
and	3’-αβ	unsaturated	aldehyde	or	5’	and	3’-P,	respectively	(O'Connor	and	Laval	1989).		
Poly	 (ADP-ribose)	 polymerase	 1	 (PARP1)	 is	 responsible	 for	 the	 recognition	 of	 SSBs	
that	 have	 occurred	 directly	 (e.g	 through	 sugar	 damage);	 upon	 recognition	 and	 binding	 of	
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PARP1	to	the	SSB,	PARP1	becomes	activated	(Figure	1.8)	(Benjamin	and	Gill	1980,	Alkhatib,	
Chen	 et	 al.	 1987,	 Gradwohl,	 Menissier	 de	 Murcia	 et	 al.	 1990,	 Satoh	 and	 Lindahl	 1992,	
Weinfeld,	Chaudhry	et	al.	1997).	The	activation	of	PARP1	induces	its	poly	(ADP-ribose)(PAR)	
polymerase	 activity,	 causing	 the	 addition	 of	 PAR	 polymers	 to	 itself	 and	 other	 proteins	
including	histones	(Ueda,	Omachi	et	al.	1975,	Tanaka,	Hayashi	et	al.	1978,	Kanai,	Miwa	et	al.	
1982,	Mendoza-Alvarez	and	Alvarez-Gonzalez	1993,	Altmeyer,	Messner	et	al.	2009,	Messner,	
Altmeyer	et	al.	2010).		
The	PARylation	of	PARP1	and	its	target	proteins	leads	to	the	recruitment	of	a	number	
of	 proteins	 to	 the	 SSB.	 One	 such	 protein	 is	 X-ray	 repair	 cross	 complementing	 protein	
(XRCC1),	which	acts	as	a	scaffold	for	other	proteins	involved	in	BER	(Caldecott,	Aoufouchi	et	
al.	1996,	Masson,	Niedergang	et	al.	1998,	El-Khamisy,	Masutani	et	al.	2003).	Before	the	SSB	
can	be	repaired,	the	DNA	ends	of	the	break	must	be	restored	to	their	conventional	3’OH	and	
5’P	 ends.	 This	 is	 achieved	 by	 various	 end-processing	 proteins,	 the	 protein	 involved	 in	 the	
end-processing	 is	 dependent	 on	 the	 type	 of	 damage	 to	 the	 termini.	 For	 example,	
polynucleotide	kinase	phosphatase	 (PNKP)	 is	necessary	 for	 the	processing	of	3’P	and	5’OH	
termini	 induced	by	ROS,	 and	 so	 is	 a	 particularly	 important	processing	 enzyme	 considering	
the	abundance	of	these	lesions	(Jilani,	Ramotar	et	al.	1999,	Whitehouse,	Taylor	et	al.	2001).		
Following	the	restoration	of	the	DNA	termini	to	their	conventional	forms,	single-strand	gap	
filling	 can	 occur	which	 can	 either	 incorporate	 one	 nucleotide	 (short-patch	 repair)	 or	 2-12	
nucleotides	 (long-patch	repair)(Dianov,	Price	et	al.	1992,	Klungland	and	Lindahl	1997).	The	
removal	 of	 displaced	 5’	 nucleotides	 produced	 during	 long-patch	 repair	 are	
resolved/removed	 by	 flap	 endonuclease	 1	 (FEN1)	 (Prasad,	 Dianov	 et	 al.	 2000).	 The	 DNA	
polymerases	 involved	 in	 short-patch	 and	 long-patch	 repair	 are	 numerous	 and	 are	
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responsible	for	DNA	gap	filling	during	BER.	Finally,	the	end	step	of	SSB	repair	is	the	ligation	of	
the	 newly	 synthesised	 DNA	which	 is	 performed	 by	 DNA	 ligase	 III	 (usually	 associated	with	
short-patch	 repair)/DNA	 ligase	 I	 (normally	 associated	 with	 long-patch	 repair)	 (Figure	 1.8)	
(Brookman,	Tebbs	et	al.	1994,	Caldecott,	McKeown	et	al.	1994,	Caldecott,	Tucker	et	al.	1995,	
Pascucci,	Stucki	et	al.	1999,	Sleeth,	Robson	et	al.	2004).	
1.2.2.2.2	Nucleotide	Excision	Repair	
SSBs	can	also	occur	during	NER	through	the	removal	of	bulky,	helix-distorting	lesions	
caused	 during	 exposure	 to	 chemicals	 which	 cause	 bulky	 chemical-induced	 adducts,	 and	
agents	 such	 as	 UV-C,	 which	 induce	 CPDs	 and	 6-4	 photoproducts	 (Wood	 1999,	 Douki	 and	
Cadet	2001).		
There	 are	 two	 forms	 of	 NER	 termed	 global-genome	 repair	 (GGR)	 NER	 and	
transcription-coupled	 repair	 (TCR).	 GGR	 NER	 involves	 the	 repair	 of	 bulky	 lesions	 in	
transcriptionally	inactive	areas	of	the	genome,	whereas	TCR	occurs	in	transcriptionally	active	
genes	(Mellon,	Spivak	et	al.	1987).	The	XPC-Rad23B-Centrin	2	(XPC)	complex	is	able	to	detect	
bulky	lesions	during	GGR	NER,	i.e.	the	detection	of	(6-4)	photoproducts	(Sugasawa,	Ng	et	al.	
1998,	Araki,	Masutani	et	al.	2001).	For	the	recognition	of	smaller	DNA	lesions	that	cannot	be	
detected	 by	 the	 XPC	 complex,	 there	 is	 the	 UV	 DNA	 damage	 binding	 protein	 (UV-DDB)	
composed	 of	 DDB1	 and	 DDB2/XPE	 to	 facilitate	 their	 recognition	 (Payne	 and	 Chu	 1994,	
Hwang,	Toering	et	al.	1998).	The	recognition	of	bulky	lesions	during	TCR	is	performed	by	the	
elongating	 polymerase	 II	 (RNAPII),	 the	 recognition	 involves	 the	 stalling	 of	 the	 polymerase	
during	 transcription	 from	 the	 collision	 with	 the	 bulky	 lesion	 (Donahue,	 Yin	 et	 al.	 1994).	
Following	the	recognition	of	the	bulky	lesion	by	either	GGR	NER	or	TCR,	the	two	DNA	repair	
pathways	merge	and	the	proceeding	steps	of	NER	occur	in	both	forms	of	NER	(Figure	1.9).		
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Figure	1.9:	Nucleotide	 Excision	Repair.	The	XPC-Rad23B-Centrin	2	and	UV-DDB	complexes	
are	responsible	 for	the	detection	of	bulky	DNA	 lesions	during	global-genome	repair	 (GGR),	
whilst	 RNA	 polymerase	 II	 detects	 bulky	 DNA	 lesions	 during	 transcription-coupled	 repair	
(TCR).	 Following	 initial	 detection	 the	 two	 pathways	 of	 nucleotide	 excision	 (NER)	 repair	
converge.	 The	 multi-subunit	 TFIIH	 transcription	 factor	 associates	 with	 the	 lesion	 and	 this	
stimulates	 the	 helicase	 activity	 of	 two	 of	 its	 subunits;	 XPB	 and	 XPD,	 resulting	 in	 the	
unwinding	 of	 the	 DNA	 to	 allow	 access	 for	 the	 repair	 machinery.	 XPA	 associates	with	 the	
lesion	 present	 on	 the	 single	 stranded	 DNA	 coated	with	 RPA.	 This	 then	 activates	 the	 XPF-
ERCC1	and	XPG	endonucleases	which	make	an	 incision	on	the	DNA	5’	and	3’	of	 the	 lesion,	
respectively.	Pol	ε.	Pol	δ	and	Pol	κ	together	with	PCNA	are	responsible	for	DNA	gap	filling.	
DNA	is	ligated	by	the	DNA	ligase	III-XRCC1	complex.			
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Following	 the	 recognition	 of	 the	 bulky	 lesion,	 the	 two	 helicase	 subunits	 of	 the	
transcription	 factor	 TFIIH,	 termed	 xeroderma	 pigmentosum	 (XP)	 XPB	 and	 XPD,	 are	
responsible	 for	 the	unwinding	of	 the	DNA,	which	allows	access	of	 the	 repair	machinery	 to	
the	 DNA	 lesion	 (Volker,	 Mone	 et	 al.	 2001,	 Tapias,	 Auriol	 et	 al.	 2004).	 	 TFIIH	 is	 then	
responsible	 for	 recruiting	 XPA	 and	 RPA	 which	 activate	 XPF-	 excision	 repair	 cross-
complementation	 group	 1	 (ERCC1)	 and	 XPG	 (5’	 endonuclease	 and	 3’	 endonuclease,	
respectively)	 which	 are	 responsible	 for	 the	 excision	 of	 the	 22-30nt	 long	 DNA	 strand	
containing	the	bulky	 lesion	(Li,	Elledge	et	al.	1994,	Odonovan,	Davies	et	al.	1994,	Park	and	
Sancar	1994,	Saijo,	Kuraoka	et	al.	1996,	Volker,	Mone	et	al.	2001).	The	DNA	polymerases	Pol	
δ,	 Pol	 ε	 and	 Pol	 κ	 are	 responsible	 for	 filling	 the	 gap	 in	 the	 DNA	 left	 behind	 from	 the	
endonucleases	 together	 with	 proliferating	 cell	 nuclear	 antigen	 (PCNA)(Shivji,	 Kenny	 et	 al.	
1992).	 The	 ligase	 III-XRCC1	 complex	 facilitates	 the	 ligation	 step	 in	NER	 (Figure	 1.9)	 (Shivji,	
Kenny	et	al.	1992,	Moser,	Kool	et	al.	2007).		
1.2.2.3	Mismatch	Repair	
DNA	base	mismatching	 occurs	 from	 errors	made	 by	DNA	 polymerases	 during	DNA	
replication.	 Deviations	 from	 the	 Watson-Crick	 base-pairs	 G-C	 and	 A-T	 are	 repaired	 by	
mismatch	repair	(MMR)	(Watson	and	Crick	1953).	In	addition	to	base-pair	mismatches,	MMR	
is	also	responsible	for	the	repair	of	insertion/deletion	loops	(IDLs)	which	are	a	consequence	
of	multiple	unpaired	nucleotides.	To	preserve	the	integrity	of	the	genome,	various	measures	
are	in	place	to	ensure	that	the	mismatch	is	removed	from	the	newly-synthesised	DNA	strand	
rather	 than	 the	 parental	 strand.	 The	 MMR	 machinery	 is	 able	 to	 recognise	 the	 newly-
synthesised	DNA	strand	through	the	recognition	of	‘nicks’	in	the	DNA	left	from	Okazaki		
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Figure	 1.10:	 Mismatch	 Repair.	 DNA	 mismatches	 are	 detected	 by	 MSH2-MSH6	
heterodimer	 and	 deletion/insertion	 loops	 by	 the	 MSH2-MSH3	 complex.	
MLH1/PMS2	 is	 then	 recruited	 to	 the	 mismatch	 where	 it	 forms	 a	 complex	 with	
MSH2-MSH6	or	MSH2-MSH3,	respectively.		PMS2	has	endonuclease	activity	which	
is	 able	 to	 generate	 a	 nick	 5’	 to	 the	 mismatch	 so	 that	 it	 can	 be	 subsequently	
removed	by	EXO1.	DNA	gap	filling	is	achieved	by	RFC-loaded	PCNA	and	DNA	Pol	δ.	
Finally	DNA	is	ligated	by	DNA	ligase	I.	
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fragment	formation	on	the	lagging	DNA	strand	(Lacks,	Dunn	et	al.	1982,	Holmes,	Clark	et	al.	
1990,	 Thomas,	 Roberts	 et	 al.	 1991).	 DNA	 base-pair	mismatches	 and	 IDLs	 are	 detected	 by	
MSH2-MSH6	(MutSα)	and	MSH2-MSH3	(MutSβ),	respectively	(Figure	1.10)	(Drummond,	Li	et	
al.	1995,	Acharya,	Wilson	et	al.	1996,	Palombo,	 Iaccarino	et	al.	1996,	McCulloch,	Gu	et	al.	
2003).	 Following	 the	 detection	 of	 the	 mismatch	 by	 MutSα	 and	 MutSβ,	 the	 MLH1/PMS2	
(MutLα)	 complex	 is	 recruited	which	 forms	a	 ternary	 complex	with	MutSα	and	MutSβ.	The	
formation	of	the	ternary	complex	induces	a	change	in	the	conformation	which	is	necessary	
for	the	movement	of	the	complex	away	from	the	site	of	the	mismatch	(Gradia,	Acharya	et	al.	
1997).	 This	 induces	 the	 endonuclease	 activity	 of	 the	 PMS2	 subunit	 of	 MutLα	 which	 is	
responsible	for	creating	a	‘nick’	5’	to	the	mismatch,	and	the	mismatch	is	then	subsequently	
removed	by	the	exonuclease	EXO1	(Genschel,	Bazemore	et	al.	2002,	Kadyrov,	Dzantiev	et	al.	
2006).	DNA	gap	filling	is	achieved	by	the	DNA	polymerase	Pol	δ	which	is	dependent	on	PCNA	
and	replication	factor	C	(RFC)	(Longley,	Pierce	et	al.	1997,	Gu,	Hong	et	al.	1998).	Ligation	by	
DNA	ligase	I	of	the	newly	synthesised	strands	completes	MMR	(Figure	1.10)	(Zhang,	Yuan	et	
al.	2005).	
1.2.2.4	Interstrand	Cross-Link	Repair	
Interstrand	cross-links	(ICLs)	can	be	defined	as	the	covalent	linkage	between	the	two	
strands	of	the	double	helix.	ICLs	are	highly	toxic	to	the	cell	since	they	prevent	the	separation	
of	DNA	strands	during	DNA	replication	and	transcription.	The	Fanconi	anaemia	(FA)	pathway	
is	 responsible	 for	 the	 resolution	 of	 ICLs	 (Raschle,	 Knipscheer	 et	 al.	 2008).	 FANCM	 is	
responsible	 for	 recognition	 of	 ICLs	 during	 DNA	 replication.	 FANCM	 forms	 a	 heterodimeric	
complex	with	FA-associated	protein	24kDa	 (FAAP24),	which	 is	necessary	 for	 the	 specificity	
and	stability	of	the	FANCM	protein	(Ciccia,	Ling	et	al.	2007).	Following	recognition	of	the	ICL		
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Figure	1.11:	 Interstrand	Cross-Link	Repair.	 ICLs	are	recognised	by	FANCM	which	 leads	
to	the	recruitment	of	the	FA	core	complex	and	the	subsequent	monoubiquitination	of	
the	ID	complex	(FANCI	and	FANCD2).	The	ID	complex	is	retained	at	the	chromatin	which	
leads	to	the	recruitment	of	repair	proteins	such	as	nucleases	and	polymerases.	BRCA1	
and	 BRCA2	 are	 responsible	 for	 the	 initiation	 of	 homologous	 recombination	 (adapted	
from	Deans	and	West	2011).		
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by	FANCM,	the	FA	core	complex	(comprised	of	FANCA/B/C/E/F/G/L)	is	recruited	to	the	ICL.	
The	FA	core	complex	has	E3	ubiquitin	ligase	activity	which	together	with	the	E2-conjugating	
enzyme	 UBE2T,	 is	 responsible	 for	 the	 monoubiquitination	 of	 FANCI	 (I)	 and	 FANCD2	 (D),	
which	 together	 form	 the	 ID	 complex	 (Machida,	 Machida	 et	 al.	 2006).	 The	
monoubiquitination	 of	 FANCI	 and	 FANCD2	 leads	 to	 the	 retention	 of	 these	 proteins	 at	
chromatin,	 where	 they	 can	 coordinate	 ICL	 repair	 through	 the	 recruitment	 of	 other	 FA	
proteins	such	as	FANCD1,	FANCJ,	FANCN,	FANCO	and	FANCP,	as	well	as	nucleases	(such	as	
FAN1)	and	polymerases	(such	as	Pol	ν)	that	are	necessary	for	ICL	repair	(MacKay,	Declais	et	
al.	2010,	Moldovan,	Madhavan	et	al.	2010).	The	removal	of	the	ICL	involves	the	generation	
of	two	incisions	on	one	DNA	strand	flanking	the	ICL,	resulting	in	the	‘unhooking’	of	the	ICL.		
Translesion	 synthesis	 then	 occurs	 over	 the	 ICL	 on	 the	 intact	 strand,	 followed	 by	 further	
incisions	to	remove	the	lesion	and	homologous	recombination	to	repair	the	DSB	formed	by	
the	incision	events	(Moldovan,	Madhavan	et	al.	2010).	The	downstream	FA	proteins	BRCA1	
(FANCS)	 and	 BRCA2	 (FANCD1)	 are	 responsible	 for	 the	 regulation	 of	 homologous	
recombination	which	is	required	for	the	stabilisation	of	the	replication	fork	during	ICL	repair	
(Figure	1.11)(Deans	and	West	2011).				
1.2.3	The	Cell	Cycle	
There	 are	 four	 phases	 of	 the	 cell	 cycle;	 gap-phase	 1	 (G1),	 DNA	 synthesis	 (S),	 gap-
phase	2	(G2)	and	mitosis	(M)	(Figure	1.12).	Progression	through	the	cell	cycle	is	controlled	by	
Cyclin	 dependent	 kinases	 (CDKs)	 together	with	 Cyclins	 that	 are	 the	 regulatory	 subunits	 of	
CDKs	which	are	responsible	for	kinase	activity	and	substrate	specificity.	When	cells	are	in	G0	
or	G1,	mitogenic	signals	stimulate	the	expression	of	Cyclin	D	proteins	which	associate	with		
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Figure	1.12:	The	Cell	Cycle	and	Cell	Cycle	Checkpoints.	Progression	through	the	four	phases	
of	 the	 cell	 cycle	 (G1,	 S,	 G2	 and	 M)	 is	 controlled	 by	 Cyclin-CDK	 complexes.	 Progression	
through	G1	is	governed	by	Cyclin	D-CDK4/6	and	Cyclin	E-CDK2	complexes.	The	formation	of	
the	 Cyclin	 A-CDK2	 complex	 marks	 the	 S/G2	 transition.	 Formation	 of	 the	 Cyclin	 A-CDK1	
complex	promotes	the	G2/M	transition.	Finally,	the	Cyclin	B-CDK1	complex	marks	the	G2/M	
transition.	 The	 CDC25	 phosphatases	 are	 responsible	 for	 the	 removal	 of	 inhibitory	
phosphatases	 on	 the	 Cyclin-CDK	 complexes.	 p21	 is	 able	 to	 inhibit	 Cyclin-CDK	 complexes	
during	G1.	Chk1/Chk2	are	able	to	phosphorylate	CDC25A	during	G1/S	phase,	 inhibiting	 its	
activity	and	in	turn	the	Cyclin-CDK	complex.	During	G2/M,	the	Chk1/Chk2/Plk/MAPK	kinases	
are	able	to	inhibit	CDC25A/B/C	and	in	turn	G2/M	Cyclin-CDK	complexes.			
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CDK4	and	CDK6,	activating	their	kinase	activities	(Matsushime,	Quelle	et	al.	1994,	Meyerson	
and	 Harlow	 1994).	 The	 formation	 of	 the	 active	 Cyclin	 D-CDK4/6	 complexes	 leads	 to	 the	
phosphorylation	 of	 the	 tumour	 suppressor	 pRB	 and	 its	 homologues	 p107	 and	 p130	 (Cao,	
Faha	et	al.	1992,	Ewen,	Sluss	et	al.	1993,	Kato,	Matsushime	et	al.	1993,	Beijersbergen,	Carlee	
et	al.	1995,	Mayol,	Garriga	et	al.	1995,	Ezhevsky,	Nagahara	et	al.	1997).	Phosphorylation	of	
pRB	leads	to	its	dissociation	from	E2F	transcription	factors	which	it	binds	to	when	in	its	non-
phosphorylated	 form	 (Chellappan,	 Hiebert	 et	 al.	 1991).	 Free	 E2F	 is	 able	 to	 stimulate	 the	
transcription	of,	amongst	a	number	of	proteins,	Cyclin	E	that	associates	with	CDK2	(Ohtani,	
DeGregori	 et	 al.	 1995).	 The	 Cyclin	 E-CDK2	 complex	 also	 phosphorylates	 pRB	 leading	 to	
further	dissociation	of	pRB	from	E2F,	which	leads	to	the	transcriptional	activation	of	S	phase	
genes	 and	 the	 G1/S	 phase	 transition	 (Lundberg	 and	Weinberg	 1998,	 Harbour,	 Luo	 et	 al.	
1999).	At	the	later	stages	of	DNA	replication	(S	phase),	Cyclin	A	binds	to	CDK2	and	this	marks	
the	S/G2	transition.	During	S	and	G2	phases,	transcription	factors	activate	the	transcription	
of	Cyclin	B1	(required	for	M	phase),	which	is	driven	by	the	Cyclin	A-CDK2	complexes.	Cyclin	A	
then	 associates	with	 CDK1,	 promoting	 the	 G2/M	 transition	where	 it	 is	 then	 subsequently	
degraded.	 During	 G2,	 Cyclin	 B1-CDK1	 complexes	 remain	 inactive	 through	 the	
phosphorylation	of	CDK1	on	Tyr15	and	Tyr14	by	the	Wee1	and	myelin	transcription	factor	1	
(Myt1)	kinases,	respectively	(Parker	and	Piwnicaworms	1992,	Liu,	Stanton	et	al.	1997).	The	
cell	 division	 cycle	 25	 C	 (CDC25C)	 phosphatase	 is	 responsible	 for	 the	 dephosphorylation	 of	
CDK1,	 thus	 activating	 the	 Cyclin	 B1-CDK1	 complex	 which	 triggers	 the	 G2/M	 transition	
(Malumbres	 and	 Barbacid	 2009).	 Active	 Cyclin	 B1-CDK1	 complexes	 are	 then	 able	 to	
phosphorylate	 CDC25A/B/C,	 forming	 a	 positive	 feedback	 loop	 for	 the	 activation	 of	 more	
Cyclin	B1-CDK1	complexes	(Figure	1.12)	(Izumi	and	Maller	1993).	
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1.2.3.1	The	Cell	Cycle	Checkpoints	
1.2.3.1.1	The	G1	Checkpoint	
The	G1	checkpoint	is	in	place	to	prevent	damaged	DNA	from	being	replicated	during	
the	 subsequent	 S	 phase.	G1	 checkpoint	 arrest	 is	 achieved	 through	DNA	damage-activated	
signalling	cascades	that	ultimately	lead	to	the	inhibition	of	the	Cyclin	D-CDK4/6	and	Cyclin	E-
CDK2	complexes	and	thus	halt	the	cell	cycle	at	G1.	Following	the	detection	of	DNA	damage,	
ATM	becomes	phosphorylated	leading	to	the	activation	of	Chk2	(see	Section	1.2.1.1),	which	
in	turn	leads	to	the	phosphorylation	of	the	transcriptional	activator	p53	(by	both	Chk2	and	
ATM	directly)(Banin,	Moyal	et	al.	1998,	Canman	and	Kastan	1998,	Shieh,	Ahn	et	al.	2000).	
Subsequently	 p53	 becomes	 transcriptionally	 activated	 and	 stabilised	 through	 the	
phosphorylation-mediated	 disruption	 of	 p53	 mouse	 double	 minute	 2	 (MDM2)	 binding,	
which	prevents	MDM2-mediated	nuclear	export	and	degradation	of	p53	(Dumaz	and	Meek	
1999,	 Schon,	 Friedler	 et	 al.	 2002).	 The	 activation	 and	 stabilisation	 of	 p53	 leads	 to	 the	
transcriptional	 activation	 of	 a	 number	 of	 target	 genes	 including	 p21,	 which	 inhibits	 G1/S	
entry	 through	 its	 role	 as	 a	CDK	 inhibitor,	 subsequently	 inhibiting	 the	Cyclin	D-CDK4/6	and	
Cyclin	D-CDK2	complexes	and	preventing	the	transition	into	S	phase	(He,	Siddik	et	al.	2005).	
ATM-mediated	 Chk2	 activation	 also	 leads	 to	 the	 removal	 of	 CDC25A,	 a	 phosphatase	 that	
normally	acts	to	remove	the	inhibitory	phosphatases	from	CDK2	and	thus	inhibit	the	Cyclin	
E-CDK2	 complexes,	 preventing	 the	G1/S	 transition.	 There	 is	 also	 evidence	 to	 suggest	 that	
ATR	is	able	to	directly	phosphorylate	p53	to	induce	cell	cycle	arrest	following	DNA	damage,	
inducing	 further	 inhibition	 of	 the	 Cyclin	 E-CDK2	 complexes	 (Tibbetts,	 Brumbaugh	 et	 al.	
1999).	
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1.2.3.1.2	The	S	Phase	Checkpoint	
The	 S	 phase	 checkpoint	 exists	 to	 ensure	 that	 damaged	 DNA	 is	 not	 replicated.	
Activation	of	 the	S	phase	checkpoint	 through	 the	ATR/Chk1	signalling	pathway	 targets	 the	
Cyclin-CDK	and	CDC7-DBF4	protein	kinase	(DDK)	complexes	which	act	to	inhibit	the	firing	of	
primed	 origins	 (Heffernan,	 Unsal-Kacmaz	 et	 al.	 2007,	 Zegerman	 and	 Diffley	 2010).	 The	
checkpoint	 also	 exists	 in	 order	 to	 preserve	 the	 integrity	 of	 the	 replication	 forks	 following	
replication	 stress,	 allowing	 time	 for	DNA	 repair	 before	 it	 is	met	 by	 an	ongoing	 replication	
fork	 (see	 Section	 1.2.4.2.2	 for	 a	 detailed	 discussion	 of	 the	 S	 phase	 checkpoint	 during	
replication).	The	S	phase	checkpoint	also	detects	DSBs	that	occur	during	S	phase	that	are	not	
associated	 with	 active	 replicons.	 DSBs	 that	 occur	 during	 S	 phase	 are	 recognised	 by	 the	
ATM/Chk2	signalling	pathway	 (see	Section	1.2.1.1),	which	 is	ultimately	activated	 to	 induce	
the	 degradation	 of	 the	 S	 phase	 promoting	 phosphatase	 CDC25A.	 Degradation	 of	 CDC25A	
leads	to	the	maintenance	of	the	inhibitory	phosphorylation,	normally	removed	by	CDC25A,	
of	the	CDK2	component	of	the	Cyclin	E/A-CDK2	complexes,	leading	to	the	inhibition	of	these	
complexes.	This	 inhibition	prevents	cell	division	cycle	45	(CDC45)	 loading	at	pre-replication	
complexes	 (see	Section	1.2.4.1),	 and	 therefore	 inhibits	 firing	of	 any	 remaining	origins	 that	
have	 been	 primed	 for	 replication	 initiation	 (Falck,	Mailand	 et	 al.	 2001).	 Activation	 of	 the	
ATR/Chk1	 pathway	 also	 leads	 to	 the	 proteasome-mediated	 degradation	 of	 CDC25A,	 thus	
also	 contributing	 to	 the	 activation	 of	 the	 S	 phase	 checkpoint	 (Zhao,	Watkins	 et	 al.	 2002,	
Sorensen,	Syluasen	et	al.	2003).				
1.2.3.1.3	The	G2/M	Checkpoint	
The	G/M	checkpoint	is	in	place	to	prevent	the	segregation	of	damaged	chromosomes	
which	have	either	 incurred	unrepaired	damage	during	G2	phase,	or	S	or	G1	phase.	At	 the	
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G2/M	checkpoint,	the	CDC25	phosphatases	(CDC25A,	CDC25B,	CDC25C)	are	phosphorylated	
leading	 to	 the	 inactivation	 of	 the	 Cyclin	 B1-CDK1	 complex	 which	 is	 necessary	 for	 the	
progression	 into	M	phase.	 Following	 the	activation	of	Chk1	and/or	Chk2	by	ATR	and	ATM	
kinases	respectively,	active	Chk1/Chk2	is	able	to	phosphorylate	CDC25C,	stimulating	the	14-
3-3	family	of	proteins	to	bind	to	CDC25C;	this	sequesters	CDC25C	to	the	cytoplasm,	where	it	
is	no	longer	able	to	remove	the	inhibitory	phosphorylation	from	CDK1	of	the	Cyclin	B1-CDK1	
complex	 (Kumagai	 and	 Dunphy	 1999,	 Lopez-Girona,	 Furnari	 et	 al.	 1999).	 Proteins	 of	 the	
mitogen-activated	 protein	 kinase	 (MAPK)	 pathway	 have	 also	 been	 shown	 to	 be	 able	 to	
phosphorylate	 CDC25A,	 CDC25B	 and	 CDC25C,	 also	 leading	 to	 14-3-3	 binding	 and	
sequestering	 of	 these	 proteins	 to	 the	 cytoplasm	 (Bulavin,	 Higashimoto	 et	 al.	 2001,	
Reinhardt,	Aslanian	et	 al.	 2007).	ATM/ATR-mediated	phosphorylation	of	polo-like	 kinase	3	
(Plk3)	has	also	been	 shown	 to	 further	 inhibit	CDC25	 function	during	 the	G2/M	checkpoint	
(Bahassi,	Hennigan	et	al.	2004).	p53	is	also	involved	in	G2/M	checkpoint	arrest	through	the	
transcriptional	activation	of	cell	cycle	inhibitors	such	as	p21,	14-3-3σ	and	growth	arrest	and	
DNA	damage	 inducible	45	alpha	 (GADD45).	p21	 is	 able	 to	 inhibit	CDK1	directly,	 14-3-3σ	 is	
responsible	 for	 the	 relocalisation	 of	 CDK1	 to	 the	 cytoplasm,	 and	GADD45	 prevents	 CDK1-
Cyclin	B1	binding	(Hermeking,	Lengauer	et	al.	1997,	Wang,	Zhan	et	al.	1999,	Zhan,	Antinore	
et	al.	1999).			
1.2.4	DNA	Replication	
1.2.4.1	DNA	Replication	Initiation	
The	 initiation	 of	 DNA	 replication	 is	 a	 two-step	 process	 involving	 origin	 licensing	
followed	 by	 origin	 firing.	 Origin	 licensing	 begins	 during	 the	 late	 phases	 of	 mitosis	 and	
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continues	 through	 to	 the	 G1	 phase	 of	 the	 cell	 cycle.	 The	 onset	 of	 origin	 licensing	 occurs	
when	the	hexameric	origin	recognition	complex	1-6	(ORC	1-6)	recruits	cell	division	cycle	10-
dependent	transcript	1	(Cdt1)	and	cell	division	cycle	6	(Cdc6)	proteins	to	replication	origins	
(Bell	 and	 Stillman	 1992,	 Gavin,	 Hidaka	 et	 al.	 1995,	 Piatti,	 Lengauer	 et	 al.	 1995,	 Nishitani,	
Lygerou	 et	 al.	 2000).	 Together,	 these	 proteins	 load	 the	 helicase	 component,	 mini	
chromosome	 maintenance	 (MCM)	 2-7	 protein	 complexes	 onto	 origins	 of	 replication;	 the	
proteins	 loaded	 at	 these	 origins	 together	 form	 a	 complex	 termed	 the	 pre-replicative	
complexes	(pre-RCs)	(Evrin,	Clarke	et	al.	2009).		Cyclin	A/CDK2	activity	marks	the	G1/S	phase	
transition	where	origin	 firing	 is	 initiated.	 In	mammalian	 cells,	 the	pre-RC	 component	Cdc6	
becomes	 phosphorylated	 upon	 S	 phase	 entry,	 leading	 to	 its	 dissociation	 from	 the	 pre-RC	
complex	 into	 the	cytoplasm	 (Petersen,	 Lukas	et	al.	1999).	Origin	 firing	during	S	phase	also	
involves	 the	 activation	 of	 the	 MCM	 2-7	 hexamer	 and	 is	 achieved	 by	 the	 subsequent	
association	of	Cdc45	and	MCM10	with	the	pre-RC	complex,	which	then	associates	with	GINS	
to	 form	 the	 active	 helicase	 complex	 (Ilves,	 Petojevic	 et	 al.	 2010).	 Treslin	 and	 TOPBP1	
associate	with	pre-RCs	which	forms	the	pre-initiation	complex	(Kumagai,	Shevchenko	et	al.	
2010).	Entry	into	S	phase	and	subsequent	origin	firing	also	involves	the	activation	of	the	DDK	
protein	kinase,	which	 is	able	to	phosphorylate	a	number	of	pre-initiation	complex	proteins	
(Heller,	Kang	et	al.	2011).	The	active	helicase	is	then	able	to	unwind	DNA	at	the	origin	site.	
GINS	and	Cdc45	are	thought	to	be	involved	in	the	recruitment	of	DNA	replication	machinery,	
which	 includes	 PCNA,	 Polα	 primase,	 RPA,	 and	 the	 leading	 and	 lagging	 strand	 DNA	
polymerases	Pol	ε	and	Pol	δ,	to	the	origin	(Aparicio,	Stout	et	al.	1999,	De	Falco,	Ferrari	et	al.	
2007).	The	loading	of	the	DNA	replication	machinery	behind	the	active	helicase	leads	to	the	
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formation	of	the	replisome	which	is	able	to	move	bi-directionally	along	the	DNA,	continuing	
to	replicate	the	DNA	over	the	entire	genome.			
1.2.4.2	Replication	Stress	
Replication	 stress	 can	 be	 defined	 as	 any	 perturbation	 in	 the	 process,	 coordination	
and	timing	of	DNA	synthesis.	One	way	of	inducing	replication	stress	is	the	slowing	or	stalling	
of	 the	 replication	 fork	 during	 DNA	 synthesis	 in	 response	 to	 a	 particular	 replication	 fork	
barrier	(RFB).	There	are	a	number	of	RFBs	that	have	the	capacity	to	lead	to	replication	stress,	
including	 unresolved	 DNA	 lesions,	 DNA-bound	 proteins	 and	 secondary	 structures	 (Zeman	
and	 Cimprich	 2014).	 A	 number	 of	 exogenous	 agents	 can	 also	 induce	 replication	 stress	
including	 agents	 that	 inhibit	 DNA	 elongation	 such	 as	 the	 DNA	 polymerase	 inhibitor	
aphidicolin,	 and	 the	 ribonucleotide	 reductase	 (RNR)	 inhibitor	 hydroxyurea	 (HU)	 (Yarbro	
1968,	Krokan,	Wist	et	al.	1981).	RNR	catalyses	the	conversion	of	NDPs	into	dNDPs,	which	is	
the	rate	limiting	step	in	the	production	of	dNTPs	(Jordan	and	Reichard	1998).	HU	treatment	
therefore	 depletes	 dNTP	 pools	 which	 stalls	 replication	 forks	 (Bianchi,	 Pontis	 et	 al.	 1986).	
Prolonged	exposure	to	HU	stalled	replication	forks	collapse	into	DSBs.	It	is	essential	that	the	
cell	is	able	to	respond	effectively	to	replication	stress	since	unresolved	replication	stress	can	
ultimately	lead	to	fork	collapse,	incomplete	DNA	replication	and	DNA	breakage.		
Replication	 fork	 stalling	 can	 be	 defined	 as	 a	 temporary	 ‘pause’	 in	 replication	 fork	
progression	 in	response	to	a	RFB.	Following	the	removal	of	the	RFB,	the	stalled	replication	
fork	 is	 able	 to	 resume	 fork	progression.	 Fork	 collapse	 can	be	defined	as	 a	 replication	 fork	
which	 is	 no	 longer	 able	 to	 complete	 replication	 in	 response	 to	 replication	 stress.	 Fork	
collapse	 is	normally	associated	with	the	dissociation	of	the	replisome,	and	deterioration	of	
the	replication	fork	into	a	DSB,	which	occurs	passively	(normally	after	long	replication	blocks)	
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or	actively	via	MUS81	endonuclease	cleavage	(Hanada,	Budzowska	et	al.	2007).	To	prevent	
fork	collapse,	replication	forks	must	be	stabilised	and	their	replisomes	retained	with	the	fork	
(see	Section	1.2.4.2.2	for	discussion	on	fork	stabilisation).	Replication	forks	subjected	to	long	
periods	of	fork	stalling	become	inactivated	and	are	no	longer	able	to	undergo	fork	restart.	In	
this	 instance,	 global	new	origin	 firing	 is	 responsible	 for	 the	 completion	of	DNA	 replication	
(Woodward,	Gohler	et	al.	2006,	Ge,	Jackson	et	al.	2007,	Petermann,	Orta	et	al.	2010).		
The	 replication	 fork	 has	 a	 number	 of	 defence	mechanisms	 that	 act	 to	 resolve	 replication	
stress.	 Firstly,	 the	 simplest	 mechanism	 to	 avoid	 replication	 stress	 is	 to	 resolve	 any	 DNA	
lesions	before	they	are	met	by	the	replication	fork.	This	can	be	performed	by	any	number	of	
DNA	 repair	 mechanisms	 depending	 on	 the	 type	 of	 damage	 incurred	 (see	 Section	 1.2.2).	
Secondly,	 if	 the	 damage	 is	 not	 resolved	 before	 association	 with	 the	 replication	 fork,	
activation	 of	 the	 replication	 checkpoint	 can	 act	 to	 temporarily	 stall	 the	 replication	 fork,	
which	can	then	be	stabilised	and	restarted	following	clearance	of	the	damage.	Finally,	if	the	
two	 previous	 mechanisms	 fail	 to	 clear	 the	 RFB	 and	 replication	 remains	 stalled,	 complex	
restart	mechanisms	are	employed	which	act	to	restart	and	complete	replication	(see	Section	
1.2.4.2.3).	
1.2.4.2.1	Sources	of	Replication	Stress	
There	are	numerous	RFBs	that	can	lead	to	replication	stress	including	DNA	damage,	
DNA-bound	protein	and	DNA	structures	amongst	others.	The	generation	of	replication	stress	
most	 commonly	 results	 in	 the	 formation	 of	 ssDNA	 as	 a	 result	 of	 DNA	 helicase	 activity	
continuing	 to	 unwind	 the	 double	 helix	 when	 the	 polymerase	 has	 stalled.	 The	 type	 of	
replication	 fork	arrest	 induced	by	 these	RFBs	 is	dependent	on	 the	 lesion/structure	 formed	
(Figure	1.13)	(Zeman	and	Cimprich	2014).		
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Figure	 1.13:	 Sources	 of	 Replication	 Stress.	 There	 are	 a	 number	 of	 replication	 fork	
barriers	that	can	perturb	the	progression	of	DNA	synthesis	and	lead	to	replication	stress.	
These	 include	 limited	 nucleotide	 pools,	 DNA	 lesions,	 fragile	 sites,	 ribonucleotide	
incorporation,	 DNA	 secondary	 structures,	 repetitive	 DNA	 and	 transcription/RNA-DNA	
hybrids.	 The	 mechanisms	 by	 which	 these	 replication	 fork	 barriers	 are	 resolved	 are	
highlighted	in	bold	(adapted	from	Zeman	and	Cimprich	2004).		
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One	common	unresolved	RFB	 is	DNA	damage,	which	 includes	 lesions	such	as	bulky	
adducts,	alkylated	bases,	pyrimidine	dimers	and	abasic	sites.	These	unresolved	lesions	pose	
a	problem	for	the	replicating	polymerases,	since	they	cannot	replicate	past	these	sites.	The	
translesion	 synthesis	 (TLS)	 pathway	 acts	 to	 resolve	 this	 problem	by	 employing	 a	 group	 of	
‘error-prone’	 polymerases,	 termed	 TLS	 polymerases,	 which	 are	 able	 to	 incorporate	
nucleotides	 opposite	 the	 damaged	 base	 allowing	 replication	 to	 proceed	 (Cordeiro-Stone,	
Zaritskaya	et	al.	1997,	Gibbs,	McGregor	et	al.	1998,	Gerlach,	Aravind	et	al.	1999).	Blocking	of	
the	 replication	 machinery	 resulting	 in	 uncoupling	 of	 polymerase	 and	 helicase	 activities	
induces	 the	 monoubiquitination	 of	 PCNA	 on	 lysine	 164	 which	 is	 catalysed	 by	 the	 E2	
ubiquitin-conjugating	enzyme	Rad6	and	the	E3	ubiquitin	ligase	Rad18	(Hoege,	Pfander	et	al.	
2002,	 Stelter	 and	 Ulrich	 2003).	 The	 ubiquitination	 of	 PCNA	 aids	 the	 association	 with	 TLS	
polymerases	 which	 are	 then	 able	 to	 by-pass	 the	 lesion,	 but	 sometimes	 at	 the	 cost	 of	
mutagenesis	 (Hoege,	 Pfander	 et	 al.	 2002,	 Stelter	 and	Ulrich	 2003,	 Kannouche,	Wing	et	 al.	
2004).	 	 Poly-ubiquitination	 of	 PCNA	 leads	 to	 a	 mode	 of	 damage	 by-pass	 that	 is	 less	
characterised	but	is	considered	to	be	error-free	(Moldovan,	Pfander	et	al.	2007).		
Single-strand	 gaps	 and	 DSBs	 also	 pose	 a	 serious	 threat	 to	 DNA	 replication.	 The	
consequence	 of	 a	 replication	 fork	meeting	 a	 single-strand	 gap	 or	 DSB	 is	 thought	 to	 be	 a	
broken	fork	with	one	arm	becoming	a	DSB,	and	two	double-strand	ends	respectively	(Cortes-
Ledesma	 and	 Aguilera	 2006).	 As	 a	 defence	 mechanism	 against	 the	 generation	 of	 passive	
DSBs,	 there	 is	 some	evidence	 to	 suggest	 that	 the	 replication	 fork	 is	 able	 to	 slow	down,	 in	
order	to	allow	for	DNA	repair	mechanisms	to	clear	the	damage	before	the	fork	arrives,	which	
would	 ultimately	 lead	 to	 replisome	 dissociation	 at	 the	 break	 and	 incomplete	 replication	
(Chaudhuri,	Hashimoto	et	al.	2012).		
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Mis-incorporation	of	ribonucleotides	into	the	DNA	backbone	is	a	significant	source	of	
replication	 stress.	 Sometimes,	 the	 replicative	 polymerases,	 Pol	 δ	 and	 Pol	 ε,	 erroneously	
incorporate	 ribonucleotides	 (rNTPs)	 instead	of	deoxyribonucleotides	 (dNTPs)	 into	 the	DNA	
backbone	 during	 DNA	 replication	 (McElhinny,	Watts	 et	 al.	 2010).	Mis-incorporated	 rNTPs	
must	be	 removed	 from	 the	DNA	backbone	 since	polymerases	 cannot	 replicate	past	 these.	
Mis-incorporated	rNTPs	are	removed	from	the	DNA	backbone	by	the	ribonucleotide	repair	
pathway,	 whereby	 RNase	 H2	 is	 responsible	 for	 the	 recognition	 and	 excision	 of	 the	 rNTP,	
together	with	the	endonucleases	FEN1	and	EXO1	(Sparks,	Chon	et	al.	2012).	In	the	absence	
of	 RNase	 H2-mediated	 excision	 of	 rNTPs,	 the	 TLS	 polymerases	 are	 able	 to	 bypass	 them	
(Lazzaro,	Novarina	et	al.	2012).		
Replication	stress	can	also	be	induced	by	DNA	structures	that	deviate	from	the	right-
handed	double	helix	B	 form	of	DNA.	Such	structures	 include	hairpins,	 triplexes,	cruciforms	
and	 G4	 quadruplexes	 (Gacy,	 Goellner	 et	 al.	 1995,	 Paeschke,	 Bochman	 et	 al.	 2013).	 The	
formation	of	these	structures	leads	to	a	significant	challenge	for	the	replication	fork.	These	
structures	 are	 thought	 to	 be	 resolved	by	 specific	 helicases,	which	 act	 to	 dissociate	 bound	
DNA	structures,	as	well	as	nucleases	(Mre11,	FEN1,	EXO1	and	DNA2)	which	are	thought	to	
cleave	 secondary	 structures	 (Sun,	 Karow	 et	 al.	 1998,	 Fry	 and	 Loeb	 1999,	 Ghosal	 and	
Muniyappa	 2005,	Masuda-Sasa,	 Polaczek	 et	 al.	 2008,	Wu,	 Shin-ya	 et	 al.	 2008,	 Vallur	 and	
Maizels	2010).		
Since	 both	 replication	 and	 transcription	occur	 on	DNA,	 it	 is	 not	 surprising	 that	 the	
two	machineries	have	 the	capacity	 to	collide.	Whilst	DNA	replication	 is	 restricted	 to	occur	
only	during	S	phase,	and	transcription	normally	occurs	during	G1	phase,	the	latter	can	also	
proceed	during	 S	phase.	 It	 is	 thought	 that	 replication	and	 transcription	occurring	during	 S	
		 50	
phase	 is	 spatially	 separated	 from	 the	 DNA	 replication	 machinery	 in	 order	 to	 prevent	
collision.	Interestingly,	there	are	a	number	of	human	genes	that	are	so	large	they	need	more	
than	 one	 cell	 cycle	 to	 be	 completely	 transcribed,	 in	 these	 cases	 the	 replication	 and	
transcriptional	machinery	are	known	to	associate	(Helmrich,	Ballarino	et	al.	2011).	Helicases	
and	 topoisomerases	 are	 known	 to	 unwind	 the	 DNA	 and	 ease	 the	 topological	 stress	
associated	 with	 replication	 and	 transcription	 machinery	 that	 are	 in	 close	 proximities	
(Bermejo,	Capra	et	al.	2009,	Tuduri,	Crabbe	et	al.	2009).		
The	 formation	 of	 R-loops	 can	 also	 cause	 significant	 replication	 stress;	 they	 can	 be	
defined	 as	 an	 RNA-DNA	 hybrid	 structure	with	 a	 displaced	 ssDNA	 strand.	 These	 structures	
cannot	 be	 replicated	 and	 are	 a	 significant	 barrier	 to	 the	 replication	 machinery.	 The	
formation	 of	 R-loops	 can	 be	 resolved	 by	 specialised	 RNA-DNA	 helicases,	 that	 operate	 to	
unwind	such	RFBs,	or	through	the	enzyme	RNase	H,	which	dissolves	the	RNA	portion	of	the	
structure	(Huertas	and	Aguilera	2003,	Alzu,	Bermejo	et	al.	2012).			
There	are	certain	regions	 in	the	genome	that	are	known	to	be	difficult	to	replicate,	
such	regions	are	predisposed,	by	default,	to	replication	stress,	and	are	termed	fragile	sites.	
Two	types	of	fragile	site	exist,	early-replicating	fragile	sites	(ERFSs)	and	common	fragile	sites	
(CFSs).	 ERFSs,	 as	 the	 name	 suggests,	 replicate	 early,	 have	 a	 high	G/C	 content	 and	 have	 a	
relaxed	 chromatin	 configuration	 (Barlow,	 Faryabi	 et	 al.	 2013).	 CFSs	 replicate	 late,	 are	 A/T	
rich	 and	 have	 a	 condensed	 chromatin	 state	 (Smeets	 and	 van	 de	 Klundert	 1990).	 Most	
significantly,	CFSs	are	prone	to	the	formation	of	secondary	structures	and	the	generation	of	
DSBs	 induced	by	replication	stress.	CFSs	are	thought	to	be	susceptible	to	replication	stress	
because	 they	 have	 a	 reduced	 number	 of	 replication	 origins,	 which	 leads	 to	 incomplete	
replication	due	 to	 lack	of	origin	 firing	upon	 replication	 stress.	 These	 regions	of	 replication	
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stress	 are	 targeted	 by	 the	 nucleases	 MUS81-EME1	 or	 ERCC1,	 resulting	 in	 controlled	 DSB	
events.	These	controlled	breaks	are	thought	to	maintain	genomic	stability	(Naim,	Wilhelm	et	
al.	2013,	Ying,	Minocherhomji	et	al.	2013).	 	More	recently,	 the	nuclease	activity	of	MUS81	
was	 shown	 to	 stimulate	DNA	 synthesis	 at	 these	 regions	 in	mitosis,	 a	mechanism	which	 is	
thought	to	preserve	genomic	stability	(Minocherhomji,	Ying	et	al.	2015).	
The	over-expression	of	oncogenes	including	Cyclin	E,	HRAS	and	c-Myc	can	also	induce	
replication	stress.	It	is	thought	that	the	over-expression	or	mutation	of	these	genes	leads	to	
the	depletion	of	nucleotide	pools	and	replication/transcription	machinery	collision	through	
increased	origin	firing	and/or	increased	initiation	events	(Halazonetis,	Gorgoulis	et	al.	2008,	
Jones,	 Mortusewicz	 et	 al.	 2013,	 Srinivasan,	 Dominguez-Sola	 et	 al.	 2013).	 Finally,	 limiting	
replication	factors	such	as	the	replication	machinery	itself,	nucleotides,	histones	and	histone	
deposition	machinery,	which	is	responsible	for	the	newly	replicated	DNA	packaging,	can	also	
lead	 to	 replication	 stress	via	 fork	 slowing	 (Figure	1.13)	 (Anglana,	Apiou	et	al.	 2003,	Groth,	
Corpet	et	al.	2007,	Poli,	Tsaponina	et	al.	2012,	Mejlvang,	Feng	et	al.	2014).			
1.2.4.2.2	Checkpoint	Activation	Following	Replication	Stress	
As	previously	discussed,	a	number	of	factors	can	stall	replication	forks	including	DNA	
damage,	DNA-protein	 adducts	 and	 secondary	 structures.	 If	 the	RFB	 is	 not	 resolved	before	
meeting	the	replication	fork,	the	next	mechanism	of	defence	to	protect	against	replication	
fork	collapse	is	to	activate	the	replication	checkpoint	which	prevents	further	replication	until	
the	 damage/lesion	 is	 repaired,	 only	 then	 will	 replication	 proceed.	 A	 common	 structure	
formed	from	replication	stress	is	ssDNA,	which	often	results	from	the	uncoupling	of	the	DNA	
polymerase	 and	 the	 DNA	 helicase,	 whereby	 the	 helicase	 continues	 to	 unwind	 the	 DNA	
following	 the	 stalling	 of	 the	DNA	polymerase	 (Pacek	 and	Walter	 2004).	 The	 generation	of	
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large	stretches	of	ssDNA	activates	the	replication	checkpoint	through	the	activation	of	ATR	
kinase,	 which	 acts	 to	 stall	 the	 cell	 cycle	 and	 thus	 prevent	 further	 DNA	 replication	 during	
replication	 stress	 (see	 Section	 1.2.1.2)	 (Byun,	 Pacek	 et	 al.	 2005).	 The	 active	 ATR	 kinase	
phosphorylates	 and	 activates	 Chk1,	 which,	 when	 activated,	 is	 able	 to	 phosphorylate	 the	
CDC25A,	 CDC25B	 and	 CDC25C	 phosphatases.	 These	 phosphatases	 are	 responsible	 for	 the	
prevention	of	the	activation	of	Cyclin	E/A-Cdk2	and	Cyclin	B-Cdk1,	which	ultimately	leads	to	
arrest	of	the	cell	cycle	allowing	for	repair/restart	of	the	replication	fork	(Sanchez,	Wong	et	al.	
1997,	Zhao,	Watkins	et	al.	2002,	Sorensen,	Syluasen	et	al.	2003).		
ATR	is	also	thought	to	respond	to	replication	stress	with	the	ultimate	aim	of	stabilising	the	
stalled	 replication	 fork	 and	 preventing	 fork	 collapse.	 A	 number	 of	 mechanisms	 of	 fork	
stabilisation	 have	 been	 proposed	 including	 late	 origin	 firing	 inhibition,	 replisome	
stabilisation	and	fork	remodelling	by	repair	enzymes	to	promote	fork	restart.	However,	the	
exact	mechanisms	by	which	ATR	stabilises	stalled	replication	forks	remain	to	be	elucidated.	
In	mammalian	cells,	the	ATR-Chk1	replication	checkpoint	has	been	shown	to	be	responsible	
for	 the	 inhibition	 of	 late	 origin	 firing	 through	 a	 Chk1-mediated	 mechanism	 (Feijoo,	 Hall-
Jackson	et	al.	 2001).	 	 There	 is	 also	evidence	 to	 suggest	 that	 the	 suppression	of	 late	origin	
firing	 is	 controlled	 through	 the	 ATR-mediated	 repression	 of	 CDC45	 chromatin	 binding,	
although	 DDK	 activity	 remains	 (Liu,	 Barkley	 et	 al.	 2006,	 Tsuji,	 Lau	 et	 al.	 2008).	 The	 ATR-
mediated	 inhibition	 of	 CDK2	 and	 the	 phosphorylation	 of	 mixed	 lineage	 leukaemia	 (MLL)	
histone	methyltransferase	are	also	responsible	for	the	suppression	of	late	origin	firing	during	
replication	 stress	 (Liu,	 Takeda	 et	 al.	 2010).	 One	 mechanism	 involved	 in	 replication	 fork	
stabilisation	 was	 thought	 to	 be	 the	 stabilisation	 of	 components	 of	 the	 replisome	 by	 the	
checkpoint	 machinery.	 Studies	 in	 human	 cells	 showed	 that	 the	 amount	 of	 chromatin-
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associated	 replisome	 components	 PCNA,	 POLE,	 POLD2	 and	 CDC45	 was	 reduced	 in	 ATR-
deficient	 cells	 treated	 with	 replicative	 stress	 agents	 when	 compared	 to	 untreated	 cells,	
suggesting	that	the	checkpoint	is	necessary	for	replisome	stabilisation	(Ragland,	Patel	et	al.	
2013).	Furthermore,	the	association	of	the	replisome	component	PCNA	was	impeded	during	
early	 origin	 firing	 following	 inhibition	 of	 ATR	 in	mammalian	 cells	 when	 compared	 to	 ATR	
competent	 cells,	 also	 suggesting	 that	 the	 checkpoint	 is	 important	 for	 replisome	 stability	
(Dimitrova	and	Gilbert	2000).	There	is	also	evidence	to	suggest	that	the	S	phase	checkpoint	
during	replication	stress	is	not	important	for	replisome	stability	at	the	fork	(De	Piccoli,	Katou	
et	 al.	 2012).	 Furthermore,	 recent	 isolation	 of	 proteins	 on	 nascent	 DNA	 (iPOND),	 using	
checkpoint-deficient	 cells,	 showed	 that	 ATR	 signalling	 plays	 no	 significant	 role	 in	 the	
stabilisation	of	the	replisome	but	that	it	is	essential	for	fork	stability	(Dungrawala	and	Cortez,	
unpublished	 data).	 In	 addition	 to	 the	 inhibition	 of	 late	 origin	 firing,	 activation	 of	 the	
replication	 checkpoint	 is	 also	 thought	 to	 stabilise	 stalled	 forks	 through	 the	 ATR-mediated	
activation	of	 repair	proteins	 such	as	Werner	 syndrome	protein	 (WRN),	BLM	and	SWI/SNF-
related	matrix-associated	actin-dependent	regulator	of	chromatin	subfamily	A-like	protein	1	
(SMARCAL1)	(Pichierri,	Rosselli	et	al.	2003,	Davies,	North	et	al.	2004,	Couch,	Bansbach	et	al.	
2013).	Activation	of	these	proteins	 is	required	 in	order	for	fork	restart	and	ultimately,	 fork	
stabilisation	(see	Section	1.2.4.2.3).			
1.2.4.2.3	Restart	Mechanisms	of	Stalled	Replication	Forks	
There	are	certain	scenarios	where	repair	of	the	RFB	is	not	achieved	before	meeting	
the	replication	fork,	or	repaired	following	the	temporary	stalling	of	the	replication	fork	via		
		 54	
	 	
SMARCAL1( BLM(
WRN(
Fork(remodelling(
Resec9on(
Mre11(
PARP1(
Rad51(ﬁlament(
forma9on(
BRCA2(
Rad51(
XRCC3(
Mre11(
Strand(invasion(
DEloop(forma9on(
BLM(TopIIIα(
hRMI1(
HJ(dissolu9on(
Restart(
Polε(
Figure	 1.14:	 A	 Model	 for	 Replication	 Fork	 Restart.	 In	 this	 model	 SMARCAL1	 is	
responsible	for	the	reannealing	of	ssDNA	that	has	formed	as	a	consequence	of	helicase	
polymerase	 uncoupling.	 BLM	 and	 WRN	 are	 responsible	 for	 the	 reversal	 of	 the	
replication	fork	 into	a	Holliday	Junction.	Mre11	 is	 then	recruited	to	the	stalled	fork	by	
PARP1,	which	subsequently	creates	a	3’	overhang	suitable	for	the	generation	of	a	Rad51	
filament.	BRCA2	and	XRCC3	then	load	Rad51	onto	the	3’	overhang.	The	Rad51	filament	
stimulates	strand	invasion	and	D-loop	formation.	The	Holliday	Junction	may	be	resolved	
by	 BLM,	 resulting	 in	 a	 non-crossover	 product	 (adapted	 from	 Jones	 and	 Petermann	
2012).			
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ATR-mediated	 mechanisms.	 It	 is	 at	 this	 point	 that	 replication	 restart	 mechanisms	 are	
employed	in	order	to	ensure	the	complete	replication	of	the	genome.	The	exact	mechanism	
by	 which	 stalled	 replication	 forks	 are	 restarted	 is	 currently	 unknown.	 A	 number	 of	
mechanisms	 for	 fork	 restart	 have	 been	 postulated,	 however,	 including	 the	 enzymatic	
reversal	 of	 stalled	 forks	 into	 a	 ‘chicken-foot’	 structure	 that	 is	 competent	 for	 replication	
(Postow,	Ullsperger	et	 al.	 2001).	 The	 remodelling	of	 stalled	 forks	by	various	ATR-activated	
repair	 proteins	 has	 also	 been	 implicated	 in	 fork	 restart,	 although	 this	 mechanism	 may	
overlap	with	fork	reversal.	HR	as	a	mechanism	of	restart	has	also	been	hypothesised,	as	well	
as	DSB-mediated	 restart	mechanisms,	which	will	 be	described	 in	 the	 following	paragraphs	
(Figure	1.14)	(reviewed	in	(Jones	and	Petermann	2012)).		
	
Reversal	of	Replication	Forks	
Replication	fork	reversal	can	be	defined	as	the	processing	of	a	replication	fork	which	
comprises	 a	 typical	 three-way	 fork,	 into	 a	 four-way	 junction	 through	 the	 annealing	of	 the	
newly	 synthesised	DNA	strands,	and	 the	 re-annealing	of	 the	parental	 strands,	producing	a	
structure	which	has	essentially	‘back-tracked’	along	the	replicating	DNA	(Postow,	Ullsperger	
et	al.	2001).	The	consequences	of	 fork	reversal	are	thought	to	be	three-fold.	Firstly,	 in	the	
context	of	a	DNA	lesion	causing	the	replication	stress,	fork	reversal	can	back-track	the	DNA	
lesion	 into	 the	 double-stranded	 region	 of	 the	 DNA,	 allowing	 the	 lesion	 to	 be	 excised	 by	
conventional	excision	mechanisms.	Secondly,	annealing	of	 the	 two	newly	synthesised	DNA	
strands	limits	the	extent	of	exposed	ssDNA,	therefore	promoting	the	stabilisation	of	the	fork.	
Finally,	 fork	 regression	 allows	 lesion	 bypass	 through	 template	 switching.	 The	 concept	 of	
replication	fork	reversal	was	first	suggested	in	1976,	when	Higgins	and	colleagues	proposed	
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the	 formation	of	 the	 four-way	replication	 fork	 to	be	a	DNA	damage	tolerance	mechanism,	
whereby	the	newly	synthesised	strands	were	used	as	a	template	for	DNA	replication	in	order	
to	bypass	a	DNA	lesion	on	the	parental	strand	(Higgins,	Kato	et	al.	1976).	Although	there	has	
been	 evidence	 for	 fork	 reversal	 in	 prokaryotes,	 only	 relatively	 recently	 has	 there	 been	
evidence	to	suggest	fork	reversal	 is	a	mechanism	used	by	higher	eukaryotes.	There	was	no	
convincing	data	to	confirm	this	until	2012,	when	fork	reversal	was	demonstrated	 in	vivo	 in	
yeast	and	mammalian	cell	lines	following	topoisomerase	1	poisoning	in	a	mechanism	that	is	
dependent	 on	 PARP1	 (Chaudhuri,	 Hashimoto	 et	 al.	 2012).	 Further	 work	 from	 this	 group	
demonstrated	 that	 the	 helicase	 RECQ1	 promotes	 the	 restart	 of	 reversed	 replication	 forks	
following	 TOP1	 inhibition.	 This	 RECQ1	 activity	 is	 inhibited	 by	 PARP1-mediated	 ADP	
ribosylation	(Berti,	Chaudhuri	et	al.	2013).	Further	evidence	for	fork	reversal	came	from	the	
work	of	Thangavel	 and	colleagues	who	 showed	 that	WRN	and	DNA2	were	 responsible	 for	
the	degradation	of	the	‘fourth	arm’	of	the	reversed	replication	fork	allowing	fork	restart	by	a	
novel	mechanism	(Thangavel,	Berti	et	al.	2015).	Recent	studies	have	demonstrated	that	fork	
reversal	 occurs	 not	 just	 in	 response	 to	 TOP1	 inhibitors,	 but	 also	 following	 treatment	with	
DNA	 synthesis	 inhibitors,	 interstrand	 cross-linking	 inducers	 and	 base-damaging	 agents,	
showing	 that	 fork	 reversal	 is	 a	 bona	 fide	 mechanism	 to	 respond	 to	 replication	 stress	
(Zellweger,	Dalcher	et	al.	2015).	In	addition,	this	work	showed	that	Rad51	was	essential	for	
the	 conversion	 of	 ssDNA	 into	 reversed	 forks	 in	 response	 to	 TOP	 inhibitors,	 depletion	 of	
nucleotides	and	interstrand	crosslinks	(Zellweger,	Dalcher	et	al.	2015).	
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Fork	Remodelling	During	Replication	Restart	
Recent	 developments	 from	 in	 vivo	 studies	 of	 fork	 reversal	 have	 furthered	 our	
understanding	 of	 replication	 restart	 following	 replication	 stress.	 However,	 a	 number	 of	
proteins	have	been	implicated	in	replication	restart	via	 in	vitro	studies,	including	additional	
proteins	that	may	be	required	for	fork	reversal,	and	also	proteins	that	have	been	implicated	
in	 branch	 migration	 via	 fork	 remodelling.	 Of	 course,	 it	 is	 possible	 that	 fork	 reversal	 and	
branch	migration	are	interlinked	and	both	processes	are	necessary	to	carry	out	fork	restart.	
Indeed,	 Holliday	 junctions	 are	 structurally	 similar	 to	 reversed	 forks,	 and	 it	 could	 be	 that	
there	is	a	dual	function	for	these	proteins	both	in	HR	and	fork	reversal.	Other	proteins	that	
have	 been	 implicated	 in	 restart	 include	 the	 DNA	 helicases	 BLM,	 WRN,	 Fanconi	 anaemia	
complementation	 group	M	 (FANCM),	 SMARCAL1	 and	 F-box	 helicase	 1	 (FBH1)	 whose	 fork	
remodelling	activities	are	thought	to	promote	fork	restart.	Defects	in	BLM	and	WRN	proteins	
have	 been	 shown	 to	 slow	 fork	 progression,	 and	 cells	 deficient	 in	 these	 proteins	 undergo	
reduced	 fork	 restart	 following	 treatment	 with	 replication	 inhibitors	 (Davies,	 North	 et	 al.	
2007,	Sidorova,	Li	et	al.	2008).	It	is	possible	that	the	helicase	activity	of	these	proteins	may	
be	a	prerequisite	for	HR-mediated	fork	restart;	both	BLM	and	WRN	have	been	implicated	in	
the	 regression	 of	 stalled	 forks	 via	 the	 formation	 of	 D-loop	 intermediates	 and	 Holliday	
junctions	(Machwe,	Xiao	et	al.	2006,	Ralf,	Hickson	et	al.	2006).	Evidence	also	suggests	that	
BLM	and	WRN	are	capable	of	unwinding	secondary	structures	in	DNA	that	would	otherwise	
be	difficult	 to	replicate	(Sun,	Karow	et	al.	1998,	Fry	and	Loeb	1999).	SMARCAL1	 is	another	
helicase	 that	 may	 play	 a	 role	 in	 replication	 restart.	 It	 is	 an	 annealing	 helicase	 which	 is	
recruited	to	stalled	replication	forks	in	response	to	replication	stress.	Defects	in	SMARCAL1	
lead	to	replication	 fork	restart	problems	and	an	accumulation	of	ssDNA;	 this	suggests	 that	
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SMARCAL1	may	 restart	 stalled	 replication	 forks	 by	 re-annealing	 ssDNA	which	has	 resulted	
from	helicase	polymerase	uncoupling	(Bansbach,	Betous	et	al.	2009,	Ciccia,	Bredemeyer	et	
al.	2009).	Interestingly,	cells	lacking	functional	FANCM	exhibit	increased	replication	speeds	in	
the	 presence	 and	 absence	 of	 DNA	 damage,	 suggesting	 that	 the	 FANCM	 helicase	 has	 the	
ability	to	slow	replication	(Luke-Glaser,	Luke	et	al.	2010).	Interestingly,	 in	DT40	cells	 loss	of	
functional	FANCM	resulted	in	an	increase	in	replication	fork	restart	following	camptothecin	
treatment	(Schwab,	Blackford	et	al.	2010).	Although	there	is	mounting	evidence	to	suggest	
that	restart	of	stalled	replication	forks	is	achieved	through	fork	remodelling,	it	is	still	unclear	
how	this	would	be	achieved	considering	the	need	for	replisome	dissociation	from	the	DNA	in	
order	for	the	fork	to	be	remodelled.	How	the	replisome	would	be	reloaded	at	the	replication	
fork	 in	 this	 scenario	 is	 currently	 unclear.	 It	 has	 therefore	 also	 been	 hypothesised	 that	
remodelling	of	the	fork	 into	Holliday	Junctions	by	the	DNA	helicases	may	be	a	prerequisite	
for	HR-mediated	fork	restart.		
	
Fork	Restart	via	Homologous	Recombination	
There	 is	 increasing	 evidence	 to	 suggest	 that	 homologous	 recombination	 plays	 an	
important	 role	 in	 the	 restart	 of	 stalled	 forks.	 HR-mediated	 fork	 restart	 involves	 the	
processing	 of	 the	 stalled	 fork	 to	 form	 Holliday	 junctions	 and	 D-loop	 intermediates	 by	 a	
mechanism	 that	 is	 functionally	distinct	 from	HR-mediated	DSB	 repair.	 Indeed,	defects	 in	a	
number	 of	 HR	 proteins	 have	 been	 shown	 to	 induce	 replication-associated	 DSBs	 including	
BRCA2,	 Fanconi	 anaemia	 complementation	 group	 A	 (FANCA),	 Fanconi	 anaemia	
complementation	 group	 D2	 (FANCD2),	 Mre11	 and	 Rad51	 (Sonoda,	 Sasaki	 et	 al.	 1998,	
Costanzo,	Robertson	et	al.	2001,	Lomonosov,	Anand	et	al.	2003,	Sobeck,	Stone	et	al.	2006).	
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In	 addition,	 following	 treatment	 with	 various	 inhibitors	 of	 replication,	 the	 loss	 of	 the	 HR	
proteins	Mre11,	Rad51	and	X-ray	 repair	 cross-complementing	protein	3	 (XRCC3)	has	been	
shown	to	negatively	affect	replication	restart,	suggesting	that	these	proteins	are	necessary	
for	this	process	(Trenz,	Smith	et	al.	2006,	Bryant,	Petermann	et	al.	2009,	Petermann,	Orta	et	
al.	 2010).	 The	HR	 resection	protein	Mre11	 is	 known	 to	be	 recruited	 to	 the	 sites	of	 stalled	
replication	forks	(Franchitto	and	Pichierri	2002,	Mirzoeva	and	Petrini	2003,	Robison,	Elliott	et	
al.	2004).	Mre11	could,	therefore,	be	recruited	to	stalled	forks	to	process	them	to	produce	
the	 lagging	 strand	gap	or	3’	overhang	necessary	 for	 subsequent	Rad51	 loading	and	strand	
invasion.	The	Rad51	paralogue	XRCC3	has	also	been	shown	to	facilitate	fork	restart	following	
the	 release	 from	 replication	 blocks	 (Bishop,	 Ear	 et	 al.	 1998).	 In	 addition,	 PARP1	 has	 been	
shown	to	 facilitate	 replication	 restart	 through	 the	 recruitment	of	Mre11	 to	 the	 replication	
fork,	 where	 it	 is	 thought	 to	 promote	 restart	 through	 its	 resection	 activities	 (Bryant,	
Petermann	et	al.	2009).	 In	support	of	the	idea	of	HR-mediated	fork	restart,	Rad51	has	also	
been	 shown	 to	 be	 necessary	 for	 replication	 fork	 restart	 following	 long	 replication	 blocks	
which	lead	to	collapse	into	DSBs	(Petermann,	Orta	et	al.	2010).	Another	HR	protein,	BRCA2,	
has	 also	 been	 implicated	 in	 HR-mediated	 fork	 restart.	 BRCA2	was	 shown	 to	 limit	Mre11-
dependent	DNA	resection	at	stalled	forks,	and	also	to	regulate	Rad51	loading	and	filament	
formation	during	replication	restart	(Hashimoto,	Chaudhuri	et	al.	2010,	Schlacher,	Christ	et	
al.	 2011).	 During	 HR-mediated	 restart,	 the	 resulting	 Holliday	 Junction	 formed	 could	 be	
resolved	in	a	process	 involving	BLM	and	TOPIIIα,	which	would	allow	replication	to	proceed	
without	 recombination	 due	 to	 crossing-over	 (Wu	 and	 Hickson	 2003).	 As	 previously	
discussed,	 it	 is	also	possible	that	HR	proteins	have	crossover	functions	in	both	HR	and	fork	
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reversal,	since	there	has	been	no	direct	 in	vivo	evidence	to	suggest	that	Holliday	Junctions	
and	homologous-recombination	mechanisms	exist	during	replication	restart.		
	
The	Role	of	Double-Strand	Break	Formation	in	Fork	Restart	
In	addition	 to	HR-mediated	 restart	 that	 is	 achieved	 in	 the	absence	of	 a	DSB,	 it	has	
been	suggested	that,	following	long	replication	blocks,	fork-associated	DSBs	are	created	by	
the	endonuclease	activity	of	MUS81-EME1	(Hanada,	Budzowska	et	al.	2007).	It	is	not	entirely	
clear	 whether	 these	 fork-associated	 DSBs	 are	 repaired	 by	 the	 canonical	 DSB	 repair	
machinery	or	whether	a	more	specific,	fork-associated	DSB	repair	mechanism	is	employed.	It	
is	 thought	 that	 fork-associated	 DSBs	 that	 occur	 passively,	 i.e.	 through	 replication	 and	
transcription	machinery	 collision	 rather	 than	 in	 an	MUS81-EME1	 dependent	 manner,	 are	
repaired	by	standard	DSB	repair	mechanisms.	Evidence	to	suggest	that	the	induction	of	DSBs	
promotes	 replication	 fork	 restart	 comes	 from	 a	 study	 using	MUS81-deficient	 cells,	 which,	
when	released	from	long	replication	blocks	(24	hours),	failed	to	restart	efficiently	(Hanada,	
Budzowska	 et	 al.	 2007).	 Conflicting	 reports	 suggest	 that	 replication	 cannot	 be	 restarted	
following	 the	 generation	 of	 DSBs	 induced	 by	 long	 replication	 blocks,	 and	 can	 only	 restart	
following	short	incubations	that	do	not	result	in	the	generation	of	DSBs	(Petermann,	Orta	et	
al.	 2010).	 Replication	 restart	 following	 long	 replication	blocks	 appears	 to	be	 as	 a	 result	 of	
new	origin	firing	rather	than	restart	of	forks	that	have	collapsed	into	DSBs	(Petermann,	Orta	
et	al.	2010).	
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1.3	ADENOVIRUS	AND	THE	DNA	DAMAGE	RESPONSE	
The	 first	 indication	 for	 a	 relationship	 between	 adenovirus	 and	 the	 DDR	 was	 seen	
when	Ad12	 infection	was	shown	to	 induce	specific	chromosomal	breaks	 in	human	embryo	
kidney	cells	(Stich,	Hsu	et	al.	1964,	Zur	Hausen	1967,	Mcdougal.Jk	1970,	Mcdougal.Jk	1971).	
At	the	initial	stages	of	adenovirus	infection,	the	host	cell	initiates	a	DDR	response	following	
the	detection	of	viral	DNA	or	cellular	stress.	This	DDR	response	can	be	measured	from	the	
levels	 of	 phosphorylated	 DDR	 proteins	 such	 as	 H2AX	 and	 RPA32	 (Carson,	 Schwartz	 et	 al.	
2003).	One	consequence	of	the	activation	of	the	cellular	DDR	is	the	‘repair’	of	viral	DNA	to	
form	viral	concatemers	which	can	no	longer	be	packaged	into	virions;	it	is	therefore	essential	
that	 adenovirus	 is	 able	 to	 circumvent	 the	 cellular	 DNA	 damage	 response	 (Weiden	 and	
Ginsberg	 1994).	 Adenovirus	 has	 evolved	 sophisticated	mechanisms	which	 lead	 to	 efficient	
evasion	 from	 the	 cellular	 DDR	 which	 will	 be	 described	 in	 more	 detail	 in	 the	 following	
passages	(Turnell	and	Grand	2012).		
1.3.1	Concatenation	of	Adenovirus	Genomes	
It	 is	well	established	that	adenovirus	has	to	circumvent	a	number	of	barriers	to	aid	
efficient	viral	 infection,	 including	detection	by	the	host	cells	 immune	response	and	evasion	
of	 apoptosis.	 In	 addition,	 it	 is	 becoming	 increasingly	 apparent	 that	 adenovirus	 must	
circumvent	the	cellular	DDR	in	order	to	effectively	replicate	 its	genome.	During	adenovirus	
infection,	the	double-stranded	DNA	ends	of	the	linear	adenovirus	genome	can	be	recognised	
by	the	host	cell	as	 ‘damaged’	DNA	in	the	form	of	cellular	DSBs.	The	outcome	of	this	 is	the	
activation	 of	 the	 DDR	 and	 subsequent	 ‘repair’	 of	 the	 double-stranded	 viral	 DNA	 ends	
through	the	DSB	repair	pathway	(Weiden	and	Ginsberg	1994).	
		 62	
The	 first	 study	 to	 document	 the	 ‘end-to-end’	 joining	 of	 viral	 double-stranded	
genomes	 showed	 that	 infection	 with	 Ad5	 mutant	 viruses	 containing	 large	 E4	 deletions	
resulted	 in	 the	 formation	of	 large	 concatemers	of	 viral	DNA	 (Weiden	and	Ginsberg	1994).	
Concatemers	can	be	defined	as	covalently	joined	monomers	of	DNA,	joined	in	a	non-specific	
orientation.	 The	net	effect	of	 this	 concatermerisation	 is	 two-fold;	 joining	of	 the	 viral	 ends	
results	in	the	loss	of	the	ITR	regions	and	thus	viral	origins	of	DNA	replication,	and	secondly,	
the	large	viral	concatemers	formed	from	end-to-end	ligation	results	in	a	product	that	is	too	
large	to	be	packaged	into	viral	capsids	(Weiden	and	Ginsberg	1994).		
To	date,	a	number	of	studies	have	shown	that	the	cellular	DDR	proteins	DNA	ligase	
IV,	 DNA-PKcs,	 and	 the	 MRN	 complex	 components	 Mre11	 and	 NBS1	 to	 be	 important	 for	
concatermisation	 of	 viral	 genomes	 (Boyer,	 Rohleder	 et	 al.	 1999,	 Riballo,	 Critchlow	 et	 al.	
1999,	 Stracker,	 Carson	 et	 al.	 2002).	 Significantly,	 studies	 using	 the	 Ad5	 E4	 mutant	 virus	
dl1004	showed	that	infection	with	this	mutant	exhibited	defective	viral	DNA	replication	and	
late	protein	synthesis	as	a	consequence	of	the	formation	of	concatemers	(Stracker,	Carson	
et	 al.	 2002).	 Since	 the	 process	 of	 viral	 concatermisation	 involves	 the	 direct	 end-to-end	
ligation	of	viral	genomes	with	some	loss	of	genetic	 information,	 it	was	speculated	that	the	
DDR,	 and	 more	 specifically	 NHEJ	 machinery,	 played	 an	 important	 role	 in	 viral	
concatermisation.	 Further	 investigations	 showed	 that	 dl1004	 infection	 in	 cell	 lines	
expressing	mutant	Mre11,	DNA	Ligase	IV	and	DNA-PKcs	were	able	to	rescue	the	formation	of	
viral	 concatemers,	 suggesting	 that	 these	 components	of	 the	NHEJ	machinery	 are	 required	
for	viral	concatemerisation	(Stracker,	Carson	et	al.	2002).	Later	studies	further	demonstrated	
the	 relationship	 between	 concatemer	 formation	 and	 defective	 DNA	 replication	 and	 late	
protein	synthesis,	showing	that	the	activity	of	the	MRN	complex	had	a	direct	effect	on	viral	
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DNA	 replication	 and	 not	 through	 the	 activation	 of	 the	 DDR	 and	 concatemer	 formation	
(Lakdawala,	Schwartz	et	al.	2008).		
1.3.2	Adenovirus-Mediated	Degradation	of	Cellular	Proteins	
In	 a	 cellular	 context,	 ubiquitin	 ligases	 are	 known	 to	 have	 important	 roles	 in	 the	
control	 of	 homeostasis	 through	 the	 addition	 of	 ubiquitin	 (Ub)	 onto	 target	 proteins.	 The	
proteins	 involved	 in	 this	 system	 include	 the	 E1	 activating	 enzymes,	 the	 E2	 conjugating	
enzymes	and	the	E3	 ligase	enzymes.	 In	brief,	 the	E1	activating	enzyme	binds	and	activates	
ubiquitin	in	an	ATP-dependent	manner,	which	is	then	passed	onto	a	specific	E2	conjugating	
enzyme	recruited	by	E1.	Together	with	the	E3	 ligase	enzyme,	E2	conjugates	ubiquitin	onto	
lysine	 residues	of	 target	proteins.	 The	end	 result	 is	 usually	being	marked	 for	proteasome-
mediated	degradation	 (reviewed	 in	 (Nakayama	and	Nakayama	2006).	 It	 is	well	established	
that	the	Ad5	and	Ad12	viral	proteins	E1B55K	and	E4orf6	 interact	with	the	cellular	proteins	
Rbx1,	 Cullin	 2/5	 and	 Elongins	 B	 and	 C	 to	 form	 an	 E3	 ubiquitin	 ligase	 complex	 (Querido,	
Blanchette	et	al.	2001).	It	is	thought	that	the	E1B55K	protein	acts	as	a	substrate	recognition	
unit	 whilst	 the	 E4orf6	 protein	 assembles	 the	 cellular	 proteins	 in	 the	 complex	 (Baker,	
Rohleder	 et	 al.	 2007,	 Blackford,	 Patel	 et	 al.	 2010,	 Forrester,	 Sedgwick	 et	 al.	 2011,	Orazio,	
Naeger	et	al.	2011,	Gupta,	Jha	et	al.	2013).	The	assembly	of	the	E3	ubiquitin	ligase	complex	
results	in	the	targeting	of	various	cellular	factors	that	are	detrimental	to	virus	replication	and	
survival,	for	proteasome-mediated	degradation.	The	cellular	proteins	targeted	by	adenovirus	
for	proteasome-mediated	degradation	will	be	discussed	in	the	following	passages.		
The	 first	 indication	 that	 adenovirus	 employed	 cellular	 proteins	 to	 form	 an	 E3	
ubiquitin	 ligase	 complex	 came	 from	 Querido	 and	 colleagues	 who	 demonstrated	 that	 the	
degradation	of	p53	was	achieved	 through	 the	Ad5	E1B55K/E4orf6	viral	proteins	 ‘hijacking’	
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the	cellular	E3	ligase	components	Rbx1,	Cul5,	and	Elongins	B	and	C	(Querido,	Marcellus	et	al.	
1997,	Steegenga,	Riteco	et	al.	1998).	During	p53	ubiquitination,	the	Ad5	E1B55K	protein	acts	
as	the	substrate	recognition	protein	whilst	the	E4orf6	protein	binds	to	Elongins	B	and	C	via	
its	BC	box	motifs	(Blanchette,	Cheng	et	al.	2004).	
Shortly	after	 this	discovery,	 the	MRN	complex	component	Mre11	was	shown	to	be	
targeted	 for	 proteasome-mediated	 degradation	 by	 adenovirus	 with	 the	 ultimate	 aim	 of	
destabilising	 the	 cellular	 DNA	 damage	 response	 and	 thus	 promoting	 viral	 replication	
(Stracker,	Carson	et	al.	2002).	Since	the	other	MRN	complex	components,	Rad50	and	NBS1,	
become	destabilised	 in	 the	absence	of	Mre11,	 targeting	Mre11	 for	degradation	essentially	
targets	 the	 entire	 complex	 (Stewart,	 Maser	 et	 al.	 1999,	 Zhong,	 Bryson	 et	 al.	 2005).	 	 As	
previously	 discussed,	 the	MRN	 complex	 recognises	DSBs	 and	 activates	 ATM,	 initiating	 the	
DDR	(Lee	and	Paull	2005).	Targeting	this	complex,	therefore,	prevents	the	activation	of	the	
DDR	and	thus	is	essential	for	viral	replication.		
Other	 DNA	 damage	 proteins	 known	 to	 be	 degraded	 during	 adenovirus	 infection	
include	 DNA	 ligase	 IV,	 BLM	 and	 TOPBP1.	 The	 NHEJ	 DSB	 repair	 pathway	 component	 DNA	
ligase	 IV	was	 shown	 to	 be	 a	 target	 for	 proteasome-mediated	 degradation	 by	 Ad5	 (Baker,	
Rohleder	et	al.	2007).	The	degradation	of	DNA	ligase	IV	prevents	viral	concatermisation	and	
is	therefore	also	beneficial	for	viral	replication.	Interestingly,	group	B,	D	and	E	adenoviruses	
only	appear	to	degrade	DNA	ligase	IV	but	not	p53,	Mre11	or	TOPBP1,	the	reason	for	this	is	
unclear	 (Forrester,	 Sedgwick	et	al.	2011).	BLM	 is	a	DDR	component	 that	 is	 known	 to	have	
DNA-end	 processing	 activity.	 BLM	 is	 degraded	 in	 a	 E1B55K/E4orf6/Cullin	 5-dependent	
manner	 during	 Ad5	 infection,	 although	 the	 precise	 function	 of	 the	 degradation	 of	 this	
protein	during	adenovirus	infection	is	unclear	(Orazio,	Naeger	et	al.	2011).	It	 is	known	that	
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BLM	 is	not	 required	 for	 viral	 concatemer	 formation	 (Orazio,	Naeger	et	 al.	 2011).	 The	DDR	
protein	TOPBP1	was	also	shown	to	be	degraded	during	Ad12	infection	(Blackford,	Patel	et	al.	
2010).	TOPBP1	is	responsible	for	the	activation	of	ATR	and	therefore	adds	another	layer	of	
complexity	to	the	inhibition	of	the	DDR	during	adenovirus	infection.	Interestingly,	TOPBP1	is	
degraded	 exclusively	 by	 Ad12	 in	 an	 E4orf6-dependent,	 E1B55K-independent	 manner,	
suggesting	 that	 E4orf6	 can	 in	 fact	 act	 as	 a	 substrate	 recognition	 unit	 as	well	 as	 a	 cellular	
linker	 protein	 (Blackford,	 Patel	 et	 al.	 2010).	 Quite	 why	 it	 is	 necessary	 for	 the	 group	 A	
adenoviruses	(which	includes	Ad12)	but	not	the	group	C	viruses	(Ad5)	to	degrade	TOPBP1	is	
unknown	at	present.			
Most	 recently,	 adenovirus	 has	 been	 shown	 to	 degrade	 the	 lysine	 acetyltransferase	
Tip60	in	an	E1B55K,	E4orf6	and	proteasome-dependent	manner.	Tip60	has	been	implicated	
in	the	DNA	damage	response	through	its	activation	of	the	ATM	and	ATR	kinases.	In	addition	
it	 is	also	able	to	 inhibit	the	DDR	through	promoting	the	dephosphorylation	of	H2AX.	 It	has	
been	 shown	 that	 Tip60	 is	 able	 to	 bind	 directly	 to	 the	 immediate	 early	 promoter	 of	 the	
adenovirus	E1A	gene,	thus	 inhibiting	 its	expression.	 It	 is,	therefore,	 important	that	Tip60	is	
degraded	 during	 adenovirus	 infection	 in	 order	 to	 evade	 the	 inhibition	 of	 E1A	 gene	
expression	(Gupta,	Jha	et	al.	2013).			
Adenovirus	 5	 has	 also	 been	 shown	 to	 degrade	 proteins	 not	 involved	 in	 the	 DDR	
including	 the	 cell	 surface	 receptor	 integrin	 α3	 (Dallaire,	 Blanchette	 et	 al.	 2009).	 This	
degradation	 is	 E1B55K/E4orf6/Cul5	 dependent	 (Dallaire,	 Blanchette	 et	 al.	 2009).	 The	
function	of	integrin	α3	during	adenovirus	infection	is	as	an	alternative	Ad	receptor,	making	
this	protein	a	target	for	proteasome-mediated	degradation	in	order	to	prevent	re-infection	
(Salone,	Martina	et	al.	2003,	Dallaire,	Blanchette	et	al.	2009).			
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The	 death	 domain-associated	 protein	 (Daxx)	 is	 another	 target	 during	 adenovirus	
infection.	Daxx	is	thought	to	be	involved	in	the	regulation	of	a	number	of	functions	including	
apoptosis	and	transcription.	Daxx	is	degraded	during	Ad5	infection	in	an	E1B55K-dependent,	
E4orf6-independent	 manner	 (Schreiner,	 Wimmer	 et	 al.	 2011).	 Further	 studies	 from	 this	
group	showed	that	X-linked	α-thalassaemia	retardation	syndrome	protein	(ATRX),	which	has	
been	 previously	 shown	 to	 form	 a	 complex	 with	 Daxx	 and	 to	 be	 involved	 in	 chromatin	
remodelling,	 is	 also	 degraded	 during	 Ad5	 infection	 (Xue,	 Gibbons	 et	 al.	 2003,	 Schreiner,	
Burck	et	al.	2013).		
It	has	also	been	suggested	 that	adenoviruses	 can	 inhibit	 the	DDR	 independently	of	
protein	degradation.	Both	Ad5	E4orf3	and	E4orf6	proteins	have	been	shown	to	interact	with	
DNA-PK	resulting	in	a	reduction	in	the	levels	of	DNA-PK	autophosphorylation	during	double-
strand	break	repair	(Boyer,	Rohleder	et	al.	1999,	Hart,	Yannone	et	al.	2005).	Intriguingly,	Ad5	
E4orf6	has	also	been	shown	to	enhance	the	DDR	through	the	inhibition	of	PP2A,	leading	to	
phosphorylation	of	H2AX,	activation	of	PARP	and	apoptosis	(Hart,	Ornelles	et	al.	2007).		
1.3.3	Relocalisation	of	Cellular	Proteins	during	Adenovirus	Infection	
In	 addition	 to	 inhibiting	 the	 cellular	 DDR	 through	 the	 proteasome-mediated	
degradation	 of	 key	 DDR	 proteins,	 adenovirus	 is	 also	 able	 to	 interfere	 with	 the	 DDR	 by	
affecting	the	localisation	of	various	DDR	proteins.	During	adenovirus	infection,	a	number	of	
DDR	proteins	are	 localised	to	VRCs	 including	RPA32,	ATR,	ATRIP,	TOPBP1,	Rad17	and	Rad9	
(Stracker,	Lee	et	al.	2005,	Blackford,	Bruton	et	al.	2008,	Carson,	Orazio	et	al.	2009).	Although	
the	 role	 for	 adenoviral-mediated	 relocalisation	 to	 VRCs	 is	 currently	 unknown,	 it	 has	 been	
suggested	 that	 the	 relocalisation	 inhibits	 the	 function	 of	 the	 DDR	 proteins,	 therefore	
circumventing	the	activation	of	the	DDR	and	promoting	viral	DNA	replication.	Alternatively	it	
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is	possible	that	these	proteins	may	be	required	to	play	a	transient	role	in	the	replication	of	
viral	DNA	(Stracker,	Lee	et	al.	2005,	Blackford,	Bruton	et	al.	2008,	Carson,	Orazio	et	al.	2009).		
As	 well	 as	 relocalisation	 to	 VRCs,	 adenovirus	 infection	 can	 also	 induce	 the	
relocalisation	of	DDR	proteins	 into	nuclear	 track	 structures	which	derive	 from	PML	bodies	
(Puvion-Dutilleul,	Chelbi-Alix	et	al.	1995,	Everett	2001).	As	previously	discussed	(see	Section	
1.1.6),	 E4orf3	 is	 responsible	 for	 the	 rapid	 reorganisation	 of	 PML	 bodies	 into	 PML	 nuclear	
tracks,	where	 it	 is	 known	 to	 relocalise	p53	and	PML	 to	 these	 sites	 (Carvalho,	 Seeler	 et	 al.	
1995,	 Konig,	 Roth	 et	 al.	 1999).	 The	 function	 of	 this	 relocalisation	 is	 largely	 unknown,	
although	 it	 is	 thought	 that	 E4orf3-mediated	 p53	 relocalisation	 induces	 H3K9me3	
heterochromatin	 formation	 at	 p53	 target	 promoter	 regions,	 silencing	 p53	 target	 genes	
(Soria,	Estermann	et	al.	2010).	A	number	of	other	proteins,	which	associate	with	PML	bodies,	
are	 degraded	 during	 adenovirus	 infection	 and	 this	 is	 distinct	 from	 PML	 reorganisation.	
Examples	 include	the	MRN	complex	which	is	relocalised	to	PML	nuclear	tracks	following	IR	
exposure,	 and	 this	 is	 thought	 to	 inhibit	 the	 activation	 of	 ATR	 and	 ultimately	 promote	 the	
degradation	 of	 the	 MRN	 complex	 (see	 Section	 1.3.2)(Evans	 and	 Hearing	 2005).	 Another	
example	is	Daxx,	where	its	E4orf3-mediated	association	with	PML	nuclear	tracks	is	thought	
to	inhibit	its	repression	of	transcriptional	activity	(Li,	Leo	et	al.	2000).			
During	 adenovirus	 infection,	 DDR	 proteins	 can	 also	 be	 relocalised	 to	 aggresomes.	
Ordinarily,	misfolded	proteins	are	transported	along	microtubules	to	microtubule-organising	
centres,	 by	 the	 motor	 protein	 dynein,	 where	 they	 are	 sequestered	 into	 these	 large	
cytoplasmic	 bodies	 known	 as	 aggresomes.	 The	 proteins	 within	 these	 structures	 are	 then	
usually	 targeted	 for	degradation.	During	Ad5	 infection,	 a	 large	number	of	 aggresomes	are	
formed	where	the	adenoviral	proteins	E1B55K,	E4orf3,	E4orf6,	Cul5	and	the	MRN	complex	
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have	been	shown	to	localise	(Zantema,	Fransen	et	al.	1985,	Araujo,	Stracker	et	al.	2005).	It	is	
thought	that	the	MRN	complex	is	initially	localised	to	nuclear	tracks	and	then	subsequently	
relocalised	 to	aggresomes	 together	with	adenoviral	proteins	where	Mre11	 is	 subsequently	
degraded	 (Liu,	 Shevchenko	 et	 al.	 2005).	 p53	 has	 also	 been	 shown	 to	 be	 relocalised	 to	
aggresomes	 in	an	E4orf3	dependent	manner,	 suggesting	 that	adenovirus	 is	 able	 to	exploit	
the	cellular	aggresome	system	 in	order	 to	 induce	degradation	of	DDR	proteins	 that	would	
otherwise	 be	 detrimental	 for	 viral	 DNA	 replication	 (Liu,	 Shevchenko	 et	 al.	 2005).	
Interestingly,	 not	 all	 E1B55K	 proteins	 from	 various	 adenovirus	 serotypes	 localises	 to	
aggresomes,	 suggesting	 that	 the	 relocalisation	 of	 E1B55K	 to	 these	 structures	 is	 not	
necessary	for	degradation	of	target	proteins	(Blanchette,	Wimmer	et	al.	2013).	In	the	case	of	
Ad4	 and	 Ad12	 infection,	 the	MRN	 complex	 is	 not	 relocalised	 into	 PML	 nuclear	 tracks	 by	
E4orf3	 and	 is	 instead	 relocalised	 to	 VRCs	 (Stracker,	 Lee	 et	 al.	 2005,	 Carson,	 Orazio	 et	 al.	
2009).	 This	 could	 prove	 detrimental	 for	 viral	 DNA	 replication	 since	 the	 localisation	 of	 the	
MRN	 complex	 to	 VRCs	 could	 initiate	 a	 DDR.	 In	 order	 to	 circumvent	 this,	 Ad4	 and	 Ad12	
viruses	 have	 evolved	 to	 also	 degrade	 TOPBP1,	 in	 order	 to	 inhibit	 ATR	 signalling	 at	 these	
regions	and	therefore	prevent	the	activation	of	the	DDR	(Blackford,	Patel	et	al.	2010).		
	
1.4	THE	CCR4-NOT	COMPLEX	
The	 chemokine	 (C-C	motif)	 receptor	 4	 -NOT	 (CCR4-NOT)	 complex	 is	 a	 large,	 highly	
conserved,	multi-subunit	complex	with	a	number	of	cellular	functions,	mainly	in	the	control	
of	gene	expression.	The	CCR4-NOT	complex	has	been	implicated	in	mRNA	regulation,		
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Yeast&Protein&Name& Human&Orthologue& Func6on&
NOT1% CNOT1% Scaﬀold%
NOT2% CNOT2% Unknown%
NOT3/NOT5% CNOT3% Unknown%
NOT4% CNOT4% E3%ligase%ac<vity%
CCR4% CNOT6% Deadenylase%
%% CNOT6L% Deadenylase%
CAF1% CNOT7% Deadenylase%
%% CNOT8% Deadenylase%
RCD1/CAF40% CNOT9%(RQCD1)% Unknown%
Unknown% CNOT10% Unknown%
Unknown% CNOT11%(C2orf29)% Unknown%
CAF130% Unknown% Unknown%
%% %% %%
Table	 1.2:	 Classification	 of	Human	 CNOT	 Subunits.	 The	yeast	
subunits	of	the	CCR4-NOT	complex	are	indicated,	together	with	
the	human	CNOT	complex	orthologues.	If	known,	the	function	
of	each	subunit	is	also	shown.		
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transcription	 elongation,	 chromatin	modifications	 and	DNA	 repair.	 The	majority	 of	 studies	
on	 the	 CCR4-NOT	 complex	 have	 been	 performed	 in	 yeast	 (both	 S.	 cerevisiae	 and	 S.	
pombe),where	 the	 complex	 comprises	 9	 core	 subunits:	 CCR4,	 CAF1,	 CAF40,	 CAF130	 and	
NOT1-5.	Whilst	much	 less	 is	known	about	the	human	CCR4-NOT	complex,	 the	orthologues	
CCR4-NOT	 transcription	 complex	 (CNOT1-CNOT10)	 have	 been	 identified	 in	 human	 cells.	
Table	 1.2	 represents	 yeast	 CCR4-NOT	 complex	 components	 along	 with	 their	 human	
orthologues.				
Two	major	enzymatic	functions	of	the	CCR4-NOT	complex	have	been	identified	in	yeast	and	
mammals,	 deadenylation	 and	 ubiquitination.	 The	 ubiquitination	 activity	 of	 the	 CCR4-NOT	
complex	 is	performed	by	 the	NOT4	component	of	 the	complex,	which	has	been	shown	 to	
have	 E3	 ubiquitin	 ligase	 activity	 (Albert,	 Hanzawa	 et	 al.	 2002).	 In	 S.	 cerevisiae,	 NOT4	 has	
been	shown	to	stably	interact	with	the	CCR4-NOT	complex;	interestingly,	however,	in	human	
cells,	the	NOT4	(hCNOT4)	protein	has	been	shown	to	exist	in	a	protein	complex	distinct	from	
the	 CCR4-NOT	 complex	 (Lau,	 Kolkman	 et	 al.	 2009,	 Panasenko	 and	 Collart	 2011).	 The	
deadenylase	activity	of	 the	CCR4-NOT	complex	 is	achieved	 through	 the	CCR4	subunit	 in	S.	
cerevisiae,	 which	 has	 3’	 exoribonuclease	 activity	 that	 targets	 poly(A)	 substrates	 (Chen,	
Chiang	et	al.	2002).	The	S.	cerevisiae	CCR4-NOT	protein	Caf1	 is	 the	 linker	protein	between	
CCR4	and	the	core	complex	components	(Tucker,	Staples	et	al.	2002).	It	has	also	been	shown	
to	have	3’-5’	 exonuclease	activity	 in	 vitro	 (Daugeron,	Mauxion	et	 al.	 2001).	 The	CCR4	and	
CAF1	human	orthologs	CNOT6/CNOT6L	and	CNOT7/CNOT8	respectively,	are	responsible	for	
deadenylase	activities	of	the	CNOT	complex	in	human	cells.		
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CNOT1&CNOT2&
CNOT3&
TAB182& CNOT10&
CNOT11&
CNOT9&
CNOT4&
CNOT7& CNOT6&
CNOT6& CNOT6L&
CNOT8& CNOT6&
CNOT8& CNOT6L&
1&
2&
3&
4&
Deadenylase&
subunits&
E3&ubiqui@n&
ligase&
Figure	1.15:	The	Human	CNOT	Complex.	The	human	CNOT	complex	comprises	of	the	core	
subunits	 CNOT1,	 CNOT2,	 CNOT3,	 CNOT9,	 CNOT10,	 CNOT11	 and	 TAB182.	 CNOT4,	 the	 E3	
ubiquitin	 ligase	component	of	 the	CNOT	complex,	 transiently	associates	with	the	complex.	
Four	deadenylase	complexes	also	transiently	associate	with	the	complex,	these	are	known	to	
be	CNOT7/CNOT6,	CNOT6/CNOT6L,	CNOT8/CNOT6	and	CNOT8/CNOT6L.			
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The	human	CNOT	complex	exists	 in	a	number	of	different	conformations	which	are	
dependent	on	the	associated	deadenylase.	The	CNOT	complex	comprises	the	core	proteins	
CNOT1,	CNOT2,	CNOT3,	CNOT9,	CNOT10,	CNOT11	and	TAB182.	 The	deadenylases	CNOT6,	
CNOT6L,	 CNOT7	 and	 CNOT8	 transiently	 associate	 with	 the	 core	 complex.	 Interestingly,	
studies	 by	 Lau	 and	 colleagues	 found	 that	 the	 deadenylases	 CNOT7	 and	 CNOT8	 do	 not	
associate	 with	 each	 other,	 suggesting	 that	 these	 proteins	 form	 distinct	 CNOT	 complexes.	
Furthermore,	 the	 deadenylases	 CNOT6	 and	 CNOT6L	 were	 found	 to	 stably	 interact	 with	
CNOT7	 but	 not	 CNOT8,	 and	 deadenylases	 CNOT6	 and	 CNOT6L	 do	 not	 interact	 with	 each	
other,	suggesting	that	these	deadenylases	are	mutually	exclusive.	Finally,	this	group	showed	
that	the	ubiquitin	ligase	component	of	the	CNOT	complex,	CNOT4,	does	not	stably	interact	
with	 the	 complex,	 but	 instead	 associates	 transiently,	 suggesting	 that	 the	 association	 of	
CNOT4	with	the	complex	is	a	regulated	event	(Figure	1.15)(Lau,	Kolkman	et	al.	2009).				
	
1.4.1	The	CCR4-NOT	Complex	and	the	DNA	Damage	Response	
A	number	of	 studies	have	 implicated	 the	CCR4-NOT	complex	 in	 the	DDR	 in	both	S.	
cerevisiae	 and	 S.	 pombe.	 In	 the	 vast	 majority	 of	 these	 studies,	 sensitivity	 assays	 were	
performed	using	yeast	 strains	 that	were	mutant	 for	various	components	of	 the	CCR4-NOT	
complex.	 CCR4	 (hCNOT6/hCNOT6L)	 was	 shown	 to	 be	 sensitive	 to	 IR,	 UV-C,	 HU,	 4-
nitroquinoline	 1-oxide	 (4-NQO)	 and	 camptothecin	 in	 both	 S.	 cerevisiae	 and	 S.	 pombe	
(Bennett,	Lewis	et	al.	2001,	Westmoreland,	Marks	et	al.	2004,	Mulder,	Winkler	et	al.	2005,	
Traven,	Hammet	et	al.	2005,	Woolstencroft,	Beilharz	et	al.	2006,	Deshpande,	Hayles	et	al.	
2009).	Caf1	 (hCNOT7/hCNOT8)	was	shown	to	be	sensitive	to	 IR,	HU,	4-NQO,	camptothecin	
and	MMS	 in	both	S.	 cerevisiae	 and	S.	pombe	 (Mulder,	Winkler	et	al.	 2005,	Woolstencroft,	
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Beilharz	et	al.	 2006,	Deshpande,	Hayles	et	al.	 2009).	NOT1,	NOT2,	NOT3,	NOT4	and	NOT5	
mutant	S.	cerevisiae	strains	have	been	shown	to	be	sensitive	to	HU	(Mulder,	Winkler	et	al.	
2005).	Together	these	data	suggest	that	the	CCR4-NOT	complex	is	involved	in	the	response	
to	 a	 number	 of	 forms	 of	 DNA	 damage	 and/or	 replication	 stress.	 The	 mechanism	 for	
sensitivity	to	various	DNA	damaging	agents	in	CCR4-NOT	complex	mutant	strains	is	currently	
unclear	and	in	some	cases	conflicting.	There	have	been	reports	that	the	deadenylase	activity	
of	 the	 CCR4-NOT	 complex	 is	 responsible	 for	 the	 sensitivity	 to	 DNA	 damaging	 agents	 in	 S.	
cerevisiae	 (Traven,	Hammet	et	al.	2005,	Woolstencroft,	Beilharz	et	al.	2006).	Some	groups	
have	reported	that	defective	RNR	accumulation	is	responsible	for	DNA	damage	sensitivity	in	
CCR4-NOT	complex	S.	cerevisiae	and	S.	pombe	mutant	strains,	whilst	one	group	suggest	that	
defective	 RNR	 accumulation	 does	 not	 contribute	 to	 DNA	 damage	 sensitivity	 observed	 in	
CCR4-NOT	S.	cerevisiae	mutant	strains	(Mulder,	Winkler	et	al.	2005,	Traven,	Hammet	et	al.	
2005,	Takahashi,	Kontani	et	al.	2007).		
To	date,	little	is	known	about	the	CNOT	complex	and	the	DDR	in	mammalian	cells.	To	
our	 knowledge,	only	one	publication	exists	by	Morita	and	colleagues	 to	 suggest	a	 role	 for	
CNOT6L	 in	 the	 DDR.	 This	 group	 showed	 that	 depletion	 of	 CNOT6L	 inhibited	 cell	 cycle	
progression	from	G1	to	S	phase,	combined	with	a	reduced	expression	of	Cyclin	D1	and	Cyclin	
A.	These	phenotypes	were	later	attributed	to	CNOT6L	being	responsible	for	deadenylation	of	
p27KIP1	mRNA	(Morita,	Suzuki	et	al.	2007).		
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1.5	TAB182	
Tankyrase	1	binding	protein	1	of	182	KDa	(TAB182),	or	TNKS1BP1,	was	first	identified	in	2002	
when	it	was	found	to	interact	with	the	telomeric	poly(ADP-ribose)	polymerase	Tankyrase	1.	
In	this	study,	a	number	of	assays	were	performed	to	elucidate	the	function	of	TAB182	and	its	
interaction	with	Tankyrase	1.	Subcellular	fractionation	of	TAB182	showed	that	it	was	located	
in	both	the	nucleus	and	the	cytoplasm,	the	nuclear	and	cytoplasmic	cellular	 localisation	of	
TAB182	 was	 further	 validated	 by	 the	 transfection	 of	 labelled	 TAB182	 protein	 and	
endogenous	 TAB182	 targeting	 antibodies.	 Through	 immunofluorescence	 analysis	 of	 a	
synchronised	 cell	 population,	 TAB182	 was	 found	 to	 associate	 with	 mitotic	 chromosomes	
(Seimiya	and	Smith	2002).	The	TAB182	protein	is	known	to	have	a	tankyrase	binding	domain	
(TBD)	 and	 two	 nuclear	 localisation	 signals	 (NLS)	 at	 the	 C-terminus	 of	 the	 protein	 (Figure	
1.16).	One	study	also	identified	TAB182	as	a	subunit	of	the	CNOT	complex,	although	its	role	
in	this	complex	is	unclear	at	present	(Lau,	Kolkman	et	al.	2009).	According	to	the	literature,	a	
function	for	TAB182	is	yet	to	be	identified.	
	
1.5.1	TAB182	and	the	DNA	Damage	Response	
TAB182	was	first	implicated	in	the	DDR	following	its	discovery	in	a	mass	spectrometry	
screen	used	to	identify	novel	ATM/ATR	substrates	following	exposure	to	IR	(Matsuoka,	Ballif	
et	al.	2007).	To	date,	no	other	studies	have	suggested	a	role	for	TAB182	in	the	DDR.		
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NLS$NLS$TBD$TAB182$N$ C$
1$ 1450$ 1542$
1629$ 1653$
1723$ 1729$
Figure	 1.16:	 Schematic	 of	 TAB182	 Protein.	 Schematic	 of	 the	 full-length	 TAB182	 protein.	
Showing	 amino	 acid	 numbers,	 tankyrase	 binding	 domain	 (TBD)	 and	 the	 two	 nuclear	
localisation	signals	(NLS)	it	contains.		
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1.6	AIMS	
Previous	 work	 in	 our	 laboratory	 has	 shown	 TAB182	 to	 be	 degraded	 following	 Ad5	
infection.	Since	more	than	80%	of	adenoviral	targets	are	known	to	be	DDR	proteins,	this	lead	
to	the	speculation	that	TAB182	may	also	be	involved	in	the	DDR.	Furthermore,	TAB182	was	
identified	 in	 a	 mass	 spectrometry	 screen	 as	 a	 potential	 substrate	 of	 ATM/ATR,	 further	
implicating	a	role	in	the	DDR	(Matsuoka,	Ballif	et	al.	2007).	Therefore	the	aims	of	this	study	
were	as	follows:	
1. To	 confirm	 the	 degradation	 of	 TAB182	 during	 adenovirus	 infection	 and	 investigate	
the	mechanism	by	which	this	occurs.	
2. To	investigate	a	role	for	TAB182	in	the	DDR	and	replication	stress	pathways.	
3. To	identify	TAB182	interacting	proteins	in	order	to	further	elucidate	the	function	of	
TAB182.	
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2.	MATERIALS	AND	METHODS	
2.1	TISSURE	CULTURE	TECHNIQUES	
2.1.1	Human	Cell	Lines	
The	cell	lines	used	in	this	study	are	summarised	in	Table	2.1.	HeLa	cells	were	used	for	
the	majority	 of	 the	 experiments	 throughout	 this	 study.	 HeLa	 cells	 respond	 to	 adenovirus	
infection	in	a	manner	similar	to	other	human	tumour	cell	lines,	such	as	A549	and	U2OS.	They	
have	 low	 levels	 of	 p53	due	 to	 the	presence	of	HPV	E6,	which	 facilitates	 p53	degradation.	
However,	the	p53	gene	in	these	cells	is	wild-type	and	expression	of	the	protein	is	induced	by	
adenovirus	E1A	during	viral	infection	as	has	been	reported	for	other	human	cell	lines	(Grand,	
Grant	et	al.	1994).	
	
2.1.2	Tissue	Culture	Media	
Unless	 otherwise	 stated,	 all	 cell	 lines	were	 cultured	 in	Dulbecco’s	modified	 Eagle’s	
medium	 (DMEM)	 (Invitrogen)	 supplemented	 with	 2mM	 L-glutamine	 and	 10%	 foetal	 calf	
serum	(FCS)	(both	Invitrogen).	When	necessary,	media	was	supplemented	with	3,000	mg	of	
streptomycin	and	30,000	units	of	penicillin.	All	media	was	stored	at	4°C	for	up	to	3	months.	
	
2.1.3	Maintenance	of	Human	Cell	Lines	
All	cell	lines	were	passaged	by	removing	existing	media,	washing	twice	in	phosphate	
buffered	saline	(PBS)	and	incubating	with	0.05%	trypsin	(Invitrogen)	at	37°C	for	a	maximum	
of	5	minutes.	Detachment	was	confirmed	by	microscopy	and	any	remaining	adherent	cells	
were	removed	by	gentle	tapping.	Following	detachment,	cells	were	collected	in	fresh	culture		
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Cell$line$ ATCC$number$ Informa1on$
HeLa% CCL'2.2%
Human%cervical%adenoma%cell%line%expressing%
human%papillomavirus%18%(HPV'18)%
transforming%genes%
Cullin2'%H1299% N/A%
Human%non'small%cell%lung%carcinoma%cell%line%
with%inducible%knockdown%of%Cul2%expression%
in%the%presence%of%1μg/ml%puromycin%
Cullin5'%H1299% N/A%
Human%non'small%cell%lung%carcinoma%cell%line%
with%inducible%knockdown%of%Cul5%expression%
in%the%presence%of%1μg/ml%puromycin%and%
500μg/ml%hygromycin%B%
Table	2.1:	Human	Cell	 Lines	 used	 throughout	 this	Study.	 The	human	cell	 lines	
used	 throughout	 the	duration	of	 this	 study	are	 indicated,	along	with	American	
type	culture	collection	(ATCC)	numbers	and	any	additional	information.		
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medium	heated	to	37°C	and	replated	at	the	desired	confluency.	All	cell	lines	were	passaged	
in	sterile	flow	hoods	and	stored	in	humidified	incubators	at	37°C	supplied	with	5%	CO2.			
2.1.4	Cryopreservation	of	Cell	Lines	
Cell	lines	were	trypsinised	as	above	and	pelleted	by	centrifugation	at	1400rpm	for	5	
minutes.	Cell	pellets	were	resuspended	in	10%	dimethyl	sulphoxide	(DMSO)	(Sigma-Aldrich)	
with	DMEM	supplemented	with	10%	FCS.	Resuspended	cells	were	 transferred	 to	 cryovials	
and	 gradually	 cooled	 to	 -80°C	 in	 isopropanol	 overnight.	 Cells	 were	 transferred	 to	 liquid	
nitrogen	tanks	for	long-term	storage	at	-180°C.	When	required,	cells	were	rapidly	thawed	at	
37°C	.	Cells	were	pelleted	by	centrifugation	at	1400rpm	for	5	minutes,	resuspended	in	fresh	
culture	media	and	replated.				
	
2.2	CELL	BIOLOGY	TECHNIQUES	
2.2.1	Viruses	
All	viruses	used	in	this	study	are	listed	in	Table	2.2	
2.2.2	Viral	Infections	
Cells	were	 grown	 to	 80%	 confluency	 prior	 to	 adenoviral	 infections.	 Cells,	 grown	 in	
6cm	dishes,	were	infected	with	the	appropriate	virus	in	DMEM	(no	FCS)	at	a	multiplicity	of	
infection	(MOI)	of	5	plaque	forming	units	(pfu)	per	cell.	Dishes	were	incubated	at	37°C	for	2	
hours,	agitating	every	15	minutes	to	ensure	the	efficient	distribution	of	media	over	the	dish.	
Following	 incubation,	 virus-containing	 media	 was	 removed	 and	 replaced	 with	 DMEM	
supplemented	with	10%	FCS.	Virus-infected	cells	were	incubated	at	37°C	until	required.		
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Name% Informa+on% Source%
Ad5$ Adenovirus$serotype$5$ Professor$J.$S.$Mymryk$
Ad12$ Adenovirus$serotype$12$ Professor$J.$S.$Mymryk$
Ad5dl1520$ Ad5E1B55K>$mutant$ Baker$and$Berk,$1987$
Ad12dl620$ Ad12E1B>$mutant$ Byrd$et$al.,$1987$
Ad5dl155$ Ad5E4>$mutant$ Professor$Thomas$Dobner$
H5pm4155$ Ad5E4orf3>Ad5E4orf6>$mutant$ Professor$Thomas$Dobner$
H5in351$ Ad5E4orf1>$mutant$ Professor$Thomas$Dobner$
H5pm4166$ Ad5E4orf4>$mutant$ Professor$Thomas$Dobner$
H5dl356$ Ad5E4orf7>$mutant$ Professor$Thomas$Dobner$
H5in352$ Ad5E4orf2>$mutant$ Professor$Thomas$Dobner$
H5pm4154$ Ad5E4orf6>$mutant$ Professor$Thomas$Dobner$
H5dl150$ Ad5E4orf3>$mutant$ Professor$Thomas$Dobner$
Table	2.2:	Adenovirus	Serotypes	and	Mutant	Viruses	used	in	this	Study.	The	
adenovirus	 serotypes	 and	 mutant	 viruses	 used	 throughout	 this	 study	 and	
their	sources	are	indicated.	
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2.2.3	Transfection	of	Cell	Lines	with	siRNA	
24	 hours	 prior	 to	 transfection,	 cells	 were	 plated	 into	 6cm	 dishes	 at	 30-40%	
confluency	 in	DMEM	supplemented	with	10%	FCS.	The	following	day,	a	siRNA	transfection	
mix	was	prepared	as	follows.	Per	transfection,	1ml	of	Opti-MEM	(Invitrogen)	was	added	to	
10μl	of	oligofectamine	(Invitrogen)	and	1.8μl	siRNA	(50μM	stock).	The	transfection	mix	was	
incubated	at	room	temperature	for	30	minutes.	During	the	incubation,	media	was	removed	
from	cells	plated	the	day	previous,	washed	once	in	Opti-MEM	and	1ml	of	Opti-MEM	added	
to	each	dish.	Following	 the	30	minute	 incubation,	 the	 transfection	mix	was	added	to	each	
dish	 and	 incubated	 at	 37°C	 for	 16	 to	 18	 hours.	 The	Opti-MEM	 transfection	mix	was	 then	
removed	 and	 replaced	with	 DMEM	 supplemented	with	 10%	 FCS.	 Cells	 were	 incubated	 at	
37°C	until	required.	A	list	of	all	the	siRNAs	used	in	this	study	is	outlined	in	Table	2.3.		
	
2.2.4	Transient	DNA	Transfections	
HeLa	 cells	 were	 transfected	 with	 plasmids	 containing	 the	 adenovirus	 genes	 as	
follows:	 	 pXC15-Ad5E1B55K,	 pCMV-Ad5E4orf6,	 pcDNA3Ad12E1B54K,	 and	
pcDNA3Ad12E4orf6	(all	E4orf6	constructs	were	HA	tagged).	GFP-TAB182,	HA-CNOT6	and	HA-
CNOT6L	plasmids	were	also	used	to	transfect	HeLa	cells	during	this	study.	24	hours	prior	to	
transfection,	cells	were	plated	at	80-90%	confluency	 into	6-well	plates	supplemented	with	
10%	FCS	in	DMEM.	The	following	day,	150μl	of	Opti-MEM	was	added	to	2.5μg	of	DNA	in	a	
1.5ml	 eppendorf	 tube	 (per	 reaction).	 In	 another	 eppendorf	 tube,	 150μl	 of	Opti-MEM	was	
added	 to	 7.5μl	 of	 Lipofectamine	 2000	 (Invitrogen)	 (per	 reaction).	 The	 contents	 of	 both	
eppendorf	 tubes	 were	 mixed	 together	 and	 left	 to	 incubate	 for	 30	 minutes	 at	 room	
temperature.	The	Opti-MEM/DNA/Lipofectamine-2000	mix	was	added	to	cells	plated	in		
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Target' siRNA' Sense'sequence' Supplier'
Non$silencing+
control+ Custom+ CGUACGCGGAAUACUUCGAdTdT+ Dharmacon+
CNOT4+ SMARTpool+ CCAAUUCUCUCAAUAGUAC+ Dharmacon+
++ ++ UAACAGAGUCACAGUCGUU+ ++
++ ++ CGUCUUUGUUGUAGGUUUA+ ++
++ ++ GGUAGUAGAUGGCAGAACA+ ++
CNOT6+ SMARTpool+ GAAAGAACGUGGCUAUAAU+ Dharmacon+
++ ++ GAGCACAGGUGGAGUAGAA+ ++
++ ++ GGGCAGAGCUUGAAAUAAG+ ++
++ ++ GCUAUAAUGUUCUUUGUGA+ ++
CNOT6L+ SMARTpool+ UGACAGCGCUGCACCUAAA+ Dharmacon+
++ ++ CCAAUUACACCUUUGAUUU+ ++
++ ++ GAGCAGGUAUGAAGCCUAU+ ++
++ ++ GGUAUUAGAGGUCCACAAA+ ++
TAB182+ SMARTpool+ GAGUUUGGGAAGAGCGCUU+ Dharmacon+
++ ++ AGGACCAGGAAUUCGGAAA+ ++
++ ++ CAGAAGCUUUGGAACGAGA+ ++
++ ++ CACCAAGGCCUGCGGUUGA+ ++
Table	 2.3:	 siRNAs	 used	 during	 this	 Study.	 The	 siRNAs	 used	 to	knockdown	 the	
expression	 of	 various	genes	 in	 this	 study	are	 shown.	The	 target	protein,	 siRNA	
type,	sense	sequence	and	source	are	indicated.	
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media	the	day	previous	and	incubated	at	37°C	for	6-7	hours.	Cells	were	then	washed	once	in	
PBS	and	supplemented	with	DMEM	with	10%	FCS	and	incubated	at	37°C	until	required.			
	
2.2.5	UV-C	and	IR	Irradiation	of	Cells	
HeLa	cells	were	mock-irradiated	or	irradiated	with	ionising	γ-rays	using	a	137C	source	
delivering	approximately	1	Gy/20	seconds.	Prior	to	UV-C	irradiation,	HeLa	cells	were	washed	
twice	with	PBS	and	any	residual	PBS	removed.	Cells	were	mock-irradiated	or	irradiated	with	
the	required	dose	of	UV-C	irradiation	from	a	254nm	UV-C	light	source.	Following	irradiation,	
DMEM	supplemented	with	10%	FCS	was	added.	Following	both	UV-C	and	IR	irradiation,	cells	
were	left	in	a	37°C	incubator	to	recover	until	harvested.		
	
2.2.6	Drug	Treatments	of	Cell	Lines	
0.5μM	 of	 Bortezomib	 (LC	 Laboratories)	 was	 added	 to	 HeLa	 cells	 24	 hours	 prior	 to	
each	 harvesting	 point.	 4μM	 of	 MLN4924	 (Active	 Biochem	 Labs)	 was	 added	 to	 HeLa	 cells	
immediately	 after	 infecting	 with	 adenovirus	 and	 left	 throughout	 the	 duration	 of	 the	
infection.	 HU	 (Sigma-Aldrich)	 was	 dissolved	 at	 the	 required	 concentration	 in	 DMEM	 and	
added	at	different	time-points	prior	to	harvesting	depending	on	the	experiment.		5μM	of	the	
ATR	 inhibitor	 (VE-821	 Selleck)(in	 DMSO)	was	 added	 2	 hours	 prior	 to	 labelling	 DNA	 fibres.	
1μM	 of	 the	 Chk1	 inhibitor	 (Go6976	 Calbiochem)(in	 DMSO)	 was	 added	 2	 hours	 prior	 to	
labelling	DNA	fibres.	25μM	of	 the	CDK	 inhibitor	 (Cdk1/2i	 III	Merck)(in	DMSO)	was	added	2	
hours	prior	to	labelling	DNA	fibres.		
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2.2.7	Flow	Cytometry	
Following	treatment	with	the	indicated	damaging	agent,	cells	were	harvested	at	the	
indicated	time	points	as	follows.	Media	was	removed	and	added	to	a	50ml	Falcon	tube,	cells	
were	 washed	 in	 PBS,	 and	 the	 PBS	 also	 added	 to	 the	 falcon	 tube	 (keeping	 all	 media	 and	
washes	ensures	no	mitotic	cells	are	lost).	Cells	were	trypsinised	as	previously	described	and	
the	harvested	cells	also	added	to	the	Falcon	tube.	All	cells	were	pelleted	by	centrifugation	at	
1400rpm	 for	 5	minutes.	 Cells	 were	 resuspended	 in	 PBS	 and	 pelleted	 by	 centrifugation	 at	
1400rpm	for	a	further	5	minutes.	Cells	were	resuspended	in	3mls	ice-cold	PBS,	followed	by	
the	addition	of	7mls	of	 ice-cold	100%	ethanol	drop-wise	whilst	 vortexing	 (preventing	 cells	
from	clumping).	Cells	were	stored	at	-20°C	for	at	least	1	hour	or	up	to	2	weeks.		
To	process	cells	for	propidium	iodide	(PI)	staining,	cells	were	washed	3	times	in	ice-
cold	PBS	and	 the	 cells	pelleted	by	 centrifugation	at	1600rpm	 for	5	minutes	between	each	
wash.	Cells	were	incubated	in	10mls	of	ice-cold	0.25%	Triton-X100	(Sigma-Aldrich)	in	PBS	for	
15	minutes	at	4°C.	Cells	were	washed	in	10mls	of	ice-cold	PBS	and	pelleted	by	centrifugation	
at	1600rpm	for	5	minutes.	Cells	were	incubated	in	1μg/ml	PI	(Sigma-Aldrich)	together	with	
0.1mg/ml	 RNase	 A	 (Sigma-Aldrich)	 in	 PBS	 for	 at	 least	 30	 minutes.	 Flow	 cytometry	 was	
performed	on	a	BD	Accuri	C6	flow	cytometer	and	analysed	using	BD	C	Flow	Plus	software.			
	
2.2.8	DNA	Fibre	Labelling	
24	 hours	 prior	 to	 labelling,	 HeLa	 cells	 were	 plated	 in	 a	 6	 well	 plate	 at	 30-40%	
confluency.	 Cells	 were	 pulse-labelled	 with	 25μM	 5-Chloro-2’-deoxyuridine	 (CldU)	 (Sigma-
Aldrich)	for	20	minutes	at	37°C.	Cells	were	washed	3	times	in	PBS	to	remove	any	remaining	
CldU.	Cells	were	then	treated	with	2mM	HU	for	2	hours	at	37°C	and	washed	3	times	in	PBS	
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to	remove	any	remaining	HU.	Cells	were	pulse-labelled	with	250μM	5-Iodo-2’-deoxyuridine	
(IdU)	(Sigma-Aldrich)	for	45	minutes	at	37°C.	IdU	was	removed	and	cells	washed	2	times	in	
ice-cold	 PBS.	 Cells	 were	 trypsinised	 as	 above	 and	 resuspended	 in	 ice-cold	 PBS	 to	 a	
concentration	of	50	x	104	cells/ml.	2μl	of	cells	resuspended	in	PBS	were	spotted	onto	glass	
slides	and	left	for	4	minutes,	and	subsequently	lysed	in	7μl	of	spreading	buffer	(200mM	Tris	
HCl	pH	7.4,	50mM	EDTA,	0.5%	SDS)	for	2	minutes.	Glass	slides	were	tilted	to	allow	DNA	to	
spread	down	the	slide,	excess	liquid	was	allowed	to	run	off	the	slide,	and	left	to	air-dry	for	2	
minutes.	Slides	were	fixed	in	methanol	/	acetone		(3:1)	for	10	minutes	and	air-dried	for	5	to	
10	minutes.	Slides	were	stored	at	4°C	for	up	to	1	year.		
	
2.2.9	Metaphase	Spread	Analysis	
HeLa	cells	were	treated	with	0.1mg/mL	colcemid	(Sigma-Aldrich)	approximately	2-4	
hours	before	harvesting.	Cells	were	then	trypsinised	and	collected,	along	with	all	media	and	
washes	into	Falcon	tubes,	and	cells	subsequently	pelleted	by	centrifugation	at	900rpm	for	5	
minutes.	 Cells	 were	 washed	 once	 in	 PBS	 and	 again	 pelleted	 by	 centrifugation.	 Following	
resuspension	of	cell	pellets	in	1-2ml	PBS,	8-10mls	of	pre-warmed	0.03M	sodium	citrate	was	
added	drop-wise	with	gentle	agitation.	Cells	were	incubated	at	37°C	for	1	hour,	transferred	
to	 a	 polypropylene	 tube	 and	 pelleted	 by	 centrifugation	 at	 900rpm	 for	 5	 minutes.	 The	
supernatant	was	discarded	and	resuspended	 in	1-2mls	PBS,	 followed	by	 the	addition	of	6-
8ml	 of	 3:1	 methanol:	 acetic	 acid	 drop-wise	 with	 gentle	 agitation.	 Cells	 were	 pelleted	 by	
centrifugation	at	900rpm	for	5	minutes.	The	resuspension	of	cells	 in	1-2mls	of	supernatant	
followed	by	the	drop-wise	addition	of	3:1	methanol:	acetic	acid	was	repeated	a	further	2-3	
times.	At	this	stage	it	was	possible	to	store	the	cells	at	-20°C	for	up	to	2	weeks.	To	‘drop’	the	
		 87	
cells	onto	slides,	 slides	were	 immersed	 in	acetic	acid,	blotted	 to	 remove	any	excess	acetic	
acid,	and	using	a	pipette,	two	drops	of	fixed	cells	were	dropped	onto	the	slides.	Slides	were	
left	 to	 dry	 overnight.	 Slides	 were	 then	 stained	 in	 Giemsa	 diluted	 1:20	 with	 H20	 for	 15	
minutes,	followed	by	a	wash	in	H20	for	a	further	3	minutes.	The	slides	were	allowed	to	dry	
overnight.	 Finally,	 mounting	 medium	 was	 added,	 along	 with	 a	 coverslip,	 and	 left	 for	 a	
minimum	of	4	hours	before	viewing	under	the	microscope.		
		
2.3	PROTEIN	BIOCHEMISTRY	TECHNIQUES	
2.3.1	Cell	Lysate	Preparation	
Cells	were	harvested	by	removing	media,	washing	once	in	warm	PBS,	and	trypsinising	
as	previously	described.	Cells	were	pelleted	by	centrifugation	at	1400rpm	for	5	minutes.	Cell	
pellets	were	then	washed	in	PBS	and	pelleted	by	centrifugation	for	a	further	5	minutes.	All	
PBS	 was	 removed	 from	 the	 cell	 pellets	 and	 the	 pellet	 resuspended	 in	 80-200μl	 UTB	 lysis	
buffer	(8M	urea,	50mM	Tris	HCl,	150mM	β-mercaptoethanol,	pH	7.5).	Cells	were	sonicated	
twice	 for	10	seconds	and	 immediately	placed	on	 ice.	Cell	 lysates	were	 then	centrifuged	at	
16000	 rpm	 for	15	minutes	 to	 remove	 cell	 debris.	 Supernatants	were	 transferred	 to	a	pre-
chilled	Eppendorf	tube,	snap-frozen	in	liquid	nitrogen	and	stored	at	-80°C.		
Cell	 lysate	 preparation	 for	 glutathione	 S-transferase	 (GST)	 pull-downs	 and	 co-
immunoprecipitation	assays	was	performed	as	follows.	Cells	were	washed	two	times	in	ice-
cold	PBS,	in	the	final	PBS	wash,	cells	were	scraped	off	of	the	tissue	culture	dish	using	a	cell	
scraper	 and	 pooled	 into	 15ml	 Falcon	 tubes.	 Cells	were	 pelleted	 by	 centrifugation	 at	 2000	
rpm	at	4°C	 for	5	minutes.	Cells	were	washed	 in	 ice-cold	PBS	a	 further	two	times,	pelleting	
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the	cells	by	centrifugation	in	between	each	wash.	Cells	were	then	lysed	in	500-1000	μl	NETN	
buffer	 (0.5%	 NP-40	 (Sigma-Aldrich),	 150mM	NaCl	 (Sigma-Aldrich),	 50mM	 Tris	 HCl	 pH	 7.5,	
0.5mM	 EDTA	 (Sigma-Aldrich))	 depending	 on	 cell	 number.	 Cell	 lysates	 were	 homogenised	
using	a	Wheaton-Dounce	homogeniser	and	centrifuged	three	times	at	4°C,	first	at	3000	rpm	
for	5	minutes,	followed	by	13000	rpm	for	15	minutes,	and	finally	45000	rpm	for	30	minutes.	
The	 supernatant	 was	 retained	 in	 preparation	 for	 the	 GST	 pull-down	 or	 co-
immunoprecipitation	assays.				
	
2.3.2	Protein	Determination	
Protein	 concentration	 of	 cell	 lysates	 were	 determined	 against	 a	 range	 of	 bovine	
serum	 albumin	 (BSA)	 (Sigma-Alrich)	 concentrations	 between	 0-500ng/ml.	 10μl	 of	 BSA	
standard	was	added	in	quadruplet	to	each	well	of	a	96-well	plate.	Cell	 lysates	were	diluted	
1:10	in	water	and	also	added	in	quadruplet	to	each	well	in	a	96-well	plate.	Bradford	reagent	
(Bio-Rad)	was	diluted	1:5	in	water	and	200μl	of	the	diluted	Bradford	reagent	was	added	to	
each	well	of	both	the	BSA	standards	and	cell	 lysates.	Absorbance	readings	were	measured	
using	a	micro-plate	reader	(Bio-Rad)	at	a	wavelength	of	595nm.	Final	protein	concentrations	
were	calculated	against	a	BSA	standard	curve.		
	
2.3.3	SDS-Polyacrylamide	Gel	Electrophoresis	(SDS-PAGE)	
For	proteins	over	or	under	50kDa	molecular	weight,	6%	or	10%	polyacrylamide	gels	
were	prepared	 respectively	 (Table	2.4).	Gel	 apparatus	 (GE	Healthcare)	was	 constructed	as	
per	the	manufacturer’s	instructions.	Cell	lysates	were	prepared	for	loading	with	the	addition	
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of	 an	 equal	 volume	 of	 2x	 Laemmli	 sample	 buffer	 (Bio-Rad),	 boiled	 for	 5	 minutes	 and	
centrifuged	at	14,000	rpm	for	1	minute.	Typically	50μg	of	cell	 lysate	was	loaded	onto	each	
gel	 lane,	 along	with	molecular	weight	markers	 (GE	 healthcare)	 to	 determine	 protein	 size.	
Gels	were	run	in	buffer	composed	of	100mM	Tris/Bicine	and	1%	SDS.	Gels	were	run	at	20mA	
from	between	4	to	6	hours	depending	on	protein	size.		
	
2.3.4	Visualisation	of	Proteins	on	Polyacrylamide	Gels	
Following	 the	separation	of	proteins	by	SDS-PAGE,	proteins	were	visualised	using	a	
Coomassie	 blue	 solution	 (0.1%	 Coomassie	 Brilliant	 Blue	 R-250	 (Sigma-Aldrich),	 40%	
methanol	 and	 10%	 acetic	 acid).	 Gels	 were	 agitated	 in	 Coomassie	 blue	 solution	 for	 10	
minutes	at	room	temperature.	To	destain,	gels	were	agitated	in	destain	(10%	acetic	acid	and	
20%	methanol)	overnight	at	room	temperature.		
	
2.3.5	Preparation	of	Proteins	for	Analysis	by	Mass	Spectrometry	
Samples	were	produced	by	co-immunoprecipitation	or	GST	pull-down	assay	and	the	
protocols	 followed	 until	 the	 point	 of	 the	 NETN	 washes	 (see	 Sections	 2.3.6	 and	 2.4.3,	
respectively).	 Beads	 were	 denatured	 by	 incubating	 in	 9M	 Urea/	 50mM	 ammonium	
bicarbonate	 at	 room	 temperature	 for	 1	 hour	 with	 agitation.	 Beads	 were	 pelleted	 by	
centrifugation	 at	 3000	 rpm	 at	 4°C	 for	 1	 minute	 and	 supernatant	 transferred	 to	 a	 fresh	
eppendorf	 tube.	 A	 final	 concentration	 of	 50mM	 dithiothreitol	 (DTT)	 was	 added	 to	 the	
supernatant	 and	 incubated	 at	 56°C	 for	 30	 minutes.	 A	 final	 concentration	 of	 100mM	
iodoacetamide	was	added	and	incubated	at	room	temperature	in	the	dark	for	30	minutes.	
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6%# 10%#
H20$ 27.4ml$ 22ml$
1M$Tris/Bicine$ 4ml$ 4ml$
30%$Acrylamide$$ 8ml$ 13.4ml$
10%$SDS$ 400μl$ 400μl$
TEMED$ 80μl$ 80μl$
Table	 2.4:	 Polyacrylamide	 Gel	 Ingredients.	
Polyacrylamide	gel	ingredients	used	throughout	this	
study	are	shown.		
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300μl	 of	 supernatant	 was	 added	 to	 FASP	 filters	 (Amicon,	 30K	 cut	 off)	 and	 centrifuged	 at	
14000	 rpm	 for	 15	 minutes	 at	 room	 temperature.	 Flow-through	 was	 discarded	 and	 the	
remaining	supernatant	added	to	the	FASP	filter	and	centrifuged	again	at	14000	rpm	for	15	
minutes	 at	 room	 temperature.	 Filters	 were	 washed	 four	 times	 with	 50mM	 ammonium	
bicarbonate,	centrifuging	at	14000	rpm	for	15	minutes	at	room	temperature	between	each	
wash,	 and	 discarding	 the	 flow-through	 each	 time.	 FASP	 filters	 were	 transferred	 to	 fresh	
collection	 tubes	 and	 mass	 spectrometry-grade	 trypsin	 (Promega),	 diluted	 in	 50mM	
ammonium	bicarbonate	to	a	final	volume	of	300μl,	added	to	the	FASP	filters	(1μg	per	filter).	
FASP	 filters	 were	 left	 in	 an	 incubator	 at	 37°C	 overnight.	 To	 collect	 tryptic	 peptides,	 FASP	
filters	were	 centrifuged	 at	 14000	 rpm	 for	 10	minutes	 at	 room	 temperature	 and	 the	 flow-
through,	 containing	 the	peptides,	 transferred	 to	a	 fresh	Eppendorf	 tube.	FASP	 filters	were	
washed	in	300μl	50mM	ammonium	bicarbonate,	centrifuged	at	14000	rpm	for	10	minutes	at	
room	temperature	and	the	flow-through	added	to	the	previous	flow-through.	Peptides	were	
dried	in	a	vacuum	centrifuge	(Eppendorf)	overnight.	Peptides	were	resuspended	in	40μl	1%	
acetonitrile/	 1%	 formic	 acid	 in	 sterile	mass-spectrometry	 grade	water	 (further	 details	 are	
given	in	Chapters	3	and	4).		
	
2.3.6	GST	Pull-Down	Assay	
In	 order	 to	 assess	 in-vitro	protein-protein	 interactions,	 GST	 pull-down	 assays	were	
performed.	10mg	of	cell	lysate	(as	prepared	in	Section	2.3.1)	was	incubated	with	25μg	GST-
fusion	protein	(see	Table	2.5	for	a	list	of	GST-fusion	proteins	used	in	this	study),	rotating	at	
4°C	 for	 3	 hours.	 To	 isolate	 protein-protein	 complexes,	 25μl	 of	 glutathione	 beads	 (Sigma-
Aldrich)	were	then	added	and	incubated	for	a	further	hour	at	4°C.	To	capture	protein-protein	
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complexes,	 glutathione	 beads	 were	 pelleted	 by	 centrifugation	 at	 3000	 rpm	 at	 4°C	 for	 1	
minute,	 and	 the	 supernatant	 discarded.	 Glutathione	 beads	 were	 washed	 in	 NETN	 buffer,	
centrifuged	at	3000	rpm	at	4°C	for	1	minute,	this	was	repeated	4	times.	Samples	were	then	
washed	 in	Buffer	B	 (2mM	EDTA	 in	PBS),	centrifuged	at	3000	rpm	at	4°C	 for	1	minute,	and	
taking	care	to	remove	all	supernatant.	To	elute	protein-protein	complexes	from	the	beads,	
60μl	of	25mM	glutathione	pH	8.2	(BDH	Laboratories)	was	incubated	with	the	samples	for	1	
hour	 at	 4°C.	 Samples	were	 centrifuged	 at	 3000	 rpm	 at	 4°C	 for	 1	minute	 and	 supernatant	
containing	 the	 protein-protein	 complexes	was	 transferred	 into	 a	 fresh	 Eppendorf	 tube.	 A	
further	30μl	of	glutathione	was	added	to	the	beads	and	incubated	at	4°C	for	30	minutes.	The	
samples	were	 centrifuged	again	 at	 3000	 rpm	at	 4°C	 for	 1	minute	 and	 supernatant	pooled	
into	 the	eppendorf	 tube.	Samples	were	 run	on	SDS-PAGE	gels	as	 follows.	25μl	of	 Laemmli	
sample	 buffer	 was	 added	 to	 the	 supernatant	 and	 boiled	 for	 5	 minutes.	 Samples	 were	
centrifuged	at	13000	rpm	and	loaded	onto	6%/10%	electrophoresis	gels	together	with	50μg	
of	cell	lysate	as	a	positive	control,	and	resolved	by	SDS-PAGE.		
	
2.3.7	Deadenylase	Assays	
The	method	is	based	on	that	described	by	Mittal	and	colleagues	(Mittal,	Aslam	et	al.	
2011).	Usually,	whole	cell	lysates	were	immunoprecipitated	as	described	in	Section	2.3.1	and	
2.4.3.	After	 the	 final	wash	the	 immunoprecipitates	were	washed	twice	with	deadenylation	
buffer	 (50mM	 Hepes-NaOH	 pH8.0,	 0.15MNaCl,	 2mMMgCl2,	 10%glycerol).	 The	
immunoprecipitated	 Protein	 G-agarose	 beads	 with	 the	 bound	 antibody-antigen	 complex	
were	incubated	in	deadenylation	buffer	(25µl)	with	2µl	5’fluoroscein-labelled	substrate	(Flc-
5’-CCUUUCCAAAAAAA-3’	final	concentration	0.2µM,	Sigma-Aldrich)	at	37o	for	1	hour.	After	
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GST$fusion+
protein+ Incorpora3ng++ Source+
GST$ N/A$ Phillip$Gallimore$
GST2TAB182C$
Spanning$the$amino$acids$8242864$fused$to$amino$acids$
122121729$of$TAB182$ Susan$Smith$$
Table	2.5:	GST-Fusion	Proteins	used	in	this	Study.	The	GST-fusion	proteins	used	
in	this	study	are	indicated	and	the	source.		
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that	 time	10µl	of	 supernatant	were	mixed	with	10µl	RNA	 loading	buffer	 (95%	 formamide,	
0.025%	 SDS,	 5mM	 EDTA,	 Blue-orange	 loading	 dye,	 Promega)	 and	 heated	 at	 85oC	 for	 5	
minutes.	RNA	was	analysed	by	electrophoresis	on	a	20%	acrylamide	gel	run	in	the	presence	
of	 8M	 urea	 and	 TBE.	 Fluoroscein-labelled	 ribonucleotide	was	 visualised	 using	 a	 Fusion	 SL	
chemiluminescence	imaging	system	(Vilber	Lourmat,	Marne-la-Vallée,	France).	On	occasion	
the	assay	was	carried	out	on	whole	cell	 lysates,	solubilised	 in	NETN	buffer	and	clarified	by	
high	speed	centrifugation.	
	
2.4	IMMUNOCHEMISTRY	TECHNIQUES	
2.4.1	Antibodies	
All	the	antibodies	used	in	this	study	are	listed	in	Table	2.6.	
	
2.4.2	Western	Blotting	
Following	separation	of	proteins	by	SDS-PAGE,	proteins	were	transferred	onto	nitrocellulose	
membrane	 using	 the	 following	 method.	 The	 gel	 and	 nitrocellulose	 membrane	 (VWR	
Laboratories)	were	 soaked	 in	 transfer	 buffer	 (20%	methanol,	 50mM	Tris,	 190mM	glycine)	
and	 placed	 in	 between	 two	 pieces	 of	 3MM	 filter	 paper	 (Whatman)	 and	 two	 pieces	 of	
sponge.	This	was	then	placed	inside	a	plastic	cassette	and	placed	in	a	transfer	tank	filled	with	
transfer	buffer	(all	transfer	apparatus	was	supplied	by	Hoeffer	Scientific).	Proteins	were	left	
to	transfer	at	200mA	at	room	temperature	for	16-18	hours	overnight.	Following	the	transfer,	
the	nitrocellulose	membrane	was	stained	to	visualise	proteins	with	Ponceau	S	solution		
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An#gen& An#body& Species& Applica#on& Dilu#on& Source&
53BP1& 53BP1& Rabbit& IF/WB& 1:1000& Novus&
Ad5E1A& M73& Mouse& WB& 1:500& Ed&Harlow&
Ad5E1B55K& 2A6& Mouse& WB/IF& 1:1000& Arnold&Levine&
Ad5E4ORF3& 6A11& Mouse& WB& 1:200& Thomas&Dobner&
Ad5E4ORF6& RSA1& Mouse& WB& 1:200& Thomas&Dobner&
Ad12E1A& M13& Mouse& WB& 1:20& In&house&
Ad12E1B55K& XPH9& Mouse& WB/IF& 1:1000& In&house&
Ad5&Hexon& Ad5&Hexon& Rabbit&& WB& 1:1000&& Vivien&Mautner&
Ad12&Knob& Ad12&Knob& Rabbit& WB& 1:1000& Paul&Freimuth&
ATR& ATR& Goat& WB& 1:1000& Santa&Cruz&
Aurora&kinase& Aurora&kinase& Mouse& WB& 1:1000& Abcam&
βWAcXn& AcXn& Mouse& WB& 1:50000& SigmaWAldrich&
BLM& BLM& Rabbit& WB& 1:1000& Bethyl&
BubR1& BubR1& Mouse& WB& 1:3000& Becton&Dickinson&
Chk1& Chk1& Mouse& WB& 1:1000& Santa&Cruz&
pChk1&S317& pChk1&S317& Rabbit& WB& 1:1000& Bethyl&
pChk1&S345& pChk1&S345& Rabbit&& WB& 1:1000& Cell&Signalling&
Chk2& Chk2& Rabbit& WB& 1:1000& Steve&Elledge&
Claspin& Claspin& Rabbit& WB& 1:1000& Bethyl&
CldU& BrdU& Rat& DNA&ﬁbres& 1:750& AbD&SeroTec&
CNOT3& CNOT3& Rabbit& WB& 1:1000& GeneTex&
CNOT4& CNOT4& Rabbit& WB& 1:1000& GeneTex&
CNOT7& CNOT7& Rabbit& WB& 1:1000& GeneTex&
CtIP& CtIP& Mouse& WB& 1:1000& Baer&Richard&
Cullin&2& Cullin&2& Rabbit&& WB& 1:1000& Abcam&
Cullin&5& Cullin&5& Rabbit& WB& 1:500& Santa&Cruz&
Cyclin&A& Cyclin&A& Rabbit& WB/IF& 1:500& Santa&Cruz&
Cyclin&B& Cyclin&B& Rabbit& WB& 1:500& Santa&Cruz&
Cyclin&E& Cyclin&E& Rabbit& WB& 1:500& Santa&Cruz&
DBP& DBP& Mouse& IF& 1:100& Pieter&van&der&Vliet&
DNAWPK& DNAWPK& Rabbit& WB& 1:1000& Abcam&
H3& H3& Rabbit& WB& 1:3000& Abcam&
Table	2.6:	Antibodies	used	throughout	this	Study.	Table	shows	the	antibodies	used	throughout	
this	study	together	with	antigen,	species,	application,	dilution	and	source.	
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An#gen& An#body& Species& Applica#on& Dilu#on& Source&
pHistone)H3)Ser10) pHistone)H3)Ser10) Rabbit) WB/FACS) 1:100) Cell)signalling)
H2AX) H2AX) Rabbit) WB) 1:1000) Millipore)
γH2AX)S139) γH2AX)S139) Mouse) WB/IF) 1:1000) Millipore)
HA) HA)12CAS) Mouse) WB) 1:1000) SigmaCAldrich)
hnRNPUL1) hnRNPUL1) Rabbit) WB) 1:1000) In)house)
IdU) BrdU) Mouse) DNA)ﬁbres) 1:500) Becton)Dickinson)
Ku80) Ku80) Mouse) WB) 1:1000) GeneTex)
MDC1) MDC1) Rabbit) WB) 1:1000) In)house)
MDM2) 2A10) Mouse) WB) 1:200) Arnold)Levine)
Mre11) Mre11) Mouse) WB) 1:1000) Genetex)
NBS1) NBS1) Rabbit) WB) 1:10000) Genetex)
pNBS1)S343) pNBS1)S343) Rabbit) WB) 1:1000) Abcam)
p53) DO1) Mouse) WB) 1:2000) David)Lane)
PCNA) PCNA) Mouse) WB) 1:1000) Santa)Cruz)
Rad9) Rad9) Rabbit) WB) 1:1000) Santa)Cruz)
Rad18) Rad18) Rabbit) WB) 1:1000) Bethyl)
Rad50) Rad50) Mouse) WB) 1:1000) GeneTex)
Rad51) Rad51) Rabbit)) WB) 1:1000) Santa)Cruz)
RNR1) RNR1) Rabbit)) WB) 1:1000) GeneTex)
RNR2) RNR2) Rabbit) WB) 1:1000) GeneTex)
p53R2) p53R2) Rabbit) WB) 1:1000) GeneTex)
RPA)) RPA) Mouse)) WB/IF) 1:1000) Calbiochem)
p21) p21) Mouse) WB) 1:500) Santa)Cruz)
pRPA)S4/8) pRPA)S4/8) Rabbit) WB) 1:1000) Bethyl)
Tab182) Tab182) Rabbit) WB) 1:500) In)house)
Tankyrase)1) Tankyrase)1) Rabbit) WB) 1:1000) GeneTex)
TOPBP1) TOPBP1) Rabbit) WB) 1:1000) Bethyl)
Mouse)IgG) AnYCmouse)HRP) Goat) WB) 1:2000) DAKO)Laboratories)
Rabbit)IgG) AnYCrabbit)HRP) Swine) WB) 1:3000) DAKO)Laboratories)
Rabbit)IgG) Alexa)ﬂuor®)488)anYCrabbit)) Donkey) FACS) 1:50) Invitrogen)
Rabbit)IgG) Alexa)ﬂuor®)546)anYCrabbit)) Goat) IF) 1:1000) Invitrogen)
Mouse)IgG) Alexa)ﬂuor®)488)anYCmouse))Goat) IF) 1:1000) Invitrogen)
Rat)IgG) Alexa)ﬂuor®)488)anYCmouse))Goat) DNA)ﬁbres) 1:500) Invitrogen)
Mouse)IgG) Alexa)ﬂuor®)488)anYCmouse))Goat) DNA)ﬁbres) 1:500) Invitrogen)
Table	2.6	Cont’d:	Antibodies	used	throughout	this	Study.	Table	shows	the	antibodies	used	
throughout	this	study	together	with	antigen,	species,	application,	dilution	and	source.	
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(Sigma-Aldrich)	for	1	minute	and	washed	with	deionised	water	three	times	to	remove	excess	
Ponceau	 S	 stain.	 Following	 visualisation	 of	 proteins,	 stain	 was	 completely	 removed	 by	
incubating	the	nitrocellulose	membrane	in	TBS-T	(20mM	Tris	HCl,	150mM	NaCl,	0.1%	Tween	
pH	7.6)	with	gentle	agitation.	Nitrocellulose	membranes	were	blocked	against	non-specific	
antibody	binding	by	incubating	the	membranes	in	5%	milk	powder	(Marvel)	in	TBS-T	for	30	
minutes	at	room	temperature,	with	agitation.	Primary	antibodies	were	diluted	in	5%	milk	or	
5%	 BSA	 at	 the	 required	 concentration	 (see	 Table	 2.6),	 and	 incubated	 with	 nitrocellulose	
membranes	 overnight	 at	 4°C	 with	 agitation.	 To	 remove	 excess	 primary	 antibodies,	
nitrocellulose	 membranes	 were	 washed	 with	 TBS-T	 three	 times	 for	 10	 minutes	 with	
agitation.	 Nitrocellulose	 membranes	 were	 then	 incubated	 with	 horseradish-peroxidase	
(HRP)-conjugated	secondary	antibodies	(Dako)	for	1	hour	with	agitation.	To	remove	excess	
secondary	antibodies,	nitrocellulose	membranes	were	washed	three	times	with	TBS-T	for	10	
minutes	 each	 time	 with	 agitation.	 Antigens	 were	 detected	 by	 incubation	 in	 enhanced	
chemoluminescence	 (ECL)	 (GE	 Healthcare)	 for	 1	 minute	 and	 visualised	 using	
autoradiography	film	(Kodak).		
	
2.4.3	Co-Immunoprecipitation	
To	 assess	 in-vivo	protein-protein	 interactions,	 co-immunoprecipitation	 assays	were	
performed	as	 follows.	5mg	of	cell	 lysate	 (as	prepared	 in	Section	2.3.1)	was	 incubated	with	
10μl	 of	 primary	 antibody	 at	 4°C	 rotating	 overnight.	 Cell	 lysates	 were	 then	 centrifuged	 at	
45000	rpm	at	4°C	for	10	minutes	and	the	supernatant	collected.	To	capture	protein-protein	
complexes,	40μl	of	Protein-G	agarose	beads	(Sigma-Aldrich)	were	added	to	the	cell	 lysates	
and	rotated	at	4°C	for	1	hour.	Following	 incubation,	the	samples	were	centrifuged	at	3000	
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rpm	 for	 1	minute	 at	 4°C	 and	 the	 supernatant	 discarded.	 The	 beads	were	 then	washed	 4	
times	 in	 NETN	 buffer,	 centrifuging	 at	 3000	 rpm	 for	 1	 minute	 at	 4°C	 and	 discarding	 the	
supernatant	 between	 each	wash.	 50μl	 of	 Laemmli	 sample	 buffer	was	 added	 to	 the	 beads	
and	boiled	for	5	minutes.	The	samples	were	centrifuged	at	13000	rpm	for	1	minute,	loaded	
onto	polyacrylamide	gels	and	resolved	by	SDS-PAGE.		
	
2.4.4	Immunofluorescence	
Cells	 were	 plated	 onto	 poly-L-lysine	 coated	 coverslips	 and	 incubated	 at	 37°C	
overnight.	Cells	were	washed	twice	 in	 ice-cold	PBS	and	permeabilised	by	 incubation	 in	 ice-
cold	pre-extraction	buffer	 (10mM	pipes	pH	6.8,	300mM	sucrose,	20mM	NaCl,	3mM	MgCl2	
and	0.5%	Triton	X-100)	 for	 5	minutes.	 Cells	were	 fixed	 in	 ice-cold	3.6%	paraformaldehyde	
(PFA)	 in	PBS	for	a	further	10	minutes.	Cover	slips	were	washed	three	times	 in	 ice-cold	PBS	
and	 incubated	 in	 10%	 FCS	 in	 PBS	 for	 1	 hour	 at	 room	 temperature	 or	 overnight	 at	 4°C.	
Primary	antibodies	were	diluted	to	the	required	concentration	(see	Table	2.6)	in	1%	FCS/PBS	
and	100μl	of	diluted	primary	antibody	was	added	to	each	coverslip	and	incubated	at	room	
temperature	for	1	hour	in	a	moistened	chamber.	Coverslips	were	washed	three	times	in	PBS	
to	 remove	 any	 residual	 primary	 antibody.	 Coverslips	 were	 incubated	 with	 secondary	
antibodies	(Alexa-Fluor,	Invitrogen)	diluted	to	the	required	concentration	in	2%	FCS/PBS	(see	
Table	2.6)	for	1.5	hours	at	room	temperature	in	a	dark	moistened	chamber.	The	coverslips	
were	then	washed	in	PBS	a	further	three	times.	Coverslips	were	mounted	onto	glass	slides	
using	 Vectashield	 Mounting	 medium	 with	 4’,	 6-diamidino-2-phenylindole	 (DAPI)	 (Vector	
Laboratories).	 Upon	 the	 addition	 of	 Vectashield,	 gentle	 pressure	 was	 applied	 to	 the	
coverslips	 to	 remove	 any	 excess,	 and	 the	 edges	 of	 the	 coverslips	 were	 sealed	 using	 nail	
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varnish.	Glass	slides	were	stored	at	4°C	in	a	light-proof	box.	Cells	were	viewed	using	a	Nikon	
Eclipse	E600	microscope	using	Velocity	software.		
	
2.4.5	Immunostaining	of	DNA	Fibres	
Slides	were	washed	 twice	 in	 H20,	 rinsed	 once	 in	 2.5M	 hydrochloric	 acid	 (HCl)	 and	
denatured	in	2.5M	HCl	for	1	hour	15	minutes.	Slides	were	rinsed	twice	in	PBS,	followed	by	
two	washes	in	blocking	solution	(1%	bovine	serum	albumin	(BSA),	0.01%	Tween	20	in	PBS).	
Slides	were	 incubated	 in	blocking	solution	 for	a	 further	30	minutes.	Slides	were	 incubated	
with	rat	anti-BrdU	(AbD	SeroTec)	(which	specifically	cross-reacts	with	CldU)	and	mouse	anti-
BrdU	 (Becton	 Dickinson)	 (which	 specifically	 cross	 reacts	 with	 IdU)	 antibodies	 in	 blocking	
solution	 for	 1	 hour.	 Slides	 were	 washed	 3	 times	 in	 PBS	 and	 incubated	 in	 5%	 PFA	 for	 10	
minutes	 to	 fix	 the	 antibodies.	 Slides	were	washed	 a	 further	 3	 times	 in	 PBS	 followed	 by	 3	
washes	 in	 blocking	 solution.	 Slides	 were	 incubated	 in	 anti-rat	 and	 anti-mouse	 secondary	
antibodies	 (Alexafluor)	 for	 1.5	 hours.	 Slides	were	washed	 twice	 in	 PBS,	 followed	 by	 three	
washes	 in	 blocking	 solution	 and	 twice	 more	 in	 PBS.	 Slides	 were	 mounted	 in	 mounting	
medium	 (Sigma-Aldrich)	 and	 stored	at	 -20°C	 for	up	 to	one	week.	DNA	 fibres	were	 viewed	
using	a	Nikon	Eclipse	E600	microscope	and	Velocity	software.		
	
2.4.6	Immunostaining	of	Cells	for	Flow	Cytometry	
Cells	were	harvested	for	analysis	by	flow	cytometry	as	described	in	Section	2.2.7.	To	
ensure	complete	removal	of	ethanol,	cells	were	washed	three	times	in	ice-cold	PBS,	pelleting	
the	 cells	 by	 centrifugation	 at	 1600rpm	 for	 5	 minutes	 between	 each	 wash.	 Cells	 were	
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incubated	 in	10mls	 ice-cold	0.25%	Triton-X100	 in	PBS	 for	15	minutes	at	4°C.	Following	the	
incubation,	cells	were	pelleted	by	centrifugation	at	1600rpm	for	5	minutes.	Cells	were	then	
washed	in	ice-cold	1%	BSA	in	PBS	and	pelleted	by	centrifugation.	Cells	were	then	incubated	
with	p-Histone	H3	Ser10	antibody	in	1%	BSA	for	1	hour	at	room	temperature.	Following	the	
incubation,	cells	were	washed	twice	in	1%	BSA,	pelleting	the	cells	by	centrifugation	between	
each	wash.	Cells	were	then	further	incubated	with	alexa-488	anti-rabbit	secondary	antibody	
in	1%	BSA	for	30	minutes	at	room	temperature	 in	the	dark.	Following	the	 incubation,	cells	
were	 washed	 once	 in	 1%	 BSA	 in	 PBS	 and	 pelleted	 by	 centrifugation	 at	 1600rpm	 for	 5	
minutes.	 From	 this	 point	 the	 cells	 were	 stained	 according	 to	 the	 PI	 protocol	 outlined	 in	
Section	2.2.7.	As	before,	flow	cytometry	was	performed	using	a	BD	Accuri	C6	flow	cytometer	
and	analysed	using	BD	C	Flow	Plus	software.		
	
2.5	MOLECULAR	BIOLOGY	TECHNIQUES	
2.5.1	Media	and	Antibiotics	
Luria	Broth	(LB)	(Sigma-Aldrich):	was	prepared	at	25g	per	litre	(pH	7.3-7.5)	and	autoclaved	
to	sterilise	prior	to	use.		
LB-agar	 plates:	1.2%	agar	 (Sigma-Aldrich)	was	added	 to	 LB	prior	 to	 sterilisation.	 Following	
sterilisation,	 LB-agar	 was	 heated	 to	 melt,	 antibiotic	 added	 when	 sufficiently	 cooled,	 and	
poured	into	agar	plates.	LB-agar	plates	were	stored	at	4°C.	
Antibiotics:	Ampicillin	(Sigma-Aldrich)	was	added	to	LB	and	LB	agar	plates	at	a	concentration	
of	50μg/ml.		
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2.5.2	Transformation	of	Bacteria	
Transformation	of	plasmids	into	Stbl2	competent	cells	(Thermo-Fisher	Scientific)	was	
achieved	as	follows.	Stbl2	competent	cells	were	thawed	on	ice,	20-50ng	of	DNA	was	added	
to	50μl	of	cells	in	a	pre-chilled	polypropylene	tube.	This	was	left	on	ice	for	30	minutes,	heat	
shocked	at	42°C	for	25	seconds,	and	immediately	placed	back	on	ice	for	2	minutes.	450μl	of	
SOC	media	(Invitrogen)	was	then	added	and	left	to	incubate	in	an	orbital	shaker	at	220rpm	
at	30°C	for	1.5	hours.	20-50μl	of	the	sample	was	spread	onto	LB-agar	plates	containing	the	
appropriate	antibiotic.	LB-agar	plates	were	incubated	at	37°C	overnight.		
	
2.5.3	Small-Scale	Preparation	of	DNA	
Colonies	 were	 picked	 from	 LB-agar	 plates	 using	 a	 sterile	 pipette	 tip	 and	 used	 to	
inoculate	3mls	of	LB	supplemented	with	the	appropriate	antibiotic	in	a	shaking	incubator	at	
37°C	at	220rpm	overnight.	Overnight	cultures	were	centrifuged	to	pellet	bacteria	at	12000	
rpm	 for	 1	 minute.	 Small-scale	 preparation	 of	 DNA	 was	 performed	 using	 the	 Sigma	
GenEluteTM	Plasmid	Miniprep	Kit	as	follows.	Bacterial	pellets	were	resuspended	in	200μl	of	
re-suspension	buffer	supplemented	with	RNAse	A.	200μl	of	lysis	buffer	was	added	to	the	re-
suspension	to	lyse	the	bacteria	for	no	longer	than	5	minutes.	300μl	of	neutralisation	solution	
was	 added	 and	 bacterial	 debris	 pelleted	 by	 centrifugation	 at	 13000	 rpm	 for	 10	 minutes.	
Following	centrifugation,	the	supernatant	was	added	to	a	mini-prep	binding	column	that	had	
been	prepared	by	the	addition	of	500μl	of	column	preparation	solution.	Columns	were	spun	
at	13000	rpm	for	1	minute	to	allow	lysate	to	flow	through.	The	columns	were	then	washed	
with	 750μl	wash	 solution	 and	 centrifuged	 again	 at	 13000	 rpm	 for	 1	minute.	 The	 columns	
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were	 transferred	 into	 a	 fresh	 collection	 tube,	 100μl	 of	 elution	 solution	 added	 and	
centrifuged	at	13000	rpm	for	1	minute.	DNA	was	stored	at	-20°C	until	required.		
	
2.5.4	Large-Scale	Preparation	of	DNA	
Colonies	 were	 picked	 from	 LB-agar	 plates	 using	 a	 sterile	 pipette	 tip	 and	 used	 to	
inoculate	3mls	of	LB	supplemented	with	the	appropriate	antibiotic	in	a	shaking	incubator	at	
37°C	at	220rpm	overnight.	The	total	volume	of	this	culture	was	used	to	inoculate	250mls	of	
LB	supplemented	with	the	appropriate	antibiotic	 in	a	shaking	 incubator	at	37°C	at	220rpm	
overnight.	Overnight	cultures	were	centrifuged	to	pellet	bacteria	at	12000	rpm	for	1	minute.	
Large-scale	 preparation	 of	 DNA	 was	 performed	 using	 the	 Invitrogen	 PureLinkTM	 HiPure	
Plasmid	 Filter	 Purification	 Kit	 as	 follows.	 Bacterial	 pellets	 were	 resuspended	 in	 20mls	 of	
resuspension	buffer	supplemented	with	RNAse	A.	The	bacteria	were	lysed	in	20mls	of	 lysis	
buffer	for	no	longer	than	5	minutes.	10mls	of	precipitation	buffer	was	added	to	the	lysate	to	
neutralise	the	reaction.	The	precipitated	 lysate	was	transferred	to	a	maxi	column	that	had	
been	 pre-prepared	 by	 the	 addition	 of	 30mls	 of	 equilibration	 buffer,	 and	 allowed	 to	 drip	
through	 the	 column	 by	 gravity.	 Columns	 were	 washed	 with	 50mls	 of	 wash	 buffer	 and	
allowed	 to	 run	 through	 the	 column	 by	 gravity.	 Columns	 were	 transferred	 into	 fresh	
collection	tubes	and	15mls	of	elution	buffer	was	added	to	elute	the	DNA.	The	eluted	DNA	
was	split	equally	into	two	Falcon	tubes	and	5.2mls	of	isopropanol	added	to	each	tube.		DNA	
was	pelleted	by	centrifugation	at	5000	rpm	for	1	hour	at	4°C.	DNA	pellets	were	resuspended	
in	5mls	70%	ethanol	(Fisher	Scientific)	and	pelleted	by	centrifugation	at	5000	rpm	for	1	hour	
at	4°C.	The	supernatant	was	removed,	DNA	pellets	were	air-dried,	resuspended	in	200-500μl	
TE	buffer	(depending	on	DNA	pellet	size),	and	stored	at	-20°C	until	required.		
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2.5.5	DNA	Concentration	Quantification	
DNA	 concentrations	 were	 measured	 using	 a	 Nanodrop	 1000	 spectrophotometer	
(Thermo-Fisher	 Scientific).	 DNA	 concentrations	 were	 measured	 in	 ng/μl	 and	 the	
OD260nm/280nm	recorded.		
	
2.5.6	Cloning	
2.5.6.1	PCR	of	TAB182	Gene	Sequence	from	cDNA	
2μl	of	cDNA	(originally	generated	from	a	lymphoblastoid	cell	line	prepared	from	cells	
of	a	normal	 individual)	 (kindly	donated	by	Dr	Phil	Byrd)	was	used	to	amplify	 the	complete	
TAB182	cDNA	using	forward	and	reverse	primers	(shown	in	Table	2.7).	The	polymerase	chain	
reaction	(PCR)	reaction	was	set	up	as	follows:	10-20ng	of	cDNA,	0.5μM	forward	and	reverse	
primers,	 1.5	 units	 of	 Q5	 High-Fidelity	 DNA	 polymerase	 (New	 England	 Biolabs),	 200mM	
dNTPs,	 1	X	Q5	 reaction	buffer	 in	 a	50μl	 reaction.	A	Veriti	 96-well	 Thermal	Cycler	 (Applied	
Biosystems)	 was	 used	 for	 the	 PCR	 reaction	 under	 the	 following	 conditions:	 an	 initial	
denaturation	step	of	98°C	for	30	seconds	was	followed	by	30	cycles	of	98°C	for	5	seconds,	
62°C	for	15	seconds,	72°C	for	4	minutes.	A	final	extension	of	5	minutes	at	72oC	followed	the	
30	cycles.		
	
2.5.6.2	Agarose	Gel	Electrophoresis	
The	 visualisation	 of	 PCR	 products	 was	 achieved	 by	 running	 the	 product	 on	 0.8%	
agarose	 gels.	 0.8g	 agarose	 (Sigma-Aldrich)	 and	 1μg/ml	 ethidium	 bromide	 (total	
concentration)	was	added	 to	100mls	of	1x	TBE	 (20mM	Na2EDTA,	880mM	Tris	and	890mM	
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orthoboric	 acid)	 and	 heated	 until	 all	 agarose	 was	 dissolved.	 Once	 dissolved,	 the	 agarose	
mixture	was	poured	into	gel	tanks	and	allowed	to	cool.	Once	cooled,	gel	tanks	were	flooded	
with	 1x	 TBE	 buffer.	 1μl	 of	 PCR	 product,	 together	 with	 2μl	 of	 loading	 buffer	 (0.25%	 w/v	
bromophenol	blue,	30%	glycerol)	and	7μl	0.25x	TBE	buffer	was	mixed	and	loaded	onto	the	
agarose	 gel	 along	 with	 DNA	molecular	 weight	 marker	 (Roche).	 Agarose	 gels	 were	 run	 at	
120V	for	30	minutes	to	1	hour	depending	on	PCR	product	size.	PCR	products	were	visualised	
using	a	G:BOX	(Syngene).		
	
2.5.6.3	Restriction	Digest	and	Ligation	
Restriction	digests	were	performed	on	plasmid	DNA	(pEGFP-C3)	or	on	PCR	products	
(full-length	TAB182)	with	engineered	restriction	sites	(Sal	I).	PCR	products	were	digested	for	
2	 hours	 at	 37oC	 in	 80μl	 1x	 CutSmart	 buffer	 (New	 England	 Biolabs)	 containing	 20	 units	 of	
High-Fidelity	Sal	I	(Sal	I-HF)	restriction	endonuclease	(New	England	Biolabs).	5μg	of	pEGFP-C3	
plasmid	DNA	was	digested	with	20	units	of	Sal	I-HF	in	100μl	1x	CutSmart	buffer	and	10	units	
of	calf	intestinal	phosphatase	(New	England	Biolabs)	to	remove	5’	phosphates	from	the	ends	
of	 linear	molecules	 generated.	 Ligation	 reactions	were	 set	 up	with	 50ng	 Sal	 I-HF	 digested	
and	 phosphatased	 pEGFP-C3	 DNA	 and	 50ng	 of	 Sal	 I-HF	 digested	 TAB182	 cDNA.	 Ligation	
reactions	were	performed	in	12μl	1x	ligation	buffer	containing	1μl	(400	units)	T4	DNA	ligase	
(New	 England	 Biolabs).	 The	 ligation	 reaction	was	 incubated	 at	 16oC	 overnight.	 3μl	 of	 the	
ligation	reaction	was	transformed	into	50μl	of	high	efficiency	NEB	5-alpha	competent	E.coli	
bacteria	 (New	 England	 Biolabs).	 Tranformation	 reactions	 were	 plated	 on	 LB-agar	 plates	
containing	30μg/ml	kanamycin	and	incubated	overnight	at	37oC.		
	
		 105	
2.5.6.4	Screening	of	Colonies	via	Bacterial	PCR	
Colonies	were	picked	and	grown	in	LB	as	previously	described.	1μl	of	the	culture	was	
incubated	 with	 0.5μl	 Taq	 polymerase	 (Roche),	 0.75μl	 of	 dNTPs	 (10mM),	 1μl	 forward	 and	
reverse	 primers,	 2.5μl	 5x	 buffer	 +Mg2+,	 into	 a	 final	 volume	of	 25μl.	 The	 reaction	mix	was	
subjected	 to	 the	 same	 conditions	 as	 before	 (Section	 2.5.6.1).	 PCR	 products	 were	 run	 on	
agarose	gels	and	assessed	as	previously	described.		
	
2.5.6.5	DNA	Sequencing	
The	DNA	sequence	of	the	ligated	product	was	determined	to	check	whether	the	gene	
sequence	had	acquired	any	mutations	during	the	cloning	process.	Sequencing	primers	were	
designed	 to	 sequence	 the	 entire	 length	 of	 the	 eGFPC3-TAB182	 gene	 (Table	 2.7).	 Plasmid	
DNA	 along	 with	 sequencing	 primers	 was	 sent	 to	 Source	 Bioscience	 for	 sequencing.	 DNA	
sequences	were	analysed	using	FinchTV	software	and	NCBI	BLAST.	
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Primer& Sequence&
pEGFP&C3)Forward)) 5')CCTGAGCAAAGACCCCAACGAGAAG)3'))
pEGFP&C3)Reverse)) 5')CCCCCTGAACCTGAAACATAAAATG)3'))
TAB182)Forward)1)) 5')ATGAAAGTGTCTACTCTCAGG)3')
TAB182)Forward)2)) 5')TTTGACACCCCCAGCTCGAT)3')
TAB182)Forward)3)) 5')TTCAACGGGGACCTGGCTAA)3')
TAB182)Forward)4)) 5')TCTTGGAGCCCCATAGCCTG)3')
TAB182)Forward)5)) 5')AGCAGGGAAGAAGGAGTGTCT)3')
TAB182)Forward)6)) 5')TGTGTTCTCTTTGCTGATGC)3')
TAB182)Forward)7)) 5')TGCTTCTCAGGACTATGGCCTT)3')
TAB182)Forward)8)) 5')ATTTGGGGAAGAGGGACCAC)3')
TAB182)Forward)9)) 5')AGTGATGCTAGCCAGGAGGT)3')
TAB182)Forward)10)) 5')CTGAGCTTGAGAGACATGAA)3')
TAB182)Forward)11)) 5')TGACCTGTGACCCAGACTCT)3')
TAB182)Forward)12)) 5')CTGTTGGAGGAGGAAGGAGC)3')
TAB182)Forward)13) 5')AGTCAGGACTTCTCCTTCATT)3')
TAB182)Reverse)1) 5')CATCTTGGCCAGGATCTCTT)3')
TAB182)Reverse)2) 5')ATTCTCTGAGGAGGGGGCTGGACTT)3')
TAB182)Reverse)3) 5')AGATGGAAACGTCCGAGTGAGAT)3')
TAB182)Reverse)4) 5')AACTTCCTGACCCACTTGGA)3')
TAB182)Reverse)5) 5')ATGCCCTACACAAGTCTTGA)3')
TAB182)Reverse)6) 5')TTGCCCATACTTGCTGGTCCA)3')
TAB182)Reverse)7) 5')AAACTCCCAGTCCTGCTCAT)3')
TAB182)Reverse)8) 5')ATCTTCCAGGTCAGCACTGC)3')
TAB182)Reverse)9) 5')TTCAGACCCTCCACTTTCCAAA)3')
TAB182)Reverse)10) 5')ATGCTCCCTGGCTTCACTTG)3')
TAB182)Reverse)11) 5')AGGCTCCAGCACCTCCTCTT)3')
TAB182)Reverse)12) 5')CTCTGTAGAGTCCTGGAACA)3')
TAB182)Reverse)13) 5')TCAGACCTTCTTCTTCTTCAGTTT)3')
Table	 2.7:	 Sequencing	 Primers	 used	 in	 this	 Study.	 Table	 illustrates	 the	
primers	used	in	this	study.	Primer	name	and	sequence	are	shown.		
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3.	THE	ROLE	OF	TAB182	DURING	ADENOVIRUS	INFECTION	
3.1	INTRODUCTION	
During	 adenovirus	 infection,	 the	 viral	 linear	 double-stranded	 genome	 can	 be	
recognised	by	the	DDR	as	DSBs	and	acted	upon	by	the	DSB	repair	machinery	in	an	attempt	to	
‘repair’	 the	adenoviral	 ends.	 The	 result	of	 such	 ‘repair’	 leads	 to	 the	 concatenation	of	 viral	
genomes	 which	 are	 unable	 to	 be	 replicated	 (Weiden	 and	 Ginsberg	 1994).	 To	 avoid	 this,	
adenovirus	has	developed	sophisticated	mechanisms	to	avoid	detection	from	the	DDR	and	
therefore	 replicate	 its	 genome.	 Such	 mechanisms	 include	 the	 degradation	 of	 proteins	
involved	in	the	DDR	and	repair	pathways	including	p53,	Mre11,	DNA	ligase	IV,	BLM,	TOPBP1	
and	Tip60	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002,	Baker,	Rohleder	et	
al.	 2007,	 Blackford,	 Patel	 et	 al.	 2010,	 Orazio,	 Naeger	 et	 al.	 2011,	 Gupta,	 Jha	 et	 al.	 2013).	
Another	 mechanism	 of	 evading	 the	 cellular	 DDR	 is	 through	 the	 relocalisation	 of	 DDR	
proteins;	 a	 number	 of	 DDR	 proteins	 are	 known	 to	 be	 relocated	 to	 VRCs	 during	 infection	
including	RPA32,	ATR,	ATRIP,	 TOPBP1,	 Rad17	 and	Rad9	 (Stracker,	 Lee	 et	 al.	 2005,	 Carson,	
Orazio	 et	 al.	 2009).	 Adenovirus	 has	 also	 been	 shown	 to	 relocalise	 DDR	 proteins	 to	 PML	
bodies	or	aggresomes,	such	proteins	include	p53	and	the	MRN	complex	(Carvalho,	Seeler	et	
al.	1995,	Konig,	Roth	et	al.	1999),	(Araujo,	Stracker	et	al.	2005,	Liu,	Shevchenko	et	al.	2005).		
Previous	 preliminary	 studies	 from	 our	 laboratory	 have	 indicated	 that	 TAB182,	 a	
protein	 previously	 shown	 to	 interact	 with	 Tankyrase	 1,	 may	 be	 down-regulated	 during	
adenovirus	 infection	 (Seimiya	 and	 Smith	 2002).	 Such	 preliminary	 studies	 included	 the	
screening	of	a	panel	of	proteins	that	had	been	previously	 implicated	 in	the	DDR	(including	
TAB182),	 to	 determine	 whether	 they	 were	 reduced	 during	 Ad5	 infection.	 Amongst	 the	
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screened	 proteins,	 TAB182	 was	 the	 only	 obvious	 candidate.	 Since	 more	 than	 80%	 of	
adenoviral	cellular	 targets	are	proteins	 involved	 in	 the	DDR,	 it	was	 therefore	hypothesised	
that	 TAB182	 could	 be	 a	 DDR	 protein	 targeted	 for	 proteasomal	 degradation	 during	
adenovirus	infection	in	order	to	promote	viral	replication.	Therefore	the	aim	of	this	chapter	
was	 to	 examine	whether	 TAB182	was	 indeed	 targeted	 for	 degradation	 during	 adenovirus	
infection	and	to	determine	the	mechanistic	basis	for	this	degradation.		
	
3.2	RESULTS	
3.2.1	TAB182	is	Down-Regulated	following	Infection	with	Ad5	and	Ad12	
To	 confirm	 the	 preliminary	 evidence	 obtained	 from	our	 laboratory	 suggesting	 that	
TAB182	is	degraded	during	adenovirus	infection,	HeLa	cells	were	mock-infected	or	infected	
with	 Ad5	 and	 Ad12	 at	 an	MOI	 of	 5	 and	 harvested	 at	 0,	 8,	 24,	 48,	 72	 and	 96	 hours	 post-
infection.	Cell	lysates	were	subjected	to	SDS-PAGE	and	Western	blotting	using	the	indicated	
antibodies	(Figure	3.1).	β-actin	was	used	as	a	loading	control.	Adenovirus	early	proteins	E1A	
and	E1B55K	were	 immunoblotted	along	with	 the	viral	 structural	proteins	Hexon	 (Ad5)	and	
Knob	 (Ad12)	 as	 markers	 of	 adenovirus	 replication.	 As	 expected,	 the	 expression	 of	 E1A,	
E1B55K,	Hexon	(Ad5)	and	Knob	(Ad12)	was	observed	between	8	and	24	hours	post-infection	
in	 both	 Ad5	 and	 Ad12	 infected	 cells.	 Mre11	 and	 p53	 were	 immunoblotted	 as	 positive	
controls	 since	 these	 proteins	 are	 known	 to	 be	 degraded	 during	 adenovirus	 infection	
(Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002).	 As	 previously	 reported,	
Mre11	and	p53	were	degraded	in	both	Ad5	and	Ad12	infected	cells	by	72	and	48	hours	post-	
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Figure	3.1:	The	Protein	Levels	of	TAB182	are	Reduced	following	Infection	with	Ad5	and	Ad12.	
HeLa	cells	were	infected	with	Ad5	(A)	or	Ad12	(B)	at	an	MOI	of	5.	Cells	were	then	harvested	at	
various	time-points	(0,	8,	24,	48,	72	and	96	hours)	post-infection.	Cell	lysates	were	subjected	to	
SDS-PAGE	and	Western	blotting	using	the	indicated	antibodies.	E1A,	E1B55K	and	Hexon/Knob	
were	immunoblotted	as	markers	of	infection.	Mre11	and	p53	were	immunoblotted	as	positive	
controls	 since	 these	 proteins	 are	 known	 to	 be	 degraded	 by	 Ad5	 and	 Ad12.	 β-Actin	 was	
immunoblotted	 as	 a	 loading	 control.	 These	 Western	 blots	 are	 representative	 of	 three	
independent	repeats.	
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infection,	 respectively.	 Interestingly,	 the	expression	 levels	of	p53	 increased	 following	both	
Ad5	 and	 Ad12	 infection	 before	 it	 was	 degraded.	 This	 is	 believed	 to	 be	 a	 consequence	 of	
adenovirus	 infection	 inducing	 a	 pseudo-S	 phase	 and	 subsequently	 p53	 expression	 is	
increased	 (Boggs	and	Reisman	2006,	Takahashi,	Polson	et	al.	 2011).	 Infection	of	 cells	with	
Ad5	 and	Ad12	 resulted	 in	 the	 reduced	 levels	 of	 TAB182	protein	 at	 72	 and	48	hours	 post-
infection	 respectively,	 confirming	 that	 TAB182	 is	 indeed	 a	 cellular	 target	 for	 certain	
adenovirus	serotypes.	Similarly	to	p53	expression	levels,	the	expression	of	TAB182	increased	
prior	 to	 degradation,	 suggesting	 that	 the	 expression	 levels	 of	 TAB182	 are	 cell	 cycle	
dependent	(Figure	3.1).			
	
3.2.2	The	Down-Regulation	of	TAB182	during	Ad5	and	Ad12	Infection	is	Dependent	on	
Proteasome	Function	
The	 degradation	 of	 DNA	 damage	 proteins	 during	 adenovirus	 infection	 is	 almost	
exclusively	dependent	on	the	proteasome	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	
et	al.	2002,	Baker,	Rohleder	et	al.	2007,	Orazio,	Naeger	et	al.	2011).	To	determine	whether	
the	 down-regulation	 of	 TAB182	 during	 adenovirus	 infection	 is	 also	 dependent	 on	 the	
proteasome,	and	therefore	is	a	degradation	target	of	adenovirus	infection,	the	proteasome	
inhibitor	bortezomib	was	used.	HeLa	cells	were	mock-infected	or	infected	with	Ad5	or	Ad12	
virus	and	subsequently	mock-treated	or	treated	with	the	proteasome	inhibitor	bortezomib	
24	hours	before	each	harvest	time	point	(to	limit	the	toxicity	of	bortezomib	treatment).	Cells	
were	harvested	at	0,	8,	24,	48	and	72	hours	post-infection.	Cell	lysates	were	fractionated	by	
SDS-PAGE	 and	 the	 filters	 were	 immunoblotted	with	 the	 indicated	 antibodies	 (Figure	 3.2).	
Again,	E1B55K	was	immunoblotted	as	an	indicator	of	infection,	expression	of	E1B55K	was		
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Figure	 3.2:	 The	 Down-Regulation	 of	 TAB182	 Protein	 Levels	 during	 Ad5	 and	 Ad12	
Infection	 can	 be	 Rescued	 by	 the	 Proteasomal	 Inhibitor	 Bortezomib.	 HeLa	 cells	 were	
infected	with	Ad5	 (A)	or	Ad12	 (B)	at	an	MOI	of	5.	Cells	were	treated	with	0.5µM	of	the	
proteasome	 inhibitor	 Bortezomib	 24	 hours	 before	 harvesting.	 Cells	 were	 harvested	 at	
various	time-points	(0,	8,	24,	48	and	72	hours)	post-infection.	Cell	lysates	were	subjected	
to	 SDS-PAGE	 and	 Western	 blotting	 using	 the	 indicated	 antibodies.	 E1B55K	 was	
immunoblotted	 as	 a	marker	 of	 infection.	Mre11,	 BLM	and	p53	were	 immunoblotted	 as	
positive	controls	since	these	proteins	are	known	to	be	degraded	by	Ad5	and	Ad12.	These	
Western	blots	are	representative	of	three	independent	repeats.	
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observed	 24	 hours	 post-infection	 in	 DMSO,	 mock-treated	 infected	 cells	 and	 bortezomib	
treated	 infected	 cells.	 Ad5	 infected	 cells	 treated	 with	 bortezomib	 showed	 a	 decrease	 in	
E1B55K	expression	when	compared	to	mock-treated	cells,	possibly	due	to	the	toxic	effects	of	
bortezomib	 on	 the	 transcriptional	machinery	 required	 for	 the	 virus.	Mre11,	 p53	 and	 BLM	
were	 immunoblotted	 as	 controls	 since	 the	 degradation	 of	 these	 proteins	 during	 Ad5	 and	
Ad12	 infection	 is	known	to	be	dependent	on	proteasome	function	(Querido,	Blanchette	et	
al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002,	 Orazio,	 Naeger	 et	 al.	 2011).	 As	 expected,	 in	 cells	
infected	with	Ad5	or	Ad12	and	mock-treated,	Mre11,	p53	and	BLM	were	degraded	during	
the	 course	 of	 infection	 (Figure	 3.2A	 and	 3.2B	 respectively).	 	 In	 cells	 infected	with	 Ad5	 or	
Ad12	 and	 bortezomib	 treated,	 the	 degradation	 of	 Mre11,	 p53	 and	 BLM	 was	 delayed	 in	
comparison	to	mock-treated	control	cells.	 	Similarly,	the	degradation	of	TAB182	in	infected	
(Ad5	 or	 Ad12),	 bortezomib	 treated	 cells	 was	 delayed	 compared	 to	 the	 degradation	 of	
TAB182	 in	 infected,	 mock-treated	 cells.	 These	 data	 indicate	 that	 the	 down-regulation	 of	
TAB182	during	 adenovirus	 infection	 is	 due	 to	 proteasomal-dependent	 degradation	 (Figure	
3.2).	
3.2.3	The	Degradation	of	TAB182	during	Ad5	and	Ad12	Infection	is	Dependent	on	Cullin	
Function	
It	is	well	established	that	during	infection,	adenoviruses	utilise	cellular	Cullin	proteins	
in	 order	 to	 degrade	 their	 targets	 (Querido,	 Blanchette	 et	 al.	 2001,	 Baker,	 Rohleder	 et	 al.	
2007,	 Blackford,	 Patel	 et	 al.	 2010,	 Forrester,	 Sedgwick	 et	 al.	 2011,	 Orazio,	 Naeger	 et	 al.	
2011).	 The	 small	molecule	 inhibitor	MLN4924	was	 used	 to	 inhibit	 cellular	 Cullin	 function;	
MLN4924	 inhibits	 the	 NEDD8-activating	 enzyme	 (NAE),	 which	 in	 turn	 inhibits	 Cullin	
neddylation	 and	 therefore	 inhibits	 Cullin-RING	 E3	 ligases	 (Brownell,	 Sintchak	 et	 al.	 2010).	
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MLN4924	was	utilised	to	determine	whether	the	degradation	of	TAB182	during	adenovirus	
infection	is	dependent	on	Cullin	function.	HeLa	cells	were	infected	with	Ad12;	immediately	
after	 infection,	 cells	 were	 also	 incubated	 with	 MLN4924	 until	 harvesting.	 Cells	 were	
harvested	 0,	 8,	 24,	 48	 and	72	hours	 post-infection.	 Cell	 lysates	were	 fractionated	by	 SDS-
PAGE	and	the	filters	were	probed	with	the	indicated	antibodies	(Figure	3.3).	Again,	E1B55K	
was	immunoblotted	as	a	marker	of	infection.	p53	was	immunoblotted	as	a	control	since	the	
degradation	 of	 this	 protein	 is	 known	 to	 be	 dependent	 on	 Cullin	 function	 (Querido,	
Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002).	Western	blotting	of	Cul2	confirmed	that	
neddylation	was	reduced	in	the	presence	of	MLN4924.	The	neddylated	form	of	Cul2	can	be	
seen	as	a	slower	migrating	band	in	the	untreated	samples;	this	was	absent	in	the	MLN4924	
treated	 samples.	As	expected,	 the	degradation	of	p53	was	delayed	 in	 adenovirus	 infected	
cells	treated	with	MLN4924	when	compared	to	infected	mock-treated	cells,	confirming	that	
the	degradation	of	this	protein	during	adenovirus	infection	is	dependent	on	Cullin	function.	
Similarly	 to	 the	 degradation	 of	 p53,	 the	 protein	 levels	 of	 TAB182	 were	 unaffected	 in	
adenovirus-infected	 cells	 treated	 with	 MLN4924	 when	 compared	 to	 the	 degradation	
observed	 in	 infected,	mock-treated	 cells,	 showing	 that	 the	 degradation	 of	 TAB182	 during	
Ad12	 infection	 is	 dependent	 on	 Nedd8	 neddylation	 and	 therefore	 Cullin	 function	 (Figure	
3.3).		
To	 confirm	 that	 the	 degradation	 of	 TAB182	 during	 adenovirus	 infection	 is	 indeed	
dependent	on	Cullin	function,	adenovirus	infections	were	also	performed	in	H1299	cells	with	
knockdown	 of	 Cul2	 or	 Cul5	 protein	 expression	 and	 the	 levels	 of	 TAB182	 protein	 were	
examined	(Blanchette,	Wimmer	et	al.	2013).	H1299	cells	lacking	Cul2	or	Cul5	were	infected	
with	Ad5	or	Ad12	serotypes	and	harvested	at	0,	8,	24,	48,	72	and	96	hours	post-infection.		
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Figure	 3.3:	 The	 Degradation	 of	 TAB182	 during	 Ad12	 Infection	 is	 Dependent	 on	 Cullin	
Function.	HeLa	cells	were	infected	with	Ad12	at	an	MOI	of	5.	Cells	were	treated	with	4µM	of	
the	Nedd8	 inhibitor	MLN4924	 immediately	 post-infection.	Cells	were	 harvested	 at	 various	
time-points	 (0,	 8,	 24,	 48	 and	 72	 hours)	post-infection.	Cell	 lysates	were	 subjected	 to	 SDS-
PAGE	and	Western	blotting	using	the	indicated	antibodies.	E1B55K	was	immunoblotted	as	a	
marker	of	infection.	p53	was	immunoblotted	as	a	positive	control	since	this	protein	is	known	
to	 be	 degraded	 by	 Ad12.	 These	 Western	 blots	 are	 representative	 of	 three	 independent	
repeats.		
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Figure	3.4:	The	Degradation	of	TAB182	during	Ad5	and	Ad12	Infection	is	Dependent	
on	Cul5	and	Cul2	Function	Respectively.	H1299	wildtype	cells	(A)	or	H1299	cells	with	
inducible	knockdown	of	Cul2	(B)	or	Cul5	(C)	were	infected	with	either	Ad5	or	Ad12	and	
harvested	at	0,	8,	24,	48,	72	and	96	hours	post-infection.	Cell	 lysates	were	subjected	
to	SDS-PAGE	and	Western	blotting.	Cul2	and	Cul5	were	immunoblotted	to	assess	the	
efficiency	 of	 the	 inducible	 knockdown.	 E1B55K	 was	 immunoblotted	 as	 a	 marker	 of	
infection.	Mre11	was	immunoblotted	since	the	Cullin	responsible	for	its	degradation	is	
known.	These	Western	blots	are	representative	of	three	independent	repeats.	
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Cell	lysates	were	subjected	to	SDS-PAGE	and	Western	blotting	using	the	indicated	antibodies	
(Figure	 3.4).	 Induction	 of	 E1B55K	 expression	 confirmed	 successful	 infection.	 Mre11	 was	
immunoblotted	since	its	degradation	during	Ad5	infection	is	known	to	be	dependent	on	Cul5	
function,	 and	 its	 degradation	 during	 Ad12	 infection	 is	 known	 to	 be	 dependent	 on	 Cul2	
function	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002,	Blackford,	Patel	et	al.	
2010).	 In	 infected	 cells	 lacking	 Cul2	 protein	 expression,	 the	 degradation	 of	 TAB182	 was	
unaffected	during	Ad5	infection,	but	was	inhibited	in	Ad12	infected	cells,	suggesting	that	the	
degradation	of	TAB182	during	Ad12	infection	is	dependent	on	Cul2	function.	In	infected	cells	
lacking	 Cul5	 protein	 expression,	 the	 degradation	 of	 TAB182	was	 partially	 inhibited	 in	 Ad5	
infected	 cells,	 and	 unaffected	 in	 Ad12	 infected	 cells,	 suggesting	 that	 the	 degradation	 of	
TAB182	during	Ad5	infection	is	dependent	on	Cul5	function	(Figure	3.4).		
	
3.2.4	The	Degradation	of	TAB182	following	Infection	with	Ad5	and	Ad12	is	Dependent	on	
the	Adenovirus	E1B55K	and	E4orf6	Proteins	
To	 determine	 which	 viral	 proteins	 are	 responsible	 for	 the	 degradation	 of	 TAB182	
during	Ad5	and	Ad12	infection,	infections	were	performed	with	mutant	viruses	which	do	not	
express	 specific	 viral	 proteins.	 HeLa	 cells	 were	mock-infected	 or	 infected	with	 Ad5dl1520	
(Ad5E1B55K-	mutant)	and	Ad12dl620	(Ad12E1B55K-	mutant)	at	an	MOI	of	5	and	harvested	at	
0,	8,	24,	48,	72	and	96	hours	post-infection.	Cell	lysates	were	fractionated	by	SDS-PAGE	and	
the	filters	were	probed	with	the	indicated	antibodies.	β-actin	was	used	as	a	loading	control.			
HeLa	 cells	 infected	with	 Ad5dl1520	 (Figure	 3.5A)	 or	 Ad12dl620	 (Figure	 3.5B)	 were	
immunoblotted	with	antibodies	against	E1A	as	a	positive	marker	for	 infection,	E1B55K	was	
immunoblotted	as	a	negative	control	to	confirm	the	authenticity	of	the	virus,	and	Hexon		
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Figure	3.5:	The	Degradation	of	TAB182	 following	 Infection	with	Ad5	and	Ad12	 is	Dependent	on	
the	Adenovirus	E1B55K	Protein.	HeLa	cells	were	infected	with	Ad5dl1520	(Ad5E1B55K-	mutant)	(A)	
or	Ad12dl620	(Ad12E1B55K-	mutant)	 (B)	at	an	MOI	of	5	and	were	then	harvested	at	various	time-
points	(0,	8,	24,	48,	72	and	96	hours)	post-infection.	Cell	 lysates	were	subjected	to	SDS-PAGE	and	
Western	 blotting	 using	 the	 indicated	 antibodies.	 E1A,	 E1B55K	 and	 Hexon/Knob	 were	
immunoblotted	as	markers	of	infection.	Mre11	and	p53	were	immunoblotted	as	positive	controls.	
β-Actin	was	used	as	a	loading	control.	These	Western	blots	are	representative	of	three	independent	
repeats.	
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(Ad5dl1520)	 and	 Knob	 (Ad12dl620)	 were	 immunoblotted	 to	 confirm	 that	 the	 loss	 of	 the	
E1B55K	protein	inhibited	viral	replication.	As	expected,	expression	of	the	E1A	protein	during	
Ad5dl1520	(Figure	3.5A)	and	Ad12dl620	(Figure	3.5B)	infection	was	unaffected	in	the	mutant	
viruses.	 Expression	 of	 E1B55K,	 Hexon	 and	 Knob	 was	 absent	 following	 infection	 with	
Ad5dl1520	(Figure	3.5A)	or	Ad12dl620	(Figure	3.5B)	as	expected.		Mre11	and	p53	were	used	
as	 controls	 since	 the	 degradation	 of	 these	 proteins	 by	 Ad5	 and	 Ad12	 is	 known	 to	 be	
dependent	on	E1B55K	protein	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002,	
Blackford,	 Patel	 et	 al.	 2010).	 As	 anticipated,	 the	 protein	 levels	 of	 Mre11	 and	 p53	 were	
unaffected	 by	 infection	 with	 Ad5dl1520	 (Figure	 3.5A)	 and	 Ad12dl620	 (Figure	 3.5B),	
confirming	that	their	degradation	is	dependent	on	the	adenoviral	E1B55K	protein	(Querido,	
Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002).	The	levels	of	TAB182	protein	were	also	
unaffected	by	Ad5dl1520	(Figure	3.5A)	and	Ad12dl620	(Figure	3.5B)	infection,	indicating	that	
the	 degradation	 of	 TAB182	 during	 Ad5	 and	 Ad12	 infection	 is	 dependent	 on	 adenoviral	
E1B55K	protein.		
Infection	 of	 cells	 with	 Ad5dl155	 (Ad5E4-	 mutant)	 showed	 that	 the	 degradation	 of	
TAB182	was	dependent	on	one	or	more	of	the	adenovirus	E4	proteins	(Figure	3.6).	In	further	
experiments,	HeLa	cells	were	 infected	with	various	Ad5	mutant	viruses	that	 fail	 to	express	
different	 E4	 proteins;	 H5in351	 (E4orf1-	 mutant),	 H5pm4154	 (E4orf6-	 mutant),	 H5pm4155	
(E4orf3-E4orf6-	 mutant),	 H5pm4166	 (E4orf4-	 mutant),	 H5dl356	 (E4orf7-	 mutant),	 H5in352	
(E4orf2-	mutant)	and	H5dl150	(E4orf3-	mutant)	 (Figure	3.7).	As	expected,	the	expression	of	
E1B55K	protein	was	unaffected	following	infection	with	E4	mutant	viruses.	The	expression	of	
E4orf6	 was	 confirmed	 but,	 unfortunately	 antibodies	 against	 other	 E4	 proteins	 were	
unavailable,	however,	these	viruses	have	been	validated	in	Professor	Thomas	Dobner’s		
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Figure	3.6:	The	Degradation	of	TAB182	following	Infection	with	Ad5	is	Dependent	on	the	
Adenovirus	E4	Protein.	HeLa	cells	were	infected	with	Ad5dl155	(Ad5E4-	mutant)	at	an	MOI	
of	5.	Cells	were	then	harvested	at	various	time-points	(0,	8,	24,	48,	72	and	96	hours)	post-
infection.	Cell	lysates	were	subjected	to	SDS-PAGE	and	Western	blotting	using	the	indicated	
antibodies.	 E1A,	 E1B55K	 and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 infection.	
Mre11	and	p53	were	immunoblotted	as	positive	controls	since	these	proteins	are	known	to	
be	 degraded	 by	 Ad5.	 β-Actin	 was	 used	 as	 a	 loading	 control.	 This	 Western	 blot	 is	
representative	of	three	independent	repeats.	
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laboratory.	The	degradation	of	TAB182	following	infection	was	similar	to	that	seen	with	the	
wt	 virus	 in	 cells	 infected	 with	 H5in351	 (E4orf1-	 mutant),	 H5pm4166	 (E4orf4-	 mutant),	
H5in352	 (E4orf2-	 mutant)	 and	 H5dl150	 (E4orf3-	 mutant),	 suggesting	 that	 E4orf1,	 E4orf2,	
E4orf3	 and	 E4orf4	 are	 not	 essential	 for	 the	 degradation	 of	 TAB182.	 The	 degradation	 of	
TAB182	 was	 inhibited	 following	 infection	 with	 H5pm4154	 (E4orf6-	 mutant),	 H5pm4155	
(E4orf3-E4orf6-	 mutant)	 and	 unexpectedly,	 following	 infection	 with	 H5dl356	 (E4orf7-	
mutant).	 Analysis	 of	 adenovirus	 protein	 expression	 in	 H5dl356	 infected	 cells,	 however,	
showed	that	the	expression	of	E4orf6	is	abrogated	and	this	may	explain	why	the	degradation	
of	TAB182	is	inhibited	following	infection	with	this	mutant	virus.	We	therefore	conclude	the	
expression	of	E4orf6	is	essential	for	the	degradation	of	TAB182	yet,	further	experiments	are	
necessary	to	establish	whether	E4orf7	is	also	essential	for	the	degradation	of	TAB182	(Figure	
3.7).			
To	 further	 examine	 whether	 the	 degradation	 of	 TAB182	 indeed	 requires	 the	
presence	of	 the	adenovirus	E1B55K	and	E4	proteins	and	to	confirm	that	 they	are	required	
for	Ad12	mediated	degradation,	DNA	 transfections	of	Ad5,	Ad12E1B55K	and	E4	were	also	
performed	 in	 HeLa	 cells.	 The	 DNA	 constructs	 pcDNA3Ad12E1B54K,	 pcDNA3Ad12E4orf6,	
pXC15-Ad5E1B55K,	 pCMV-Ad5E4orf6	 were	 used	 to	 transfect	 the	 cells	 together	 with	 a	
pcDNA3	 empty	 plasmid	 as	 a	 negative	 control.	 The	 E4orf6	 DNA	 constructs	 used	 for	 this	
experiment	were	HA-tagged.	For	Ad5	and	Ad12	transfections,	the	following	combinations	of	
DNA	constructs	were	used	for	the	transfections,	pcDNA	alone;	E1B55K	alone;	E4orf6	alone;	
E1B55K	and	E4orf6.	48	hours	after	transfection,	the	cells	were	harvested,	subjected	to	SDS-
PAGE	and	immunoblotting	using	the	indicated	antibodies	(Figure	3.8).	Antibodies	against	HA	
confirmed	successful	transfection	of	the	E4orf6	plasmid.	Antibodies	against	E1B55K		
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Figure	3.7:	The	Degradation	of	TAB182	following	 Infection	with	Ad5	is	Dependent	on	the	
Adenovirus	 E4orf6	 Protein.	 HeLa	 cells	 were	 infected	 with	 either	 the	 E4	 mutant	 H5in351	
(E4orf1-	 mutant)	 (A),	 H5pm4154	 (E4orf6-	 mutant)	 (A),	 H5pm4155	 (E4orf3-E4orf6-	mutant)	
(B),	H5pm4166	(E4orf4-	mutant)	(B),	H5dl356	(E4orf7-	mutant)	(C)	H5in352	(E4orf2-	mutant)	
(C)	 and	 H5dl150	 (E4orf3-	 mutant)	 (D)	 	 at	 an	MOI	 of	 5.	 The	 cells	 were	 then	 harvested	 at	
various	 time-points	 (0,	 8,	 24,	 48,	 72,	 96	 and	 120	 hours)	 post-infection.	 Cell	 lysates	were	
subjected	 to	 SDS-PAGE	 and	Western	 blotting	 using	 the	 indicated	 antibodies.	 E1B55K	was	
immunoblotted	 as	 a	 marker	 of	 infection.	 E4orf6	 was	 immunoblotted	 to	 validate	 the	
expression	 of	 the	mutant	 viruses.	Mre11	was	 immunoblotted	 as	 a	 positive	 control.	 These	
Western	blots	are	representative	of	three	independent	repeats.	
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Figure	3.7	Cont’d:	The	Degradation	of	TAB182	following	 Infection	with	Ad5	 is	Dependent	
on	the	Adenovirus	E4orf6	protein.	HeLa	cells	were	infected	with	E4	mutant	H5in351	(E4orf1-	
mutant)	 (A),	 H5pm4154	 (E4orf6-	 mutant)	 (A),	 H5pm4155	 (E4orf3-E4orf6-	 mutant)	 (B),	
H5pm4166	(E4orf4-	mutant)	(B),	H5dl356	(E4orf7-	mutant)	(C),	H5in352	(E4orf2-	mutant)	(C)	
and	H5dl150	(E4orf3-	mutant)	(D)	at	an	MOI	of	5.	Cells	were	then	harvested	at	various	time-
points	(0,	8,	24,	48,	72,	96	and	120	hours)	post-infection.	Cell	lysates	were	subjected	to	SDS-
PAGE	and	Western	blotting	using	the	indicated	antibodies.	E1B55K	was	immunoblotted	as	a	
marker	 of	 infection.	 E4orf6	was	 immunoblotted	 to	 validate	 the	 expression	 of	 the	mutant	
viruses.	 Mre11	 was	 immunoblotted	 as	 a	 positive	 control	 since	 Mre11	 is	 known	 to	 be	
degraded	by	Ad5.	This	Western	blot	is	representative	of	three	independent	repeats.	
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Figure	3.8:	The	Degradation	of	 TAB182	during	Ad5	 and	Ad12	 Infection	 is	Dependent	on	
the	Adenovirus	E1B55K	and	E4orf6	Proteins.	2μg	of	plasmid	DNA	was	transfected	into	HeLa	
cells	and	48	hours	later,	the	cells	were	harvested	and	the	lysates	subjected	to	SDS-PAGE	and	
Western	 blotting	 using	 the	 indicated	 antibodies.	 E1B55K	 and	 HA	 (E4orf6)	 were	
immunoblotted	 as	markers	 of	 efficient	 transfection.	 Mre11	 was	 immunoblotted	 since	 its	
degradation	is	known	to	be	dependent	on	E1B55K	and	E4orf6.	β-Actin	was	immunoblotted	
as	a	loading	control.	This	Western	blot	is	representative	of	three	independent	repeats.	
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confirmed	 successful	 transfection	 of	 the	 E1B55K	 plasmid.	 TAB182	 was	 immunoblotted	 to	
assess	which	combination	DNA	plasmid	transfections	affected	the	protein	levels	of	TAB182;	
Mre11	was	immunoblotted	as	a	positive	control.	The	results	demonstrate	that	expression	of	
both	 E1B55K	 and	 E4orf6	 is	 necessary	 for	 the	 degradation	 of	 TAB182	 during	 Ad5	 or	 Ad12	
transfections	(Figure	3.8).	
	
3.2.5	E1A	Protein	Expression	is	Elevated	in	Adenovirus	Infected	TAB182	Depleted	Cells		
To	 elucidate	 the	 relationship	 between	 TAB182	 and	 adenovirus	 infection	 more	
extensively,	HeLa	cells	were	depleted	of	TAB182	protein	using	siRNA	against	 four	different	
TAB182	sequences	(see	Table	2.3).	HeLa	cells	were	transfected	with	a	final	concentration	of	
45nM	of	control	(non-targeting)	or	TAB182	siRNA,	and	48	hours	 later	the	cells	were	mock-
infected	 or	 infected	 with	 Ad5,	 Ad12,	 Ad5dl1520	 (Ad5E1B55K-	 mutant),	 Ad12dl620	
(Ad12E1B55K-	mutant)	or	H5pm4155	 (Ad5E4-	mutant)	at	an	MOI	of	5.	The	cells	were	 then	
harvested	at	0,	8,	24,	48,	72	and	96	hours	post-infection,	 cell	 lysates	 fractionated	by	SDS-
PAGE	and	immunoblotted	with	the	indicated	antibodies	(Figure	3.9).	As	before,	E1A,	E1B55K	
and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 adenovirus	 infection.	 β-actin	 was	
immunoblotted	 as	 a	 loading	 control.	 Mre11	 and	 p53	 were	 immunoblotted	 as	 positive	
controls	 since	 they	 are	 known	 to	 be	 degraded	 during	 adenovirus	 infection	 (Querido,	
Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002).	 TAB182	was	 immunoblotted	 to	 test	
whether	 the	 siRNA-mediated	 knockdown	 of	 TAB182	 was	 effective.	 During	 Ad5	 and	 Ad12	
infection,	the	comparative	levels	of	the	degradation	of	Mre11	and	p53	were	unaffected	by	
the	 depletion	 of	 TAB182	 protein	 levels.	 Interestingly,	 the	 total	 protein	 levels	 of	 p53	were	
reduced	in	cells	depleted	of	TAB182	in	the	absence	of	adenovirus	infection.	The	protein		
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Figure	 3.9:	 E1A	Protein	 Expression	 is	 Elevated	 in	Adenovirus	 Infected	 TAB182	 Depleted	
Cells.	 HeLa	cells	were	 transfected	with	 control	or	TAB182	 siRNA.	48	hours	 later,	 the	 cells	
were	 infected	 with	 Ad5	 (A),	 Ad12	 (B),	 Ad5dl1520	 (Ad5E1B55K-	 mutant)	 (C),	 Ad12dl620	
(Ad12E1B55K-	mutant)	(D)	or	Ad5dl4155	(Ad5E4-	mutant)	(E)	at	an	MOI	of	5.	Cells	were	then	
harvested	at	various	time-points	(0,	8,	24,	48,	72	and	96	hours)	post-infection.	Cell	 lysates	
were	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 using	 the	 indicated	 antibodies.	 E1A,	
E1B55K	 and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 infection.	 Mre11	 and	 p53	
were	immunoblotted	as	positive	controls	since	these	proteins	are	known	to	be	degraded	by	
Ad5	 and	 Ad12.	 β-Actin	was	 immunoblotted	 as	 a	 loading	 control.	 These	Western	 blot	 are	
representative	of	three	independent	repeats.	
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Figure	 3.9	 Cont’d:	 E1A	 Protein	 Expression	 is	 Elevated	 in	 Adenovirus	 Infected	 TAB182	
Depleted	 Cells.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA.	48	hours	 later,	
the	 cells	 were	 infected	 with	 Ad5	 (A),	 Ad12	 (B),	 Ad5dl1520	 (Ad5E1B55K-	 mutant)	 (C),	
Ad12dl620	 (Ad12E1B55K-	mutant)	 (D)	 or	 Ad5dl4155	 (Ad5E4-	mutant)	 (E)	 at	 an	MOI	 of	 5.	
Cells	 were	 then	 harvested	 at	 various	 time-points	 (0,	 8,	 24,	 48,	 72	 and	 96	 hours)	 post-
infection.	Cell	lysates	were	subjected	to	SDS-PAGE	and	Western	blotting	using	the	indicated	
antibodies.	 E1A,	 E1B55K	 and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 infection.	
Mre11	and	p53	were	immunoblotted	as	positive	controls	since	these	proteins	are	known	to	
be	 degraded	 by	 Ad5	 and	 Ad12.	 β-Actin	 was	 immunoblotted	 as	 a	 loading	 control.	 These	
Western	blot	are	representative	of	three	independent	repeats.	
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levels	of	E1B55K	in	Ad5	and	Ad12	infected	cells	were	comparable	in	TAB182	depleted	cells	
compared	to	control	siRNA.	Interestingly,	during	Ad5	and	Ad12	infection,	the	protein	levels	
of	E1A	appeared	earlier	in	cells	depleted	of	TAB182	compared	to	control	siRNA	treated	cells,	
suggesting	that	the	adenovirus	infection	appeared	to	go	through	faster	 in	cells	depleted	of	
TAB182	compared	to	control	siRNA	treated	cells	(Figure	3.9).		
Since	 the	 protein	 levels	 of	 E1A	 appeared	 earlier	 into	 the	 course	 of	 adenovirus	
infection,	 we	 next	 decided	 to	 determine	 whether	 infection	 of	 cells	 with	 the	 mutant	
adenoviruses	 Ad5dl1520	 (Ad5E1B55K-	 mutant),	 Ad12dl620	 (Ad12E1B55K-	 mutant)	 or	
H5pm4155	(Ad5E4-	mutant)	also	displayed	the	same	phenotype	in	the	absence	of	TAB182	as	
that	with	the	wild-type	Ad5	and	Ad12	viruses.	HeLa	cells	were	depleted	of	TAB182	protein	
using	siRNA	as	previously	described	or	were	transfected	with	a	non-silencing	control	siRNA.	
Following	siRNA-mediated	TAB182	depletion,	control	and	TAB182	siRNA	treated	cells	were	
mock-infected	 or	 infected	 with	 the	 mutant	 adenoviruses	 Ad5dl1520,	 Ad12dl620	 or	
H5pm4155.	Cells	were	harvested	at	0,	8,	24,	48,	72	and	96	hours	post-infection	and	resolved	
by	 SDS-PAGE	 and	Western	 blotting	 using	 the	 required	 antibodies	 (Figure	 3.9).	 As	 before,	
E1A,	E1B55K	and	Hexon	(Ad5)	or	Knob	(Ad12)	were	immunoblotted	as	markers	of	infection,	
β-Actin	as	a	 loading	control,	TAB182	to	assess	the	efficiency	of	the	knockdown	and	Mre11	
and	 p53	 as	 positive	 controls	 since	 they	 are	 known	 to	 be	 degraded	 during	 the	 course	 of	
adenovirus	 infection	 (Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002).	 As	
previously	observed,	 the	degradation	of	Mre11	and	p53	during	mutant	virus	 infection	was	
unaffected	 by	 the	 down-regulation	 of	 TAB182	 levels	 when	 compared	 to	 control	 siRNA	
treated	cells.	Again,	the	total	protein	levels	of	p53	after	TAB182	knockdown	were	decreased	
when	 compared	 to	 cells	 treated	with	 control	 siRNA.	 The	 protein	 levels	 of	 E1B	 and	Hexon	
		 130	
(Ad5)	 or	 Knob	 (Ad12)	were	 also	 unaffected	 by	 TAB182	 depletion	when	 compared	 to	 cells	
treated	with	control	 siRNA	 in	cells	 infected	with	mutant	viruses.	The	protein	 levels	of	E1A	
were	increased	in	cells	depleted	of	TAB182	when	infected	with	all	mutant	viruses,	similarly	
to	that	observed	with	wild-type	viruses	(Figure	3.9).	
	
3.2.6	Expression	of	Cyclin	E	is	Elevated	in	Infected,	TAB182	Depleted	Cells	
Since	 E1A	 expression	 appeared	 to	 be	 elevated	 during	 adenovirus	 infection	 in	 the	
absence	of	TAB182	protein	expression,	we	therefore	hypothesised	that	the	cell	cycle	may	be	
altered	following	TAB182	knockdown	leading	to	more	efficient	adenovirus	infection.	To	test	
this,	 the	expression	of	Cyclin	E	was	examined	during	 the	course	of	adenovirus	 infection	 in	
the	 presence	 and	 absence	 of	 TAB182	 protein	 expression.	 HeLa	 cells	 were	 treated	 with	
TAB182	siRNA	or	with	a	non-targeting	control	siRNA.	48	hours	after	siRNA	treatment,	cells	
were	mock-infected	or	 infected	with	Ad5	or	Ad12	and	harvested	at	0,	8,	24,	48,	72	and	96	
hours	 post-infection.	 Cell	 lysates	were	 subjected	 to	 SDS-PAGE	 and	Western	 blotting	 using	
the	indicated	antibodies	(Figure	3.10).	There	was	no	difference	in	Cyclin	E	expression	in	Ad5	
infected,	 control	 siRNA	 treated	 cells	 when	 compared	 to	 Ad5	 infected	 and	 TAB182	 siRNA	
treated	 cells.	 Interestingly,	 elevated	 Cyclin	 E	 expression	 was	 observed	 in	 Ad12	 infected,	
TAB182	 siRNA	 treated	 cells	when	 compared	 to	Ad12	 infected,	 control	 siRNA	 treated	 cells,	
suggesting	 that	 the	 cell	 cycle	 may	 be	 altered	 in	 Ad12	 infected	 cells	 depleted	 of	 TAB182	
(Figure	3.10).	
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Figure	3.10:	Expression	of	Cyclin	E	 is	Elevated	 in	 Infected,	TAB182	Depleted	Cells.	HeLa	
cells	were	 transfected	with	 control	or	TAB182	 siRNA.	48	hours	 later,	 the	cells	were	also	
infected	with	adenovirus	serotype	5	(A)	or	serotype	12	(B)	at	an	MOI	of	5.	Cells	were	then	
harvested	at	various	time-points	(0,	8,	24,	48,	72	and	96	hours)	post-infection.	Cell	lysates	
were	subjected	to	SDS-PAGE	and	Western	blotting	using	the	indicated	antibodies.	E1B55K	
was	 immunoblotted	as	a	marker	of	 infection.	TAB182	was	 immunoblotted	 to	assess	 the	
efficiency	 of	 the	 TAB182	 siRNA	 mediated	 depletion.	 β-Actin	 was	 immunoblotted	 as	 a	
loading	control.	These	Western	blots	are	representative	of	three	independent	repeats.	
	
		 132	
3.2.7	Adenovirus	Early	Region	E1B55K	Interacts	with	TAB182	in	Vitro	and	in	Vivo	
To	determine	whether	TAB182	interacts	with	the	adenovirus	early	region	E1B55K	 in	
vitro,	 GST	 pull-down	 assays	 were	 performed.	 Ad5E1HEK293	 and	 Ad12E1HER2	 cell	 lysates	
were	 incubated	with	a	C-terminal	 fragment	of	 TAB182	 tagged	 to	GST	 (referred	 to	as	GST-
TAB182C),	spanning	a	region	of	amino	acids	824-867	fused	to	one	of	amino	acids	1221-1729	
of	TAB182	(Figure	3.11)(Seimiya	and	Smith	2002).		Cell	lysates	were	also	incubated	with	GST	
alone	as	a	non-specific	binding	control,	and	cell	 lysate	alone	was	run	as	a	positive	control.	
Protein	complexes	were	captured	using	glutathione-agarose	beads,	subjected	to	SDS-PAGE	
and	Western	blotting	(Figure	3.12A,	3.12B).	Protein	complexes	isolated	using	Ad5E1HEK293	
cell	 lysates	 were	 immunoblotted	 with	 Ad5E1B55K	 antibody.	 Analysis	 showed	 that	 the	 C-
terminal	 fragment	 of	 TAB182	 interacts	 with	 Ad5E1B55K	 in	 vitro	 (Figure	 3.12A).	 Protein	
complexes	 isolated	 using	Ad12E1HER2	 cell	 lysates	were	 immunoblotted	with	Ad12E1B55K	
antibody.	Analysis	showed	that	the	C-terminal	fragment	of	TAB182	also	interacts	with	Ad12	
E1B55K	in	vitro	(Figure	3.12B).		
To	 confirm	 the	 interaction	 between	 TAB182	 and	 Ad5E1B55K/Ad12E1B55K,	 co-
immunoprecipitation	 assays	 were	 performed.	 Ad5E1HEK293	 and	 Ad12E1HER2	 cell	 lysates	
were	 incubated	 with	 antibodies	 against	 TAB182	 along	 with	 IgG	 alone	 as	 a	 non-specific	
binding	 control.	 Immuno-complexes	 were	 isolated	 using	 Protein-G	 agarose	 beads	 and	
subsequently	 resolved	 by	 SDS-PAGE	 and	 Western	 blotting	 using	 antibodies	 against	
Ad5/Ad12	E1B55K	along	with	cell	 lysate	alone	as	a	positive	control.	 	Analysis	 showed	 that	
TAB182	 does	 indeed	 interact	with	 Ad5E1B55K	 and	 Ad12E1B55K	 in	 vivo	 (Figure	 3.12C	 and	
Figure	 3.12D).	 In	 a	 reciprocal	 experiment,	 Ad5E1HEK293	 and	 Ad12E1HER2	 cells	 were	
transfected	with	pEGFPC3-TAB182.	After	48	hours	cells	were	harvested	and	lysates		
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Figure	 3.11:	 Schematic	 of	 the	 GST-TAB182C	 Fragment	 used	 in	 the	 GST	 Pull-Down	
Assays.	 (A)	 Schematic	 of	 full-length	 TAB182.	 Showing	 amino	 acid	 numbers,	 tankyrase	
binding	 domain	 (TBD)	 and	 the	 two	 nuclear	 localisation	 signals	 (NLS)	 it	 contains.	 (B)	
Schematic	of	the	GST-TAB182C	fragment	of	TAB182	provided	as	a	kind	gift	from	Susan	
Smith.	 GST-TAB182C	 incorporates	 the	 amino	 acids	 824-867	 fused	 to	 1221-1729	 of	
TAB182.			
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Figure	3.12:	Adenovirus	Early	Region	E1B55K	 Interacts	with	TAB182	 in	Vitro	and	 in	Vivo.	
Ad12E1HER2	(A)	and	Ad5E1HEK293	(B)	cell	lysates	were	incubated	with	either	GST-TAB182C,	
or	with	GST	alone	(non-specific	binding	control)	or	cell	lysate	alone	(positive	control).	Protein	
complexes	 were	 captured	 by	 glutathione-agarose	 beads,	 subjected	 to	 SDS-PAGE	 and	
Western	 blotting.	Ad5E1HEK293	 (C)	 and	Ad12E1HER2	 (D)	 cell	 lysates	were	 incubated	with	
antibodies	 against	 TAB182	 together	 with	 IgG	 (non-specific	 binding	 control).	 Immuno-
complexes	were	isolated	using	Protein-G	agarose	beads	and	subsequently	resolved	by	SDS-
PAGE	 and	Western	 blotting	 using	 antibodies	 against	 Ad5/Ad12	 E1B	 along	with	 cell	 lysate	
alone	 as	 a	 positive	 control.	 (E)	 pEGFPC3-TAB182	 was	 transfected	 into	 Ad5E1HEK293	 and	
Ad12E1HER2	 cell	 lines	 and	 harvested.	 Cell	 lysates	 were	 incubated	 with	 Ad5	 and	 Ad12	
E1B55K	 antibodies	 together	 with	 IgG	 (non-specific	 binding	 control).	 Immuno-complexes	
were	 isolated	 using	Protein-G	agarose	beads	 and	 subsequently	 resolved	 by	SDS-PAGE	and	
Western	blotting	using	antibodies	against	TAB182	along	with	cell	 lysate	alone	as	a	positive	
control.	These	Western	blots	are	representative	of	three	independent	repeats.	
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incubated	with	antibodies	against	Ad5E1B55K	and	Ad12E1B55K	and	the	immuno-complexes	
formed	 isolated	 using	 Protein-G	 agarose	 beads.	 Protein	 complexes	were	 resolved	 by	 SDS-
PAGE	 and	 Western	 blotting	 using	 antibodies	 against	 TAB182.	 Analysis	 confirmed	 that	
TAB182	does	indeed	interact	with	Ad5E1B55K	and	Ad12E1B55K	in	vivo	(Figure	3.12E).		
3.2.8	TAB182	does	not	Localise	to	VRCs	during	Adenovirus	Infection	
Although	 a	 number	 of	 DNA	 damage	 proteins	 are	 degraded	 during	 adenovirus	
infection,	it	is	also	well	established	that	a	number	are	relocalised	to	VRCs	during	adenovirus	
infection	 including	 RPA32,	 ATR,	 ATRIP,	 Rad9,	 TOPBP1	 and	 Rad17	 (Carson,	 Schwartz	 et	 al.	
2003,	Blackford,	Bruton	et	al.	2008,	Carson,	Orazio	et	al.	2009,	Blackford,	Patel	et	al.	2010).	
To	 determine	 whether	 TAB182	 is	 relocalised	 to	 VRCs	 during	 the	 course	 of	 adenovirus	
infection,	immunofluorescence	microscopy	analysis	was	performed	(Figure	3.13).		
HeLa	 cells	 were	 transfected	 with	 pEGFPC3-TAB182	 or	 an	 empty	 pEGFPC3	 construct	 as	 a	
negative	 control	 (see	 Section	 2.5.6	 for	 information	 on	 the	 generation	 of	 the	 pEGFPC3-
TAB182	 construct).	24	hours	 later,	cells	were	re-plated	onto	glass	cover	slips	and,	after	24	
hours,	 infected	with	wild-type	Ad5	or	Ad12	virus	at	an	MOI	of	5.	After	a	 further	24	hours	
cells	were	 fixed,	 permeabilised	 and	 probed	with	 the	 appropriate	 antibodies.	 Ad5	 infected	
cells	were	stained	for	Ad5E1B55K	and	DBP	and	Ad12	infected	cells	stained	with	antibodies	
against	Ad12E1B55K	and	RPA32	which	has	been	shown	previously	to	localise	to	Ad12	VRCs	
(Blackford,	 Bruton	 et	 al.	 2008).	 There	was	 no	 localisation	 of	 TAB182	 to	 VRCs	 observed	 in	
neither	Ad5	or	Ad12	infected	cells	(Figure	3.13).			
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Figure	 3.13:	 TAB182	 does	 not	 Localise	 to	 VRCs	 during	 Adenovirus	 Infection.	 HeLa	 cells	
were	transfected	with	pEGFPC3-TAB182	and	24	hours	later	were	infected	with	Ad5	or	Ad12.	
24	 hours	 following	 infection	 the	 cells	 were	 fixed,	 permeabilised	 and	 probed	 with	 the	
appropriate	 antibodies.	 Ad5	 infected	 cells	were	 probed	with	Ad5E1B55K	 and	 DBP,	 whilst	
Ad12	 infected	cells	were	probed	with	Ad12E1B55K	and	RPA2.	These	 immunofluorescence	
images	are	representative	of	three	independent	experiments.		
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3.2.9	Adenovirus	Replication	Centres	after	TAB182	Knockdown	
Since	 TAB182	 knockdown	 altered	 the	 expression	 of	 E1A	 and	 Cyclin	 E	 during	
adenovirus	infection,	we	next	wanted	to	examine	the	whether	TAB182	knockdown	had	any	
effect	 on	 the	 formation	 of	 VRCs.	 To	 investigate	 this	 further,	 immunofluorescence	
microscopy	 analysis	 of	 cells	 deficient	 in	 TAB182	 protein	 expression	 was	 performed.	 HeLa	
cells	 were	 treated	 with	 TAB182	 siRNA	 along	 with	 a	 non-targeting	 control	 siRNA.	
Confirmation	 of	 TAB182	 knockdown	was	 achieved	 by	Western	 blotting	 (data	 not	 shown).	
Cells	were	infected	with	wild-type	Ad5	or	Ad12	virus	(MOI	of	5)	for	24	hours	and	were	then	
harvested	 for	 immunofluorescence	 microscopy	 analysis.	 Cells	 were	 fixed,	 permeabilised,	
probed	and	were	immunostained	with	Ad5/Ad12	E1B55K	and	DBP	or	Ad5/Ad12	E1B55K	and	
RPA32	antibodies.	Ad5	and	Ad12	E1B55K	expression	was	used	as	a	marker	of	infection.	DBP	
and	RPA	were	probed	as	markers	of	VRCs.	In	HeLa	cells	treated	with	control	siRNA,	24	hours	
after	Ad5	and	Ad12	infection,	the	formation	of	VRCs	can	be	observed	through	positive	DBP	
and	RPA	staining.	Viral	infection	can	also	be	confirmed	from	the	appearance	of	Ad5E1B55K	
and	Ad12E1B55K	staining.	In	HeLa	cells	treated	with	TAB182	siRNA,	no	significant	changes	in	
the	formation	of	VRCs	were	observed.	In	addition,	there	were	also	no	significant	changes	in	
Ad5E1B55K	or	Ad12E1B55K	staining	observed	(Figure	3.14).	In	order	to	further	quantify	this,	
E1B55K	and	RPA	(Ad5	and	Ad12)	and	E1B55K	and	DBP	(Ad5	only)	positive	cells	were	counted	
as	a	percentage	of	the	total	number	of	cells.	No	significant	difference	in	the	percentage	of	
E1B55K/RPA	 and	 E1B55K/DBP	 staining	 was	 observed	 between	 control	 siRNA	 and	 TAB182	
siRNA	treated	cells	(Figure	3.14D).	
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Figure	 3.14:	 Adenovirus	 Replication	 Centres	 after	 TAB182	 Knockdown.	 HeLa	 cells	 were	
transfected	with	control	or	TAB182	siRNA	and	24	hours	later,	infected	with	either	Ad5	or	Ad12.	
The	cells	were	fixed,	permeabilised	and	probed	with	Ad5	E1B	and	DBP	(A)	or	Ad5	(B)	Ad12	(C)	
E1B	and	RPA32	antibodies.	 (D)	Graph	depicting	 the	percentage	of	Ad5	E1B+	RPA+,	Ad5	E1B+	
DBP+	and	Ad12	E1B+	RPA+	cells	as	a	total	number	of	cells.	These	immunofluorescence	images	
are	representative	of	three	independent	experiments.		
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3.3	DISCUSSION	
It	 is	 well	 established	 that	 a	 number	 of	 cellular	 proteins	 are	 degraded	 following	
adenovirus	infection.	Most	notably,	a	significant	proportion	of	these	proteins	are	involved	in	
the	 DNA	 damage	 response	 (DDR),	 suggesting	 that	 adenovirus	 degrades	 these	 proteins	 in	
order	to	circumvent	this	pathway	specifically	(Querido,	Blanchette	et	al.	2001,	Stracker,	Lee	
et	 al.	 2005,	Baker,	Rohleder	et	 al.	 2007,	Blackford,	Patel	 et	 al.	 2010,	Orazio,	Naeger	et	 al.	
2011,	 Gupta,	 Jha	 et	 al.	 2013).	 	 The	 end	 result	 of	 blocking	 the	 DDR	 is	 the	 evasion	 of	
concatemerisation	of	viral	genomes,	and	the	replication	of	the	virus	and	production	of	viral	
progeny	(Weiden	and	Ginsberg	1994).		
Results	presented	in	this	chapter	implicate	the	Tankyrase	1	binding	protein,	TAB182,	
as	 a	 novel	 degradation	 target	 during	 adenovirus	 infection.	 TAB182	 was	 shown	 to	 be	
degraded	 following	 Ad5	 and	 Ad12	 infection,	 in	 an	 E1B55K	 and	 E4orf6	 dependent	 fashion	
(Figures	3.1,	3.5,	3.6,	3.7	and	3.8).	Furthermore,	using	the	proteasome	inhibitor	bortezomib,	
it	 was	 shown	 that	 the	 degradation	 of	 TAB182	 was	 dependent	 on	 proteasome	 function	
(Figure	3.2),	and	through	the	use	of	the	NEDD8	inhibitor	MLN4924,	this	degradation	was	also	
found	to	be	dependent	on	Cullin	function	(Figure	3.3).	Further	studies	using	Cul2	and	Cul5	
negative	 H1299	 cell	 lines	 showed	 that	 the	 degradation	 of	 TAB182	 during	 Ad5	 infection	 is	
dependent	on	Cul5,	and	TAB182	degradation	following	Ad12	infection	is	dependent	on	Cul2	
(Figure	3.4).	 This	 is	 consistent	with	other	 targets,	 such	as	p53,	which	are	degraded	during	
viral	 infection	 (Querido,	 Blanchette	 et	 al.	 2001,	 Blackford,	 Patel	 et	 al.	 2010).	Using	 siRNA-
mediated	depletion	of	TAB182,	it	was	shown	that	TAB182	suppresses	E1A	protein	expression	
at	early	time	points	post-infection	(Figure	3.9).		From	these	studies	it	was	shown	that	in	the	
absence	 of	 TAB182,	 the	 expression	 of	 Cyclin	 E	 was	 enhanced	 following	 Ad12	 infection,	
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suggesting	that	TAB182	may	have	a	role	in	the	regulation	of	the	cell	cycle	(Figure	3.10).	Co-
immunoprecipitation	studies	showed	that	TAB182	interacts	with	both	Ad5	and	Ad12	E1B55K	
in	 vitro	 and	 in	 vivo	 (Figure	 3.12).	 Finally,	 immunofluorescence	 microscopy	 showed	 that	
TAB182	does	not	appear	to	 localise	to	VRCs,	nor	does	the	depletion	of	TAB182	expression	
effect	the	formation	of	VRCs	(Figures	3.13	and	3.14).			
In	 this	 study,	 TAB182	was	 shown	 to	be	degraded	 following	 infection	with	Ad5	and	
Ad12	serotypes	(Figure	3.1).	TAB182	is	also	known	to	be	degraded	following	Ad4	infection,	
but	 not	 following	 infection	 with	 Ad3,	 Ad7,	 Ad9	 and	 Ad11	 (R	 Grand,	 personal	
communication).	 A	 comprehensive	 study	 from	 Forrester	 and	 colleagues	 analysing	 the	
degradation	 patterns	 of	 various	 DDR	 proteins	 following	 infection	 with	 a	 panel	 of	 Ad	
serotypes	showed	that	Mre11	and	p53	are	degraded	following	infection	with	Ad4,	Ad5	and	
Ad12	serotypes,	but	not	following	Ad3,	Ad7,	Ad9	and	Ad11	infection.	In	agreement	with	this,	
Cheng	 and	 colleagues	 also	 showed	 that	Mre11	 is	 degraded	with	 group	A	 and	C	 serotypes	
(also	group	F),	but	not	degraded	during	 infection	with	serotypes	 from	group	B1,	B2	and	D	
viruses	(Cheng,	Gilson	et	al.	2011).	The	study	by	Forrester	and	colleagues	also	showed	that	
the	degradation	of	DNA	ligase	IV	occurs	following	infection	with	every	serotype	tested	(i.e.	
Ad3,	Ad4,	Ad5,	Ad7,	Ad9,	Ad11	and	Ad12),	which	is	also	in	agreement	with	the	study	from	
Cheng	et	al.	and	TOPBP1	is	degraded	following	infection	with	only	Ad12	(Cheng,	Gilson	et	al.	
2011,	Forrester,	Sedgwick	et	al.	2011).		These	data,	together	with	the	data	presented	in	this	
study,	suggest	that	the	degradation	of	TAB182	follows	the	same	pattern	as	the	degradation	
of	p53	and	Mre11	suggesting	that	TAB182	may	be	degraded	by	the	same	mechanism.	More	
recently,	BLM	and	Tip60	were	also	shown	to	be	degraded	following	Ad5	infection,	although	
no	other	serotypes	were	tested	for	these	proteins	(Orazio,	Naeger	et	al.	2011,	Gupta,	Jha	et	
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al.	2013).	In	comparison	to	other	proteins	degraded	during	adenovirus	infection,	TAB182	is	
degraded	 relatively	 late.	 As	 previously	 discussed,	 there	 are	 large	 variations	 in	 the	 ways	
adenoviruses	 target	DDR	proteins,	 for	 example,	Ad5	and	Ad12	degrade	p53	but	Ad3	does	
not	 (Querido,	Marcellus	 et	 al.	 1997,	 Forrester,	 Sedgwick	 et	 al.	 2011).	 Furthermore,	 some	
proteins	 are	degraded	 later	 than	others,	 for	 example	p53	 is	 normally	degraded	 very	 early	
during	adenovirus	infection	(less	than	24	hours)	whilst	BLM	is	degraded	in	the	later	stages	of	
infection	 (Querido,	 Marcellus	 et	 al.	 1997,	 Orazio,	 Naeger	 et	 al.	 2011).	 Why	 degradation	
targets	 are	 down-regulated	 at	 different	 times	 during	 adenovirus	 infection	 is	 currently	
unknown	 but	 presumably	 is	 linked	 to	 their	 function.	 One	 explanation	 for	 why	 TAB182	 is	
degraded	 so	 late	 in	 the	 virus	 cycle	 could	 be	 that	 TAB182	 expression	 is	 detrimental	 to	
adenovirus	persistent	infection.	There	is	mounting	evidence	to	suggest	that	adenovirus	can	
persist	 in	 a	 latent	 state.	 Latent	 adenovirus	 has	 been	 found	 in	 lymphocytes	 in	 tonsil	 and	
intestinal	tissue,	as	well	as	lung	epithelial	cells	(Leung,	Chan	et	al.	2005,	Garnett,	Talekar	et	
al.	2009,	Roy,	Calcedo	et	al.	2011).	It	is	currently	unclear	why	TAB182	would	be	detrimental	
to	this	process	but	could	be	one	explanation	as	to	why	it	is	degraded	late	in	the	virus	cycle.		
The	 viral	 proteins	 responsible	 for	 the	 degradation	 of	 adenoviral	 targets	 have	 been	
closely	 studied.	 As	 previously	 discussed,	 the	 degradation	 of	 cellular	 adenovirus	 targets	 is	
thought	to	be	achieved	through	the	viral	proteins	E1B55K	and	E4orf6	proteins,	which	recruit	
a	 Cullin-based	 E3	 ubiquitin	 ligase	 composed	 of	 Rbx1	 and	 Elongins	 B	 and	 C.	 In	 this	
investigation,	through	the	use	of	mutant	viruses	and	the	transfection	of	plasmids	expressing	
viral	 proteins,	 the	 viral	 proteins	 shown	 to	 be	 responsible	 for	 the	 degradation	 of	 TAB182	
following	Ad5	and	Ad12	infection	were	shown	to	be	the	E1B55K	and	E4orf6	proteins	(Figures	
3.5,	3.6,	3.7	and	3.8).	The	degradation	of	p53,	Mre11,	DNA	ligase	IV,	Tip60	and	BLM	have	all	
		 142	
been	shown	to	also	be	dependent	on	the	E1B55K	and	E4orf6	proteins	(Querido,	Blanchette	
et	al.	2001,	Stracker,	Carson	et	al.	2002,	Baker,	Rohleder	et	al.	2007,	Blackford,	Patel	et	al.	
2010,	 Forrester,	 Sedgwick	 et	 al.	 2011,	Orazio,	Naeger	 et	 al.	 2011,	Gupta,	 Jha	 et	 al.	 2013).	
Whilst	 the	 degradation	 of	 DDR	 proteins	 during	 adenovirus	 infection	 appeared	 to	 be	
conserved	 amongst	 these	 proteins,	 interestingly,	 the	 degradation	 of	 TOPBP1	 by	 Ad12	 has	
been	 proposed	 to	 be	 dependent	 on	 the	 E4orf6	 protein	 alone,	 together	 with	 a	 cellular	
Cullin2-based	E3	ubiquitin	 ligase,	 suggesting	 there	are	different	mechanisms	employed	 for	
the	 degradation	 of	 proteins	 during	 adenovirus	 infection	 (Blackford,	 Patel	 et	 al.	 2010).	
Similarly,	 Daxx	 proteasome-mediated	 degradation	 by	 Ad5	 appears	 to	 only	 require	 the	
E1B55K	protein	and	not	E4orf6	(Schreiner,	Wimmer	et	al.	2011).		
Whilst	 different	 viral	 proteins	 may	 be	 employed	 for	 the	 degradation	 of	 proteins	
during	adenovirus	infection,	the	general	consensus	during	the	degradation	process	is	that	all	
adenoviral	 targets	 are	 processed	 by	 the	 proteasome.	 All	 DDR	 proteins	 that	 are	 degraded	
during	adenovirus	infection	have	been	shown	to	be	dependent	on	the	proteasome	through	
the	 use	 of	 the	 proteasome	 inhibitor	 MG132	 (Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	
Carson	et	al.	2002,	Baker,	Rohleder	et	al.	2007,	Blackford,	Patel	et	al.	2010,	Orazio,	Naeger	et	
al.	2011,	Gupta,	Jha	et	al.	2013).	In	our	hands,	MG132	(following	only	a	24	hour	incubation)	
was	 highly	 toxic	 to	 HeLa	 cells,	 with	 the	majority	 of	 the	 cells	 dead	 (rounded	 cells	 that	 no	
longer	adhered	to	 the	 tissue	culture	dish),	when	compared	to	mock-treated,	 infected	cells	
(data	not	shown).	For	this	reason	the	proteasome	inhibitor	bortezomib	was	used;	this	was	
found	to	be	much	less	toxic	to	the	cells	which	allowed	incubation	for	longer	time-points.	As	a	
precaution	 bortezomib	 was	 added	 24	 hours	 before	 the	 harvesting	 of	 each	 time	 point	 in	
order	 to	 limit	 its	 toxic	 effects	 (Figure	 3.2).	 Similarly	 to	 every	 other	DDR	 protein	 degraded	
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during	adenovirus	infection,	the	degradation	of	TAB182	was	shown	to	be	dependent	on	the	
proteasome.		
Since	 adenovirus	 has	 been	 shown	 to	 employ	 a	 cellular,	 Cullin-based	 E3	 ubiquitin	
ligase	to	degrade	its	targets	during	infection,	the	NEDD8	inhibitor	MLN4924,	which	inhibits	
cellular	Cullins	through	the	inhibition	of	neddylation,	was	used.	The	degradation	of	TAB182	
during	Ad5	and	Ad12	infection	was	shown	to	be	dependent	on	Cullin	function	(Figure	3.3).	
Furthermore,	 through	 the	 use	 of	 H1299	 cells	 negative	 for	 Cul2	 and	 Cul5	 expression,	 the	
degradation	of	TAB182	during	Ad5	 infection	was	shown	to	be	dependent	on	Cul5,	and	the	
degradation	of	TAB182	during	Ad12	 infection	was	shown	to	be	dependent	on	Cul2	 (Figure	
3.4).	 Interestingly,	 the	degradation	of	p53	during	Ad5	and	Ad12	 infection	 is	dependent	on	
Cul5	 and	 Cul2	 respectively,	 suggesting	 that	 similar	 mechanisms	 are	 employed	 for	 the	
degradation	of	TAB182	as	p53	 (Cheng,	Gilson	et	al.	2011,	Forrester,	Sedgwick	et	al.	2011).	
There	are	contradictory	reports	on	the	Cullins	responsible	for	the	degradation	of	Mre11	and	
DNA	ligase	IV.	Whilst	initial	studies	showed	that	Cul5	was	responsible	for	the	degradation	of	
these	proteins,	more	recent	studies	have	shown	that	knockdown	of	Cul5	using	siRNA	has	no	
effect	on	the	degradation	of	these	proteins	following	Ad4,	Ad5	and	Ad12	infection	(Cul2	was	
also	 not	 responsible	 for	 the	 degradation	 of	 these	 proteins)	 (Stracker,	 Carson	 et	 al.	 2002,	
Baker,	 Rohleder	 et	 al.	 2007,	 Forrester,	 Sedgwick	 et	 al.	 2011).	 The	 degradation	 of	 TOPBP1	
during	Ad12	infection	was	shown	to	be	dependent	on	Cul2	function,	whilst	the	degradation	
of	BLM	and	Tip60	was	shown	to	be	dependent	on	Cul5	during	Ad5	infection	(other	serotypes	
were	not	tested)	 (Blackford,	Patel	et	al.	2010,	Orazio,	Naeger	et	al.	2011,	Gupta,	 Jha	et	al.	
2013).	These	data	supports	the	idea	that	adenovirus	adopts	a	mechanism	similar	to	p53	to	
degrade	TAB182.		
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From	 studies	 described	 in	 Chapter	 4,	 there	 are	 a	 number	 of	 indications	 that	
suggested	 that	 TAB182	may	 be	 involved	 in	 the	 control	 of	 the	 cell	 cycle.	 It	 was	 therefore	
hypothesised	 that	 TAB182	 may	 hinder	 the	 cell	 cycle	 progression	 which	 is	 induced	 by	
adenovirus.	To	test	this	hypothesis,	the	expression	of	a	panel	of	viral	proteins	was	examined	
in	 infected	 cells	 that	were	deficient	 in	 TAB182	expression.	 Interestingly,	 the	expression	of	
E1A	was	 increased	 in	 infected	cells	 (Ad5	and	Ad12,	along	with	mutant	viruses)	deficient	 in	
TAB182	 expression	 when	 compared	 to	 non-silencing	 controls	 (Figure	 3.9).	 These	 data	
suggest	 that	 TAB182	 may	 be	 involved	 in	 the	 suppression	 of	 viral	 gene	 expression.	 The	
increase	 in	E1A	expression	 in	TAB182	knockdown	cells	varies	between	virus	strains	(higher	
expression	of	E1A	in	Ad5	than	Ad12	infection).	Each	virus	strain	has	different	properties	and	
therefore	progress	differently	during	infection	which	may	explain	why	there	is	a	difference	in	
expression	 levels.	Alternatively	 the	 removal	of	 TAB182	expression	may	be	more	beneficial	
during	 Ad5	 than	 Ad12	 infection.	 Interestingly,	 during	 adenovirus	 infection,	 the	 siRNA-
mediated	 knockdown	 of	 Tip60	 expression	 also	 has	 an	 effect	 on	 the	 expression	 of	 viral	
proteins,	with	an	increase	in	the	expression	of	all	early	viral	genes	including	E1A	(measured	
by	 quantitative	 PCR	 and	 immunoblotting)	 (Gupta,	 Jha	 et	 al.	 2013).	 Further	 Tip60	 studies	
showed	that	Tip60	suppresses	viral	early	gene	expression	through	the	acetylation	of	Histone	
H4	at	 the	E1A	promoter	 (Gupta,	 Jha	et	al.	2013).	Since	TAB182	knockdown	also	displays	a	
similar	phenotype	 to	Tip60	with	an	 increase	 in	E1A	expression,	 it	 could	be	 that	TAB182	 is	
also	degraded	to	prevent	suppression	of	the	expression	of	early	viral	proteins.		
Since	 the	 previous	 result	 suggested	 that	 TAB182	may	 hinder	 cell	 cycle	 progression	
during	adenovirus	infection,	the	expression	of	the	cell	cycle	protein	Cyclin	E	was	examined	in	
TAB182	deficient	cells	following	adenovirus	infection.	The	expression	of	Cyclin	E	in	infected,	
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TAB182	deficient	cells	was	increased	when	compared	to	infected	cells	transfected	with	non-
silencing	control	siRNA,	suggesting	that	TAB182	retards	cell	cycle	progression	(Figure	3.10).	
Indeed,	E1A	is	known	to	target	the	pRB,	p107	and	p130	proteins	in	order	to	induce	the	E2F-
mediated	expression	of	Cyclin	E	and	Cyclin	A	which	stimulate	progression	of	the	cell	cycle.	
Since	Cyclin	E	expression	following	TAB182	depletion	is	 increased,	 it	therefore	seems	likely	
that	 TAB182	 is	 degraded	 during	 adenovirus	 infection	 in	 order	 to	 relieve	 the	 TAB182-
mediated	suppression	of	cell	cycle	progression	and	therefore	promote	viral	DNA	replication	
(Bagchi,	Raychaudhuri	et	al.	1990,	Grand,	 Ibrahim	et	al.	1998).	Further	analyses	of	 the	cell	
cycle	(by	flow	cytometry)	during	adenovirus	would	be	required	to	establish	whether	or	not	
this	 is	 the	 case.	 As	 with	 E1A	 expression,	 Cyclin	 E	 expression	 in	 TAB182	 knockdown	 cells	
varies	between	Ad5	and	Ad12	virus	strains	(higher	expression	in	Ad12	than	Ad5).	Again,	virus	
strains	have	different	properties	and	 this	may	explain	 the	differences	 in	expression	 levels.	
Alternatively	the	removal	of	TAB182	expression	may	effect	Cyclin	E	expression	to	a	greater	
extent	during	Ad12	than	Ad5	 infection	as	 there	are	 large	variations	 in	 the	ways	difference	
adenoviruses	target	DDR/cell	cycle	proteins.			
With	 the	exception	of	TOPBP1,	E1B55K	 is	known	to	 interact	directly	with	all	 tested	
DDR	 proteins	 that	 it	 targets	 for	 degradation	 including	 p53,	 DNA	 ligase	 IV,	 BLM	 and	 Tip60	
(Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	 Lee	 et	 al.	 2005,	 Baker,	 Rohleder	 et	 al.	 2007,	
Blackford,	Patel	et	al.	2010,	Orazio,	Naeger	et	al.	2011,	Gupta,	Jha	et	al.	2013).	Following	GST	
pull-down	 and	 co-immunoprecipitation	 experiments,	 E1B55K	 was	 shown	 to	 interact	 with	
TAB182	 in	vitro	and	 in	vivo	respectively	(Figure	3.12).	These	data	compliment	the	previous	
results	showing	that	TAB182	forms	an	E3	ubiquitin	 ligase	composed	of	at	 least	the	E1B55K	
protein	together	with	Cullins	and	presumably	Elongins	and	Rbx1.	
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Following	 analysis	 by	 immunofluorescence	 microscopy,	 it	 was	 determined	 that	
TAB182	 does	 not	 localise	 to	 VRCs	 during	 adenovirus	 infection	 (Figure	 3.13).	 Furthermore,	
the	 composition	 of	 VRCs	 were	 analysed	 following	 siRNA-mediated	 TAB182	 knockdown;	 it	
was	found	that	TAB182	deficient	cells	displayed	no	problems	in	VRC	formation	determined	
by	counting	E1B55K,	DBP	and	RPA32	positive	cells	as	a	percentage	of	total	number	of	cells	
following	 infection.	 No	 significant	 differences	 were	 observed	 between	 control	 siRNA	 and	
TAB182	deficient	cells	 (Figure	3.14).	Most	other	DDR	proteins	degraded	during	adenovirus	
infection	have	been	located	at	VRCs.	Prior	to	degradation,	p53	was	shown	to	be	localised	to	
PML-containing	 nuclear	 tracks	 rather	 than	 VRCs	 during	 Ad4,	 Ad5	 and	Ad12	 infection.	 p53	
was	also	shown	to	be	located	at	nuclear	tracks	during	Ad9	infection,	although	there	was	no	
evidence	of	any	p53	degradation	throughout	the	course	of	infection	(Forrester,	Sedgwick	et	
al.	2011).	Contradictory	data	is	available	for	Mre11	degradation	during	Ad4	infection,	which	
was	shown	to	localise	to	VRCs	or	PML	nuclear	tracks	in	various	studies	(Stracker,	Lee	et	al.	
2005,	 Forrester,	 Sedgwick	 et	 al.	 2011).	During	Ad5	and	Ad12	 infection,	Mre11	 is	 found	 to	
localise	 to	 nuclear	 tracks	 and	 VRCs	 respectively	 (Stracker,	 Lee	 et	 al.	 2005,	 Forrester,	
Sedgwick	 et	 al.	 2011).	 During	 Ad3,	 Ad7	 and	 Ad11	 infection	 Mre11	 is	 localised	 to	 VRCs	
whereas	 during	 Ad9	 infection	Mre11	 is	 localised	 to	 nuclear	 tracks.	 During	 Ad3,	 Ad4,	 Ad5,	
Ad7,	Ad9,	Ad11	and	Ad12	infection,	TOPBP1	was	shown	to	be	localised	to	VRCs	(Forrester,	
Sedgwick	 et	 al.	 2011).	 BLM	has	 been	 shown	 to	 be	 localised	 to	 VRCs	 during	 Ad5	 infection	
(Orazio,	 Naeger	 et	 al.	 2011).	 DNA	 ligase	 IV	 has	 no	working	 immunofluorescence	 antibody	
and	the	location	of	Tip60	during	adenovirus	infection	is	currently	unknown	(Baker,	Rohleder	
et	al.	2007,	Gupta,	Jha	et	al.	2013).	From	these	data	it	is	clear	that	different	virus	serotypes	
adopt	different	localisation	strategies	for	different	DDR	proteins.	Although	TAB182	was	not	
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found	to	be	located	at	VRCs	during	Ad5	or	Ad12	infection,	that	is	not	to	say	it	may	not	be	at	
nuclear	tracks	or	aggresomes.	Furthermore,	it	is	not	known	for	certain	if	TAB182	localises	to	
VRCs.	The	ectopic	TAB182	protein	was	fused	to	GFP	and	its	expression	was	forced;	it	is	not	
known	 whether	 the	 protein	 is	 functional	 and	 to	 what	 level	 it	 is	 expressed	 compared	 to	
endogenous	 TAB182	 protein	 levels.	 Further	 investigative	 analysis	 will	 determine	 whether	
TAB182	is	located	at	these	structures.		
In	 conclusion,	 this	 chapter	 presents	 evidence	 to	 suggest	 that	 TAB182	 is	 a	 novel	
protein	degraded	during	adenovirus	infection.	The	degradation	of	which	is	dependent	on	the	
E1B55K	 and	 E4orf6	 proteins,	 together	 with	 a	 cellular	 Cullin	 E3	 ubiquitin	 ligase	 complex.	
These	 data	 suggest	 that	 TAB182	 is	 degraded	 during	 adenovirus	 infection	 to	 prevent	
suppression	 of	 cell	 cycle	 progression,	 although	 further	 studies	 are	 required	 to	 determine	
whether	or	not	this	is	the	case.	Finally,	TAB182	was	not	found	to	be	localised	to	VRCs	during	
adenovirus	infection,	although	whether	or	not	TAB182	is	located	at	PML-containing	nuclear	
tracks	or	aggresomes	is	also	to	be	investigated	further.		
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4.	THE	ROLE	OF	TAB182	IN	THE	DNA	DAMAGE	AND	REPLICATION	STRESS	PATHWAYS	
4.1	INTRODUCTION	
The	DDR	and	 repair	pathways	are	a	 complex	and	coordinated	set	of	networks	 that	
detect	and	repair	DNA	damage	with	the	ultimate	aim	to	protect	the	integrity	of	the	genome.	
The	DDR	can	respond	to	a	variety	of	genomic	insults,	including	SSBs,	DSBs,	bulky	lesions	and	
DNA	mismatches.	 In	 addition,	 the	 DDR	 can	 also	 detect	 and	 respond	 to	 replication	 stress	
induced	by	unresolved	DNA	lesions,	DNA-bound	proteins	and	secondary	structures.	The	two	
major	proteins	responsible	for	the	detection	of	DNA	damage	and	replication	stress	are	the	
ATM	and	ATR	 kinases.	Upon	 activation	 of	 the	ATM	and	ATR	 kinases,	 a	 complex	 signalling	
network	ensues	that	leads	to	the	activation	of	the	Chk2	and	Chk1	kinases	respectively,	which	
act	to	stall	the	cell	cycle	in	order	to	prevent	replication	of	damaged	DNA	and	allow	time	for	
repair.	In	parallel,	activated	ATM	and	ATR	kinases	also	activate	DNA	repair	proteins	including	
BRCA1,	53BP1	and	BLM	amongst	others	to	promote	the	repair	of	damaged	DNA	(see	Section	
1.2.1.1).	 If	DNA	damage	 is	not	 repaired	before	DNA	replication,	 this	can	 lead	 to	stalling	of	
replication	 forks	 and	 perturbation	 of	 DNA	 synthesis.	 To	 prevent	 this,	 cells	 have	 also	
developed	mechanisms	of	DNA	damage	tolerance	that	allow	the	by-pass	of	DNA	lesions	 in	
order	to	ensure	completion	of	genome	duplication.	In	fact,	a	complex	set	of	networks	that	
respond	to	replication	stress	and	facilitate	replication	restart	exist	but	the	exact	mechanisms	
are	less	understood	(see	Section	1.2.4.2).		
The	 function	 of	 TAB182	 is	 currently	 unknown,	 although	 studies	 from	 Seiyima	 and	
colleagues	have	previously	shown	TAB182	to	interact	with	Tanykrase	1,	a	protein	implicated	
in	telomere	regulation,	and	to	also	associate	with	mitotic	chromosomes	(Seimiya	and	Smith	
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2002).	More	 recently,	 TAB182	was	 identified	 in	 a	mass	 spectrometry	 screen	where	 it	was	
identified	as	an	ATM/ATR	substrate	following	DNA	damage	(IR	specifically)	(Matsuoka,	Ballif	
et	 al.	 2007).	 Results	 from	 Chapter	 Three	 showed	 that	 TAB182	 was	 degraded	 following	
infection	with	Ad5	and	Ad12	serotypes.	Since	more	than	80%	of	adenoviral	targets	are	DDR	
proteins,	we	 thus	hypothesised	 that	 TAB182	 could	 also	be	 implicated	 in	 the	DDR.	 Further	
evidence	 obtained	 from	 Chapter	 Three	 suggested	 that	 TAB182	 was	 able	 to	 influence	 the	
expression	 of	 Cyclin	 E	 during	 adenovirus	 infection,	 suggesting	 that	 TAB182	 may	 also	 be	
involved	cell	cycle	progression.	The	aim	of	this	chapter	was	therefore	to	elucidate	a	potential	
role	of	TAB182	in	the	DDR	and/or	the	cell	cycle.		
	
4.2	RESULTS	
4.2.1	Optimisation	of	TAB182	siRNA	Knockdown	
Since	 the	 majority	 of	 the	 experiments	 planned	 for	 this	 chapter	 involved	 RNA	
interference	of	TAB182,	 the	optimal	 conditions	 for	 siRNA-mediated	knockdown	of	TAB182	
were	 established.	 HeLa	 cells	 were	 transfected	 with	 increasing	 concentrations	 of	 control	
(non-targeting)	 or	 TAB182	 siRNA	 (20nm,	 45nm,	 90nm	 and	 180nm).	 48	 hours	 following	
transfection,	the	cells	were	harvested,	subjected	to	SDS-PAGE	and	Western	blotting.	TAB182	
was	 immunoblotted	 to	 confirm	 siRNA-mediated	 knockdown	of	 the	 protein	 along	with	 the	
DNA	damage	proteins	NBS1,	 Chk1,	 RPA	and	H2AX	 to	determine	whether	 the	depletion	of	
TAB182	affects	the	expression	of	core	DNA	damage	proteins.	β-Actin	was	immunoblotted	as	
a	 loading	 control.	 All	 concentrations	 of	 TAB182	 siRNA	 (ranging	 from	 20nm	 to	 180nm)	
significantly	down-regulated	TAB182	protein	expression	when	compared	to	the	expression		
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Figure	 4.1:	 Optimisation	 of	 TAB182	 siRNA	Knockdown.	 HeLa	cells	were	 transfected	with	
increasing	 concentrations	 of	 non-targeting	 control	 or	 TAB182	 siRNA.	 The	 cells	 were	 then	
harvested	 48	 hours	 post-transfection.	 The	 cell	 lysates	 were	 subjected	 to	 SDS-PAGE	 and	
Western	 blotting.	 TAB182	was	 immunoblotted	 to	 assess	 the	 efficiency	 of	 the	 knockdown	
with	 increasing	concentrations	of	siRNA.	β-Actin	was	 immunoblotted	as	a	 loading	control.	
Various	 DDR	 proteins	were	 immunoblotted	 to	 assess	 expression	 levels	 following	 TAB182	
siRNA-mediated	 knockdown.	 This	 Western	 blot	 is	 representative	 of	 three	 independent	
experiments.		
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of	 TAB182	 in	 control	 siRNA	 treated	 cells.	Upon	overexposure	of	 the	autoradiography	 film,	
some	 residual	 TAB182	 protein	 expression	 was	 observed	 in	 cells	 treated	 with	 20nm	 of	
TAB182	siRNA.	It	was	therefore	decided	that	the	optimal	concentration	of	TAB182	siRNA	for	
all	 future	experiments	would	be	45nm.	This	was	to	 limit	any	toxicity	and	off-target	effects	
from	 the	use	of	higher	 concentrations	of	 siRNA	 than	necessary.	 The	protein	expression	of	
the	DNA	damage	proteins	NBS1,	 Chk1,	 RPA	and	H2AX	were	unaffected	by	 TAB182	 siRNA-
mediated	 knockdown,	 suggesting	 that	 the	 down-regulation	 of	 TAB182	 protein	 expression	
has	no	effect	on	the	expression	of	a	number	of	DNA	damage	proteins	(Figure	4.1).		
	
4.2.2	Cells	Depleted	of	TAB182	are	Sensitive	to	Agents	that	Induce	Replicative	Stress	but	
not	IR	
Since	 results	 from	 the	 Chapter	 Three	 and	 those	 from	 Matsuoka	 and	 colleagues	
suggested	 that	 TAB182	may	 be	 involved	 in	 the	DDR,	 the	 cell	 survival	 of	 TAB182	 deficient	
cells	 was	 assessed	 following	 exposure	 to	 various	 DNA	 damaging	 agents.	 Cells	 previously	
treated	 with	 control	 or	 TAB182	 siRNA	 were	 plated	 at	 various	 densities	 and	 exposed	 to	
increasing	concentrations	of	IR,	UV-C	irradiation	or	HU.	Confirmation	of	TAB182	knockdown	
was	achieved	by	Western	blotting	(data	not	shown).	Following	exposure,	the	cells	were	the	
incubated	for	14	days	to	allow	colony	formation	and	the	colonies	formed	were	stained	and	
counted.	Colony	numbers	were	plotted	on	 survival	 graphs	and	analysed.	Cells	depleted	of	
TAB182	were	not	sensitive	to	IR	(Figure	4.2A),	but	were	sensitive	to	UV-C	irradiation	and	HU	
exposure	when	compared	to	the	survival	of	cells	treated	with	control	siRNA	(Figure	4.2B	and	
4.2C).	 This	 suggests	 that	 cells	 depleted	 of	 TAB182	 are	 sensitive	 to	 agents	 that	 induce	
replicative	stress,	but	not	to	those	inducing	DNA	DSBs.	
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Figure	4.2:	Cells	Depleted	of	TAB182	are	not	Sensitive	to	 IR,	but	are	Sensitive	 to	UV-C	
Irradiation	 and	 HU	 Treatment.	 	 Clonogenic	 survival	 assays	 were	 performed	 in	 cells	
depleted	 of	 TAB182,	 along	 with	 non-targeting	 control	 siRNA.	 Following	 the	 indicated	
siRNA	 transfections,	 the	 cells	 were	 exposed	 to	 (A)	 increasing	 doses	 of	 IR	 (B)	 increasing	
doses	of	UV-C	irradiation	or	(C)	increasing	doses	of	HU	treatment.	Following	exposure,	the	
cells	were	further	incubated	in	media	for	14	days	and	the	colonies	formed	were	stained	
with	0.5%	crystal	violet	in	20%	ethanol.	Colonies	were	counted	and	the	data	was	plotted	
on	 survival	 graphs.	 Error	 bars	 represent	 SEM.	 This	 graph	 is	 representative	 of	 three	
independent	experiments.		
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Figure	4.2	Cont’d:	Cells	Depleted	of	TAB182	are	not	Sensitive	 to	 IR,	but	are	Sensitive	to	
UV-C	 Irradiation	 and	 HU	 Treatment.	 	 Clonogenic	 survival	 assays	were	 performed	 in	 cells	
depleted	of	TAB182,	along	with	non-targeting	control	siRNA.	Following	the	indicated	siRNA	
transfections,	 the	cells	were	exposed	 to	 (A)	 increasing	doses	of	 IR	 (B)	 increasing	doses	of	
UV-C	irradiation	or	(C)	increasing	doses	of	HU	treatment.	Following	exposure,	the	cells	were	
further	 incubated	 in	 fresh	media	 for	 14	 days	 and	 the	 colonies	 formed	were	 stained	with	
0.5%	 crystal	 violet	 in	 20%	 ethanol.	 Colonies	 were	 counted	 and	 the	 data	 was	 plotted	 on	
survival	 graphs.	 Error	 bars	 represent	 SEM.	 These	 graphs	 are	 representative	 of	 three	
independent	experiments.		
	
		 155	
4.2.3	DDR	Signalling	is	Increased	in	TAB182	Depleted	Cells	Compared	to	Control	Cells	
following	Exposure	to	IR	and	HU	Treatment,	but	not	after	UV-C	Irradiation.		
HeLa	 cells	 were	 treated	 with	 control	 or	 TAB182	 siRNA	 and	 48	 hours	 later	 mock-
exposed	or	exposed	to	either	3	Gy	of	IR,	5	Jm-2	of	UV-C	or	2mM	HU	for	2	hours	after	which	
HU	was	removed	and	the	cells	incubated	in	drug-free	media	(denoted	‘wash-out’)	(all	further	
references	to	HU	‘wash-out’	refer	to	these	conditions).	Cells	were	harvested	at	0,	1,	4,	8	and	
24	hours	post-exposure	(an	additional	sample	was	taken	at	the	‘wash-out’	time-point	which	
was	the	time	of	HU	removal).	Cells	were	subjected	to	SDS-PAGE	and	Western	blotting	using	
the	appropriate	antibodies.	TAB182	was	immunoblotted	to	assess	the	efficiency	of	TAB182	
depletion	after	siRNA	treatment.	The	total	protein	levels	of	NBS1,	Chk1,	RPA	and	H2AX	were	
immunoblotted	 to	determine	whether	 the	depletion	of	TAB182	affected	 the	expression	of	
these	proteins.	The	levels	of	pNBS1	(S343),	pChk1	(S317	and	S345),	pRPA	(S4/8)	and	γH2AX	
(S139)	were	also	assessed	since	the	phosphorylation	of	these	proteins	indicates	activation	of	
the	DDR	(Figure	4.3).	
In	cells	transfected	with	control	or	TAB182	siRNA	and	exposed	to	IR,	the	total	protein	
levels	 of	 NBS1,	 Chk1,	 RPA	 and	 H2AX	 were	 unaffected	 in	 TAB182	 depleted	 cells	 when	
compared	to	control	cells.	The	protein	levels	of	pNBS1	(S343),	pChk1	(S317	and	S345),	pRPA	
(S4/8)	 and	 γH2AX	 (S139)	 increased	 following	 exposure	 to	 IR	 in	 both	 control	 and	 TAB182	
siRNA	 treated	 cells.	 	 Interestingly,	 the	phosphorylation	of	 pNBS1	 (S343),	 pChk1	 (S317	 and	
S345),	pRPA	(S4/8)	and	γH2AX	(S139)	was	elevated	 in	TAB182	depleted	cells	above	that	of	
control	 siRNA	treated	cells	 (Figure	4.3A).	This	suggests	 that	depletion	of	TAB182	enhances	
certain	phosphorylation	events	during	the	DDR	signalling	following	IR	exposure	despite	the	
lack	of	difference	in	cell	survival.		
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In	 cells	 transfected	with	 control	or	TAB182	 siRNA	and	exposed	 to	UV-C	 irradiation,	
the	total	protein	levels	of	NBS1,	Chk1,	RPA	and	H2AX	were	unaffected	by	TAB182	depletion	
when	compared	to	cells	treated	with	control	siRNA.	The	levels	of	pNBS1	(S343),	pChk1	(S317	
and	 S345),	 pRPA	 (S4/8)	 and	 γH2AX	 (S139)	 increased	 following	UV-C	 irradiation	 confirming	
activation	 of	 the	 DDR.	 However,	 there	 was	 little	 observable	 difference	 in	 the	 levels	 of	
phosphorylated	 DNA	 damage	 proteins	 between	 control	 and	 TAB182	 siRNA	 treated	 cells	
apart	 from	 the	 levels	 of	 pChk1	 (S317),	 which	 appeared	 to	 be	 slightly	 elevated	 in	 TAB182	
depleted	 cells	 compared	 to	 control	 cells	 (Figure	 4.3B).	 Therefore,	 the	 siRNA-mediated	
depletion	of	 TAB182	does	not	 impact	on	DNA	damage	 signalling	 after	UV-C	 irradiation,	 at	
least	with	respect	to	the	phosphorylation	events	examined	here.		
In	 cells	 transfected	with	 control	or	 TAB182	 siRNA	and	exposed	 to	2mM	HU	 (wash-
out),	 the	 total	 protein	 levels	 of	 NBS1,	 Chk1,	 RPA	 and	 H2AX	 were	 unaffected	 in	 TAB182	
depleted	 cells	 compared	 to	 cells	 treated	 with	 control	 siRNA.	 The	 levels	 of	 pNBS1	 (S343),	
pChk1	(S317	and	S345),	pRPA	(S4/8)	and	γH2AX	(S139)	increased	following	exposure	to	2mM	
HU	(wash-out),	confirming	activation	of	DDR	signalling.	There	was	no	observable	difference	
in	the	phosphorylation	of	pNBS1	(S343)	in	TAB182	deficient	cells	compared	to	control	cells	
exposed	to	2mM	HU	(wash-out).	However,	the	expression	of	pChk1	(S317	and	S345),	pRPA	
(S4/8)	and	γH2AX	 (S139)	was	elevated	 in	TAB182	depleted	cells	 compared	 to	 control	 cells	
following	 2mM	 HU	 (Figure	 4.3C).	 This	 suggests	 that	 depletion	 of	 TAB182	 enhances	 DDR	
signalling	following	release	from	HU	exposure.		
Taken	 together,	 these	 data	 suggest	 that	 the	 DNA	 damage	 signalling	 in	 TAB182	
depleted	cells	is	elevated	upon	exposure	to	certain	damaging	agents	such	as	IR	and	HU,	but		
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Figure	4.3:	DDR	Signalling	 is	 Increased	 in	 TAB182	Depleted	 Cells	Compared	 to	 Control	
Cells	following	Exposure	to	IR	and	HU	Treatment,	but	not	after	UV-C	Irradiation.	50µg	of	
TAB182	 depleted	 or	 control	 siRNA	 treated	 HeLa	 cell	 extracts	 were	 immunoblotted	 for	
proteins	 involved	 in	DDR	signalling	 in	response	to	 (A)	 3	Gy	 IR	exposure,	 (B)	 5	 Jm-2	UV-C	
irradiation	or	(C)	2	hour	treatment	with	2mM	HU,	followed	by	3	washes	in	HU-free	media	
and	 incubation	 in	 fresh	 media	 for	 the	 indicated	 time-points.	 TAB182	 expression	 was	
analysed	 to	 assess	 the	 efficiency	 of	 TAB182	 depletion	 following	 siRNA	 treatment.	 This	
Western	 blot	 is	 representative	 of	 three	 independent	 repeats.	 	 Wash-out	 (WO)	
corresponds	 to	 the	 time-point	 at	 which	 cells	 were	 harvested	 immediately	 after	 HU	
treatment.		
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Figure	 4.3	 Cont’d:	 DDR	 Signalling	 is	 Increased	 in	 TAB182	 Depleted	 Cells	 Compared	 to	
Control	Cells	following	Exposure	to	IR	and	HU	Treatment,	but	not	after	UV-C	Irradiation.	
50µg	of	TAB182	depleted	or	control	siRNA	treated	HeLa	cell	extracts	were	immunoblotted	
for	proteins	involved	in	DDR	signalling	in	response	to	(A)	3	Gy	IR	exposure,	(B)	5	Jm-2	UV-C	
irradiation	or	(C)	2	hour	treatment	with	2mM	HU,	followed	by	3	washes	in	HU-free	media	
and	 incubation	 in	 fresh	 media	 for	 the	 indicated	 time-points.	 TAB182	 expression	 was	
analysed	 to	 assess	 the	 efficiency	 of	 TAB182	 depletion	 following	 siRNA	 treatment.	 This	
Western	 blot	 is	 representative	 of	 three	 independent	 repeats.	 	 Wash-out	 (WO)	
corresponds	 to	 the	 time-point	 at	 which	 cells	 were	 harvested	 immediately	 after	 HU	
treatment.		
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Figure	 4.3	Cont’d:	DDR	Signalling	 is	 Increased	 in	TAB182	Depleted	 Cells	 Compared	 to	
Control	Cells	following	Exposure	to	IR	and	HU	Treatment,	but	not	after	UV-C	Irradiation.	
50µg	 of	 TAB182	 depleted	 or	 control	 siRNA	 treated	 HeLa	 cell	 extracts	 were	
immunoblotted	 for	 proteins	 involved	 in	 DDR	 signalling	 in	 response	 to	 (A)	 3	 Gy	 IR	
exposure,	(B)	5	Jm-2	UV-C	irradiation	or	(C)	2	hour	treatment	with	2mM	HU,	followed	by	3	
washes	 in	HU-free	media	 and	 incubation	 in	 fresh	media	 for	 the	 indicated	 time-points.	
TAB182	expression	was	analysed	to	assess	the	efficiency	of	TAB182	depletion	following	
siRNA	 treatment.	 This	 Western	 blot	 is	 representative	 of	 three	 independent	 repeats.		
Wash-out	(WO)	corresponds	to	the	time-point	at	which	cells	were	harvested	immediately	
after	HU	treatment.		
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not	 following	UV-C	 irradiation,	despite	 the	 fact	 that	TAB182	depleted	cells	are	sensitive	to	
UV-C	irradiation	as	shown	by	previous	cell	survival	assays	(Figure	4.2).			
	
4.2.4	Depletion	of	TAB182	has	no	Effect	on	Cell	Cycle	Progression	in	HeLa	Cells	
Activation	of	the	DDR	can	result	in	cell	cycle	arrest	and	therefore,	a	number	of	DDR	
proteins	 can	directly	 affect	 the	 cell	 cycle	 following	 their	 activation.	 To	assess	whether	 the	
depletion	of	TAB182	had	any	effect	on	cell	cycle	progression	 in	HeLa	cells,	 flow	cytometry	
analysis	was	performed.	To	begin	with,	HeLa	cells	were	transfected	with	control	or	TAB182	
siRNA	and	harvested	at	0,	24,	48	and	72	hours	post	siRNA-mediated	knockdown	in	order	to	
ascertain	 whether	 knockdown	 of	 TAB182	 has	 any	 effect	 on	 cell	 cycle	 progression	 in	 the	
absence	 of	 DNA	 damage.	 Confirmation	 of	 TAB182	 knockdown	 was	 achieved	 by	 Western	
blotting	(data	not	shown).	Cells	were	stained	with	the	DNA	stain	PI	and	the	cell	cycle	profile	
analysed	 by	 flow	 cytometry.	 There	was	 no	 observable	 difference	 in	 the	 cell	 cycle	 profiles	
between	control	siRNA	and	TAB182	depleted	cells	(Figure	4.4A).	The	data	are	represented	in	
a	 graphical	 format,	 where	 the	 average	 cell	 cycle	 was	 plotted	 from	 three	 independent	
experiments	(Figure	4.4B).			
	
4.2.5	Cells	Depleted	of	TAB182	Exhibit	Delayed	Cell	Cycle	Progression	following	Exposure	
to	Various	DNA	Damaging	Agents.		
Since	 there	was	no	effect	of	 TAB182	depletion	on	 the	 cell	 cycle	progression	 in	 the	
absence	of	DNA	damage,	we	next	performed	the	same	experiment	but	following	exposure		
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Figure	4.4:	Depletion	of	TAB182	has	no	Effect	on	Cell	Cycle	Progression	in	HeLa	Cells.	
HeLa	cells	were	transfected	with	either	non-targeting	control	or	TAB182	siRNA,	stained	
with	PI	and	the	cell	cycle	profile	was	analysed	by	flow	cytometry	at	various	time-points	
post-transfection.	 (A)	 is	 representative	 of	 a	 typical	 flow	 cytometry	 plot	 observed	 (B)	
Graph	 depicts	 the	 average	 cell	 cycle	 profile	 observed	 in	 three	 independent	
experiments.			
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to	various	DNA	damaging	agents.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA,	
and	48	hours	later	were	exposed	to	either	3	Gy	of	IR,	5	Jm-2	of	UV-C	or	2mM	HU	washed	out	
following	2	hours	exposure	 (wash-out).	 Samples	were	harvested	and	 fixed	with	ethanol	at	
various	time-points	post-exposure	depending	on	the	DNA	damaging	agent	used.	Cells	were	
stained	 with	 PI	 and	 the	 cell	 cycle	 profile	 analysed	 by	 flow	 cytometry	 (Figure	 4.5).	
Confirmation	of	TAB182	knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
Ordinarily,	exposure	to	IR	delays	the	progression	through	the	cell	cycle	through	the	
activation	 of	 cell	 cycle	 checkpoints	 (namely	 the	 G1	 checkpoint,	 the	 S	 checkpoint	 and	 the	
G2/M	checkpoint).	Delay	in	the	progression	through	the	cell	cycle	after	exposure	to	IR	occurs	
in	 all	 phases	of	 the	 cell	 cycle;	 however,	 the	delay	during	 the	G2	phase	of	 the	 cell	 cycle	 is	
most	noticeable	(Lucke-Huhle,	Blakely	et	al.	1979).	In	control	cells,	exposure	to	IR	induced	a	
notable	delay	in	G2	phase	progression	(caused	by	the	activation	of	the	G2/M	checkpoint).	24	
hours	post-IR,	the	cell	cycle	arrest	induced	by	IR	was	attenuated	and	the	cell	cycle	resumed,	
36	hours	post-IR	exposure	the	cell	cycle	profile	of	control	cells	was	similar	to	pre-IR	exposure	
levels.	Cells	transfected	with	TAB182	siRNA	appeared	to	accumulate	at	the	G2/M	phase	of	
the	cell	cycle	to	a	greater	extent	than	control	cells	exposed	to	IR	(most	notable	at	8hrs	post-
IR).	 Similarly	 to	 control	 cells,	 the	G2/M	arrest	 seen	 in	TAB182	 siRNA	 transfected	 cells	was	
also	 alleviated	 24	 hours	 after	 the	 initial	 IR	 exposure,	 and	 the	 cell	 cycle	 profile	 of	 TAB182	
siRNA	 treated	 cells	 returned	 to	 a	 pre-IR	 exposure	 profile	 36	 hours	 following	 IR	 exposure	
(Figure	4.5A).		
Exposure	to	UV-C	irradiation	induced	cell	cycle	arrest	in	control	cells	which,	however,	
was	most	notable	as	a	delay	in	S	phase	progression	(Figure	4.5B)	(Domon	and	Rauth	1968).	
This	delay	in	S	phase	progression	was	visible	by	cell	cycle	profile	analysis	8	hours	following	
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UV-C	 irradiation.	 24	 hours	 post-UV-C	 irradiation,	 a	 release	 from	 the	 cell	 cycle	 arrest	 was	
observed	which,	 in	 turn,	 led	 to	 the	progression	 through	S	phase,	 and	 then	 into	 the	G2/M	
phase	of	the	cell	cycle.	48	hours	post	initial	UV-C	irradiation,	the	cell	cycle	profile	of	control	
cells	began	to	return	to	that	of	a	pre-exposure	profile.	 In	TAB182	defective	cells,	cell	cycle	
arrest	following	UV-C	irradiation	exposure	was	also	observed.	Interestingly,	the	percentage	
of	cells	in	S	phase	appeared	to	be	two-fold	higher	in	TAB182	knockdown	cells	than	in	control	
cells	4	hours	post-UV-C	irradiation.	A	greater	percentage	of	cells	in	G2/M	following	TAB182	
depletion	was	 also	 noticeable	 24	 hrs	 after	UV-C	 irradiation,	 compared	 to	 control	 cells.	 48	
hours	after	exposure	 to	UV-C	 irradiation	the	cell	 cycle	profile	of	cells	 treated	with	TAB182	
siRNA	had	returned	to	that	of	a	pre-exposure	profile	(Figure	4.5B).	
Control	and	TAB182	siRNA	transfected	cells	exposed	2mM	HU	for	two	hours	(wash-
out)	were	harvested	at	0,	the	point	of	HU	removal,	1,	4,	8	and	24	hours	post-exposure.	Cells	
were	harvested,	fixed	and	stained	with	PI	and	the	cell	cycle	profile	of	the	cells	was	analysed	
by	flow	cytometry.	In	cells	treated	with	2mM	HU	for	two	hours,	a	cell	cycle	arrest	which	was	
most	noticeable	as	a	delay	 in	 the	G2	phase	of	 the	cell	 cycle	was	observed.	24	hours	post-
initial	HU	exposure,	cell	cycle	arrest	induced	by	HU	was	alleviated	and	the	cells	continued	to	
go	 through	 the	 cell	 cycle.	 Interestingly,	 cells	 transfected	with	 TAB182	 siRNA	 exhibited	 an	
increase	in	the	percentage	of	cells	 in	G2/M	phase	when	compared	to	control	cells	and	this	
was	observed	at	both	8	hours	and	24	hours	post-2mM	HU	release	(Figure	4.5C).			
Taken	together,	these	results	show	that	following	exposure	to	IR,	UV-C	and	2mM	HU	
(wash-out),	 TAB182	 deficient	 cells	 exhibit	 a	 delay	 in	 cell	 cycle	 progression	 (namely	 G2/M	
phase	following	IR	and	HU	exposure,	and	S	phase	following	UV-C	irradiation).	Delays	in	cell	
cycle	progression	in	TAB182	deficient	cells	could	indicate	a	cell	cycle	checkpoint	defect.		
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Figure	 4.5:	Cells	Depleted	of	 TAB182	 Exhibit	Delayed	Cell	Cycle	 Progression	 following	
Exposure	to	Various	DNA	Damaging	Agents.	HeLa	cells	were	transfected	with	either	non-
targeting	control	or	TAB182	siRNA,	and	48	hours	later	mock-exposed	or	exposed	to	(A)	3	
Gy	of	 IR,	 (B)	5	Jm-2	UV-C	 irradiation	or	 (C)	2	hour	treatment	with	2mM	HU	 for	2	hours,	
followed	by	3	washes	 in	HU-free	media	and	 incubation	 in	 fresh	media	for	the	 indicated	
time-points.	 Cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post-exposure,	
stained	with	PI	and	the	cell	cycle	profile	analysed	by	flow	cytometry.	 (I)	Representative	
images	 of	 the	 flow	 cytometry	 plot	 obtained	 (II)	 Graph	 depicting	 the	 average	 cell	 cycle	
profile	obtained	from	three	independent	experiments.		
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Figure	 4.5	 Cont’d:	 Cells	 Depleted	 of	 TAB182	 Exhibit	 Delayed	 Cell	 Cycle	 Progression	
following	 Exposure	 to	 Various	 DNA	 Damaging	 Agents.	 HeLa	 cells	 were	 transfected	 with	
either	non-targeting	control	or	TAB182	siRNA,	and	48	hours	later	mock-exposed	or	exposed	
to	 (A)	 3	Gy	 of	 IR,	 (B)	 5	 Jm-2	UV-C	 irradiation	or	 (C)	 2	 hour	 treatment	with	2mM	HU	 for	2	
hours,	 followed	 by	 3	 washes	 in	 HU-free	 media	 and	 incubation	 in	 fresh	 media	 for	 the	
indicated	 time-points.	 Cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post-
exposure,	 stained	 with	 PI	 and	 the	 cell	 cycle	 profile	 analysed	 by	 flow	 cytometry.	 (I)	
Representative	images	of	the	flow	cytometry	plot	obtained	(II)	Graph	depicting	the	average	
cell	cycle	profile	obtained	from	three	independent	experiments.		
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Figure	 4.5	 Cont’d:	 Cells	 Depleted	 of	 TAB182	 Exhibit	 Delayed	 Cell	 Cycle	 Progression	
following	 Exposure	 to	 Various	 DNA	 Damaging	 Agents.	 HeLa	 cells	 were	 transfected	 with	
either	non-targeting	control	or	TAB182	siRNA,	and	48	hours	later	mock-exposed	or	exposed	
to	 (A)	 3	Gy	 of	 IR,	 (B)	 5	 Jm-2	UV-C	 irradiation	 or	 (C)	 2	 hour	 treatment	with	 2mM	HU	 for	 2	
hours,	 followed	 by	 3	 washes	 in	 HU-free	 media	 and	 incubation	 in	 fresh	 media	 for	 the	
indicated	 time-points.	 Cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post-
exposure,	 stained	 with	 PI	 and	 the	 cell	 cycle	 profile	 analysed	 by	 flow	 cytometry.	 (I)	
Representative	images	of	the	flow	cytometry	plot	obtained	(II)	Graph	depicting	the	average	
cell	cycle	profile	obtained	from	three	independent	experiments.		
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4.2.6	The	G2/M	Checkpoint	is	Proficient	in	TAB182	Depleted	Cells	following	Exposure	to	
Various	DNA	Damaging	Agents.		
Since	 the	 cell	 cycle	 profile	 of	 cells	 deficient	 in	 TAB182	 expression	 revealed	 some	
accumulation	 in	G2/M	phase	of	 the	 cell	 cycle	 following	exposure	 to	 various	 types	of	DNA	
damaging	 agents,	 we	 also	 wanted	 to	 examine	 whether	 the	 G2/M	 checkpoint	 was	 intact.	
HeLa	cells	were	treated	with	either	control	or	TAB182	siRNA,	and	48	hours	later	exposed	to	
either	3	Gy	of	IR,	5	Jm-2	of	UV-C	or	2mM	HU	(wash-out).	Samples	were	harvested	and	fixed	
at	 various	 time-points	 post-exposure	 depending	 on	 the	 DNA	 damaging	 agent	 used.	 Cells	
were	 stained	 with	 an	 antibody	 recognising	 Histone	 H3	 phosphorylated	 on	 Serine	 10	
(phospho-H3	 Ser10)	 as	 a	 marker	 of	 cells	 entering	 mitosis.	 The	 cell	 cycle	 profiles	 of	 the	
samples	 were	 then	 analysed	 by	 flow	 cytometry	 (Figure	 4.6).	 Confirmation	 of	 TAB182	
knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
1-4	 hours	 following	 IR,	 the	 percentage	 of	 control	 cells	 entering	mitosis	 (shown	 by	
phospho-H3	 (Ser10)	 staining)	 was	 steadily	 reduced	 as	 the	 G2/M	 checkpoint	 became	
activated.	24	hours	after	the	initial	IR	exposure,	the	percentage	of	cells	in	mitosis	began	to	
increase	 and	 36	 hours	 later	 it	 reached	 pre-exposure	 levels.	 Importantly,	 there	 was	 no	
significant	 difference	 in	 the	 percentage	 of	 cells	 in	mitosis	 between	 TAB182	 deficient	 and	
control	cells	at	any	of	the	time-points	examined	(Figure	4.6A).	
Within	 4-8	 after	 UV-C	 irradiation	 at	 5	 Jm-2,	 the	 percentage	 of	 cells	 in	 mitosis	
decreased	 as	 a	 consequence	 of	 the	 activation	 of	 the	 G2/M	 checkpoint,	 with	 a	 gradual	
release	 from	 the	 checkpoint	 becoming	 evident	 24	 to	 48	 hours	 after	 UV-C	 irradiation.	 In	
TAB182	siRNA	treated	cells,	there	was	a	slight	increase	in	the	percentage	of	cells	in	mitosis	
throughout	the	time-course	following	UV-C	irradiation	when	compared	to	control	siRNA		
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Figure	4.6:	The	G2/M	Checkpoint	is	Proficient	in	TAB182	Depleted	Cells	following	Exposure	
to	 Various	 DNA	 Damaging	 Agents.	 HeLa	 cells	 were	 transfected	 with	 either	 control	 or	
TAB182	siRNA	and	48	hours	post-transfection	exposed	to	either	(A)	3	Gy	of	IR,	(B)	5	Jm-2	of	
UV-C	 or	 (C)	 2mM	 HU	 wash-out	 (washed	 out	 after	 2	 hours	 of	 incubation).	 Following	
treatment,	 the	 cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post	 exposure,	
stained	with	phospho-H3	(Ser10)	antibody	as	a	marker	of	cells	entering	mitosis	and	analysed	
by	flow	cytometry.	Graphs	are	representative	of	three	independent	experiments,	error	bars	
represent	SEM.	
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Figure	4.6	Cont’d:	The	G2/M	Checkpoint	 is	Proficient	 in	TAB182	Depleted	Cells	 following	
Exposure	to	Various	DNA	Damaging	Agents.	HeLa	cells	were	transfected	with	either	control	
or	TAB182	siRNA	and	48	hours	post-transfection	exposed	to	either	(A)	3	Gy	of	IR,	(B)	5	Jm-2	
of	 UV-C	 or	 (C)	 2mM	 HU	 wash-out	 (washed	 out	 after	 2	 hours	 of	 incubation).	 Following	
treatment,	 the	 cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post	 exposure,	
stained	with	phospho-H3	(Ser10)	antibody	as	a	marker	of	cells	entering	mitosis	and	analysed	
by	flow	cytometry.	Graphs	are	representative	of	three	independent	experiments,	error	bars	
represent	SEM.	
	
		 170	
treated	 cells.	 	 Since	 this	 difference	was	mild	 it	 was	 concluded	 that	 the	 G2/M	 checkpoint	
following	UV-C	irradiation	was	intact	(Figure	4.6B).		
In	control	siRNA	treated	cells	exposed	to	2mM	HU	(wash-out),	the	percentage	of	cells	
in	mitosis	decreased	following	initial	exposure	and	continued	to	decrease	up	to	4	hours	post-
exposure	(Figure	4.6C).	This	was	expected	and	was	indicative	of	the	activation	of	the	G2/M	
checkpoint	following	acute,	high-dose	HU	exposure.	8	hours	after	HU	exposure	and	release,	
the	 percentage	 of	 cells	 in	 mitosis	 increased	 and	 by	 24	 hours,	 the	 percentage	 of	 cells	 in	
mitosis	had	reached	pre-exposure	levels.	 In	cells	depleted	of	TAB182	and	exposed	to	2mM	
HU,	the	same	reduction	in	the	percentage	of	cells	in	mitosis	up	to	4	hours	post-exposure	was	
observed,	 followed	 by	 a	 comparable	 increase	 in	 the	 percentage	 of	 cells	 in	mitosis	 after	 8	
hours	initial	HU	exposure,	recovering	to	pre-exposure	levels	following	24	hours	(Figure	4.6C).	
Taken	 together,	 these	 results	 show	 that	 the	G2/M	 checkpoint	 in	 TAB182	 depleted	
cells	 is	proficient	 following	 IR,	UV-C	 irradiation	and	HU	 treatment.	 	 Since	cells	depleted	of	
TAB182	 appeared	 to	 accumulate	 in	 G2/M	 phase	 of	 the	 cell	 cycle	 following	 exposure	 to	
various	types	of	DNA	damaging	agents,	it	could	also	be	that	there	is	a	problem	with	the	G1	
checkpoint	in	these	cells.		
	
4.2.7	TAB182	Depletion	has	no	Effect	on	Replication	Fork	Progression	in	the	Absence	of	
Replication	Stress	or	following	Release	from	HU.		
Since	 the	 previous	 results	 showed	 potential	 cell	 cycle	 progression	 abnormalities	 in	
TAB182	deficient	 cells	 in	 response	 to	DNA	damage	without	 any	G2/M	checkpoint	defects,	
these	 could	 reflect	 problems	 during	 S	 phase/DNA	 replication.	 To	 assess	 DNA	 replication	
speed	in	TAB182	depleted	cells,	DNA	fibre	analysis	was	performed	by	the	 immunolabelling	
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of	DNA	using	the	DNA	analogues	CldU	and	IdU.	HeLa	cells	were	transfected	with	control	or	
TAB182	 siRNA	 and	 48	 hours	 later,	 CldU	 was	 added	 to	 the	 cells	 to	 label	 the	 DNA	 during	
replication.	CldU	was	removed	from	the	cells	and	the	cells	were	subsequently	mock-treated	
or	treated	with	2mM	HU	to	induce	replication	stress.	Following	2	hours	of	HU	treatment,	HU	
was	 removed	 from	 the	 cells	 and	 ldU	 was	 added	 in	 HU-free	 media	 to	 label	 nascent	 DNA	
synthesis.	DNA	replication	speed	was	calculated	by	measuring	the	 lengths	of	 the	CldU	and	
IdU	 tracks	 using	 Image	 J	 software.	 The	 lengths	 obtained	 in	 Image	 J	 were	 converted	 into	
micrometers	 using	 the	 scale	bars	 on	 the	microscope	 (Figure	4.7).	 Confirmation	of	 TAB182	
knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
In	control	cells	the	average	fork	speed	before	exposure	to	HU	was	1.45kb	per	minute	
(CldU	 staining).	 In	 TAB182	depleted	 cells,	 there	was	 little	 significant	 difference	 in	 average	
fork	 speed	 (1.22kb	 per	 minute)	 compared	 to	 control	 cells	 before	 exposure	 to	 HU	 (CldU	
staining),	showing	that	knockdown	of	TAB182	alone	does	not	affect	replication	fork	kinetics.	
In	control	siRNA	treated	cells	the	average	fork	speed	following	exposure	to	HU	was	reduced	
to	 0.54	 kb	 per	 minute	 (IdU	 staining),	 showing	 that	 treatment	 with	 HU	 followed	 by	 a	 45	
minute	 incubation	 in	 HU-free	 media	 induces	 replication	 stress	 and	 therefore	 slows	 DNA	
replication.	 Similarly,	 in	 TAB182	 deficient	 cells,	 the	 average	 fork	 speed	 following	 HU	
treatment	 was	 reduced	 to	 0.47	 kb	 per	 minute	 (measured	 by	 IdU	 staining),	 showing	 that	
there	was	no	significant	difference	in	the	replication	fork	kinetics	in	these	cells	compared	to	
control	siRNA	cells	after	HU	treatment	(Figure	4.7).		
From	this	experiment	we	concluded	that	TAB182	defective	cells	replicate	their	DNA	
as	efficiently	as	control	cells	both	in	the	absence	and	presence	of	replication	stress	induced	
by	HU.		
		 172	
	 	
(B)$
!"HU"
+"HU"
(A)$
0"
5"
10"
15"
20"
25"
<0.2" <0.6" <1" <1.4" <1.8" <2.2" <2.6" <3" <4"
Pe
rc
en
ta
ge
"o
f"t
ot
al
"ﬁ
br
e"
le
ng
th
s"%
"
CldU"kb/min"
Average"CldU"fork"speed"
Control"siRNA"
Tab182"siRNA"
0"
5"
10"
15"
20"
25"
<0.2"<0.6" <1" <1.4"<1.8"<2.2"<2.6" <3" <4"
Pe
rc
en
ta
ge
"o
f"t
ot
al
"ﬁ
br
e"
le
ng
th
s"%
"
IdU"kb/min"
Average"IdU"fork"speed"
Control"siRNA"
Tab182"siRNA"
0"
10"
20"
30"
40"
50"
60"
<0.2" <0.6" <1" <1.4" <1.8" <2.2" <2.6" <3" <4"Pe
rc
en
ta
ge
"o
f"t
ot
al
"ﬁ
br
e"
le
ng
th
s"%
"
IdU"kb/min"
Average"IdU"fork"speed"(aNer"2mM"
HU)"
Control"siRNA"
Tab182"siRNA"
Control'siRNA'
Untreated' ''
TAB182'siRNA'
Untreated' ''
Control'siRNA'
2mM'HU' ''
TAB182'siRNA'
2mM'HU' ''
CldU'kb/min'
average'
IdU'kb/min'
average'
CldU'kb/min'
average'
IdU'kb/min'
average'
CldU'kb/min'
average'
IdU'kb/min'
average'
CldU'kb/min'
average'
IdU'kb/min'
average'
1.45% 1.60% 1.22% 1.48% 1.45% 0.54% 1.16% 0.47%
Figure	4.7:	TAB182	Depletion	has	no	Effect	on	Replication	Fork	Progression	in	the	Absence	
of	Replication	Stress	or	following	Release	from	HU.	HeLa	cells	were	transfected	with	control	
or	TAB182	siRNA.	48	hours	post-tranfection,	cells	were	incubated	with	CldU	for	20	minutes,	
followed	 by	 mock-treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours.	 Following	 HU	
treatment,	 cells	 were	 incubated	 with	 IdU	 for	 45	 minutes.	 DNA	 was	 spread	 onto	 slides,	
probed	 with	 the	 appropriate	 antibodies	 and	 visualised	 by	 fluorescence	 microscopy.	 DNA	
fibre	speed	was	calculated	by	measuring	the	lengths	of	the	CldU	and	IdU	tracks	using	Image	J	
software.	 (A)	 Graphs	 represent	 the	 average	 CldU	 fork	 speed	 (before	 HU	 exposure)	 and	
average	 IdU	 fork	 speed	 (HU	 exposure).	 (B)	 Table	 shows	 the	 average	 CldU	 and	 IdU	 fork	
speeds	 in	 control	 siRNA	and	TAB182	 siRNA	 treated	cells	mock-exposed	or	exposed	 to	HU.	
These	data	are	representative	of	three	independent	experiments.	Error	bars	represent	SEM.	
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4.2.8	Cells	Depleted	of	TAB182	Display	Excessive	New	Origin	Firing	and	Increased	Fork	
Restart	following	Release	from	HU	
To	further	investigate	whether	TAB182	deficient	cells	exhibit	any	irregularities	during	
DNA	replication,	DNA	fibre	analysis	was	performed	by	analysing	the	structures	of	DNA	fibres	
following	replication	stress.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA	and	
48	 hours	 later	 were	 incubated	 with	 media	 containing	 the	 DNA	 analogue	 CldU.	 Following	
CldU	 incorporation,	 the	cells	were	mock-treated	or	 treated	with	2mM	HU	for	2	hours,	 the	
HU	was	then	removed	and	the	cells	were	further	incubated	with	HU-free	media	containing	
IdU	 for	 45	 minutes.	 Cells	 were	 fixed,	 spread	 onto	 slides	 and	 incubated	 with	 antibodies	
against	 CldU	 and	 IdU.	 DNA	 was	 viewed	 under	 the	 microscope	 and	 the	 observed	 DNA	
structures	 recorded	 (Figure	 4.8).	 Confirmation	 of	 TAB182	 knockdown	 was	 achieved	 by	
Western	blotting	(data	not	shown).	
DNA	 tracks	 were	 analysed	 and	 categorised	 into	 the	 following	 structures.	 Ongoing	
forks	represent	forks	that	have	continued	to	replicate	following	the	removal	of	HU	and	are	
denoted	by	a	CldU	(red)	together	with	IdU	(green)	tracks.	1st	label	origins	represent	an	origin	
of	replication	that	occurred	during	the	first	label	and	which	continued	to	replicate	following	
the	 removal	 of	 HU	 in	 both	 directions,	 these	 are	 denoted	 by	 a	 CldU	 (red)	 track	 with	 IdU	
(green)	 tracks	 on	 either	 side.	 2nd	 label	 origins	 represent	 new	 origins	 of	 replication	 that	
occurred	during	 the	 second	 label	 and	are	denoted	by	an	 IdU	 (green)	 track	alone.	1st	 label	
terminations	represent	forks	that	collapsed	during	the	first	 label	and	did	not	restart	during	
the	 second	 label.	 They	 are	 denoted	 by	 a	 CldU	 (red)	 track	 alone.	 2nd	 label	 terminations	
represent	 two	 forks	 that	 were	 ongoing	 and	 replicating	 during	 the	 first	 label	 and	 have	
converged	and	terminated	during	the	second	label.	They	are	denoted	by	an	IdU	track	(green)	
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with	 two	 CldU	 (red)	 tracks	 on	 either	 side.	 The	 different	 fibre	 structures	 are	 further	
represented	 in	 Figure	 4.8A.	DNA	 fibre	 structures	were	 calculated	 as	 a	 percentage	of	 total	
number	of	CldU	positive	structures	counted.		
In	 control,	 undamaged	 HeLa	 cells	 subjected	 to	 DNA	 fibre	 structure	 analysis,	 the	
following	 distribution	 of	 structures	 were	 obtained;	 70-80%	 of	 DNA	 fibre	 structures	 were	
‘ongoing	 forks’,	 approximately	 5%	 of	 forks	were	 ‘1st	 label	 origins’,	 10%	 of	 forks	were	 ‘2nd	
label	 origins’,	 10%	 of	 forks	 were	 ‘1st	 label	 terminations’	 and	 5%	 of	 forks	 were	 ‘2nd	 label	
terminations’	(78%,	5%,	8%,	8%	and	5%	respectively	(Figure	4.8B)).	Following	treatment	with	
HU,	 these	 cells	 generally	 displayed	 the	 following	 DNA	 structure	 changes.	 ‘Ongoing	 forks’	
decreased	 to	 approximately	 65%	 due	 to	 an	 increase	 in	 the	 percentages	 of	 other	 DNA	
structures	 in	 response	 to	 HU	 treatment	 (63%	 in	 Figure	 4.8B).	 ‘1st	 label	 origins’	 remained	
unchanged	 at	 approximately	 5%	 of	 DNA	 structures	 (5%	 in	 Figure	 4.8B).	 ‘2nd	 label	 origins’	
decreased	 to	3%	of	 forks	 (3%	 in	 Figure	4.8B),	 this	 is	because	 the	 induction	of	new	origins	
following	 replicative	 stress	 is	 normally	 prevented	 by	 the	 S	 phase	 checkpoint	 to	 prevent	
deleterious	DNA	replication.	 ‘1st	 label	 terminations’,	 i.e.	stalled	ongoing	forks,	 increased	to	
approximately	30%	(27%	 in	Figure	4.8B),	due	to	 the	replication	stress	exhibited	during	the	
HU	treatment	stalling	ongoing	forks	in	order	to	prevent	deleterious	DNA	replication.	Finally,	
‘2nd	label	terminations’	were	reduced	from	approximately	5%	to	3%	(3%	in	Figure	4.8B),	due	
to	 ongoing	DNA	 replication	 decreasing	 and,	 therefore,	 the	 termination	 of	DNA	 replication	
also	decreasing	as	a	consequence.		
In	undamaged,	 TAB182	deficient	 cells,	 the	distribution	of	DNA	 fibre	 structures	was	
comparable	to	undamaged,	control	cells,	the	percentage	of	ongoing	forks	was	79%,	1st	label	
origins	were	5%,	2nd	label	origins	and	1st	label	terminations	were	9%	and	8%	respectively,		
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Figure	 4.8:	 Cells	 Depleted	 of	 TAB182	 Display	 Excessive	 New	Origin	 Firing	 and	 Increased	
Fork	Restart	following	Release	from	HU.	HeLa	cells	were	transfected	with	control	or	TAB182	
siRNA.	 48	 hours	 post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	 minutes,	
followed	 by	 mock-treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours.	 Following	 HU	
treatment,	cells	were	incubated	with	HU-free	media	containing	IdU	for	45	minutes.	DNA	was	
spread	onto	 slides,	probed	with	 the	appropriate	antibodies	and	visualised	by	 fluorescence	
microscopy.	 (A)	 Diagram	 illustrates	 the	 various	 types	 of	 replication	 structures	 scored.	 (B)	
Graph	shows	the	fibre	structures	as	a	percentage	of	all	CldU	labelled	structures.	Error	bars	
represent	SEM.	These	data	are	representative	of	three	independent	experiments.		
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and	2nd	label	terminations	were	4%	(Figure	4.8B).	These	data	suggest	that	the	knockdown	of	
TAB182	 has	 no	 effect	 on	 DNA	 replication	 in	 the	 absence	 of	 replicative	 stress.	 In	 TAB182	
depleted	 cells	 treated	 with	 HU,	 the	 percentage	 of	 ongoing	 forks	 decreased	 from	 79%	 in	
undamaged	 cells	 to	 only	 74%,	 which	 was	 not	 comparable	 to	 control	 cells	 where	 the	
reduction	was	more	significant	(78%	to	63%).	The	percentage	of	1st	 label	origins	in	TAB182	
deficient	 cells	 was	 5%	 and	 was	 similar	 to	 control	 HU	 exposed	 cells.	 Interestingly,	 the	
percentage	of	2nd	label	origins	following	HU	treatment	in	TAB182	deficient	cells	increased	to	
20%,	 in	contrast	 to	control	cells	 in	which	 it	was	3%,	suggesting	that	TAB182	deficient	cells	
excessively	 fire	 new	 origins.	 Furthermore,	 TAB182	 defective	 cells	 displayed	 no	 significant	
increase	 in	the	percentage	of	1st	 label	terminations	following	HU	(11%	in	TAB182	depleted	
cells	 vs	 27%	 in	 control	 cells),	 suggesting	 that	 these	 cells	 may	 be	 defective	 at	 fork	
stalling/collapse	in	response	to	HU,	the	reason	for	this	being	currently	unknown.	Finally,	the	
percentage	of	2nd	label	terminations	observed	in	TAB182	deficient	cells	was	3%,	which	was	
comparable	to	the	percentage	of	2nd	label	terminations	observed	in	control	cells	(Figure	4.8).	
Taken	 together,	 these	 results	 demonstrate	 that	 TAB182	 depleted	 cells	 exhibit	
excessive	 new	 origin	 firing	 as	 well	 as	 increased	 fork	 recovery	 following	 release	 from	 HU,	
suggesting	 that	 TAB182	 suppresses	 new	 origin	 firing	 and	 prevents	 fork	 restart	 following	
replication	stress.		
	
4.2.9	DNA	Fibre	Structures	in	TAB182	Deficient	Cells	following	Replication	Stress	in	the	
Absence	of	Chk1	and	ATR	
Since	 TAB182	 deficient	 cells	 exhibit	 irregularities	 during	 DNA	 replication	 in	 the	
presence	of	replication	stress,	the	next	aim	was	to	understand	how	these	defects	occurred.	
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As	 there	had	already	been	an	 indication	 that	 they	may	be	attributed	to	defects	 in	 the	cell	
cycle	checkpoint	regulation,	DNA	fibre	analysis	was	performed	as	before,	but	 this	 time	we	
also	made	use	of	the	checkpoint	Chk1	and	ATR	inhibitors.		
To	this	end,	HeLa	cells	were	transfected	with	either	control	or	TAB182	siRNA	and	48	
hours	 later,	 were	 incubated	 in	 media	 containing	 CldU	 and	 subsequently	 mock-treated	 or	
treated	with	HU	or	both	HU	and	1μM	Chk1	inhibitor	for	2	hours.	Following	HU	or	both	HU	
and	Chk1	inhibitor	treatment,	the	cells	were	then	incubated	with	HU-free	media	containing	
IdU.	After	 this	 incubation	the	cells	were	then	 fixed,	spread	onto	slides	and	 incubated	with	
antibodies	against	CldU	and	IdU.	DNA	was	viewed	under	the	microscope	and	DNA	structures	
observed	recorded	(Figures	4.9	and	4.10).	Confirmation	of	TAB182	knockdown	was	achieved	
by	Western	blotting	(data	not	shown).	
Since	we	were	mainly	 interested	 in	 ‘2nd	 label	origins’	and	 ‘1st	 label	 terminations’	at	
this	stage	none	of	the	other	structures	will	be	referred	to	in	this	section	(see	Figure	4.9	for	
more	detailed	results).	 In	undamaged	control	cells,	as	previously	observed,	the	percentage	
of	2nd	label	origins	decreased	following	HU	treatment	from	11%	to	3%	due	to	the	activation	
of	the	S	phase	checkpoint	that	suppresses	new	origin	firing	(Maya-Mendoza,	Petermann	et	
al.	 2007,	 Petermann,	Woodcock	 et	 al.	 2010).	 In	 the	 same	 cells	 treated	with	 both	HU	 and	
Chk1	 inhibitor,	 the	percentage	of	2nd	 label	origins	 increased	from	3%	to	41%,	as	expected,	
since	Chk1	activation,	known	to	suppress	new	origin	firing,	was	inhibited.	The	percentage	of	
1st	label	terminations	in	control	cells	increased	with	HU	treatment	from	approximately	9%	to	
31%	 and	 up	 to	 55%	 when	 the	 cells	 were	 also	 incubated	 with	 the	 Chk1	 inhibitor.	 This	
suggested	that	Chk1	inhibition	following	HU	treatment	compromises	replication	fork	restart		
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Figure	4.9:	DNA	Fibre	Structures	 in	TAB182	Deficient	Cells	 following	Replication	Stress	 in	
the	Absence	of	Chk1.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA.	48	hours	
post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	 minutes,	 followed	 by	 mock-
treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours	 together	 with	 1μM	 of	 Chk1	 inhibitor.	
Following	HU	 treatment,	 the	 cells	were	 incubated	 in	HU-free	media	 containing	 IdU	 for	 45	
minutes.	 DNA	 was	 spread	 onto	 slides	 and	 staining	 processed	 as	 in	 Figure	 4.8.	 The	 graph	
shows	 the	DNA	 fibre	 structures	 as	a	 percentage	 of	 all	 CldU	 labelled	 structures.	 Error	bars	
represent	SEM.	These	data	are	representative	of	three	independent	experiments.		
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in	 control	 cells	 in	 agreement	with	 previous	 reports	 (Figure	 4.9)	 (Feijoo,	Hall-Jackson	 et	 al.	
2001,	Petermann,	Orta	et	al.	2010).					
Similarly	to	the	previous	results	obtained	in	Section	4.2.8,	the	percentage	of	2nd	label	
origins	in	TAB182	deficient	cells	was	higher	than	that	in	control	cells	following	HU	treatment	
(3%	 in	 control	 vs	 28%	 in	 TAB182	 deficient	 cells).	 Furthermore,	 inhibition	 of	 Chk1	 during	
exposure	to	HU	led	to	a	further	increase	in	the	percentage	of	2nd	label	origins	in	both	control	
and	 TAB182	 deficient	 cells,	 but	 more	 importantly,	 the	 difference	 was	 marginal	 (40%	 in	
control	cells	vs	50%	in	TAB182	depleted	cells).	This	suggested	that	1)	inhibiting	Chk1	activity	
attenuated	 the	 difference	 observed	 in	 new	 origin	 firing	 between	 control	 and	 TAB182	
deficient	cells	following	release	from	HU	and	2)	that	Chk1	is	important	for	suppressing	new	
origin	firing	in	response	to	HU	in	both	control	and	TAB182	depleted	cells	(Figure	4.9).					
	 Addition	of	the	Chk1	inhibitor	during	HU	treatment	 led	to	a	marked	increase	in	the	
percentage	 of	 1st	 label	 terminations	 in	 control	 cells	 compared	 to	 those	 treated	 with	 HU	
alone	 (31%	 to	 approximately	 55%).	 Strikingly,	 the	 percentage	 of	 1st	 label	 terminations	 in	
TAB182	deficient	cells	treated	with	both	HU	and	Chk1	inhibitor	was	no	different	than	those	
treated	with	HU	alone	(from	20%	to	15%,	respectively).	Thus,	 inhibition	of	Chk1	in	TAB182	
depleted	cells	had	neither	any	significant	effect	on	1st	label	terminations	nor	any	impact	on	
the	 ability	 of	 these	 cells	 to	 promote	 replication	 fork	 restart.	 This	 suggests	 that	 TAB182	 is	
required	 for	 fork	 stalling/collapse	 following	 release	 from	 fork	 blocking	 and	 prevents	
replication	fork	restart	even	in	the	absence	of	Chk1	activity	(Figure	4.9).		
To	examine	the	effects	of	ATR	 inhibition	on	TAB182	deficient	cells,	HeLa	cells	were	
treated	with	 either	 control	 or	 TAB182	 siRNA	 and	 48	 hours	 later,	mock-treated	 or	 treated	
with	 HU	 or	 HU	 and	 5μM	 ATR	 inhibitor.	 	 Following	 HU	 or	 both	 HU	 and	 ATR	 inhibitor	
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treatment,	 the	 cells	were	 incubated	with	 HU-free	media	 containing	 IdU.	 Cells	were	 fixed,	
spread	 onto	 slides	 and	 incubated	with	 antibodies	 against	 CldU	 and	 IdU.	 DNA	was	 viewed	
under	the	microscope	and	DNA	structures	observed	recorded	(Figure	4.10).		
Since,	in	this	experiment,	we	are	mainly	interested	in	‘2nd	label	origins’	and	‘1st	label	
terminations’	at	this	stage	none	of	the	other	structures	will	be	referred	to	in	this	section	(see	
Figure	4.10	 for	more	detailed	 results).	As	previously	observed,	 the	percentage	of	2nd	 label	
origins	in	control	cells	decreased	following	HU	treatment.	Treatment	with	both	HU	and	ATR	
inhibitor	led	to	an	increase	in	2nd	label	origins	compared	to	those	exposed	to	HU	alone	from	
3%	to	46%	as	expected	since	ATR	 is	known	to	suppress	new	origin	firing	via	Chk1	(Tercero	
and	Diffley	2001,	Heffernan,	Unsal-Kacmaz	et	al.	2007).	Regarding	the	percentage	of	1st	label	
terminations	in	control	cells,	HU	treatment	led	to	an	increase	from	9%	to	31%	with	a	further	
increase	in	the	percentage	of	fork	stalling	to	up	to	49%	upon	ATR	inhibition	as	ATR	is	known	
to	stabilise	replication	forks	(see	Section	1.2.4.2.2)(Figure	4.10).		
We	 previously	 observed	 that	 the	 percentage	 of	 2nd	 label	 origins	 increased	 following	 HU	
treatment	in	TAB182	deficient	cells	compared	to	control	cells	following	release	from	HU	(3%	
in	control	cells	vs	28%	in	TAB182	depleted	cells).	Notably,	control	and	TAB182	depleted	cells	
exposed	 to	 both	 HU	 and	 ATR	 inhibitor	 displayed	 a	 similar	 percentage	 of	 2nd	 label	 origins	
(46%	and	47%,	respectively).	Similarly	to	Chk1,	ATR	inhibition	in	response	to	HU	treatment	
completely	abrogated	the	difference	between	the	two	cell	lines	by	increasing	the	percentage	
of	new	origin	 firing	 to	approximately	45%	 in	both	cell	 lines.	This	was	also	 the	case	 for	 the	
decreased	amount	of	1st	label	terminations	observed	in	TAB182	deficient	cells	in	response	to	
HU	(15%)	compared	to	control	cells	(12%)	as	addition	of	the	ATR	inhibitor	resulted	in	an		
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Figure	4.10:	DNA	Fibre	Structures	in	TAB182	Deficient	Cells	following	Replication	Stress	in	
the	 Absence	 of	 ATR.	HeLa	cells	were	 transfected	with	 control	 or	 TAB182	 siRNA.	48	hours	
post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	minutes,	 followed	 by	 mock-
treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours	 together	 with	 5μM	 of	 ATR	 inhibitor.	
Following	HU	 treatment,	 the	 cells	were	 incubated	 in	HU-free	media	 containing	 IdU	 for	 45	
minutes.	 DNA	 was	 spread	 onto	 slides	 and	 staining	 processed	 as	 in	 Figure	 4.8.	 The	 graph	
shows	 the	DNA	 fibre	 structures	 as	a	 percentage	 of	all	 CldU	 labelled	 structures.	 Error	 bars	
represent	SEM.	These	data	are	representative	of	three	independent	experiments.		
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increase	 in	replication	fork	stalling/collapse	of	approximately	50%	 in	both	cell	 lines	 (Figure	
4.10).		
Taken	 together,	 these	 results	 show	 that	 Chk1	 and	 ATR	 activity	 is	 important	 for	
suppressing	new	origin	firing	in	both	control	and	TAB182	defective	cells.	In	addition,	TAB182	
is	 important	 for	 fork	 stalling/collapse	 even	 in	 the	 absence	 of	 Chk1	 activity	 but	 not	 upon	
inhibition	of	ATR.			
4.2.10	DNA	Fibre	Structures	in	TAB182	Deficient	Cells	following	Replication	Stress	in	the	
Absence	of	CDK	
Based	on	 the	DNA	 fibre	 data	 from	Figure	 4.8,	we	wondered	whether	 the	 elevated	
new	 origin	 firing	 observed	 in	 TAB182	 deficient	 cells	 compared	 to	 control	 cells	 following	
release	 from	HU	(20%	vs	3%),	was	occurring	 in	order	 to	rescue	DNA	replication	 in	TAB182	
depleted	cells	in	response	to	replication	stress.	For	this	reason	the	same	experiments	were	
performed	but	this	time	 in	the	presence	of	a	CDK	1/2	 inhibitor	that	suppresses	new	origin	
firing.	HeLa	cells	were	treated	with	control	or	TAB182	siRNA	and	48	hours	later,	stained	with	
CldU	 and	mock-treated	 or	 treated	 with	 HU	 or	 treated	 with	 both	 HU	 and	 25μM	 CDK	 1/2	
inhibitor	 III.	 The	 cells	were	 then	 incubated	with	HU-free	media	 containing	 IdU,	harvested,	
fixed,	spread	onto	slides	and	incubated	with	antibodies	against	CldU	and	IdU	(Figure	4.11).	
Confirmation	of	TAB182	knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
We	focused	on	‘2nd	label	origins’	and	‘1st	label	terminations’	(see	Figure	4.11	for	more	
detailed	results).	As	before,	control	cells	exhibited	a	decrease	in	the	percentage	of	2nd	label	
origins	 following	 exposure	 to	 HU	 when	 compared	 to	 mock-treated	 cells	 (10%	 to	 2%).	
Incubation	 of	 these	 cells	 with	 the	 CDK	 inhibitor	 during	 HU	 treatment	 led	 to	 a	 further	 a	
decrease	in	the	percentage	of	2nd	label	origins	by	1%	since	CDKs	are	required	for	new	origin	
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firing	(Petermann,	Woodcock	et	al.	2010).	In	TAB182	deficient	cells,	HU	treatment	led	to	an	
increase	 in	2nd	 label	origins	 from	2%	to	21%	but	 this	was	completely	suppressed	 following	
incubation	with	 the	 CDK	 inhibitor	 that	 led	 to	 a	marked	 reduction	 down	 to	 control	 levels.	
Thus,	 inhibition	of	 CDK	during	 replication	 stress	 almost	 completely	 suppressed	new	origin	
firing	 in	 both	 control	 and	 TAB182	 depleted	 cells	 as	 expected.	 This	 showed	 that	 CDK	
inhibition	 is	able	to	suppress	excessive	new	origin	firing	observed	 in	TAB182	deficient	cells	
following	release	from	HU	and	that	the	defect	 in	new	origin	firing	suppression	is	therefore	
dependent	on	CDK	function.		
The	 1st	 label	 termination	 percentage	 in	 untreated	 control	 cells	 was	 11%	 and	
increased	to	34%	following	HU	treatment	and	remained	unaltered	following	CDK	inhibition	
(Figure	4.11).	 This	was	not	unexpected	 since	CDK	 inhibition	has	no	documented	effect	 on	
replication	restart	(Petermann,	Orta	et	al.	2010).	More	importantly,	since	the	percentage	of	
1st	 label	 terminations	 in	TAB182	deficient	cells	exposed	 to	both	HU	and	CDK	 inhibitor	was	
comparable	to	TAB182	deficient	cells	treated	with	HU	alone	(15%),	it	can	be	concluded	that	
the	 defect	 in	 terminations	 observed	 in	 TAB182	 deficient	 cells	 is	 not	 dependent	 on	 CDK	
function	(Figure	4.11).		
Taken	together,	these	data	show	that	the	excessive	new	origin	firing	defect	observed	
in	TAB182	deficient	cells	is	dependent	on	CDK	function	but	that	the	elevated	fork	recovery	in	
TAB182	depleted	cells	is	not	due	to	increased	new	origin	firing.		
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Figure	4.11:	DNA	Fibre	Structures	in	TAB182	Deficient	Cells	following	Replication	Stress	in	
the	 Absence	 of	 CDK.	HeLa	cells	were	 transfected	with	 control	or	TAB182	 siRNA.	48	hours	
post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	minutes,	 followed	 by	 mock-
treatment	or	treatment	with	2mM	HU	for	2	hours	together	with	25μM	of	CDK	1/2	inhibitor	
III.	Following	HU	treatment,	the	cells	were	incubated	in	HU-free	media	containing	IdU	for	45	
minutes.	 DNA	 was	 spread	 onto	 slides	 and	 staining	 processed	 as	 in	 Figure	 4.8.	 The	 graph	
shows	 the	 fibre	 structures	 as	 a	 percentage	 of	 all	 CldU	 labelled	 structures.	 Error	 bars	
represent	SEM.	These	data	are	representative	of	three	independent	experiments.		
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4.2.11	The	C-Terminal	Fragment	of	TAB182	Interacts	with	Tankyrase	1,	Chk1	and	Aurora	
Kinase	in	Vitro.		
To	gain	further	insight	into	the	role	of	TAB182,	a	series	of	GST	pull-down	assays	were	
performed	with	a	panel	of	DDR	and	cell	 cycle	proteins	using	antibodies	 that	were	already	
available	in	the	lab.	HeLa	cell	lysates	were	incubated	with	a	C-terminal	fragment	of	TAB182	
tagged	to	GST	(referred	to	as	GST-TAB182C),	spanning	amino	acids	824-867	fused	to	amino	
acids	1221-1729	of	TAB182	 (Figure	1.16)	 (Seimiya	and	Smith	2002).	 	Cell	 lysates	were	also	
incubated	with	GST	alone	as	a	non-specific	binding	control,	and	cell	lysate	alone	was	run	as	a	
positive	 control.	 Protein	 complexes	 were	 captured	 using	 glutathione-agarose	 beads,	
subjected	to	SDS-PAGE	and	Western	blotting	(Figure	4.12).	Protein	complexes	isolated	using	
HeLa	cell	 lysates	were	 immunoblotted	with	a	panel	of	antibodies	 involved	 in	 the	DDR	and	
cell	 cycle	 control.	 The	 analysis	 showed	 that	 the	 C-terminal	 fragment	 of	 TAB182	 interacts	
with	Tankyrase	1,	Chk1	and	Aurora	kinase	in	vitro	(Figure	4.12).	Table	4.1	shows	the	proteins	
that	were	found	to	not	be	associated	with	TAB182C	in	vitro.		
	
4.2.12	TAB182	does	not	Localise	to	DNA	Damage	Foci	following	HU	or	IR	Exposure	
It	 is	 well	 established	 that	 DNA	 damage	 can	 be	 indirectly	 observed	 through	 the	
detection	 of	 the	 accumulation	 of	 proteins	 at	 regions	 of	 DNA	 damage	which	 form	 distinct	
sites	 known	 as	 foci.	 To	 determine	 whether	 TAB182	 is	 relocalised	 to	 DNA	 damage	 foci	
following	 DNA	 damage,	 immunofluorescence	 analysis	 was	 performed.	 A	 TAB182	 DNA	
construct	 (eGFPC3-TAB182)	 was	 made	 by	 performing	 a	 PCR	 reaction	 from	 cDNA	
encompassing	the	genomic	sequence	of	TAB182	(Section	2.5.6).	The	PCR	product	was	ligated	
into	a	construct	containing	GFP.	eGFPC3-TAB182	was	transfected,	along	with	an	empty		
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Figure	4.12:	The	C-Terminal	Fragment	of	TAB182	Interacts	with	Tankyrase	1,	Chk1	and	
Aurora	Kinase	 in	Vitro.	HeLa	and	U20S	cell	 lysates	were	incubated	with	GST-TAB182C,	
together	 with	 GST	 alone	 (non-specific	 binding	 control)	 or	 cell	 lysate	 alone	 (positive	
control).	Protein	complexes	were	captured	by	glutathione-agarose	beads,	subjected	to	
SDS-PAGE	and	Western	blotting	with	antibodies	against	(A)	Tankyrase	1	(B)	Chk1	and	(C)	
Aurora	kinase.	These	Western	blots	are	representative	of	three	independent	repeats.	
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Table	 4.1:	 GST-TAB182C	 Non-Interacting	 Proteins.	 Table	 to	
illustrate	the	proteins	that	do	not	interact	with	the	C-terminal	
part	 of	 TAB182	 following	 GST	 pull-down	 assays	 using	 GST-
TAB182C.		
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eGFPC3	construct	as	a	negative	control,	into	HeLa	cells	and	left	for	48	hours.	48	hours	post-
transfection,	 the	 cells	 were	 exposed	 to	 2mM	 HU	 (left-in	 throughout	 the	 course	 of	 the	
experiment)	or	3	Gy	of	 IR.	2	hours	post-exposure,	the	cells	were	then	fixed,	permeabilised	
and	probed	with	antibodies	against	γH2AX	(Figure	4.13).			
Mock-exposed,	 GFP-TAB182	 transfected	 cells	 exhibited	 a	 pan-cellular	 staining	
pattern	 that	 appeared	 to	 be	 concentrated	 around	 the	 nucleus.	 	 It	 can	 be	 seen	 from	 the	
γH2AX	staining	that	DNA	damage	foci	are	formed	in	both	HU	and	IR	exposed	cells.	Following	
exposure	to	either	IR	or	HU,	the	staining	pattern	of	GFP-TAB182	did	not	change,	suggesting	
that	 TAB182	 does	 not	 localise	 to	DNA	damage	 foci	 following	DNA	damage	 at	 least	 at	 the	
time-points	examined	(Figure	4.13).			
	
4.2.13	γH2AX	and	53BP1	Foci	after	HU	Exposure	are	Reduced	in	TAB182	Knockdown	Cells	
Since	TAB182	depleted	cells	displayed	elevated	levels	of	replication	fork	recovery,	we	
wanted	to	monitor	the	levels	of	DNA	damage	as	these	cells	were	released	from	a	two	hour	
HU	exposure,	a	treatment	that	was	also	employed	during	our	fibre	analysis.	HeLa	cells	were	
treated	with	control	or	TAB182	siRNA	and	48	hours	later	either	mock-exposed	or	exposed	to	
2mM	HU	for	two	hours.	Cells	were	fixed	and	extracted	at	0,	the	point	of	HU	removal,	1,	2,	4	
and	24	hours	post-HU	release.	Fixed	cells	were	then	probed	with	antibodies	against	γH2AX	
to	monitor	the	formation	of	DNA	damage	and	53BP1	that	represents	sites	of	DNA	DSBs.	Cells	
were	 analysed	 by	 fluorescence	 microscopy,	 γH2AX	 and	 53BP1	 foci	 positive	 cells	 were	
counted	 and	 are	 denoted	 as	 those	 that	 had	 more	 than	 7	 foci	 per	 cell	 (Figure	 4.14).	
Confirmation	of	TAB182	knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
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Figure	4.13:	TAB182	does	not	Localise	to	DNA	Damage	Foci	following	HU	Treatment	or	IR	
Exposure.	 HeLa	 cells	 were	 transfected	 with	 eGFPC3-TAB182	 and	 48	 hours	 later,	 mock-
exposed	 or	 exposed	 to	 2mM	 HU	 (left-in	 throughout	 the	 duration	 of	 the	 experiment)	 or	
irradiated	at	3	Gy	IR.	2	hours	post-treatment	the	cells	were	then	fixed,	permeabilised	and	
probed	 with	 antibodies	 against	 γH2AX.	 These	 immunofluorescence	 images	 are	
representative	of	three	independent	experiments.		
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In	 the	absence	of	any	DNA	damage,	 there	was	a	basal	 level	of	γH2AX	 foci	positive	control	
cells	 (approximately	 12%).	 Following	2	hours	 incubation	with	2mM	HU,	 the	percentage	of	
γH2AX	foci	positive	cells	increased	to	approximately	20%,	this	is	indicative	of	the	initiation	of	
formation	of	DNA	damage	following	the	addition	of	HU.	1	hour	after	release	from	HU,	the	
percentage	 of	 γH2AX	 foci	 positive	 cells	 was	 approximately	 49%,	 representing	 the	 highest	
percentage	of	 γH2AX	 foci	 positive	 cells	 throughout	 the	 course	 of	 the	 experiment.	 2	 to	 24	
hours	 post-release	 from	 HU,	 the	 percentage	 of	 γH2AX	 foci	 positive	 cells	 was	 reduced	 to	
around	21	to	30%,	indicating	that	there	was	dissolution	of	γH2AX	foci	and	possibly	clearance	
of	DNA	damage.	Upon	TAB182	depletion,	the	basal	 levels	of	γH2AX	foci	positive	cells	were	
similar	 to	 control	 siRNA	 treated	 cells	 (approximately	 10%).	 The	 percentage	 of	 γH2AX	 foci	
positive	cells	at	 the	point	of	HU	removal	 in	 the	absence	of	TAB182	was	also	equivalent	 to	
control	 siRNA	 treated	 cells	 (approximately	 20%).	 This	 was	 not	 the	 case	 1	 hour	 post-HU	
release	where	only	14%	of	TAB182	depleted	cells	displayed	γH2AX	foci	when	compared	to	
50%	of	control	cells.	This	reduction	in	the	percentage	of	cells	with	γH2AX	positive	foci	was	
evident	 in	 all	 the	 other	 time-points	 examined	 (Figure	 4.14A).	 This	 suggested	 that	 there	 is	
either	less	DNA	damage/faster	clearance	of	damage	or	fork	recovery	following	release	from	
HU	 in	 TAB182	 deficient	 cells	 in	 agreement	 with	 the	 observation	 that	 there	 is	 less	 fork	
stalling,	 or	 that	 the	 phosphorylation/dephosphorylation	 equilibrium	 of	 γH2AX	 in	 TAB182	
defective	cells	is	compromised	(Figure	4.14A).		
To	ascertain	whether	there	is	less	DNA	damage	in	the	form	of	DSBs	in	TAB182	cells,	
we	 also	 examined	 the	 levels	 of	 53BP1	 foci	 positive	 cells.	 The	 percentage	 of	 cells	 with	
constitutive	53BP1	positive	 foci	was	approximately	3%	but	 following	2	hours	 incubation	of	
2mM	HU	treatment,	the	percentage	of	cells	with	53BP1	positive	foci	increased	to	20%,		
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Figure	4.14:	γH2AX	and	53BP1	Foci	after	HU	Exposure	are	Reduced	 in	TAB182	Knockdown	
Cells.	HeLa	cells	were	treated	with	control	or	TAB182	siRNA	and	48	hours	later,	were	mock-
exposed	or	exposed	to	2mM	HU	for	2	hours.	The	cells	were	then	fixed	and	permeabilised	at	0,	
point	 of	 release,	 1,	 2,	 4	 and	 24	 hours	 post-HU	 treatment.	 Fixed	 cells	 were	 probed	 with	
antibodies	 against	 ΥH2AX	 or	 53BP1.	 Cells	 were	 analysed	 by	 fluorescence	 microscopy	 and	
ΥH2AX+	or	53BP1+	cells	scored	as	those	having	more	than	7	foci	per	cell.	(A)	Graph	shows	the	
percentage	of	cells	with	γH2AX+	foci	across	various	time-points	after	2mM	HU	exposure.	(B)	
Graph	depicts	the	percentage	of	 cells	with	53BP1+	foci	 across	various	time-points	 following	
2mM	 HU	 exposure.	 Error	 bars	 represent	 SEM.	 These	 data	 are	 representative	 of	 three	
independent	experiments.					
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representing	induction	of	DNA	breaks	and/or	collapsed	forks.	1	hour	after	release	from	HU	
the	percentage	of	 cells	with	53BP1	positive	 foci	was	 approximately	24%,	 representing	 the	
maximal	 percentage	 of	 53BP1	 positive	 cells	 throughout	 the	 course	 of	 the	 experiment.	 At	
later	 time-points	 the	 levels	 of	 53BP1	positive	 cells	 reduced	 suggesting	 that	 the	DNA	DSBs	
were	 resolved/repaired.	 In	 TAB182	 depleted	 cells	 the	 percentage	 of	 cells	 displaying	
constitutive	53BP1	positive	foci	was	equivalent	to	control	cells.	At	the	point	of	HU	removal,	
the	 percentage	 of	 cells	 with	 53BP1	 positive	 foci	 was	 approximately	 17%	 and	 slightly	
decreased	 compared	 to	 control	 cells	 (20%).	 Strikingly,	 1	 hour	 after	 HU	 release	 the	
percentage	of	TAB182	depleted	cells	with	53BP1	positive	foci	was	approximately	8%,	which	
was	 significantly	 lower	 than	 the	 percentage	 of	 control	 cells	 with	 53BP1	 positive	 foci	
(approximately	 24%).	 The	 levels	 of	 53BP1	 foci	 remained	 relatively	 constant	 thereafter	 but	
were	 always	 reduced	 compared	 to	 control	 cells.	 These	 data	 suggest	 that	 DNA	 DSBs	 or	
collapsed	forks	marked	by	53BP1	formed	with	HU	treatment	are	resolved	faster	 in	TAB182	
depleted	 cells	 in	 agreement	 with	 the	 reduction	 in	 1st	 label	 terminations	 we	 previously	
observed	compared	to	control	cells	in	our	fibre	analysis	(Figure	4.14B).		
	
4.2.14	TAB182	Depleted	Cells	Exhibit	Elevated	Levels	of	53BP1	Bodies	in	G1	following	
Release	from	HU	
Unresolved	 replication	 intermediates	 or	 under-replicated	 DNA	 transmitted	 to	
daughter	 cells	 in	 G1	 phase,	 is	 sequestered	 in	 nuclear	 compartments	 that	 are	 marked	 by	
53BP1	 (Harrigan,	 Belotserkovskaya	 et	 al.	 2011,	 Lukas,	 Savic	 et	 al.	 2011).	 These	 53BP1	
positive	 bodies	 protect	 chromosomal	 fragile	 sites	 in	 these	 compartments	 against	 erosion.	
Despite	the	faster	replication	fork	recovery	upon	release	from	HU	blocking,	TAB182	deficient	
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cells	are	sensitive	to	replication	stress,	and	so	we	wondered	whether	there	is	more	under-
replicated	DNA	in	these	cells	transmitted	into	the	ensuing	G1	phase	than	in	control	cells.	For	
this	 reason,	 we	 quantified	 the	 percentage	 of	 G1	 cells	 with	 53BP1	 bodies	 as	 well	 as	 the	
number	of	53BP1	bodies	following	exposure	of	cells	to	HU.	HeLa	cells	were	transfected	with	
control	or	TAB182	siRNA	and	48	hours	later	were	mock-exposed	or	exposed	to	2mM	HU	for	
2	hours.	Cells	were	fixed,	permeabilised	and	stained	with	antibodies	against	Cyclin	A	(Cyclin	
A	negative	cells	were	scored	as	G1	cells)	and	53BP1	at	4	and	24	hours	post-HU	release.	Cells	
were	visualised	by	fluorescence	microscopy	and	G1	cells	(Cyclin	A	negative)	were	scored	into	
the	 following	 categories;	 1-2	 53BP1	 bodies	 per	 cell,	 3-4	 53BP1	 bodies	 per	 cell,	 5-6	 53BP1	
bodies	 per	 cell,	 7-8	 53BP1	 bodies	 per	 cell	 or	 9+	 53BP1	 bodies	 per	 cell	 (Figure	 4.15).	
Confirmation	of	TAB182	knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
In	 the	 HeLa	 cells	 that	 were	 utilised	 for	 this	 experiment,	 there	 was	 a	 high	 level	 of	
background	53BP1	bodies	in	G1	in	both	control	and	TAB182	depleted,	untreated	cells	(Figure	
4.15A).	 4	 hours	 post-HU	 release	 there	was	 a	mild	 induction	 of	 1-2	 53BP1	 bodies	 in	 both	
control	 cells	and	TAB182	depleted	cells.	24	hours	 following	 release	 from	HU	there	was	an	
increase	 in	 the	 percentage	 of	 cells	 containing	 1-2	 53BP1	 bodies	 that	 were	 deficient	 in	
TAB182	compared	to	controls	(37%	of	TAB182	knockdown	cells	vs	27%	of	control	cells).	This	
suggested	that	after	release	from	replication	blocking	with	HU,	 in	particular	24	hours	after	
release,	there	 is	an	 increase	 in	the	 levels	of	under-replicated	DNA	or	regions	of	replication	
stress	in	TAB182	cells	(Figure	4.15).	
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Figure	 4.15:	 TAB182	 Depleted	 Cells	 Exhibit	 Elevated	 Levels	 of	 53BP1	 Bodies	 in	 G1	
following	Release	 from	HU.	HeLa	cells	were	treated	with	control	or	TAB182	siRNA	and	48	
hrs	 later,	were	mock-exposed	 (A)	or	exposed	 to	 2mM	HU	 for	 2	 hrs.	Cells	were	 fixed	 and	
permeabilised	 at	 4	 (B)	 and	 24	 hrs	 (C)	 post-HU	 treatment.	 Fixed	 cells	 were	 probed	 with	
antibodies	against	Cyclin	A	and	53BP1.	The	cells	were	analysed	by	fluorescence	microscopy	
and	the	number	of	53BP1	bodies	in	G1	counted.	Graphs	illustrate	the	percentage	of	G1	cells	
with	 53BP1+	 bodies	 across	 various	 time-points	 following	 2mM	HU	 treatment.	 Error	 bars	
represent	SEM.	These	data	are	representative	of	three	independent	experiments.					
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4.2.15	TAB182	Depleted	Cells	Exhibit	Increased	Micronuclei	after	HU	Treatment	
Micronuclei	are	parts	of,	or	whole,	chromosomes	that	have	been	separated	from	the	
nucleus	during	mitosis	and	are	markers	of	genome	instability.	To	determine	whether	TAB182	
deficient	 cells	are	genetically	unstable,	micronuclei	analysis	of	TAB182	depleted	cells	after	
HU	treatment	was	performed.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA	and	
48	hours	later,	either	exposed	or	mock-exposed	to	2mM	HU	for	2	hours.	The	cells	were	then	
fixed,	permeabilised	and	stained	with	DAPI.	Cells	with	no	micronuclei,	1	micronucleus,	2-5	
micronuclei	or	5+	micronuclei	associated	with	each	cell	were	quantified.	Mitotic	catastrophe	
and	 anaphase	 bridging	 were	 also	 determined	 (Figure	 4.16).	 Confirmation	 of	 TAB182	
knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
Prior	to	HU	exposure,	less	than	1%	of	control	cells	had	any	associated	micronuclei	as	
expected	(data	not	shown).	Similarly,	the	percentage	of	cells	with	micronuclei	in	undamaged	
TAB182	deficient	cells	was	also	less	than	1%.	48	hours	following	release	from	HU	treatment	
2.2%	 of	 cells	 had	 1	 micronucleus,	 0.4%	 of	 cells	 had	 2-5	 micronuclei,	 no	 cells	 had	 5+	
micronuclei	 and	 0.2%	 of	 cells	 exhibited	 mitotic	 catastrophe	 but	 there	 were	 no	 observed	
anaphase	 bridges.	 In	 TAB182	 depleted	 cells	 48	 hours	 after	 HU	 release,	 the	 percentage	 of	
cells	 with	 micronuclei	 was	 slightly	 higher	 than	 that	 of	 control	 cells;	 4.9%	 of	 cells	 had	 1	
micronucleus,	 1.0%	 of	 cells	 had	 2-5	micronuclei	 and	 0.3%	 of	 cells	 had	 5+	micronuclei.	 In	
addition,	 0.7%	 of	 cells	 exhibited	mitotic	 catastrophes	 and	 0.1%	 of	 cells	 showed	 anaphase	
bridging.	 These	 data	 show	 that	 cells	 depleted	 of	 TAB182	 have	 an	 increased	 number	 of	
associated	micronuclei	following	treatment	with	HU,	a	marker	of	genomic	instability	(Figure	
4.16).		
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Figure	4.16:	TAB182	Depleted	Cells	Exhibit	 Increased	Micronuclei	after	HU	Exposure.	HeLa	
cells	were	transfected	with	control	or	TAB182	siRNA	and	48	hours	later,	were	mock-exposed	
or	exposed	to	2mM	HU	for	2	hours.	After	removal	of	HU,	the	cells	were	further	incubated	for	
48	hours	before	being	fixed,	permeabilised	and	stained	with	DAPI.	The	cells	were	analysed	by	
fluorescence	microscopy	and	scored	into	various	categories	(see	above).	Error	bars	represent	
SEM.	These	data	are	representative	of	three	independent	experiments.		
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4.2.16	TAB182	Deficient	Cells	Display	Less	DNA	Gaps/Breaks	following	Exposure	to	HU	
Since	TAB182	deficient	 cells	 displayed	elevated	numbers	of	micronuclei	 and	53BP1	
bodies	 in	 response	 to	 replication	stress,	metaphase	spread	analysis	was	also	performed	 in	
order	 to	 analyse	 chromosomal	 damage	 of	 metaphase	 chromosomes.	 HeLa	 cells	 were	
transfected	with	control	or	TAB182	siRNA	and	48	hours	later	were	either	mock-exposed	or	
incubated	 in	media	 containing	 2mM	HU	 for	 2	 hours.	 48	 hours	 after	 HU	 release,	 the	 cells	
were	treated	with	colcemid	to	block	cells	in	mitosis.	The	cells	were	then	fixed	and	dropped	
onto	slides,	 followed	by	Giemsa	staining	 to	allow	visualisation	of	 chromosomal	damage	of	
metaphase	chromosomes.	The	total	number	of	chromatid	gaps/breaks	was	scored	in	a	total	
of	50	metaphase	spreads	in	both	control	and	TAB182	depleted	cells.	Confirmation	of	TAB182	
knockdown	was	 achieved	 by	Western	 blotting	 (data	 not	 shown).	 In	 control	 siRNA	 treated	
cells,	 the	 total	 number	 of	 chromatid	 gaps/breaks	was	 0.67	 per	metaphase,	 in	 contrast	 to	
TAB182	 deficient	 cells	 where	 the	 total	 number	 of	 chromatid	 gaps/breaks	 following	 HU	
treatment	was	 0.32	 per	metaphase	 (Figure	 4.17).	 These	 data	 show	 that	 TAB182	 depleted	
cells	have	less	DNA	gaps/breaks	compared	to	control	cells	following	exposure	to	HU.			
	
4.2.17	TAB182	is	Down-Regulated	during	G1	Phase	of	the	Cell	Cycle	
Given	that	TAB182	depletion	in	response	to	replication	stress	 leads	to	a	defective	S	
phase	checkpoint	but	reduced	1st	label	terminations	compared	to	control	cells,	we	wished	to	
examine	the	levels	of	TAB182	protein	throughout	the	cell	cycle.	To	this	end,	we	made	use	of	
the	 mitotic	 spindle	 formation	 inhibitor	 nocodazole,	 which	 blocks	 cells	 in	 prometaphase.	
HeLa	cells	were	mock-treated	or	treated	with	nocodazole	for	18	hours	then	released	from	
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Figure	4.17:	TAB182	Deficient	Cells	Display	Less	DNA	Gaps/Breaks	following	Exposure	to	
HU.	HeLa	cells	were	transfected	with	control	siRNA	or	TAB182	siRNA	and	48	hours	later,	
were	 exposed	 to	 2mM	HU	 for	 2	 hours	 and	 then	 incubated	 in	HU-free	media.	 48	 hours	
later,	 the	 cells	 were	 treated	 with	 colcemid	 to	 block	 cells	 in	 mitosis.	 Cells	 were	 fixed,	
dropped	onto	slides	and	stained	with	Giemsa	ready	for	analysis.	Metaphase	spreads	were	
visualised	 by	 light	 microscopy	 and	 counted	 for	 the	 number	 of	 chromatid	 gaps/breaks.	
Error	 bars	 represent	 SEM.	 These	 data	 are	 representative	 of	 two	 independent	
experiments.	Experiment	performed	by	Dr	John	Reynolds.	
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the	G2/M	block	into	fresh	media	and	samples	were	harvested	at	0,	1,	2,	4,	6,	8,	10	and	24	
hours	 later.	 Budding	 uninhibited	 by	 benzimidazoles-related	 1	 (BubR1)	 and	 Cdc27	 were	
immunoblotted	 since	 they	 are	 highly	 phosphorylated	 in	 mitosis	 but	 become	 gradually	
dephosphorylated	as	the	cells	exit	M	phase	and	proceed	into	G1.	Claspin	and	Cyclin	A	levels	
are	high	during	S	phase	but	are	 largely	diminished	during	mitosis	and	G1.	Cyclin	B	and	H3	
phosphorylated	 on	 Ser10	 are	 markers	 of	 mitosis	 with	 their	 levels	 being	 greatly	 reduced	
during	entry	into	G1	phase.	All	proteins	were	present	in	the	asynchronous	population	apart	
from	phospho-H3	(Ser10)	which	is	specifically	phosphorylated	during	mitosis	and	therefore,	
only	displays	a	very	weak	band	in	the	asynchronous	cell	lysate	sample.	Interestingly,	TAB182	
appeared	to	migrate	more	slowly	in	the	nocodazole	treated	population,	suggesting	that	it	is	
modified	 during	 mitosis.	 During	 the	 release	 from	 nocodazole	 block	 (between	 1	 and	 24	
hours),	the	phosphorylation	(denoted	by	retarded	migration	on	the	gel)	of	BubR1	and	Cdc27	
was	diminished	as	 the	cells	progress	 through	G1	and	 into	S	phase.	The	protein	expression	
levels	of	Claspin	and	Cyclin	A	(between	1	and	24	hours)	started	to	increase	at	approximately	
6-8	hours	after	nocodazole	release	as	the	cells	were	going	from	G1	into	S	phase.	Finally,	the	
protein	 expression	 levels	 of	 Cyclin	 B	 and	 phospho-H3	 (Ser10)	 decreased	 during	 the	
nocodazole	release	as	the	cells	exited	mitosis	and	enter	G1	phase.	Interestingly,	the	intensity	
of	the	TAB182	band	decreased	during	nocodazole	release	and	exit	into	G1	and	increased	as	
the	cells	entered	S	phase.	This	result	suggests	that	TAB182	in	down-regulated	during	G1	but	
the	protein	levels	increase	during	S	phase	(Figure	4.18).		
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Figure	4.18:	TAB182	 is	Down-Regulated	during	G1	Phase	of	the	Cell	Cycle.	HeLa	cells	were	
mock-treated	or	treated	with	nocodazole	for	18	hours.	Cells	were	harvested	at	1,	2,	4,	6,	8,	10	
and	24	hours	post-nocodazole	release,	along	with	a	mock-treated	sample	and	a	nocodazole	
treated	 but	 not	 released	 control.	 Cells	 lysates	 were	 subjected	 to	 SDS-PAGE	 and	 Western	
blotting	 with	 the	 indicated	 antibodies.	 This	 Western	 blot	 is	 representative	 of	 three	
independent	experiments.		
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4.3	DISCUSSION	
To	 date,	 very	 little	 is	 known	 about	 the	 function	 of	 TAB182.	 It	 has	 been	 previously	
established	 that	 it	 interacts	 with	 Tankyrase	 1,	 and	 that	 Tankyrase	 1	 is	 able	 to	 ribosylate	
TAB182	 in	 vitro	 (Seimiya	 and	 Smith	 2002).	 In	 addition	 to	 this	 interaction,	 it	 has	 been	
suggested	 that	 TAB182	may	 be	 involved	 in	 the	DDR	pathways,	 since	 it	 is	 thought	 to	 be	 a	
substrate	of	ATM/ATR	phosphorylation	(Matsuoka,	Ballif	et	al.	2007).	Work	presented	in	this	
chapter	 has	 implicated	 TAB182	 in	 the	 DDR	 for	 several	 reasons.	 Firstly,	 cells	 deficient	 in	
TAB182	are	sensitive	to	agents	that	induce	replicative	stress	(UV-C	irradiation	and	HU),	but	
not	IR	(Figure	4.2).	Secondly,	following	exposure	to	various	DNA	damaging	agents	such	as	IR	
and	 HU,	 TAB182	 deficient	 cells	 exhibited	 an	 increase	 in	 DDR	 signalling	 measured	 by	 the	
elevated	levels	of	phosphorylated	DDR	proteins	such	a	pChk1	(S317	and	S345),	pRPA	(S4/8)	
and	γH2AX	(Figure	4.3).	Furthermore,	a	minor	delay	in	the	progression	through	G2/M	after	
IR	 or	 HU	 treatment,	 or	 in	 the	 progression	 through	 S	 phase	 after	 UV-C	 irradiation	 was	
observed	in	TAB182	depleted	cells	(Figure	4.5).	Further	analysis	of	the	G2/M	checkpoint	by	
flow	 cytometry,	 measuring	 the	 content	 of	 pHistone	 H3	 (Ser	 10),	 a	 marker	 of	 mitosis,	
revealed	that	the	G2/M	checkpoint	in	TAB182	depleted	cells	after	all	types	of	DNA	damage	
tested	was	intact	(Figure	4.6).	
Work	presented	in	this	chapter	has	also	shown	that	TAB182	depletion	does	not	affect	
replication	 fork	speeds	before	or	after	 replication	stress	 (Figure	4.7).	 Interestingly,	TAB182	
depleted	cells	exhibit	elevated	levels	of	new	origin	firing	and	reduced	fork	stalling	following	
release	from	HU	(Figure	4.8).	Furthermore,	the	new	origin	firing	defect	observed	in	TAB182	
deficient	cells	was	abrogated	upon	inhibition	of	CDK	activity	(Figure	4.11).	The	reduced	fork	
stalling	 observed	 in	 TAB182	 deficient	 cells	 following	 HU	 treatment	 was	 shown	 to	 be	
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dependent	 on	 ATR	 but	 not	 on	 Chk1	 or	 CDK	 function,	 suggesting	 that	 in	 the	 absence	 of	
TAB182,	 ATR	 is	 important	 for	 replication	 resumption	 (Figures	 4.10,	 4.9	 and	 4.11,	
respectively).		
It	was	shown	that	TAB182	does	not	 localise	to	DNA	damage	foci	 following	exposure	to	HU	
(Figure	4.13).	Further	analyses	revealed	that	TAB182	depletion	 leads	to	a	reduction	 in	 	the	
numbers	 of	 γH2AX	 and	 53BP1	 foci	 positive	 cells	 following	 1hr	 release	 from	 2mM	 HU	
exposure,	 suggesting	 that	 TAB182	 defective	 cells	 resolve	 DNA	 damage	 and	 DSBs,	
respectively	more	than	control	cells	(alternatively	recruitment	of	these	proteins	to	foci	may	
be	deficient)	(Figure	4.14).	Furthermore,	TAB182	depletion	resulted	in	a	mild	increase	in	the	
percentage	of	cells	having	1-2	53BP1	bodies	in	G1,	indicative	of	increased	replication	stress	
and	elevated	levels	of	under-replicated	DNA	(Figure	4.15).	We	also	detected	higher	levels	of	
associated	 micronuclei	 following	 exposure	 to	 HU	 in	 TAB182	 deficient	 cells	 (Figure	 4.16).	
Interestingly,	 metaphase	 spread	 analysis	 showed	 that	 TAB182	 depleted	 cells	 have	 less	
chromatid	 gaps/breaks	 following	 exposure	 to	 HU,	 the	 reason	 for	 this	 result	 is	 unclear	 at	
present	 (Figure	 4.17).	 Finally,	 using	 nocodazole	 release	 assays,	 TAB182	 was	 shown	 to	 be	
down-regulated	during	G1	and	its	expression	increased	as	the	cells	progressed	through	the	
cell	 cycle,	 further	 suggesting	 that	 TAB182	may	be	 important	 during	 S	 phase	 (Figure	 4.18).	
Similarly,	 it	was	observed	that	as	adenovirus	 infection	progressed	there	was	an	increase	in	
TAB182	 expression	 before	 its	 degradation.	 This	 is	 probably	 due	 to	 infected	 cells	 entering	
pseudo-S	phase	(Figure	3.1).		
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Clonogenic	 Survival,	 DNA	Damage	 Response	 Signalling	 and	 Cell	 Cycle	 Control	 in	 TAB182	
Deficient	Cells	
Clonogenic	survival	assays	demonstrated	that	TAB182	depleted	cells	are	sensitive	to	
UV-C	 and	 HU	 treatment,	 but	 not	 to	 IR	 (Figure	 4.2).	 These	 data	 suggest	 that	 TAB182	 is	
important	for	cellular	survival	in	response	to	replication	stress	and	bulky	lesions	induced	by	
HU	and	UV-C	exposure,	but	it	is	dispensable	for	survival	in	response	to	lesions	induced	by	IR	
such	as	DSBs.	These	data	are	the	first	evidence	to	suggest	that	TAB182	may	be	important	for	
cell	viability	following	replication	stress.	For	this	reason,	the	DNA	damage	signalling	response	
to	various	DNA	damaging	agents	in	TAB182	deficient	cells	was	also	examined.	The	levels	of	
pNBS1	 S343,	 pChk1	 S317/S345,	 pRPA	 S4/8	 and	 γH2AX	 S139	 were	 determined.	 ATM	 is	
responsible	for	the	phosphorylation	of	NBS1	on	S343,	which	is	indicative	of	the	activation	of	
the	 S	 phase	 checkpoint	 (Lim,	 Kim	 et	 al.	 2000).	 ATM	 and	 ATR	 have	 been	 shown	 to	
phosphorylate	 Chk1	 on	 S317	 or	 S345	 (Zhao	 and	 Piwnica-Worms	 2001,	Gatei,	 Sloper	 et	 al.	
2003).	 Phosphorylation	 of	 Chk1	 at	 S317	 is	 required	 for	 cell	 cycle	 re-entry	 after	 stalled	
replication	(Martin	and	Ouchi	2008).	Phosphorylation	of	Chk1	on	S345	is	required	for	Chk1	
localisation	to	the	nucleus	following	activation	of	the	checkpoint	(Jiang,	Pereira	et	al.	2003).	
Phosphorylation	 on	 S4/8	 of	 RPA	 is	 indicative	 of	 RPA-bound	 ssDNA	 formed	 as	 a	 result	 of	
replication	 stress,	 or	 following	 resection	 of	 DSBs	 during	 HR	 repair	 (Shi,	 Feng	 et	 al.	 2010).	
Finally,	phosphorylation	of	H2AX	on	S139	(termed	γH2AX)	is	 indicative	of	an	activated	DDR	
and	can	be	phosphorylated	by	both	ATM,	ATR	and	DNA-PK	(Rogakou,	Pilch	et	al.	1998,	Ward	
and	Chen	2001).	Following	exposure	to	IR,	TAB182	depleted	cells	displayed	slightly	elevated	
levels	of	pNBS1	(S343),	pChk1	(S317	and	S345),	pRPA	(S4/8)	and	γH2AX	(S139).	This	does	not	
necessarily	 indicate	that	the	cells	should	be	sensitive	to	 IR	as	the	differences	observed	are	
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mild	 and	 there	may	be	 compensatory	pathways	 to	promote	 cellular	 survival	 in	 these	 cells	
following	exposure	to	IR.	Following	exposure	to	2mM	HU,	TAB182	defective	cells	displayed	
slightly	elevated	levels	of	pRPA	(S4/8)	and	γH2AX	(S139)	and	elevated	levels	of	pChk1	(S317	
and	 S345),	 suggesting	 that	 there	 is	 a	 higher	 checkpoint	 activation	 immediately	 after	
treatment	with	HU.	How	and	whether	this	may	be	connected	to	the	cellular	hypersensitivity	
observed	in	these	cells	is	unknown.	Following	UV-C	irradiation,	a	mild	hyperphosphorylation	
of	Chk1	(S317)	was	observed	in	TAB182	knockdown	cells	but	again,	as	before,	whether	this	
can	 account	 for	 the	 UV-C	 hypersensitivity	 observed	 is	 unclear.	 Significantly,	 however,	
TAB182	depleted	cells	appeared	to	progress	through	S	phase	slower	than	control	cells	after	
UV-C	 irradiation,	 indicating	that	there	may	be	a	role	for	TAB182	in	replication	progression.	
Progression	 through	 S	 phase	 in	 the	 presence	 of	 other	 types	 of	DNA	damage/stress	 under	
conditions	 of	 down-regulation	 of	 TAB182	 expression,	 appeared	 to	 be	 intact,	 but	 with	 a	
bigger	fraction	of	cells	accumulating	in	G2/M	compared	to	control	cells.			
Using	 nocodazole	 release	 assays,	 it	 was	 shown	 that	 TAB182	 was	 down-regulated	
during	G1	phase	of	the	cell	cycle	(Figure	4.18).	The	reason	for	this	down-regulation	is	unclear	
at	present.	 Interestingly,	 during	mitosis	 TAB182	appeared	 to	migrate	more	 slowly	by	 SDS-
PAGE,	 suggesting	 that	 TAB182	 may	 undergo	 post-translational	 modifications	 such	 as	
phosphorylation	 or	 ribosylation	 during	 mitosis.	 Indeed,	 studies	 from	 Matsuoka	 and	
colleagues	 have	 identified	 ATM/ATR	 phosphorylation	 sites	within	 TAB182,	 although	 these	
have	not	been	confirmed	in	this	study	(Matsuoka,	Ballif	et	al.	2007).	
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DNA	Fibre	Analysis	
The	sensitivity	of	TAB182	knockdown	cells	to	HU	suggested	that	it	may	play	a	role	in	
S	phase.	DNA	fibre	analysis	is	a	robust	technique	facilitating	the	visualisation	of	single	DNA	
molecules	 during	 DNA	 replication	 following	 release	 from	 replication	 stress	 (Jackson	 and	
Pombo	1998).	This	technique	was	therefore	employed	to	analyse	the	replication	dynamics	in	
TAB182	 deficient	 cells.	 In	 both	 unperturbed	 cells	 as	 well	 as	 cells	 released	 from	 2mM	HU	
treatment,	 the	 speed	 of	 replication	 fork	 progression	 in	 TAB182	 depleted	 cells	 was	
comparable	 to	 control	 siRNA	 cells,	 suggesting	 that	 TAB182	depletion	has	no	effect	on	 the	
progression	 of	 actively	 replicating	 forks	 (Figure	 4.7).	 Interestingly,	 TAB182	 depleted	 cells	
exhibited	 excessive	 new	 origin	 firing	 (measured	 by	 the	 elevated	 percentage	 of	 2nd	 label	
origins	compared	to	control	siRNA	treated	cells),	as	well	as	an	increase	in	fork	restart	events	
(measured	 by	 decreased	 fork	 stalling	 compared	 to	 control	 siRNA	 treated	 cells),	 following	
release	from	HU	(Figure	4.8).	This	suggested	that	TAB182	deficient	cells	may	fire	new	origins	
to	 facilitate	 replication	progression,	 thus	 ensuring	 replication	 completion.	 In	 this	 scenario,	
the	elevated	fork	restart	observed	in	TAB182	deficient	cells	could	be	an	indirect	effect,	or	at	
least	 in	part,	of	elevated	origin	firing	observed	in	these	cells.	To	determine	whether	or	not	
replication	fork	recovery	was	dependent	on	elevated	new	origin	firing,	a	CDK	inhibitor	was	
employed	 to	 ablate	 new	 origin	 firing	 and	 the	 effect	 on	 fork	 restart	 was	 assessed	 (Figure	
4.11).	The	CDK	 I/II	 inhibitor	abolished	new	origin	 firing	as	expected,	but	strikingly,	 this	did	
not	 impact	 on	 the	 percentage	 of	 fork	 restart	 events	 in	 TAB182	 knockdown	 cells,	 showing	
that	the	increased	fork	restart	observed	in	these	cells	is	not	a	result	of	elevated	new	origin	
firing.	Interestingly,	DT40	cells	lines	that	do	not	express	the	FANCM	helicase,	a	protein	which	
has	previously	been	 implicated	 in	fork	restart,	display	both	 increased	new	origin	firing	and	
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elevated	 fork	 restart	 following	 release	 from	 replication	 blocks	 (Schwab,	 Blackford	 et	 al.	
2010).	However,	 the	 increased	fork	restart	observed	 in	FANCM	negative	cells	 is	a	result	of	
new	 origin	 firing,	 as	 upon	 CDK	 inhibition,	 increased	 fork	 restart	 reaches	 control	 levels.	
Furthermore,	in	contrast	to	TAB182	depleted	cells	that	replicate	their	DNA	at	similar	rates	to	
control	 cells,	 FANCM	 deficient	 HeLa	 cells	 show	 increased	 fork	 replication	 speeds	 in	 both	
unperturbed	and	replication	stressed	cells	(Luke-Glaser,	Luke	et	al.	2010).	This	suggests	that	
FANCM	 is	 able	 to	 slow	 down	 replication	 fork	 progression.	 Nethertheless,	 in	 this	 study,	
FANCM	 defective	 cells	 displayed	 decreased	 fork	 restart	 (as	 opposed	 to	 increased	 fork	
restart)	following	release	from	replication	blocks,	suggesting	that	there	is	some	discrepancy	
between	DT40	and	HeLa	cells	(Luke-Glaser,	Luke	et	al.	2010).	
Our	results	show	that	TAB182	is	important	for	the	suppression	of	new	origin	firing	in	
the	absence	of	both	Chk1	and	ATR	function.	In	addition,	TAB182	is	important	for	fork	stalling	
or	collapse	even	in	the	absence	of	Chk1	activity	but	not	upon	inhibition	of	ATR.	Whether	the	
elevated	levels	of	new	origin	firing	in	TAB182	defective	cells	reflect	a	checkpoint	function	for	
TAB182	is	unclear.	Moreover,	it	has	been	shown	in	this	study	that	the	C-terminal	fragment	
of	TAB182	interacts	with	Chk1	in	vitro	(Figure	4.12).	However,	cells	with	defective	ATR/Chk1	
signalling	display	 increased	new	origin	 firing	 even	 in	 the	 absence	of	 replication	 stress	 and	
this	is	also	accompanied	by	a	decrease	in	the	speed	of	replication	fork	progression.	Examples	
of	such	proteins	 include	ATR,	Chk1,	CLASPIN	and	TIMELESS	(Petermann,	Maya-Mendoza	et	
al.	2006,	Maya-Mendoza,	Petermann	et	al.	2007,	Wilsker,	Petermann	et	al.	2008).	These	two	
phenotypes	are	not	observed	in	TAB182	deficient	cells	suggesting	that	1)	either	TAB182	has	
checkpoint	 roles	 outside	 the	 ATR/Chk1	 pathways	 or	 2)	 that	 it	 does	 not	 have	 a	 role	 in	
checkpoint	function.		
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Taken	 together,	 we	 hypothesise	 that	 TAB182	 may	 be	 involved	 in	 promoting	 fork	
stalling	 or	 collapse	 in	 response	 to	 replication	 stress.	 In	 this	 scenario,	 in	 the	 absence	 of	
TAB182,	forks	do	not	stall	but	continue	to	replicate	in	a	manner	that	is	dependent	on	ATR.	
Meanwhile,	new	origins	are	fired	independently	as	part	of	the	response	to	replication	stress,	
in	a	CDK	dependent	manner.		
	
Localisation	of	TAB182	in	the	Cell	
Immunofluorescence	analysis	showed	that	TAB182	does	not	localise	to	nuclear	DNA	
damage	foci	following	replication	stress	induced	by	HU	(Figure	4.13).	A	lack	of	accumulation	
into	nuclear	foci	upon	DNA	damage	does	not	necessarily	indicate	that	TAB182	may	not	have	
a	role	in	the	DDR	or	a	role	following	replication	stress.	For	example,	the	Ku	heterodimer	as	
well	as	other	established	components	of	the	cellular	DDR	fail	to	form	DNA	damage-induced	
foci	(Britton,	Coates	et	al.	2013).	Furthermore,	due	to	the	fact	that	there	were	no	available	
specific	 antibodies	 against	 TAB182	 that	 could	 be	 utilised	 to	 allow	 the	 visualisation	 of	 the	
localisation	of	the	endogenous	protein	within	the	cell,	we	made	use	of	a	pEGFPC3-TAB182	
construct	 to	 perform	 this	 analysis.	 GFP-TAB182	 exhibited	 pan-cellular	 localisation	 that	
remained	unaltered	upon	the	induction	of	replication	stress.	However,	due	to	the	fact	that	
the	ectopic	protein	 is	 fused	to	GFP	and	that	 its	expression	was	forced,	we	cannot	rule	out	
that	some	of	it,	if	not	all,	is	not	functional	in	the	cell.	
	
Formation	of	γH2AX	and	53BP1	foci	following	Release	from	HU	
The	examination	of	γH2AX	and	53BP1	positive	foci	following	release	from	HU	can	be	
used	to	assess	the	kinetics	of	DNA	damage	and	DSBs,	respectively.	We	observed	a	reduction	
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in	 cells	 exhibiting	 γH2AX	 and	 53BP1	 foci	 upon	 TAB182	 depletion,	 suggesting	 that	 TAB182	
may	be	promoting	the	stalling/collapsing	of	forks	into	DSBs	(Figure	4.14).	We	do	not	know	if	
TAB182	 acts	 directly	 at	 the	 fork	 but	 since	 in	 silico	analysis	 has	 not	 revealed	 any	 nuclease	
domains	 in	 TAB182,	 it	 is	 unlikely	 that	 it	 may	 be	 nucleolytically	 processing	 forks.	 Yet,	 we	
cannot	exclude	the	possibility	that	TAB182	binds	to	factors	that	remodel	 forks	or	promote	
the	collapse	of	forks	in	response	to	replication	stress.	
	
Genome	Instability	Induced	by	Unresolved	Replication	Stress	
Stalling	of	replication	forks	can	lead	to	regions	of	DNA	being	left	under	replicated	or	
replication	intermediates,	which	if	left	unresolved	may	be	detrimental	to	genomic	instability.	
Unresolved	replication	stress	can	be	visualised	in	the	cell	in	a	number	of	different	ways.	One	
example	is	the	presence	of	nuclear	compartments	that	are	positive	for	53BP1	(termed	53BP1	
bodies)	 in	 G1	 following	 replication	 stress	 (Harrigan,	 Belotserkovskaya	 et	 al.	 2011,	 Lukas,	
Savic	et	al.	2011).	Knockdown	of	TAB182	slightly	increased	the	levels	of	53BP1	bodies	above	
those	 observed	 in	 control	 cells	 indicative	 of	 elevated	 levels	 of	 under-replicated	 DNA	 or	
replication	stress	(Figure	4.15).	Another	example	of	unresolved	replication	stress	leading	to	
genomic	 instability	 is	 the	presence	of	chromatid	gaps	and	breaks	that	can	be	visualised	by	
chromosomal	 metaphase	 spreads	 following	 replication	 stress.	 Our	 analysis	 showed	 that	
knockdown	 of	 TAB182	 lead	 to	 a	 reduction	 in	 the	 average	 number	 of	 gaps	 and	 breaks	
following	release	from	HU.	Nevertheless,	an	increase	in	micronuclei	was	observed	in	TAB182	
defective	cells	upon	replication	stress.	
Taken	 together,	 in	 the	 absence	 of	 TAB182,	 cells	 are	 sensitive	 to	 replication	 stress,	
with	more	 replication	 forks	 restarting	 following	 release	 from	HU.	Finally,	TAB182	depleted	
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cells	 display	 elevated	 levels	 of	 under-replicated	DNA	 and	 a	 higher	 number	 of	micronuclei	
indicative	of	elevated	genomic	instability.	
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5.	THE	ROLE	OF	TAB182	AND	THE	CNOT	COMPLEX	IN	THE	DNA	DAMAGE	RESPONSE	AND	
REPLICATION	STRESS	PATHWAYS	
5.1	INTRODUCTION	
Work	presented	in	the	previous	chapters	has	implicated	TAB182	in	the	DDR.	The	first	
indication	that	TAB182	may	be	involved	in	the	DDR	comes	from	work	presented	in	Chapter	
Three,	 where	 TAB182	 was	 shown	 to	 be	 degraded	 following	 infection	 with	 a	 number	 of	
adenovirus	serotypes.	More	than	80%	of	proteins	known	to	be	degraded	by	adenovirus	are	
involved	 in	 the	 DDR,	 therefore	 adenoviral	 targets	 are	 likely	 to	 be	 DDR	 proteins	 (Querido,	
Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002,	 Baker,	 Rohleder	 et	 al.	 2007,	 Orazio,	
Naeger	et	al.	2011,	Gupta,	Jha	et	al.	2013).	Furthermore,	work	presented	in	Chapter	Three	
showed	that	TAB182	depletion	enhanced	the	expression	of	 the	cell	cycle	protein,	Cyclin	E,	
and	 elevated	 the	 expression	 of	 the	 adenoviral	 E1A	 protein	 (Figures	 3.10	 and	 3.9,	
respectively).	This	suggested	that,	firstly,	TAB182	may	be	involved	in	cell	cycle	control	or	the	
regulation	of	 replication,	and	 secondly,	 that	 the	degradation	of	TAB182	during	adenovirus	
infection	is	beneficial	for	both	viral	replication	and	the	production	of	viral	progeny.	
A	potential	role	for	TAB182	in	the	DDR	was	further	indicated	in	Chapter	Four.	Using	
cell	 survival	 assays,	 TAB182	depleted	 cells	 appeared	 to	 be	 sensitive	 to	 agents	 that	 induce	
replication	 stress	 (Figure	 4.2).	 Moreover,	 TAB182	 deficient	 cells	 displayed	 increased	 DDR	
signalling	 following	 exposure	 to	 various	 DNA	 damaging	 agents	 (Figure	 4.3).	 Cell	 cycle	
analyses	 revealed	 that	 TAB182	 deficient	 cells	 exhibit	 a	 delay	 in	 cell	 cycle	 progression	
following	exposure	 to	DNA	damaging	agents	 (especially	 after	UV-C	 irradiation),	which	was	
not	due	to	a	defective	G2/M	checkpoint	(Figures	4.5	and	4.6,	respectively).	
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Using	DNA	fibre	assays,	 the	replication	checkpoint	 in	TAB182	deficient	cells	both	 in	
the	absence	of	stress	and	following	HU	release	was	shown	to	be	proficient,	since	replication	
elongation	 speeds	 were	 comparable	 to	 control	 cells	 (also	 shown	 by	 proficient	 Chk1	
phosphorylation)	(Figures	4.7	and	4.3,	respectively).	However,	DNA	fibre	structures	following	
replication	 stress	demonstrated	 that	TAB182	deficient	 cells	displayed	excessive	new	origin	
firing	 and	 increased	 fork	 restart	 following	 release	 from	 replication	 blocks	 induced	 by	 HU	
(Figure	4.8).	A	CDK	I/II	 inhibitor	was	used	to	 inhibit	new	origin	firing	 in	order	to	determine	
whether	 the	 elevated	 new	 origin	 firing	 and	 increased	 fork	 restart	 observed	 in	 TAB182	
depleted	 cells	 following	 replication	 stress	were	 dependent	 upon	 each	 other	 (Figure	 4.11).	
Since	elevated	new	origin	firing	was	shown	to	be	independent	of	the	increased	fork	restart	
in	TAB182	deficient	cells	after	HU	release,	TAB182	was	thought	to	have	direct	involvement	in	
fork	stalling	following	replication	stress	(see	Chapter	Four).	The	fact	that	there	are	less	cells	
with	 γH2AX	 and	 53BP1	 foci	 and	 less	 chromatid	 gaps/breaks	 are	 formed	 after	 replication	
stress	upon	TAB182	depletion,	suggests	 that	 less	replication	 forks	stall	 in	TAB182	deficient	
cells	 and	 therefore	 less	 DSBs	 may	 be	 accumulating	 (Figures	 4.14	 and	 4.17,	 respectively).	
However,	 TAB182	 deficient	 cells	 displayed	 increased	 levels	 of	 micronuclei	 as	 well	 as	
increased	numbers	of	 cells	with	1-2	53BP1	bodies	 in	G1,	 suggesting	 that	TAB182	deficient	
cells	may	also	exhibit	phenotypes	of	genomic	instability	(Figures	4.16	and	4.15,	respectively).	
Taken	 together,	 the	 work	 presented	 in	 Chapters	 Three	 and	 Four	 indicates	 that	
TAB182	may	be	involved	in	the	response	to	replication	stress	as	well	as	in	the	maintenance	
of	genome	stability.	However,	no	precise	mechanism	for	the	involvement	of	TAB182	in	the	
DDR	has	been	elucidated	thus	 far.	The	aim	of	 this	chapter	was	 therefore	 to	 try	 to	 identify	
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putative	 novel	 TAB182	 binding	 partners,	 in	 an	 attempt	 to	 elucidate	 the	 role	 that	 TAB182	
plays	in	the	DDR.		
	
5.2	RESULTS	
5.2.1	TAB182	Interacts	with	the	CNOT	Complex	in	Vivo	
GST	 pull-down	 assays	 previously	 performed	 in	 Chapter	 Four	 revealed	 that	 TAB182	
interacted	with	Tankyrase	1,	Chk1	and	Aurora	 kinase	 (Figure	4.12).	 To	gain	 further	 insight	
into	the	function	of	TAB182,	co-immunoprecipitation	experiments	were	performed	in	HeLa	
cell	 lysates,	 along	 with	 Ad5	 and	 Ad12	 infected	 HeLas	 and	 the	 resulting	 TAB182-protein	
complexes	were	analysed	by	mass	spectrometry.	After	immunoprecipitation,	proteins	were	
digested	with	 trypsin	as	described	 in	Section	2.3.5.	 The	 resulting	peptides	were	 separated	
using	a	Bruker	amaZon	ion	trap	mass	spectrometer	and	processed	and	analysed	by	using	the	
ProteinScape	 central	 bioinformatic	 platform	 (Bruker). Protein	 names,	 peptide	 number,	
percentage	coverage	and	Mascot	score	were	all	determined	(Table	5.1).	
TAB182	 co-immunoprecipitations	 performed	 in	 uninfected	 HeLa	 cells	 revealed	 a	
number	 of	 components	 of	 the	 CNOT	 complex	 to	 interact	 with	 TAB182	 including	 CNOT1,	
CNOT2,	CNOT3,	CNOT6L,	CNOT8,	CNOT9,	CNOT10	and	CNOT11.	In	addition,	protein	arginine	
N-methyltransferase	3	(PRMT3)	and	four	and	a	half	LIM	domain	2	(FHL2)	proteins	were	also	
consistently	found	to	interact	with	TAB182	in	this	screen	(Table	5.1A).	Similarly,	the	TAB182	
immunoprecipitations	 performed	 in	 Ad5	 and	 Ad12	 infected	 HeLa	 cells	 also	 identified	 a	
number	of	components	of	the	CNOT	complex	including	CNOT1,	CNOT2,	CNOT3,	CNOT6L		
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(A)$Uninfected$HeLas:$
Protein$ Pep6de$number$ Percentage$coverage$ Mascot$Score$$
!! !! !! !!
TAB182! 68! 49.4! 3491!
CNOT1! 38! 17.4! 1472!
CNOT3! 7! 10.2! 237!
CNOT7! 6! 28.8! 211!
CNOT2! 5! 12.2! 245!
CNOT6L! 1! 1.8! 21!
CNOT10! 1! 1.3! 29!
CNOT11! 1! 2.4! 56!
CNOT9! 6! 20.4! 224!
!! !! !! !!
PRMT3! 9! 18.5! 377!
FHL2! 12! 52.3! 470!
!! !! !! !!
(B)$Ad5$Infected$
HeLas$(24hr):$
Protein$ Pep6de$number$ Percentage$coverage$ Mascot$Score$$
!! !! !! !!
TAB182! 70! 47.2! 4302!
CNOT1! 51! 22.6! 2423!
CNOT3! 15! 19.1! 607!
CNOT2! 7! 15.4! 343!
CNOT10! 5! 10.2! 219!
CNOT6L! 2! 4.1! 90!
CNOT8! 1! 4.8! 45!
CNOT11! 3! 8! 122!
CNOT9! 10! 36.5! 470!
!! !! !! !!
PRMT3! 8! 17.3! 356!
FHL2! 18! 60.6! 707!
!! !! !! !!
(C)$Ad12$Infected$HeLas$(24hr):$
Protein$ Pep6de$number$ Percentage$coverage$ Mascot$Score$$
!! !! !! !!
TAB182! 68! 49.4! 3491!
CNOT1! 38! 17.4! 1472!
CNOT2! 5! 12.2! 245!
CNOT3! 7! 10.2! 237!
CNOT7! 6! 28.8! 211!
CNOT10! 1! 1.3! 29!
CNOT6L! 1! 1.8! 21!
CNOT11! 1! 2.4! 56!
CNOT9! 6! 20.4! 234!
!! !! !! !!
PRMT3! 9! 18.5! 376.8!
FHL2! 12! 52.3! 470!
!! !! !! !!
Table	 5.1:	 TAB182	 Interacts	 with	 the	 CNOT	 Complex	 in	 Vivo.	 TAB182	 was	
immunoprecipitated	from	(A)	uninfected,	(B)	Ad5	or	(C)	Ad12	infected	HeLa	cell	lysates	and	
the	 resulting	 associated	 proteins	 identified	 by	mass	 spectrometry.	 Proteins	 identified	 are	
shown	in	the	above	table,	together	with	peptide	number,	percentage	coverage	and	Mascot	
scores.				
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CNOT7	 (Ad12	 only),	 CNOT8	 (Ad5	 only),	 CNOT9,	 CNOT10	 and	 CNOT11.	 Again,	 PRMT3	 and	
FHL2	proteins	were	found	to	interact	with	TAB182	in	this	screen	(Table	5.1B	and	Table	5.1C).	
These	 results	 are	 representative	 of	 10	 independent	 mass	 spectrometry	 screens	
performed	 throughout	 the	 duration	 of	 this	 study.	 Taken	 together	 these	 data	 show	 that	
TAB182	 is	 likely	 to	 interact	with	various	 components	of	 the	CNOT	complex,	as	well	 as	 the	
proteins	 PRMT3	 and	 FHL2.	 Interestingly,	 CNOT4	 was	 never	 identified	 in	 any	 of	 the	 co-
immunoprecipitations.	 It	 is	 assumed	 that	 the	peptides	 identified	 as	deriving	 from	CNOT6L	
could	 have	 also	 been	 components	 of	 CNOT6	 due	 to	 the	 high	 similarity	 between	 the	 two	
proteins.	When	the	TAB182	immunoprecipitation	was	performed	in	the	presence	of	Ad5	and	
Ad12	 infected	 lysates,	 no	 additional	 interactions	 were	 observed.	 This	 suggests	 that	
adenoviral	infection	did	not	affect	TAB182	interactions	with	other	proteins	detected	in	this	
screen.	A	representation	of	the	interactions	of	TAB182,	identified	by	mass	spectrometry,	 is	
shown	in	Table	5.1.		
	
5.2.2	Adenovirus	Down-Regulates	Components	of	the	CNOT	complex	during	Ad5	and	Ad12	
Infection	
Since	the	previous	mass	spectrometry	data	(Table	5.1)	showed	a	potential	interaction	
between	 TAB182	 and	 various	 components	 of	 the	 CNOT	 complex	 (namely	 CNOT1,	 CNOT2,	
CNOT3,	 CNOT6L,	 CNOT7,	 CNOT9,	 CNOT10	 and	CNOT11),	we	 aimed	 to	 determine	whether	
components	of	the	CNOT	complex	were	also	down-regulated	during	adenovirus	infection	as	
TAB182	is.	To	test	this	hypothesis,	HeLa	cells	were	infected	with	Ad5	and	Ad12	serotypes	at	
an	MOI	of	5.	Cells	were	harvested	at	0,	8,	24,	48,	72	and	96	hours	post-infection	and		
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Figure	5.1:	Adenovirus	Down-Regulates	Components	of	the	CNOT	Complex	during	Ad5	and	
Ad12	Infection.	HeLa	cells	were	infected	with	(A)	Ad5	or	(B)	Ad12	at	an	MOI	of	5.	Cells	were	
harvested	 at	 0,	 8,	 24,	 48,	 72	 and	 96	 hours	 post-infection,	 subjected	 to	 SDS-PAGE	 and	
Western	blotting	using	the	indicated	antibodies.	These	Western	blots	are	representative	of	
three	independent	experiments.		
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subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 with	 the	 required	 antibodies.	 	 β-actin	 was	
immunoblotted	 as	 a	 loading	 control.	 Adenovirus	 early	 proteins	 E1A	 and	 E1B55K	 were	
immunoblotted	 along	 with	 the	 viral	 structural	 proteins	 Hexon	 (Ad5)	 and	 Knob	 (Ad12)	 as	
markers	of	adenovirus	 infection.	As	expected,	the	expression	of	E1A,	E1B55K,	Hexon	(Ad5)	
and	Knob	(Ad12)	was	observed	between	8	and	24	hours	post-infection	in	both	Ad5	and	Ad12	
infected	 cells	 confirming	 infection	 with	 these	 serotypes.	 Mre11	 and	 p53	 were	
immunoblotted	as	positive	controls	since	these	proteins	are	known	to	be	degraded	during	
adenovirus	 infection	 (Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002).	 As	
anticipated,	Mre11	and	p53	were	degraded	in	both	Ad5	and	Ad12	infected	cells	by	72	hours	
post-infection.	CNOT4	expression	was	unaffected	during	 the	course	of	both	Ad5	and	Ad12	
infection.	 CNOT3	and	CNOT7	were	down-regulated	72	hours	 post-Ad5	 and	Ad12	 infection	
(Figure	5.1).	Other	members	of	the	CNOT	complex	were	not	examined.	These	data	show	that	
adenovirus	is	able	to	down-regulate	components	of	the	CNOT	complex.		
	
5.2.3	Optimisation	of	CNOT4	and	CNOT6	siRNA	Knockdown	in	HeLa	Cells	
		 Two	 of	 the	 major	 enzyme	 activities	 associated	 with	 the	 CCR4-NOT	 complex	 are	
deadenylation	 and	 E3	 ubiquitin	 ligase	 activity,	 which	 have	 been	 attributed	 to	 CNOT6	 and	
CNOT4	respectively	(Albert,	Hanzawa	et	al.	2002,	Chen,	Chiang	et	al.	2002).	Since	CNOT4	and	
CNOT6	are	 the	 two	most	 characterised	CNOT	subunits,	we	decided	 to	 focus	on	 these	 two	
proteins	for	the	following	experiments.	To	examine	to	what	extent	these	proteins	impacted	
on	 the	 DDR	 and	 adenovirus	 infection,	 siRNA	 knockdown	 experiments	 were	 undertaken.	
Therefore	 optimal	 conditions	 for	 siRNA-mediated	 knockdown	 of	 these	 protein	 were	
established.	 HeLa	 cells	 were	 transfected	 with	 increasing	 concentrations	 of	 control	 (non-
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targeting),	 CNOT4	 or	 CNOT6	 siRNA	 (20nm,	 45nm	 and	 90nm).	 48	 hours	 post-transfection,	
cells	 were	 harvested,	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting.	 CNOT4	 was	
immunoblotted	 to	 confirm	 siRNA-mediated	 knockdown	 of	 these	 proteins.	 TAB182	 was	
immunoblotted	to	determine	 if	 the	siRNA-mediated	knockdown	of	CNOT4	and	CNOT6	had	
any	effect	on	TAB182	protein	levels.	β-Actin	was	immunoblotted	as	a	loading	control	(Figure	
5.2A).	
The	 expression	 of	 CNOT4	 was	 significantly	 down-regulated	 in	 all	 CNOT4	 siRNA	
concentrations	 used	 (20nm,	 45nm	 and	 90nm)	 when	 compared	 to	 control	 siRNA	 treated	
samples.	 Upon	 overexposure	 of	 autoradiography	 film,	 there	 was	 some	 residual	 CNOT4	
expression	 in	 the	 cell	 lysate	 treated	with	20nm	of	CNOT4	 siRNA.	 It	was	 therefore	decided	
that	 the	 45nm	 CNOT4	 siRNA	 concentration	 would	 be	 used	 for	 all	 future	 experiments.	 A	
number	 of	 known	 commercial	 CNOT6	 antibodies	 were	 tested	 but	 in	 each	 case	 the	
expression	 of	 CNOT6	was	 seen	 to	 be	 unaffected	 in	 all	 CNOT6	 siRNA	 concentrations	 used	
(data	 not	 shown)	 (Figure	 5.2A).	 The	 reason	 for	 this	 could	 be	 either	 that	 none	 of	 the	
commercial	antibodies	detected	CNOT6	or	the	CNOT6	siRNA	does	not	work.	
TAB182	was	also	immunoblotted	in	cells	transfected	with	control,	CNOT4	or	CNOT6	
siRNA	 to	 determine	 whether	 the	 knockdown	 of	 these	 proteins	 had	 any	 effect	 on	 the	
expression	 of	 TAB182.	 siRNA	 mediated	 knockdown	 of	 CNOT6	 had	 no	 effect	 on	 the	
expression	of	TAB182	when	compared	to	control	cells.	Interestingly,	the	depletion	of	CNOT4	
appeared	 to	 slightly	down-regulate	 the	 levels	of	TAB182	when	compared	 to	control	 siRNA	
treated	cells.	 This	 suggests	 that	CNOT4	may	play	a	 role	 in	 the	 regulation	of	TAB182	 levels	
(Figure	5.2A).	
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Figure	 5.2:	 Optimisation	 of	 CNOT4	 and	 CNOT6	 siRNA	 Knockdown.	 (A)	 HeLa	 cells	 were	
transfected	with	control,	CNOT4	or	CNOT6	siRNA	at	the	indicated	concentrations.	48	hours	
post-transfection,	cells	were	harvested,	subjected	to	SDS-PAGE	and	Western	blotting	using	
the	indicated	antibodies.	(B)	Optimisation	of	HA-NOT6	and	HA-NOT6L	transfections.	HeLa	or	
U20S	 cells	were	 transfected	with	 2μg	 of	 either	HA-CNOT6	 or	HA-CNOT6L	 or	 pcDNA3.1	 or	
pEGFP-C3	only	as	negative	controls.	48	hours	later,	the	cells	were	harvested,	fractionated	by	
SDS-PAGE	 and	 subjected	 to	 Western	 blotting.	 HA	 was	 immunoblotted	 to	 assess	 the	
efficiency	 of	 the	 transfection.	 (C)	 CNOT6	 siRNA	 optimisation.	 HeLa	 or	 U20S	 cells	 were	
transfected	 with	 control,	 CNOT6,	 CNOT6L	 or	 CNOT6/CNOT6L	 siRNA	 and	 48	 hours	 later	
transfected	with	2μg	of	either	HA-CNOT6,	HA-CNOT6L,	both	HA-CNOT6	and	HA-CNOT6L	or	
pcDNA3.1	 or	 pEGFP-C3	 only	 as	 negative	 controls.	 48	 hours	 post-transfection	 cells	 were	
harvested	 and	 the	 cell	 lysates	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 using	 HA	
antibodies.		
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Since	 it	 had	 not	 been	 determined	 whether	 the	 lack	 of	 down-regulation	 of	 CNOT6	
expression	 after	 the	 use	 of	 increasing	 concentrations	 of	 CNOT6	 siRNA	was	 due	 to	 a	 non-
specific	antibody	or	a	failure	of	the	CNOT6	siRNA	to	effectively	knockdown	the	expression	of		
the	protein,	the	following	experiment	was	carried	out.	Figure	5.3B	shows	validation	of	HA-
CNOT6	 and	 HA-CNOT6L	 plasmids	 received	 from	 Dr	 Sebastian	 Winkler	 (University	 of	
Nottingham).	U20S	and	HeLa	cells	were	transfected	with	HA-CNOT6	and	HA-CNOT6L	along	
with	 pEGFP-C3	 and	 pcDNA3.1	 as	 controls.	 48	 hours	 later	 the	 cells	 were	 harvested,	
fractionated	by	SDS-PAGE	and	subjected	to	Western	blotting	using	a	HA	antibody	to	assess	
the	 efficiency	 of	 the	 transfection	 (Figure	 5.2B).	 Following	 confirmation	 of	 successful	
transfection,	the	experiment	was	repeated	but	this	time	in	the	presence	of	siRNA.	HeLa	cells	
were	transfected	with	control	siRNA,	CNOT6,	CNOT6L	or	CNOT6/CNOT6L	siRNA	and	48	hours	
later,	were	further	transfected	with	HA-CNOT6	or	HA-CNOT6L	along	with	the	empty	vectors	
pEGFP-C3	and	pcDNA3.1.	 	48	hours	 later	cells	were	harvested,	subjected	to	SDS-PAGE	and	
Western	 blotting	with	 the	 required	 antibodies.	Western	 blot	 analysis	 showed	 that	 CNOT6	
siRNA	 does	 indeed	 reduce	 the	 levels	 of	 ectopically	 expressed	 CNOT6	 (Figure	 5.2C).	
Furthermore,	 knockdown	 of	 CNOT6L	 has	 no	 effect	 on	 CNOT6	 expression	 and	 vice	 versa	
(Figure	5.2C).			
	
5.2.4	CNOT4	or	CNOT6	Knockdown	has	no	Effect	on	Adenoviral	Protein	Expression	
To	further	investigate	if	the	CNOT	complex	has	any	role	during	adenovirus	infection,	
the	effect	of	CNOT4	or	CNOT6	knockdown	on	the	expression	of	various	adenoviral	proteins	
was	also	analysed.	HeLa	cells	were	transfected	with	control,	CNOT4	or	CNOT6	siRNA	and	48	
hours	 later,	either	mock-infected	or	 infected	with	Ad5	or	Ad12	at	an	MOI	of	5.	Cells	were	
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harvested	at	0,	8,	24,	48	and	72	hours	post-infection,	subjected	to	SDS-PAGE	and	Western	
blotting	 using	 the	 appropriate	 antibodies.	 CNOT4	 was	 immunoblotted	 to	 assess	 the	
efficiency	of	the	CNOT4	siRNA,	CNOT6	was	not	immunoblotted	since	no	known	commercial	
antibodies	 are	 specific	 for	 this	 protein	 (see	 Section	 5.2.3).	 E1A,	 E1B55K,	Hexon	 (Ad5)	 and	
Knob	 (Ad12)	were	 immunoblotted	as	markers	of	adenovirus	 infection,	Mre11	as	a	protein	
known	 to	 be	 degraded	 during	 Ad5	 and	Ad12	 infection	 and	 β-Actin	was	 used	 as	 a	 loading	
control	(Figure	5.3)	(Stracker,	Carson	et	al.	2002).			
In	 control	 siRNA	 treated	 cells	 infected	with	 Ad5,	 the	 expression	 of	 the	 adenovirus	
early	protein	E1A	appeared	8	hours	post-infection,	whilst	the	expression	of	the	adenovirus	
early	protein	E1B55K	and	the	adenovirus	structural	protein	Hexon	was	seen	24	hours	post-
infection.	Mre11	had	begun	to	be	degraded	by	24	hours	post-infection.	In	both	CNOT4	and	
CNOT6	 siRNA	 treated	 cells	 infected	 with	 Ad5,	 the	 protein	 expression	 of	 the	 adenoviral	
proteins	was	comparable	to	control	siRNA	treated,	infected	cells.	The	expression	of	E1A	also	
appeared	8	hours	post-infection	in	cells	treated	with	both	CNOT4	and	CNOT6	siRNA,	whilst	
the	expression	of	E1B55K	and	Hexon	appeared	24	hours	post-infection	 in	both	CNOT4	and	
CNOT6	siRNA	treated	cells.	Finally,	the	degradation	of	Mre11	during	Ad5	infection	in	CNOT4	
and	CNOT6	siRNA	treated	cells	was	also	comparable	to	control	siRNA	treated	cells,	where	it	
began	to	be	degraded	24	hours	post-infection	(Figure	5.3A).			
In	control	 siRNA	treated	cells	 infected	with	Ad12,	 the	expression	of	 the	adenovirus	
early	protein	E1A	appeared	8	hours	post-infection,	whilst	the	expression	of	the	adenovirus	
early	protein	E1B55K	and	the	viral	structural	protein	Knob	appeared	24	hours	post-infection.	
Mre11	 was	 degraded	 24	 hours	 post-infection	 in	 control	 siRNA	 treated	 infected	 cells.	 In	
CNOT4	and	CNOT6	siRNA	treated	cells	infected	with	Ad12,	the	protein	expression	of	both		
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Figure	5.3:	CNOT4	or	CNOT6	Knockdown	has	no	Effect	on	Adenoviral	Protein	Expression.	
HeLa	cells	were	transfected	with	control,	CNOT4	or	CNOT6	siRNA	and	48	hours	later	mock-
infected	or	infected	with	(A)	Ad5	or	(B)	Ad12	at	an	MOI	of	5.	Cells	were	harvested	at	0,	8,	24,	
48	 and	 72	 hours	 post-infection,	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 using	 the	
indicated	 antibodies.	 These	 Western	 blots	 are	 representative	 of	 three	 independent	
experiments.		
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adenoviral	early	and	structural	proteins	was	comparable	to	control	siRNA	treated	cells.	The	
expression	of	E1A	also	appeared	8	hours	post-infection,	whilst	the	expression	of	E1B55K	and	
Knob	also	appeared	24	hours	post-infection.	The	degradation	of	Mre11	in	CNOT4	and	CNOT6	
siRNA	 treated	 cells	 was	 also	 comparable	 to	 control	 siRNA	 treated	 cells,	 where	 it	 was	
degraded	24	hours	post-infection	(Figure	5.3B).	
Taken	 together	 these	 data	 show	 that	 the	 knockdown	 of	 CNOT4	 or	 CNOT6	 has	 no	
effect	on	the	expression	of	adenovirus	proteins	during	Ad5	or	Ad12	infection.		
	
5.2.5	CNOT4	Depleted	Cells	Display	Normal	DNA	Fibre	Structures	following	HU	Release,	
Whilst	CNOT6	Depleted	Cells	Display	Excessive	New	Origin	Firing	
Studies	in	budding	yeast	have	shown	that	CCR4-NOT	complex	may	have	a	role	in	the	
response	 to	 replication	 stress,	 since	 a	 number	 of	 yeast	 mutant	 strains	 of	 various	
components	of	the	CCR4-NOT	complex	are	sensitive	to	agents	that	induce	replication	stress	
(Bennett,	Lewis	et	al.	2001,	Westmoreland,	Marks	et	al.	2004,	Mulder,	Winkler	et	al.	2005,	
Traven,	Hammet	et	al.	2005,	Woolstencroft,	Beilharz	et	al.	2006,	Deshpande,	Hayles	et	al.	
2009).	 To	 investigate	 this	 further,	 DNA	 fibre	 structure	 analysis	 was	 performed	 in	 cells	
depleted	of	CNOT4	and	CNOT6.		HeLa	cells	were	transfected	with	control,	CNOT4	or	CNOT6	
siRNA	 and	 48	 hours	 later,	 labelled	with	 the	DNA	 analogue	 CldU.	 Following	 CldU	 labelling,	
cells	were	mock-treated	or	treated	with	2mM	HU	for	2	hours,	and	subsequently	 incubated	
with	 IdU	 in	 HU-free	 media.	 	 Cells	 were	 fixed,	 spread	 onto	 slides	 and	 incubated	 with	
antibodies	against	CldU	and	IdU.	DNA	was	viewed	under	the	microscope	and	DNA	structures	
observed	recorded	(Figure	5.4).	DNA	tracks	were	analysed	and	categorised	into	the			
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Figure	 5.4:	 CNOT4	 Depleted	 Cells	 Display	 Normal	 DNA	 Fibre	 Structures	 following	 HU	
Release,	Whilst	CNOT6	Depleted	Cells	Display	Excessive	New	Origin	Firing.	HeLa	cells	were	
transfected	with	control,	CNOT4	or	CNOT6	siRNA.	48	hours	post-transfection,	the	cells	were	
incubated	with	CldU	for	20	minutes	and	then	were	mock-treated	or	treated	with	2mM	HU	
for	2	hours.	Following	HU	treatment,	the	cells	were	incubated	with	IdU	in	HU-free	media	for	
45	 minutes.	 DNA	 was	 spread	 onto	 slides,	 probed	 with	 the	 appropriate	 antibodies	 and	
visualised	by	fluorescence	microscopy.	Graphs	show	the	fibre	structures	as	a	percentage	of	
all	CldU	labelled	structures.	(A)	DNA	fibre	structures	after	CNOT4	knockdown.	(B)	DNA	fibre	
structures	after	CNOT6	knockdown.	Error	bars	represent	SEM.	These	data	are	representative	
of	three	independent	experiments.		
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structures	as	described	previously	 (Section	4.2.8).	 Confirmation	of	CNOT4	knockdown	was	
achieved	by	Western	blotting	(data	not	shown).	
In	 CNOT4	 siRNA	 treated,	 undamaged	 cells,	 the	 percentage	 of	 ‘ongoing	 forks’	 was	
comparable	to	control	siRNA	treated,	undamaged	cells	at	79%.	The	percentage	of	‘1st	 label	
origins’	was	4%	and	‘2nd	label	origins’	were	11%.	‘1st	label	terminations’	were	13%	and	finally	
‘2nd	label	terminations’	were	4%.	In	CNOT4	siRNA	cells	exposed	to	2mM	HU	for	2	hours,	the	
percentages	 of	 the	 different	DNA	 structures	were	 all	 similar	 to	 control,	HU	exposed	 cells.	
Again,	in	CNOT6	transfected,	undamaged	cells,	the	percentages	of	DNA	fibre	structures	were	
all	 similar	 to	 control,	 undamaged	 cells.	 However,	 even	 though	 ‘ongoing	 forks’,	 ‘1st	 label	
origins’,	 ‘1st	 label	 terminations’	 and	 ‘2nd	 label	 terminations	 were	 similar	 in	 CNOT6	 and	
control	 siRNA	 transfected	 cells	 after	 release	 from	HU	block,	 this	was	not	 the	 case	 for	 ‘2nd	
label	 origins’	 that	 were	 significantly	 increased	 in	 CNOT6	 siRNA	 treated	 cells	 by	 34%	
compared	to	control	cells	(Figure	5.4).		
Taken	together,	these	results	showed	that	CNOT4	knockdown	has	no	effect	on	DNA	
replication	progression	 following	HU	 treatment.	However,	 the	depletion	of	CNOT6	 in	 cells	
exposed	to	HU	caused	a	similar	effect	on	‘2nd	 label	origins’	as	the	one	previously	observed	
following	 TAB182	 knockdown.	 This	 suggested	 that	 TAB182	 and	CNOT6	may	be	 acting	 in	 a	
common	pathway	in	response	to	replication	stress.		
	
5.2.6	Fibres	Structure	Analysis	after	Double	Knockdown	of	TAB182	and	either	CNOT4	or	
CNOT6	
Double	knockdowns	with	TAB182	and	either	CNOT4	or	CNOT6	were	also	performed	
and	 the	 DNA	 fibre	 structures	 determined.	 HeLa	 cells	 were	 transfected	with	 the	 following	
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combinations;	control;	TAB182;	CNOT4;	CNOT6;	TAB182	and	CNOT4;	or	TAB182	and	CNOT6.	
48	 hours	 later,	 cells	were	 labelled	with	 the	 DNA	 analogue	 CldU.	 Following	 CldU	 labelling,	
cells	were	mock-treated	or	treated	with	2mM	HU	for	2	hours,	and	subsequently	 incubated	
with	 IdU	 in	 HU-free	media.	 	 Cells	 were	 then	 processed	 for	 DNA	 fibre	 analysis	 as	 before.	
Double	knockdowns	were	validated	by	Western	blotting,	note	there	was	no	specific	CNOT6	
antibody	 available	 in	 this	 study	 and	 therefore	 CNOT6	 knockdown	 could	 not	 be	 validated		
(Figures	5.2	and	5.5C).	
Since	we	are	purely	interested	in	‘2nd	label	origins’	and	‘1st	label	terminations’	at	this	
stage	 none	 of	 the	 other	 structures	will	 be	 referred	 to	 in	 this	 section	 (see	 Figure	 5.5A	 for	
more	 detailed	 results).	 As	 previously	 discussed,	 the	 percentage	 of	 ‘2nd	 label	 origins’	 in	
control	siRNA	treated	undamaged	cells	was	approximately	11%,	decreasing	to	3%	upon	the	
addition	 of	 HU	 treatment.	 As	 previously	 seen	 in	 Figure	 4.8,	 the	 percentage	 of	 ‘2nd	 label	
origins’	in	TAB182	siRNA	treated	undamaged	cells	was	also	approximately	10%,	but	upon	the	
addition	of	HU	treatment	was	increased	to	approximately	18%.	The	percentage	of	‘2nd	label	
origins’	 in	 CNOT4	 siRNA	 treated,	 undamaged	 cells	 was	 approximately	 11%,	 decreasing	 to	
approximately	3%	upon	the	addition	of	HU,	which	was	similar	to	control	siRNA	treated	cells	
(Figure	5.5A).	In	TAB182/CNOT4	double	knockdown	cells	this	percentage	was	approximately	
11%	 in	 undamaged	 cells	 and	 upon	 the	 addition	 of	 HU,	 remains	 similar,	 suggesting	 that	
CNOT4	 may	 be	 able	 to	 partially	 rescue	 elevated	 new	 origin	 firing	 observed	 in	 TAB182	
deficient	cells	alone	(Figure	5.5A).	In	contrast	to	CNOT4,	the	percentage	of	‘2nd	label	origins’	
after	 CNOT6	 siRNA	 treatment	 was	 approximately	 9%	 and	 following	 release	 from	 HU	
treatment,	increased	to	approximately	19%.	In	TAB182/CNOT6	double	knockdown	cells,	this	
percentage	increased	from	8%	in	undamaged	cells,	to	17%,	similar	to	TAB182	or	CNOT6		
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Figure	5.5:	DNA	Fibre	Structures	After	Double	Knockdowns	of	TAB182	with	either	CNOT4	
or	 CNOT6.	 HeLa	 cells	 were	 transfected	 with	 control,	 TAB182,	 CNOT4,	 CNOT6,	
TAB182/CNOT4	 or	 TAB182/CNOT6	 siRNA	 and	 were	 then	 treated	 as	 in	 Figure	 5.4.	 Graphs	
show	 the	 fibre	 structures	 as	 a	 percentage	 of	 all	 CldU	 structures.	 (A)	DNA	 fibre	 structures	
after	 TAB182/CNOT4	 double	 knockdown.	 (B)	 DNA	 fibre	 structures	 after	 TAB182/CNOT6	
double	knockdown.	Error	bars	represent	SEM.	(C)	Western	blot	shows	validation	of	TAB182,	
CNOT4,	 CNOT6,	 TAB182/CNOT4	 and	 TAB182/CNOT6	 knockdowns.	 These	 data	 are	
representative	of	three	independent	experiments.			
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siRNA	transfected	cells	alone.	This	suggests	that	firstly,	upon	deletion	of	TAB182	or	CNOT6	a	
similar	defect	in	new	origin	firing	is	observed	in	response	to	replication	stress	and	secondly,	
that	this	defect	is	not	further	enhanced	in	cells	deficient	in	both	TAB182	and	CNOT6	(Figure	
5.5B).		
The	percentage	of	‘1st	label	terminations’	in	control	siRNA	undamaged	cells	was	12%	
and	 increased	to	28%	upon	the	addition	of	HU.	 In	TAB182	defective,	undamaged	cells,	 the	
percentage	of	‘1st	label	terminations’	was	approximately	10%	increasing	up	to	14%	upon	the	
addition	 of	 HU.	 In	 CNOT4	 depleted,	 undamaged	 cells	 the	 percentage	 of	 ‘1st	 label	
terminations’	 was	 approximately	 12%	 and	 increased	 up	 to	 31%	 upon	 the	 addition	 of	 HU	
similarly	 to	 control	 cells.	 In	 TAB182/CNOT4	 double	 knockdown	 undamaged	 cells	 the	
percentage	 of	 ‘1st	 label	 terminations’	 was	 approximately	 12%	 and	 following	 HU	 release	
increased	 up	 to	 29%.	 This	 suggests	 that	 CNOT4	 depletion	 can	 restore	 the	 ‘1st	 label	
termination’	 defect	 observed	 in	 TAB182	 deficient	 cells	 to	 control	 levels	 following	 HU	
treatment	(Figure	5.5A).	
In	CNOT6	deficient,	undamaged	cells	 the	percentage	of	 ‘1st	 label	 terminations’	was	
9%,	increasing	to	approximately	27%	after	HU	release,	as	in	control	cells.	In	TAB182/CNOT6	
double	 knockdown	undamaged	 cells	 this	 percentage	was	 approximately	9%	and	 remained	
the	same	after	release	from	HU.	This	indicates	that	CNOT6	knockdown	cannot	rescue	the	‘1st	
label	termination’	defect	observed	in	TAB182	deficient	cells.		
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5.2.7	Depletion	of	CNOT4	or	CNOT6	Results	in	Hypersensitivity	to	HU	which	is	Additive	
Upon	Co-Depletion	of	TAB182.	
Since	 TAB182	was	 shown	 to	 associate	with	 components	 of	 the	 CNOT	 complex,	we	
also	aimed	 to	examine	how	CNOT4	and	CNOT6	 impacts	on	cellular	 survival	 in	 response	 to	
replication	 stress.	 To	 this	 end,	 HeLa	 cells	 were	 transfected	 with	 the	 following	 siRNA	
combinations;	control;	TAB182;	CNOT4;	CNOT6;	TAB182	and	CNOT4;	or	TAB182	and	CNOT6.		
48	 hours	 later,	 the	 cells	were	 plated	 at	 various	 densities	 and	were	 exposed	 to	 increasing	
concentrations	 of	 HU	 (0-10mM	HU).	 Following	 exposure,	 the	 cells	 were	 incubated	 for	 14	
days	and	the	colonies	formed	were	stained	and	counted.	Colony	numbers	were	plotted	on	
survival	 graphs	and	analysed	 (Figure	5.6).	Confirmation	of	 TAB182	and	CNOT4	knockdown	
was	achieved	by	Western	blotting	(Figure	5.5C).	
As	 previously	 shown	 (Figure	 4.2),	 TAB182	 deficient	 cells	 are	 sensitive	 to	 HU.	
Interestingly,	CNOT4	and	CNOT6	are	also	similarly	sensitive	to	HU	as	TAB182.	When	double	
knockdowns	 of	 TAB182	 and	 CNOT4,	 or	 TAB182	 and	 CNOT6	 were	 performed,	 the	 HU	
sensitivity	 was	 additive	 in	 all	 cases	 compared	 to	 single	 knockdowns	 of	 these	 proteins,	
suggesting	 that	 TAB182	 and	 CNOT4/CNOT6	 are	 not	 epistatic	 in	 the	 survival	 following	
replication	stress	(Figure	5.6).		
	
5.2.8	TAB182	Depletion	has	no	Effect	on	RNR	Expression	
Previous	studies	in	the	literature	suggested	that	components	of	the	yeast	CCR4-NOT	
complex	were	 able	 to	 affect	 the	 expression	 of	 components	 of	 the	 RNR	 complex	 (Mulder,	
Winkler	 et	 al.	 2005,	 Takahashi,	 Kontani	 et	 al.	 2007).	 To	 determine	 whether	 some	
components	of	the	CNOT	complex	have	a	similar	function	in	mammalian	cells,	the		
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Figure	 5.6:	 Depletion	 of	 CNOT4	 or	 CNOT6	 Results	 in	 Hypersensitivity	 to	 HU	 which	 is	
Additive	 Upon	 Co-Depletion	 of	 TAB182.	 HeLa	 cells	 were	 transfected	 with	 one	 of	 the	
following	combinations;	TAB182;	CNOT4;	CNOT6;	TAB182	and	CNOT4;	TAB182	and	CNOT6	
TAB182,	along	with	non-targeting	control	siRNA.	48	hours	later,	the	cells	were	then	exposed	
to	 increasing	doses	of	HU.	Following	exposure,	 the	cells	were	replated	 in	 fresh	media	and	
further	incubated	for	14	days.	The	colonies	formed	were	stained	with	0.5%	crystal	violet	in	
20%	ethanol.	Colonies	were	counted	and	the	data	plotted	on	survival	graphs.	This	graph	is	
representative	of	three	independent	experiments.		
	
		 231	
	 	
p53R2&
R2&
R1&
CNOT4&
TAB182&
Co
nt
ro
l&s
iR
N
A&
TA
B1
82
&si
RN
A&
CN
O
T4
&si
RN
A&
CN
O
T6
&si
RN
A&
Figure	5.7:	TAB182	Depletion	has	no	Effect	on	RNR	Expression.	HeLa	cells	were	
transfected	 with	 control,	 TAB182,	 CNOT4	 or	 CNOT6	 siRNA.	 48	 hours	 post-
transfection	cells	were	harvested,	and	the	resulting	cell	 lysates	subjected	to	SDS-
PAGE	and	Western	blotting	using	the	indicated	antibodies.		
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expression	 levels	of	components	of	 the	RNR	complex	were	assessed	after	TAB182,	CNOT4	
and	CNOT6	depletion.	HeLa	cells	were	transfected	with	control,	TAB182,	CNOT4	or	CNOT6	
siRNA	and	harvested	48	hours	later.	Cells	were	subjected	to	SDS-PAGE	and	Western	blotting	
using	antibodies	against	R1,	R2	and	p53R2	(Figure	5.7).		
Knockdown	of	TAB182	expression	appeared	 to	have	no	effect	on	 the	expression	of	
R1,	R2	or	p53R2.	Slightly	 reduced	 levels	of	R1	and	R2	expression	were	observed	 in	CNOT4	
deficient	 cells,	 whilst	 the	 expression	 of	 p53R2	 remained	 unaltered	 following	 CNOT4	
knockdown.	 Similarly	 to	 TAB182	depleted	 cells,	 in	CNOT6	deficient	 cells,	 no	differences	 in	
the	expression	of	R1,	R2	or	p53R2	were	observed.	Interestingly,	knockdown	of	both	CNOT4	
and	CNOT6	appeared	to	reduce	the	expression	of	TAB182,	suggesting	that	the	expression	of	
these	proteins	may	be	important	for	TAB182	levels	(Figure	5.7).		
	
5.2.9	TAB182	is	Associated	with	Deadenylase	Activity	
To	 ascertain	 whether	 TAB182	 is	 associated	 with	 an	 enzymatically	 active	 CNOT	
complex,	 simple	 deadenylation	 assays	were	 carried	 out.	 TAB182	was	 immunoprecipitated	
from	 a	 HeLa	 cell	 extract	 and	 then	the	washed	 protein	 G-agarose/antibody/antigen	
pellet	was	incubated	with	an	adenylated	ribonucleotide	(see	Section	2.3.7).	After	an	hour,	an	
aliquot	of	the	assay	mixture	was	fractionated	on	an	acrylamide	gel	run	in	the	presence	of	8M	
urea.	Figure	5.8A	shows	that	 the	TAB182	 immunoprecipitate	has	deadenylase	activity	with	
the	deadenylated	ribonucleotide	migrating	faster	(as	it	has	a	lower	molecular	weight	due	to	
the	 loss	 of	 adenyl	moieties)	and	 the	 concentration	 of	 the	 full-length	 ribonucleotide	 being	
markedly	reduced	(Figure	5.8A).	 Interestingly,	Ad5	and	Ad12	E1B	immunoprecipitates	were	
also	shown	to	have	deadenylase	activity.	Furthermore,	Figure	5.8B	shows	that	deadenylase		
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Figure	 5.8:	 TAB182	 is	 Associated	 with	 Deadenylase	 Activity.	 (A)	 TAB182	 and	 adenovirus	
E1B55K	proteins	were	 immunoprecipitated	from	HeLa	and	adenovirus	E1	transformed	cells,	
respectively.	 Antibody/antigen	 complexes	 were	 incubated	 at	 37ᵒC	 in	 appropriate	 buffer	
containing	a	target	 fluorescein-labelled	ribonucleotide	as	described	 in	Section	2.3.7.	After	1	
hour	 the	 reaction	 supernatant	 was	 mixed	 with	 RNA	 loading	 buffer,	 heated	 at	 85ᵒC	 and	
subjected	 to	electrophoresis	on	a	20%	 acrylamide	gel	 run	 in	 the	presence	of	8M	urea/TBE.	
Fluoroscein-labelled	 ribonucleotide	 was	 visualised	 using	 a	 Fusion	 SL	 chemiluminescence	
imaging	system.	‘Control’	lane	represents	untreated	ribonucleotide.	(B)	Cell	lysates	from	Ad5	
and	 Ad12	 infected	 HeLa	 cells	 were	 incubated	 with	 fluorescein-labelled	 ribonucleotide	 as	
described	 above.	 After	 1	 hour	 an	 aliquot	 was	 subjected	 to	 electrophoresis	 and	 the	 gel	
visualised	using	the	Fusion	SL	chemiluminescence	imaging	system.	
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activity	is	present	in	the	cell	lysates	from	adenovirus	infected	cells.	As	CNOT	components	are	
degraded	during	viral	 infection	we	considered	that	this	might	result	 in	 loss	of	deadenylase	
activity;	however	the	data	presented	suggested	that	this	is	not	the	case.	
5.3	DISCUSSION	
Mass	spectrometry	experiments	described	in	this	chapter	indicated	that	TAB182	was	
associated	 with	 a	 number	 of	 subunits	 of	 the	 CNOT	 complex	 including	 CNOT1,	 CNOT2,	
CNOT3,	CNOT6L,	CNOT7,	CNOT8,	CNOT9,	CNOT10	and	CNOT11	in	both	uninfected	HeLa	cells	
and	Ad5	and	Ad12	 infected	cells	 (Table	5.1).	CNOT3	and	CNOT7	were	 shown	 to	be	down-
regulated	following	both	Ad5	and	Ad12	infection,	suggesting	that	components	of	the	CNOT	
complex	may	also	be	targeted	by	adenovirus	for	degradation	(Figure	5.1).	DNA	fibre	analysis	
revealed	 that	CNOT4	depleted	 cells	 exhibited	 replication	dynamics	 similar	 to	 control	 cells,	
but	 interestingly,	CNOT4	knockdown	 in	TAB182	deficient	 cells	was	able	 to	partially	 rescue	
the	 new	origin	 firing	 defect	 observed	 and	 to	 completely	 rescue	 the	 increased	 fork	 restart	
observed	in	TAB182	deficient	cells	following	release	from	replication	block	(Figures	5.4	and	
5.5).	CNOT6	depleted	cells	showed	firstly,	an	increase	in	new	origin	firing	after	release	from	
HU	 that	was	 comparable	 to	 that	 observed	 in	 TAB182	depleted	 cells,	 and	 secondly,	 a	mild	
increase	 in	fork	restart	 (Figure	5.4).	 Interestingly,	CNOT6	and	TAB182	were	epistatic	 in	the	
new	 origin	 defect	 observed	 following	 release	 from	 HU.	 However,	 CNOT6	 knockdown	 in	
TAB182	 deficient	 cells	 had	 no	 effect	 on	 the	 increased	 fork	 restart	 observed	 in	 these	 cells	
(Figure	 5.5).	 Interestingly,	 colony	 survival	 assays	 of	 single	 or	 double	 knockdowns	 showed	
that	 CNOT4	 or	 CNOT6	 were	 not	 epistatic	 with	 TAB182	 (Figure	 5.6).	 Defects	 observed	 in	
TAB182,	 CNOT4	 and	 CNOT6	 proteins	 were	 shown	 to	 not	 be	 a	 product	 of	 affecting	 RNR	
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expression,	although	depletion	of	CNOT4	was	 shown	 to	mildly	affect	 the	expression	of	R1	
and	R2	 (Figure	5.7).	 Finally,	 TAB182	was	 shown	 to	have	associated	deadenylase	activity	 in	
vivo	(Figure	5.8).		
There	 is	 limited	 information	about	the	function	of	TAB182,	but	some	reports	 in	the	
literature	have	suggested	that	TAB182	interacts	with	a	large,	multi-subunit	complex	known	
as	 the	 CCR4-NOT	 complex	 in	 yeast,	 and	 the	 CNOT	 complex	 in	 mammalian	 cells	 (Morita,	
Suzuki	et	al.	2007,	Lau,	Kolkman	et	al.	2009).	Our	mass	spectrometry	data	have	confirmed	
that	 TAB182	 interacts	with	 a	 number	 of	 subunits	 of	 the	 CNOT	 complex	 including	 CNOT1,	
CNOT2,	CNOT3,	CNOT6L,	CNOT7,	CNOT8,	CNOT9,	CNOT10	and	CNOT11	 in	both	uninfected	
HeLa	cells	and	Ad5	and	Ad12	infected	cells	(Table	5.1).	Regarding	adenovirus	infection,	this	
suggests	that	infection	has	no	effect	on	the	interaction	between	TAB182	and	components	of	
the	CNOT	 complex.	 Interestingly,	 neither	CNOT4	nor	CNOT6	were	detected	 in	 TAB182	 co-
immunoprecipitates.	The	explanation	for	the	lack	of	detection	of	CNOT6	may	be	due	to	the	
high	amino	acid	sequence	similarity	(79%)	between	CNOT6	and	CNOT6L,	and	so	CNOT6	may	
be	 identified	 as	 CNOT6L.	 The	 CNOT	 complex	 is	 a	 highly	 conserved,	multi-subunit	 complex	
with	roles	in	the	regulation	of	gene	expression.	It	has	been	implicated	in	mRNA	regulation,	
transcription	 elongation,	 chromatin	 modifications	 and	 interestingly,	 the	 DDR	 (Liu,	
Badarinarayana	et	al.	1998,	Bennett,	Lewis	et	al.	2001,	Tucker,	Valencia-Sanchez	et	al.	2001,	
Westmoreland,	Marks	et	al.	2004,	Mulder,	Winkler	et	al.	2005,	Traven,	Hammet	et	al.	2005,	
Woolstencroft,	Beilharz	et	al.	2006,	Deshpande,	Hayles	et	al.	2009).	Although	the	majority	of	
studies	on	the	CCR4-NOT	complex	have	been	performed	in	mutant	yeast	strains,	a	study	by	
Lau	 and	 colleagues	 in	 HeLa	 cells	 has	 helped	 to	 elucidate	 the	 composition	 of	 the	 CNOT	
complex	 and	 its	 interacting	 proteins	 in	 human	 cells.	 Also	 using	 mass	 spectrometry,	 this	
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group	 found	 the	 core	 components	 of	 the	 CNOT	 complex	 to	 be	 CNOT1,	 CNOT2,	 CNOT3,	
CNOT9,	 CNOT10	 and	 the	 two	previously	 unidentified	CNOT	 complex	 components	 CNOT11	
and	 TAB182.	 Interestingly,	 the	 deadenylases	 CNOT6,	 CNOT6L,	 CNOT7	 and	 CNOT8	 were	
found	 to	 be	 variable	 subunits	 of	 the	 CNOT	 complex.	 CNOT7	 was	 not	 found	 in	 CNOT8	
purifications,	nor	CNOT8	 found	 in	CNOT7	purifications,	 suggesting	 that	CNOT7	and	CNOT8	
exist	 in	 separate	complexes.	Furthermore,	both	CNOT6/CNOT6L	were	 identified	 in	CNOT7,	
but	not	CNOT8	purifications,	 suggesting	 that	CNOT6/CNOT6L	does	not	 stably	 interact	with	
CNOT8	(Figure	1.15)	(Lau,	Kolkman	et	al.	2009).	In	the	TAB182	purifications	presented	in	this	
chapter,	 no	 co-purification	 between	 TAB182	 and	 CNOT4	 was	 observed,	 confirming	 that	
CNOT4	is	not	a	core	component	of	the	CNOT	complex.	In	this	regard,	the	lack	of	TAB182	co-
purification	with	CNOT6	may	also	be	due	to	CNOT6	not	being	a	core	component	of	the	CNOT	
complex.	In	addition,	CNOT7	and	CNOT8	were	identified	in	our	co-purifications	even	though	
these	 subunits	are	not	 thought	 to	 stably	 interact	with	 the	core	CNOT	complex,	 suggesting	
that	 either	 CNOT7/CNOT8	 transiently	 associate	 with	 TAB182	 and/or	 TAB182	may	 be	 in	 a	
complex	 with	 CNOT7/CNOT8	 (Table	 5.1).	 PRMT3	 and	 FHL2	 were	 also	 identified	 in	 the	
TAB182	 mass	 spectrometry	 screen.	 PRMT3	 is	 a	 type	 I	 arginine	 methyltransferase	 which	
catalyses	 the	methylation	 of	 guanidine	 nitrogens	 of	 arginine	 residues	 of	 proteins.	 Protein	
arginine	methylation	has	a	 role	 in	a	number	of	 cellular	 functions	 including	protein-protein	
interactions,	protein	 localisation	and	DNA	 repair	 (Tang,	Gary	et	al.	 1998).	 FHL2	belongs	 to	
the	FHL	family	of	transcription	co-repressors	and	has	been	shown	to	interact	with	a	number	
of	transcription	factors	linked	to	tumour	development	(Kleiber,	Strebhardt	et	al.	2007).	FHL2	
has	also	been	shown	to	interact	with	BRCA1	and	enhances	the	transactivation	of	FHL2	(Yan,	
Zhu	et	al.	2003).	As	yet	the	function	of	the	potential	interaction	between	PRMT3	and	FHL2	
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with	TAB182	is	unknown	(Table	5.1).	The	TAB182	interacting	proteins	Tankyrase	1,	Chk1	and	
Aurora	 kinase	 that	were	 identified	 in	 the	 GST	 pull-downs	 performed	 in	 this	 study	 (Figure	
4.12),	 were	 not	 identified	 in	 the	 mass	 spectrometry	 screen.	 There	 are	 a	 number	 of	
explanations	 for	 the	different	 interacting	proteins	 identified	between	experiments.	 Firstly,	
the	mass	spectrometry	screen	was	performed	following	co-immunoprecipitation	assays	and	
not	GST	pull-downs,	and	so	could	yield	different	results.	Secondly,	the	GST	pull-downs	were	
performed	 using	 a	 C-terminal	 fragment	 (Figure	 3.11)	 of	 TAB182	 only	 and	 may	 not	 be	
representative	of	the	entire	TAB182	protein	as	in	the	mass	spectrometry	experiment.	Finally,	
the	mass	spectrometry	experiment	was	performed	in	whole	cell	lysates	and	thus	a	large	pool	
of	 TAB182	 interacting	proteins	were	 identified,	whereas	 the	GST	pull-downs	were	only	an	
examination	 of	 TAB182	 interaction	 with	 one	 protein.	 For	 this	 reason	 less	 abundant	
interactions,	 for	example,	 Tankyrase	1,	Chk1	and	Aurora	kinase,	may	be	masked	by	 larger	
protein	pools,	for	example,	such	as	those	with	the	CNOT	complex.			
Results	 from	 Table	 5.1	 showed	 that	 adenovirus	 infection	 had	 no	 effect	 on	 the	
interaction	between	TAB182	and	components	of	the	CNOT	complex.	Since	TAB182	appeared	
to	 be	 a	 stable	 core	 component	 of	 the	 CNOT	 complex,	 and	 TAB182	 is	 degraded	 during	
infection	with	 a	 number	 of	 different	 adenovirus	 serotypes,	 it	 was	 next	 hypothesised	 that	
components	of	the	CNOT	complex	may	also	be	targeted	for	degradation	during	adenovirus	
infection	 (Figure	 5.1).	 CNOT4	was	not	 down-regulated	 following	 infection	with	 adenovirus	
serotypes	 5	 or	 12.	 Interestingly,	 CNOT3	 and	CNOT7	were	 down-regulated	during	Ad5	 and	
Ad12	 infection,	 indicating	 that	 adenovirus	 may	 also	 target	 at	 least	 two	 other	 CNOT	
components	for	degradation.	Unfortunately,	of	the	panel	of	CNOT6	antibodies	tested,	none	
were	shown	to	be	specific	(using	CNOT6	siRNA)	and	therefore,	analysis	of	CNOT6	levels	after	
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adenovirus	infection	was	not	performed.	Since	depletion	of	TAB182	was	shown	to	affect	the	
levels	 of	 the	 early	 adenoviral	 protein	 E1A	 during	 adenovirus	 infection,	 it	 was	 next	
determined	whether	depletion	of	CNOT4	and	CNOT6	had	 the	 same	effect	on	viral	protein	
expression.	Depletion	of	CNOT4	and	CNOT6	had	no	effect	on	 the	expression	of	any	of	 the	
viral	proteins	detected,	suggesting	that	the	depletion	of	TAB182	may	be	directly	responsible	
for	 the	 changes	 in	 E1A	 protein	 expression	 observed	 in	 TAB182	 deficient	 cells	 in	 Chapter	
Three	(Figures	3.9	and	5.3).		
DNA	 fibre	 analysis	 revealed	 that	 cells	 depleted	 of	 CNOT4	 exhibit	 replication	
structures	similar	to	control	cells	 following	release	from	HU.	 Interestingly,	cells	deficient	 in	
CNOT6	exhibit	a	similar	replication	structure	profile	to	that	of	TAB182	depleted	cells	(Figure	
5.4).	Following	release	from	HU,	CNOT6	knockdown	cells	showed	an	increase	in	new	origin	
firing	similar	to	TAB182	depleted	cells.	Although	CNOT4	depletion	alone	displayed	a	normal	
replication	profile	following	release	from	HU,	CNOT4/TAB182	depleted	cells	partially	rescued	
the	 new	 origin	 firing	 defect	 and	 completely	 rescued	 the	 increased	 fork	 restart	 present	 in	
TAB182	 deficient	 cells	 alone	 (Figure	 5.5).	 This	 suggests	 that	 the	 new	 origin	 firing	 defect	
observed	in	TAB182	depleted	cells	following	release	from	HU	is	partially	dependent	on	the	
activity	 of	 the	 CNOT4	 protein,	 and	 the	 increased	 fork	 restart	 observed	 in	 these	 cells	 is	
completely	dependent	on	CNOT4	activity.	This	leads	to	the	question	of	whether	the	defects	
in	 new	 origin	 firing	 and	 fork	 restart	 are	 dependent	 on	 the	 E3	 ubiquitin	 ligase	 activity	 of	
CNOT4.	 To	 date,	 only	 two	 substrates	 of	 NOT4	 have	 been	 identified	 in	 yeast.	 Nascent	
associated	polypeptide	complex	(NAC),	a	chaperone	protein	which	has	been	shown	to	bind	
nascent	peptides	associated	with	the	ribosome	(Panasenko,	Landrieux	et	al.	2006).	Although	
the	role	for	the	ubiquitination	of	NAC	by	NOT4	is	currently	unknown,	it	has	been	suggested	
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that	the	ubiquitination	of	NAC	stimulates	its	association	with	the	ribosome	and	proteasome	
and	acts	as	a	surveillance	protein	for	transcriptionally-damaged	proteins	(Panasenko,	David	
et	al.	2009).	In	both	yeast	and	human	cells,	NOT4/hCNOT4	has	been	shown	to	ubiquitinate	
and	subsequently	target	the	yeast	histone	3	Lys	4	(H3K4)	demethylase	Jhd2/human	jumonji	
and	 AT-rich	 interaction	 domain	 1C	 (JARID1C)	 protein	 for	 degradation.	 This	 function	 is	
thought	to	achieve	a	balance	between	histone	demethylase	and	histone	methyltransferases	
and	therefore	H3K4	methylation	and	transcription	(Mersman,	Du	et	al.	2009).	Since	only	two	
NOT4/hCNOT4	 substrates	 have	 been	 identified	 to	 date,	 it	 is	 difficult	 to	 speculate	 why	
knockdown	 of	 CNOT4	 is	 able	 to	 rescue	 the	 defects	 observed	 in	 TAB182	 depleted	 cells	
following	release	from	HU.	Since	CNOT4	has	been	shown	to	exist	in	a	complex	distinct	from	
the	core	CNOT	complex,	it	is	likely	that	CNOT4	interacts	with	other	proteins	that	are	yet	to	
be	 identified.	 Identification	of	 such	proteins	may	help	 to	elucidate	 the	 role	of	CNOT4	and	
TAB182	in	response	to	replication	stress.		
Double	 knockdown	of	CNOT6/TAB182	 revealed	 that	 the	excessive	new	origin	 firing	
observed	 following	 release	 from	HU	 in	 these	cells	was	epistatic	 (Figure	5.5).	However,	 the	
double	knockdown	of	CNOT6/TAB182	had	no	effect	on	the	increased	fork	restart	observed	
in	TAB182	deficient	cells	alone,	suggesting	that	CNOT6	cannot	rescue	this	defect.	Reports	in	
the	 literature	 have	 suggested	 that	 sensitivity	 to	 DNA	 damaging	 agents	 in	 CCR4	 (hCNOT6)	
mutant	yeast	strains	is	due	to	the	loss	of	deadenylation	activity	(Traven,	Hammet	et	al.	2005,	
Woolstencroft,	Beilharz	et	al.	2006).	Indeed,	CCR4	has	been	shown	to	regulate	compromised	
recognition	 of	 TCV	 1	 (CRT1)	 mRNA	 poly(A)	 tail	 length,	 a	 transcriptional	 repressor	 of	 a	
number	of	DNA	damage	related	genes	 (Woolstencroft,	Beilharz	et	al.	2006).	We	have	also	
identified	TAB182	to	be	associated	with	a	deadenylase	activity	(Figure	5.8),	suggesting	that	
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together	TAB182	and	CNOT6,	 together	with	other	proteins,	may	deadenylate	various	DNA	
damage	and/or	replication	stress	genes,	and	in	their	absence,	a	number	of	these	genes	are	
not	 deadenylated,	 thus	 explaining	 why	 these	 cells	 display	 elevated	 new	 origin	 firing	
following	release	from	HU.	
Since	 the	 CNOT	 complex	 component	 TAB182	was	 shown	 to	 be	 sensitive	 to	 agents	
that	induced	replication	stress,	and	studies	in	yeast	mutant	strains	had	shown	a	number	of	
components	of	 the	CCR4-NOT	complex	 to	be	sensitive	 to	almost	all	DNA	damaging	agents	
tested,	it	was	hypothesised	that	cells	depleted	of	CNOT4	and	CNOT6	in	mammalian	cells	may	
also	be	sensitive	to	DNA	damaging	agents,	particularly	those	that	induced	replicative	stress	
(Bennett,	Lewis	et	al.	2001,	Westmoreland,	Marks	et	al.	2004,	Mulder,	Winkler	et	al.	2005,	
Traven,	Hammet	et	al.	2005,	Woolstencroft,	Beilharz	et	al.	2006,	Deshpande,	Hayles	et	al.	
2009).	In	this	study,	both	CNOT4	and	CNOT6	depleted	cells	were	shown	to	be	sensitive	to	HU	
to	 a	 similar	 extent	 to	 the	 observed	 sensitivity	 of	 TAB182	 depleted	 cells.	 However,	 double	
knockdown	of	TAB182/CNOT4	or	TAB182/CNOT6	revealed	that	TAB182	and	CNOT4/CNOT6	
act	 independently	 of	 one	 another	 (Figure	 5.6).	 These	 data	 suggest	 the	 mechanisms	 of	
promoting	survival	 in	TAB182	depleted	cells	and	CNOT4/CNOT6	depleted	cells	are	distinct.	
Thorough	studies	have	been	performed	 in	yeast	mutant	strains	 to	address	 the	mechanism	
behind	 the	 sensitivity	 observed	 in	 CNOT4/CNOT6	 deficient	 cells.	 As	 previously	 discussed,	
CCR4	(hCNOT6/hCNOT6L)	yeast	mutant	strains	have	been	shown	to	be	sensitive	to	IR,	UV-C,	
HU,	4-NQO	and	camptothecin	(Bennett,	Lewis	et	al.	2001,	Westmoreland,	Marks	et	al.	2004,	
Mulder,	Winkler	et	al.	2005,	Traven,	Hammet	et	al.	2005,	Woolstencroft,	Beilharz	et	al.	2006,	
Deshpande,	Hayles	et	al.	2009).	Caf1	(CNOT7/CNOT8)	yeast	mutant	strains	have	been	shown	
to	 be	 sensitive	 to	 IR,	 HU,	 4-NQO,	 camptothecin,	 MMS	 (Mulder,	 Winkler	 et	 al.	 2005,	
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Woolstencroft,	 Beilharz	 et	 al.	 2006,	 Deshpande,	 Hayles	 et	 al.	 2009).	 NOT1,	 NOT2,	 NOT3,	
NOT4	 and	 NOT5	 mutant	 yeast	 strains	 have	 been	 shown	 to	 be	 sensitive	 to	 HU	 (Mulder,	
Winkler	 et	 al.	 2005).	 A	 number	 of	 mechanisms	 of	 sensitivity	 have	 been	 postulated.	
Interestingly,	 Woolstencroft	 and	 colleagues	 demonstrated	 that	 CCR4	 (hCNOT6/hCNOT6L)	
yeast	strains	with	mutations	in	the	region	responsible	for	deadenylase	activity	also	displayed	
sensitivity	to	HU,	but	not	to	the	same	extent	as	the	CCR4	deletion	yeast	strain,	suggesting	
that	 the	 sensitivity	 to	 HU	 observed	 in	 CCR4	 mutants	 operates	 via	 both	 deadenylation-
dependent	 and	 independent	 mechanisms.	 Studies	 from	 Traven	 and	 colleagues	 also	
suggested	 that	 the	deadenylase	activity	of	 the	CCR4-NOT	complex	 is	 required	 for	 the	DDR	
(Traven,	 Hammet	 et	 al.	 2005,	 Woolstencroft,	 Beilharz	 et	 al.	 2006).	 Further	 studies	 from	
these	groups	revealed	that	CCR4	and	Chk1	cooperate	 in	 the	same	pathway	 in	 response	to	
replication	stress	induced	by	HU.	CCR4	was	later	found	to	regulate	CRT1	mRNA	poly(A)	tail	
length,	 CRT	 is	 a	 transcriptional	 repressor	 of	 a	 number	 of	 DNA	 damage-related	 genes	 and	
therefore	 the	 sensitivity	 of	 CCR4	 yeast	mutants	was	 attributed	 to	 deregulated	 CRT	mRNA	
poly(A)	 tail	 length	 (Woolstencroft,	 Beilharz	 et	 al.	 2006).	 Another	 study	 by	 Mulder	 and	
colleagues	 suggested	 that	 defective	 RNR	 mRNA	 accumulation	 in	 CCR4-NOT	 mutants	 was	
responsible	for	the	HU	sensitivity	observed	in	these	strains	(Mulder,	Winkler	et	al.	2005).	In	
contrast,	Traven	and	colleagues	showed	that	sensitivity	 to	HU	 is	not	due	to	defective	RNR	
expression	(Traven,	Hammet	et	al.	2005).	Takahashi	and	colleagues	suggested	that	the	Caf1	
(hCNOT7/hCNOT8)	 component	 of	 the	 CNOT	 complex	 is	 responsible	 for	 Spd1	 degradation	
and	 Suc22	 translocation	 (Spd1	 is	 the	 RNR	 inhibitory	 protein	 that	 holds	 Suc22,	 the	 RNR	
regulatory	subunit	in	the	nucleoplasm),	and	therefore	is	sensitive	to	HU	(Takahashi,	Kontani	
et	 al.	 2007).	 It	 therefore	 remains	unclear	what	 the	exact	mechanism	 for	 the	 sensitivity	 to	
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various	 DNA	 damaging	 agents	 is	 in	 cells	 depleted	 of	 various	 CCR4-NOT	 components,	
although	 data	 presented	 here	 suggests	 that	 the	 mechanism	 of	 sensitivity	 of	 TAB182	
depleted	cells	is	distinct	from	CNOT4/CNOT6	depleted	cells.	It	should	be	borne	in	mind	that	
mutation/deletion	of	one	CNOT	component	could	affect	the	complex	as	a	whole	and	might	
impinge	on	other	necessary	activities.		
Numerous	reports	have	suggested	that	RNR	activity	 is	related	to	the	sensitivities	to	
DNA	 agents	 observed	 in	 CCR4-NOT	 mutant	 yeast	 strains	 (Mulder,	 Winkler	 et	 al.	 2005,	
Traven,	Hammet	et	al.	2005,	Takahashi,	Kontani	et	al.	2007).	RNR	catalyses	the	conversion	of	
NDPs	 into	 dNDPs,	 which	 is	 the	 rate	 limiting	 step	 in	 the	 production	 of	 dNTPs	 which	 are	
necessary	 for	 DNA	 replication	 (Jordan	 and	 Reichard	 1998).	 RNR	 activity	 is	 also	 important	
during	 DNA	 damage	 and	 replication	 stress,	 RNR	 genes	 become	 transcriptionally	 active	 in	
response	to	these	conditions.	In	yeast,	four	RNR	subunits	exist	(RNR1-4)	which	are	activated	
in	response	to	DNA	damage	and/or	replication	stress	in	a	Mec1p/Rad53p/Dun1p	dependent	
manner	(Chabes,	Georgieva	et	al.	2003).	Interestingly,	RNR	1,	2,	and	4	yeast	mutant	strains	
display	sensitivities	 to	DNA	damaging	agents	 (Elledge	and	Davis	1989,	Wang,	Chabes	et	al.	
1997).	 In	 mammalian	 cells,	 three	 RNR	 subunits	 exist,	 R1	 and	 R2,	 which	 become	
transcriptionally	 activated	 during	 S	 phase	 in	 order	 to	 allow	 dNTP	 production	 during	 DNA	
replication	 (Chabes,	 Bjorklund	 et	 al.	 2004,	 Hakansson,	 Hofer	 et	 al.	 2006).	 The	 third	
mammalian	 RNR	 subunit,	 known	 as	 p53R2,	 becomes	 transcriptionally	 activated	 by	 p53	
following	DNA	damage	(Tanaka,	Arakawa	et	al.	2000).	Since	the	sensitivity	to	DNA	damaging	
agents	observed	 in	CCR4-NOT	complex	mutants	has	been	 linked	to	RNR	expression,	 it	was	
thought	 that	 TAB182	 depletion	 may	 have	 an	 effect	 on	 mammalian	 RNR	 expression.	
However,	 no	 differences	 in	 the	 expression	 of	 the	 RNR	 subunits	were	 observed	 in	 TAB182	
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depleted	cells,	suggesting	that	the	sensitivity	to	HU	observed	in	these	cells	is	not	due	to	the	
direct	effect	of	TAB182	on	RNR	subunits	expression	(Figure	5.7).	
In	 mammalian	 cells,	 the	 deadenylase	 activity	 of	 the	 CNOT	 complex	 is	 achieved	
through	 the	 CNOT6,	 CNOT6L,	 CNOT7	 and	 CNOT8	 components,	 which	 are	 thought	 to	
transiently	associate	with	the	CNOT	complex	(Figure	1.14)(Lau,	Kolkman	et	al.	2009).	In	this	
study	 it	 was	 shown	 that	 TAB182	 containing	 complexes	 have	 deadenylase	 activity	 (Figure	
5.8).	Interestingly,	it	had	previously	been	assumed	that	the	deadenylase	components	of	the	
CNOT	complex	only	associated	with	the	complex	transiently.	On	the	other	hand,	it	could	be	
that	TAB182	is	not	a	core	component	of	the	complex	as	previously	thought.	 Indeed,	 in	our	
hands	we	have	only	performed	the	co-immunoprecipitations	followed	by	mass	spectrometry	
using	TAB182	as	bait	and	not	vice	versa.	Perhaps,	if	components	of	the	CNOT	complex	were	
used	 as	 bait,	 TAB182	would	 not	 always	 be	 identified	 in	 the	 purifications,	 suggesting	 that	
TAB182	 is	 not	 a	 core	 component	 of	 the	 CNOT	 complex,	 however,	 this	 would	 be	
contradictory	 to	 the	 results	 obtained	 from	 Lau	 and	 colleagues	 (Lau,	 Kolkman	et	 al.	 2009).	
Furthermore,	 deadenylation	 activity	 (or	 lack	 of)	 was	 thought	 to	 be	 responsible	 for	 the	
observed	sensitivities	of	CCR4,	NOT4	and	Caf1	to	DNA	damaging	agents	in	the	yeast	studies	
(Mulder,	Winkler	et	al.	2005,	Woolstencroft,	Beilharz	et	al.	2006,	Takahashi,	Kontani	et	al.	
2007).	 If	 defective	 deadenylation	 activity	 was	 responsible	 for	 the	 sensitivity	 of	 TAB182	
depleted	cells	following	HU,	it	would	be	expected	that	TAB182	and	CNOT6	would	appear	to	
be	epistatic,	 that	 is	of	course	assuming	both	sensitivities	seen	 in	TAB182	and	CNOT6	were	
due	 to	 defective	 deadenylation.	 Of	 course	 the	 diversity	 of	 mechanisms	 that	 have	 been	
postulated	for	the	sensitivities	to	DNA	damaging	agents	of	CCR4-NOT	components	show	that	
a	definitive	mechanism	for	the	observed	sensitivities	is	currently	unclear.					
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6.	FINAL	DISCUSSION	AND	FUTURE	WORK	
6.1	ADENOVIRUS,	TAB182	AND	THE	CNOT	COMPLEX	
Previous	 to	 this	 study,	 little	was	 known	about	 the	 function	of	 TAB182.	 Preliminary	
evidence	from	our	laboratory	suggested	that	TAB182	may	be	degraded	following	adenovirus	
infection.	 Furthermore,	 TAB182	 was	 thought	 to	 be	 a	 potential	 substrate	 of	 ATM/ATR	
phosphorylation	 (Matsuoka,	Ballif	 et	 al.	 2007).	 Taken	 together	 these	observations	pointed	
towards	a	role	for	TAB182	in	the	DNA	damage	response	(DDR).		
In	 this	 study,	 it	 was	 found	 that	 TAB182	 was	 degraded	 following	 Ad5	 and	 Ad12	
infection,	 in	a	manner	that	was	dependent	on	the	adenoviral	E1B55K	and	E4orf6	proteins.	
Furthermore,	the	degradation	of	TAB182	following	Ad5	and	Ad12	infection	was	shown	to	be	
dependent	on	Cul5	and	Cul2,	respectively.	In	addition,	knockdown	of	TAB182	elevated	E1A	
expression	 to	 a	 limited	 extent	 following	 Ad5	 and	 Ad12	 infection,	 suggesting	 that	 its	
expression	 has	 an	 inhibitory	 effect	 on	 viral	 infection.	 This	 is	 also	 the	 case	 for	 Cyclin	 E	
expression	 following	 Ad12	 infection	 in	 TAB182	 depleted	 cells,	 where	 its	 expression	 was	
increased,	 but	 whether	 this	 is	 directly	 regulated	 by	 TAB182,	 or	 via	 transcriptional	
hyperactivation	 mediated	 by	 the	 upregulation	 of	 E1A	 levels	 is	 unclear.	 TAB182	 did	 not	
localise	 to	 VRCs	 following	Ad	 infection,	 but	may	 localise	 to	 nuclear	 tracks	 or	 aggresomes,	
something	that	is	yet	to	be	examined.		
TAB182	 is	 a	 component	 of	 the	 CNOT	 complex,	 which	 in	 yeast,	 has	 roles	 in	mRNA	
regulation,	 transcriptional	 elongation,	 chromatin	 modification	 and	 the	 DDR	 (Liu,	
Badarinarayana	et	al.	1998,	Bennett,	Lewis	et	al.	2001,	Tucker,	Valencia-Sanchez	et	al.	2001,	
Westmoreland,	Marks	et	al.	2004,	Mulder,	Winkler	et	al.	2005,	Traven,	Hammet	et	al.	2005,	
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Woolstencroft,	Beilharz	et	al.	2006,	Deshpande,	Hayles	et	al.	2009).	In	mammalian	cells,	the	
role	of	the	CNOT	complex	is	unknown.	In	this	study,	similarly	to	TAB182,	subunits	of	the	core	
CNOT	complex	(CNOT3	and	CNOT7)	were	shown	to	be	down-regulated	following	adenovirus	
infection.	However,	 in	contrast	to	TAB182,	depletion	of	subunits	of	the	CNOT	complex	had	
no	effect	on	E1A	expression	 following	 infection,	although	 the	CNOT	subunits	used	 for	 this	
experiment	were	 not	 part	 of	 the	 core	 CNOT	 complex.	Whether	 targeting	 both	 TAB182	 as	
well	as	components	of	the	CNOT	complex	provides	an	additional	advantage	for	adenovirus	
infection,	is	unclear	at	present.	
The	use	of	adenovirus	to	study	the	function	of	TAB182	has	suggested	a	role	for	the	
protein	in	the	DDR,	and	more	specifically,	a	potential	role	in	the	regulation	of	the	cell	cycle.	
We	 can	 envisage	 a	 number	 of	 reasons	 why	 adenovirus	 may	 degrade	 TAB182.	 Firstly,	 if	
TAB182	 is	 indeed	 a	 cell	 cycle	 regulatory	 protein,	 its	 degradation	will	 be	 advantageous	 to	
promote	viral	 infection.	Removal	of	 cell	 cycle	 regulatory	proteins	 (such	as	p53)	allows	 the	
cell	 cycle	 to	 proceed	 thus	 allowing	 viral	 DNA	 replication.	 If	 TAB182	 is	 also	 a	 cell	 cycle	
regulatory	protein	this	could	be	the	reason	for	its	degradation	during	adenovirus	infection.		
Secondly,	 it	 is	 also	 plausible	 that	 the	 effects	 on	 the	 cell	 cycle	 observed	 upon	 TAB182	
depletion	are	indirectly	linked	to	a	potential	role	of	TAB182	in	the	DDR.	To	further	examine	
whether	adenovirus	degrades	TAB182	to	promote	viral	infection,	cell	cycle	analysis	could	be	
performed	 following	 infection	 in	 the	 presence	 and	 absence	 of	 TAB182.	 Furthermore,	
quantification	of	E1A	expression	by	quantitative	PCR	in	TAB182	deficient,	infected	cells	will	
confirm	the	elevated	E1A	expression	observed	by	Western	blotting.	Indeed,	depletion	of	the	
DDR	protein	Tip60	also	leads	to	the	same	elevation	in	E1A	expression	following	adenovirus	
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infection,	which	in	this	case,	relieves	the	Tip60	transcriptional	repression	on	the	adenovirus	
E1A	promoter	(Gupta,	Jha	et	al.	2013).		
Adenovirus	 is	 known	 to	 relocalise	 some	 components	 of	 the	 DDR	 to	 VRCs,	 nuclear	
tracks	and	aggresomes,	which,	at	least	in	the	case	of	VRCs,	is	thought	to	inhibit	the	function	
of	 the	 DDR	 proteins	 to	 promote	 viral	 DNA	 replication	 (Stracker,	 Lee	 et	 al.	 2005,	 Carson,	
Orazio	et	al.	2009).	In	this	study,	TAB182	was	not	found	to	localise	to	VRCs.	Further	analysis	
of	 TAB182	 localisation	 to	 nuclear	 tracks	 and	 aggresomes	 will	 establish	 whether	 it	 is	
advantageous	for	adenovirus	to	sequester	TAB182	within	these	structures.		
Components	of	 the	core	CNOT	complex	are	also	down-regulated	during	adenovirus	
infection	 (CNOT3	 and	 CNOT7),	 but	 it	 is	 unknown	 whether	 the	 down-regulation	 of	 these	
proteins	has	any	effect	on	the	efficiency	of	adenovirus	infection.	If	similar	phenotypes	were	
observed	 for	 TAB182	 and	 the	 CNOT	 complex,	 this	 would	 suggest	 that	 adenovirus	 may	
degrade	 these	 proteins	 to	 compromise	 a	 common	 pathway	 in	 order	 to	 promote	 viral	
infection.	However,	 CNOT4	 and	 CNOT6	 depletion	 had	 no	 effect	 on	 E1A	 expression	 during	
adenovirus	infection,	but	at	the	same	time	these	proteins	were	not	shown	to	associate	with	
TAB182	in	the	mass	spectrometry	screen	performed	in	this	study.	Therefore,	further	analysis	
of	the	kinetics	of	adenovirus	infection	following	depletion	of	other	components	of	the	CNOT	
complex	 may	 elucidate	 the	 relationship	 between	 TAB182	 and	 the	 CNOT	 complex	 during	
adenovirus	infection.		
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6.2	THE	POTENTIAL	ROLE	OF	TAB182	IN	THE	DDR	AND	REPLICATION	STRESS	PATHWAYS	
One	of	the	most	striking	phenotypes	observed	in	TAB182	depleted	cells	is	increased	
fork	restart	with	a	concomitant	increase	in	new	origin	firing	following	release	from	HU.	This	
suggests	 that	 TAB182	 prevents	 fork	 restart	 and	 suppresses	 new	 origin	 firing	 following	
release	 from	 replication	 stress	 even	 though	 the	 mechanism	 through	 which	 this	 occurs	 is	
unknown.	 In	 silico	 analysis	 did	 not	 reveal	 any	 predicted	 functional	 domains	 in	 TAB182.	
Therefore,	 the	 question	 arises	 as	 to	 how	 does	 TAB182	 regulate	 fork	 recovery	 and	 origin	
firing	upon	 release	 from	 replication	blocking.	One	possibility	 could	be	 that	 it	 is	 present	 at	
stalled	forks	where	it	associates	with	proteins	involved	in	the	response	to	replication	stress.	
In	 support	of	 this,	TAB182	was	 found	 to	directly	 interact	with	Chk1	 (Figure	4.12),	which	 is	
necessary	 for	 checkpoint	activation	and	suppression	of	new	origin	 firing	during	 replication	
stress	 (Maya-Mendoza,	 Petermann	 et	 al.	 2007,	 Petermann,	 Woodcock	 et	 al.	 2010).	
Furthermore,	TAB182	may	be	associated	with	fork	remodelling	complexes	at	the	fork.	In	this	
respect,	FANCM,	a	helicase	mutated	in	the	Fanconi	anaemia	M	group,	displays	a	very	similar	
phenotype	 to	 TAB182.	 In	 fact,	 amongst	 the	 helicases	 implicated	 in	 the	 regulation	 of	
replication	fork	restart,	such	as	BLM,	WRN,	SMARCAL1	and	FBH1,	it	is	only	FANCM	depletion	
that	 leads	 to	 elevated	 fork	 restart,	 something	we	 also	 observed	 in	 TAB182	 deficient	 cells	
(Schwab,	Blackford	et	al.	2010).	However,	FANCM	deficient	cells	exhibit	an	increase	in	DSB	
formation,	something	that	was	not	observed	in	TAB182	deficient	cells	(Blackford,	Schwab	et	
al.	 2012).	Another	possibility	 is	 that	TAB182	may	be	 required	 for	 fork	 collapse	 in	order	 to	
facilitate	 an	 alternative	 pathway	 of	 replication	 intermediate	 resolution	 at	 sites	 of	 stalled	
replication.	 If	 TAB182	 is	 necessary	 for	 fork	 collapse,	 it	may	 act	 in	 concert	with	 structure-
specific	 endonucleases	 at	 the	 fork.	 Interestingly,	 similarly	 to	 TAB182	 deficient	 cells,	
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depletion	 of	 the	 structure-specific	 endonuclease	 MUS81	 leads	 to	 a	 minor	 increase	 in	
micronuclei	formation	as	well	as	a	reduction	in	gaps	and	breaks	following	replication	stress	
(Ying,	 Minocherhomji	 et	 al.	 2013,	 Pepe	 and	 West	 2014,	 Sarbajna,	 Davies	 et	 al.	 2014).	
Moreover,	MUS81	depleted	cells	show	reduced	DSB	formation	following	replication	stress	as	
measured	 by	 pulse-field	 gel	 electrophoresis	 (PFGE),	 a	 phenotype	 also	 present	 in	 TAB182	
deficient	 cells	 as	 indicated	 by	 the	 reduction	 of	 53BP1	 foci	 positive	 cells	 following	 release	
from	 HU	 (Pepe	 and	 West	 2014).	 Similarly	 to	 TAB182,	 MUS81	 depleted	 cells	 show	 no	
differences	in	fork	speed	both	during	unperturbed	replication	as	well	as	following	replication	
stress,	 but	 display	 elevated	 new	 origin	 firing	 following	 release	 from	HU	 (Fu,	Martin	 et	 al.	
2015).	 However,	 in	 contrast	 to	 TAB182	 deficient	 cells,	 MUS81	 depleted	 cells	 exhibit	 a	
decrease	in	replication	fork	restart	following	release	from	replication	stress	(Naim,	Wilhelm	
et	al.	2013,	Ying,	Minocherhomji	et	al.	2013).	Finally,	the	possibility	cannot	be	excluded	that	
TAB182	down-regulation	may	impact	on	the	expression	levels	of	factors	that	are	important	
for	replication	fork	recovery	and	new	origin	firing,	following	replication	stress.		
DNA	 fibre	 analysis	 revealed	 that	 the	 elevated	 fork	 restart	 observed	 in	 TAB182	
depleted	cells	following	release	from	HU	was	unaffected	by	CDK	or	Chk1	inhibition	but	was	
dependent	on	ATR.	This	suggests	that	1)	excessive	new	origin	firing	does	not	account	for	the	
elevated	fork	restart	 in	TAB182	deficient	cells,	2)	 inhibition	of	Chk1	does	not	suppress	fork	
recovery	or	increase	fork	stalling/collapse	in	TAB182	depleted	cells	but	3)	ATR	is	essential	for	
fork	 stability	 and	 restart	 in	 TAB182	 knockdown	 cells.	 A	 number	 of	 different	 experiments	
described	 below	 will	 allow	 us	 to	 understand	 more	 about	 the	 role	 of	 TAB182	 during	
replication	stress.		
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Firstly,	to	address	the	question	of	whether	TAB182	is	associated	with	the	replication	
fork,	 iPOND	 followed	 by	 mass	 spectrometry	 could	 be	 performed.	 iPOND	 involves	 the	
labelling	 of	 nascent	 DNA	 using	 the	 nucleoside	 analogue	 5-ethynyl-2’-deoxyuridine	 (EdU).	
Biotin	 can	be	conjugated	 to	EdU-labelled	DNA	using	click	 chemistry	and	allows	a	one-step	
purification	 of	 nascent	 DNA-bound	 proteins.	 Using	 this	 technique,	 it	 can	 be	 determined	
whether	 TAB182	 is	 associated	 with	 active,	 stalled	 or	 collapsed	 replication	 forks	 (Sirbu,	
McDonald	et	al.	2013).	Furthermore,	performing	TAB182	immunoprecipitation	experiments	
in	human	cells	before	and	after	replication	stress	would	give	insight	about	the	proteins	that	
TAB182	 associates	 with.	 DNA	 damage	 signalling	 in	 TAB182	 deficient	 cells	 can	 be	 further	
examined	 by	 monitoring	 the	 activation	 of	 additional	 factors	 activated	 upon	 replication	
stress.	 To	 better	 characterise	 the	 phenotypes	 observed	 after	 release	 from	 HU,	 we	 could	
examine	the	ability	of	cells	to	form	Rad51	foci	to	see	whether	homologous	recombination	is	
the	 pathway	 that	 facilitates	 replication	 fork	 restart	 in	 the	 absence	 of	 TAB182.	 To	 confirm	
whether	the	decreased	γH2AX	and	53BP1	foci	observed	in	TAB182	deficient	cells	 following	
release	 from	 HU	 are	 a	 consequence	 of	 fork	 collapse	 into	 DSBs,	 we	 could	 perform	 PFGE	
and/or	comet	assays	to	measure	the	amount	of	DNA	breaks	resulting	from	collapsed	forks.	
Whether	 structure-specific	 endonucleases	 and/or	 helicases	 are	 important	 for	 fork	 restart	
after	HU	 in	TAB182	deficient	cells	 is	also	an	 important	question	that	could	be	 investigated	
through	 the	 use	 of	 DNA	 fibre	 analysis	 in	 TAB182	 and	 helicase/nuclease	 co-depleted	 cells	
following	release	from	replication	stress.			
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6.3	A	POTENTIAL	ROLE	FOR	THE	CNOT	COMPLEX	IN	THE	DDR	AND	REPLICATION	STRESS	
PATHWAYS	
Together	with	a	previous	publication,	mass	spectrometry	performed	in	this	study	has	
confirmed	TAB182	to	interact	with	the	CNOT	complex	(Lau,	Kolkman	et	al.	2009).	Using	fibre	
analysis,	it	was	shown	that	cells	depleted	of	the	E3	ubiquitin	ligase,	CNOT4,	displayed	normal	
replication	 fork	 dynamics,	 but	 cells	 depleted	 of	 the	 CNOT	 deadenylation	 subunit,	 CNOT6,	
exhibited	elevated	new	origin	 firing	 following	 release	 from	replication	stress.	 Interestingly,	
co-depletion	of	CNOT4	and	TAB182	was	able	to	partially	rescue	the	new	origin	firing	defect	
and	completely	restore	the	increased	fork	restart	observed	in	TAB182	depleted	cells	alone	to	
control	levels	following	release	from	replication	stress.	Furthermore,	co-depletion	of	CNOT6	
and	TAB182	showed	that	the	new	origin	firing	defect	observed	in	CNOT6	or	TAB182	deficient	
cells	 alone	 was	 epistatic,	 suggesting	 that	 they	may	 be	 acting	 in	 a	 common	 pathway	 that	
regulates	 new	 origin	 firing.	 However,	 CNOT6	 and	 TAB182	 depletion	 had	 no	 effect	 on	 the	
increased	fork	restart	observed	following	replication	stress	in	TAB182	cells	alone.	This	leads	
to	 the	 question	 as	 to	 whether	 the	 phenotypes	 observed	 in	 TAB182	 deficient	 cells	 is	
dependent	on	the	E3	ubiquitin	ligase	and	deadenylation	activity	of	the	CNOT	complex.	In	our	
hands,	 TAB182	 was	 shown	 to	 have	 associated	 deadenylase	 activity.	 Interestingly,	 the	
sensitivity	 to	 HU	 observed	 in	 TAB182	 and	 CNOT4/6	 deficient	 cells	 was	 shown	 to	 be	
independent	 of	 one	 another,	 perhaps	 suggesting	 that	 the	 sensitivity	 and	 replication	 fork	
dynamics	of	TAB182	deficient	cells	operate	by	 independent	mechanisms.	To	address	these	
questions,	co-depletions	of	TAB182	together	with	CNOT4	or	CNOT6	could	be	performed	to	
see	 whether	 the	 replication	 functions	 of	 TAB182	 are	 linked	 to	 the	 CNOT	 complex.	 For	
example,	 the	 formation	 of	 γH2AX	 and	 53BP1	 foci,	 levels	 of	 53BP1	 bodies	 in	 G1	 and	
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micronuclei	could	be	assessed	following	replication	stress	 in	cells	depleted	of	both	TAB182	
and	 CNOT4/CNOT6.	 It	 may	 also	 be	 important	 to	 study	 other	 components	 of	 the	 CNOT	
complex,	such	as	those	that	were	also	shown	to	be	degraded	following	adenovirus	infection,	
to	determine	which	components	of	the	complex,	together	with	TAB182	are	involved	in	the	
response	to	replication	stress.		
	
The	 identification	 of	 novel	 proteins	 involved	 in	 the	 DDR	 and	 replication	 stress	
pathways	 has	 important	 implications	 for	 the	 understanding	 of	 genomic	 instability,	 a	
hallmark	 of	 cancer	 (Hanahan	 and	 Weinberg	 2011).	 	 Work	 presented	 in	 this	 thesis	 has	
demonstrated	TAB182	to	be	degraded	during	adenovirus	infection,	implicating	a	role	for	this	
protein	 in	 the	 DDR.	 In	 this	 study	we	 show	 TAB182	 prevented	 replication	 fork	 restart	 and	
suppressed	new	origin	firing	following	replication	stress.	Furthermore,	TAB182	deficient	cells	
displayed	markers	of	genome	instability.	To	date,	the	precise	role	of	TAB182	in	the	DDR	and	
replication	stress	pathways	is	currently	unknown.	Further	studies	such	as	those	discussed	in	
this	 chapter,	will	 elucidate	 a	 role	 for	 TAB182,	 either	 alone	 or	 together	 in	 a	 complex	with	
CNOT,	in	these	pathways.		
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